Home The Word Brain My Amedeo FAQ Privacy About   


Hanzi Hunter — ultra-fast Hanzi study

All 1,152 characters from the aioLingua manual

AbstractAboutThe 20 audio files

← aioLingua Chinese Online

← Chinese aioLingua PDF


  Alzheimer's Disease

  Free Subscription


Articles published in J Alzheimers Dis

Retrieve available abstracts of 1489 articles:
HTML format



Single Articles


    November 2025
  1. VON SALZEN D, Senn K, Cho HK, Cahill CM, et al
    PROTEIMERs as catalytic inhibitors of APP mRNA translation: Toward a new therapeutic for Alzheimer's disease.
    J Alzheimers Dis. 2025 Nov 19:13872877251393907. doi: 10.1177/13872877251393907.
    PubMed     Abstract available


  2. WANG K, Zhu Y, Albert M, Miller M, et al
    Modeling the age-specific incidence of mild cognitive impairment incorporating the time-varying relationship of Alzheimer's disease biomarkers over 28 years.
    J Alzheimers Dis. 2025 Nov 19:13872877251393729. doi: 10.1177/13872877251393729.
    PubMed     Abstract available


  3. UCHEAGWU VA, Morgan D, Rose S, Odilora C, et al
    Alzheimer's Disease Biomarker-Nigeria (ADIBIO-N): Cohort description and baseline data report.
    J Alzheimers Dis. 2025 Nov 18:13872877251394384. doi: 10.1177/13872877251394384.
    PubMed     Abstract available


  4. GEORGESCU MF
    Agitation and neuropsychiatric symptoms in Alzheimer's disease: Potential for reverse causal associations.
    J Alzheimers Dis. 2025 Nov 17:13872877251396056. doi: 10.1177/13872877251396056.
    PubMed     Abstract available


  5. BRAMEN JE, Siddarth P, Popa ES, Kress GT, et al
    A multi-modal medical management and lifestyle intervention increase cerebral blood flow and lowers diabetic risk in persons with early Alzheimer's disease: Mid-trial results from the PREVENTION trial.
    J Alzheimers Dis. 2025 Nov 16:13872877251388933. doi: 10.1177/13872877251388933.
    PubMed     Abstract available


  6. BOSIRE EN, Kamau LW, Kiio C, Blackmon K, et al
    Community perceptions and willingness to donate biospecimen for Alzheimer's disease research in Nairobi, Kenya.
    J Alzheimers Dis. 2025 Nov 12:13872877251389227. doi: 10.1177/13872877251389227.
    PubMed     Abstract available


  7. BOUTIN S, Houze B, Pichet Binette A, Brambati SM, et al
    Uncovering pathology, subjective cognitive complaints, and sex in early Alzheimer's disease.
    J Alzheimers Dis. 2025 Nov 11:13872877251393268. doi: 10.1177/13872877251393268.
    PubMed     Abstract available


  8. VRANCEANU AM, Szapary CL, Cornelius T, Monin JK, et al
    Behavioral dyadic interventions in the context of Alzheimer's disease and related dementia: A call to action.
    J Alzheimers Dis. 2025 Nov 10:13872877251392184. doi: 10.1177/13872877251392184.
    PubMed     Abstract available


  9. DUBOIS KN, Pal S, Reader JM, Jackman B, et al
    Evaluation of a panel of plasma biomarkers for Alzheimer's disease in a diverse research cohort.
    J Alzheimers Dis. 2025 Nov 10:13872877251393405. doi: 10.1177/13872877251393405.
    PubMed     Abstract available


  10. HAMDI A, Stathopoulou P, Gharbi A, Saadouli I, et al
    Salivary microbiome dysbiosis in patients with Alzheimer's disease.
    J Alzheimers Dis. 2025 Nov 10:13872877251393229. doi: 10.1177/13872877251393229.
    PubMed     Abstract available


  11. SONG W, Fang M, Geng Z, Pang X, et al
    Mechanistic study of Alzheimer's disease with behavioral and psychological symptoms based on electroencephalography microstates.
    J Alzheimers Dis. 2025 Nov 10:13872877251393715. doi: 10.1177/13872877251393715.
    PubMed     Abstract available


  12. FRANCIA M, Ramesh N, Boltz T, Bot M, et al
    Integrative analysis of cerebrospinal fluid biomarkers, metabolomics, and polygenic risk reveals novel metabolite associations with Alzheimer's disease.
    J Alzheimers Dis. 2025 Nov 7:13872877251389924. doi: 10.1177/13872877251389924.
    PubMed     Abstract available


  13. GARCIA-CHIALVA DE, Itzcovich T, Cifarelli D, Apecetche M, et al
    Clinical and functional evidence supporting the pathogenicity of the novel PSEN1 p.R358P variant in early-onset Alzheimer's disease.
    J Alzheimers Dis. 2025 Nov 6:13872877251392236. doi: 10.1177/13872877251392236.
    PubMed     Abstract available


  14. WANG X, Yang X, Duan M, Duan H, et al
    Mitochondrial energy metabolism and Alzheimer's disease: Identifying key differentially expressed genes in blood.
    J Alzheimers Dis. 2025 Nov 6:13872877251387584. doi: 10.1177/13872877251387584.
    PubMed     Abstract available


  15. SHAW BC, Kaiser KE, Smith BC, Timken JP, et al
    Astrocytes upregulate interleukin-15 in response to neuroinflammation during Alzheimer's disease.
    J Alzheimers Dis. 2025 Nov 5:13872877251393275. doi: 10.1177/13872877251393275.
    PubMed     Abstract available


  16. ZENG Z, Dai M, Jing Y, Zhao K, et al
    Exploring toxicity and mechanisms of DDTs in Alzheimer's disease through network toxicology and molecular docking insights.
    J Alzheimers Dis. 2025 Nov 5:13872877251393503. doi: 10.1177/13872877251393503.
    PubMed     Abstract available


  17. CAO Y, Liu S, He Z, Pan W, et al
    Unfriendly dialogue of gut microbiota and lipid metabolism in Alzheimer's disease.
    J Alzheimers Dis. 2025 Nov 5:13872877251391771. doi: 10.1177/13872877251391771.
    PubMed     Abstract available


  18. WEBSTER H, Zelinsky M, Rico V, Martinez K, et al
    Reconciling recommendations for ethical sharing of biomarker results with Alzheimer's disease research participants: A systematic review and qualitative synthesis.
    J Alzheimers Dis. 2025 Nov 5:13872877251392555. doi: 10.1177/13872877251392555.
    PubMed     Abstract available


  19. FERNANDEZ FX, Grandner MA
    Amyloid-beta as a cytokine-like somnogen: Rethinking its role in sleep homeostasis and Alzheimer's disease.
    J Alzheimers Dis. 2025 Nov 5:13872877251392186. doi: 10.1177/13872877251392186.
    PubMed     Abstract available


  20. ALSHAHERI DURAZO A, McDonough IM
    Midlife brain vulnerability: Sex differences in functional magnetic resonance imaging and Alzheimer's disease risk.
    J Alzheimers Dis. 2025 Nov 5:13872877251392238. doi: 10.1177/13872877251392238.
    PubMed     Abstract available


  21. GU H, Yu K, Zhou J, Chu B, et al
    Perturbations in lipid metabolism mediate the relationship between cholecystectomy and dementia: A mediation Mendelian randomization study.
    J Alzheimers Dis. 2025;108:324-333.
    PubMed     Abstract available


  22. ABBATE C, Gallucci A
    The study of plaques and tangles makes few and inaccurate predictions about the main features of cognitive disorders: A narrative review.
    J Alzheimers Dis. 2025;108:5-18.
    PubMed     Abstract available


  23. XUE D, Blue EE, Wood AC, Rotter JI, et al
    Risk score roulette: A cautionary tale of polygenic risk score reliability.
    J Alzheimers Dis. 2025;108:65-70.
    PubMed     Abstract available


  24. SHINOZAKI M, Hishida H, Gondo Y, Yamamoto M, et al
    Machine learning model for predicting the conversion to dementia using the Cube Copying Test.
    J Alzheimers Dis. 2025;108.
    PubMed     Abstract available


  25. HUANG Y, Li Z, Liu F, Li B, et al
    Application of machine learning in EEG-based dementia diagnosis: Classification and differential diagnosis.
    J Alzheimers Dis. 2025;108.
    PubMed     Abstract available


  26. DUBBELMAN MA, Elias U, Palmer P, Dafni-Merom A, et al
    Investigating the associations between tau and mental orientation among cognitively unimpaired individuals.
    J Alzheimers Dis. 2025;108.
    PubMed     Abstract available


  27. LIBON DJ, Swenson R, Langford DT, Cosentino S, et al
    Precision neurocognition: An emerging diagnostic paradigm leveraging digital cognitive assessment technology.
    J Alzheimers Dis. 2025;108.
    PubMed     Abstract available


  28. SINGH D, Grazia A, Reiz A, Hermann A, et al
    A computational ontology framework for the synthesis of multi-level pathology reports from brain MRI scans.
    J Alzheimers Dis. 2025;108.
    PubMed     Abstract available


  29. SILVA-SPINOLA A, Baldeiras I, Santana I, Arrais JP, et al
    Predicting progression of mild cognitive impairment patients through four distinctive subgroups obtained by unsupervised learning algorithms.
    J Alzheimers Dis. 2025;108.
    PubMed     Abstract available


  30. LAUBER MV, Bellitti M, Kapadia K, Jasodanand VH, et al
    Global amyloid burden enhances network efficiency of tau propagation in the brain.
    J Alzheimers Dis. 2025;108.
    PubMed     Abstract available


  31. CHEN Z, Qi B, Jing B, Dong R, et al
    A multi-modal and multi-stage region of interest-based fusion network convolutional neural network model to differentiate progressive mild cognitive impairment from stable mild cognitive impairment.
    J Alzheimers Dis. 2025;108.
    PubMed     Abstract available


  32. IWAME S, Izu K, Murata Y, Taniguchi M, et al
    Impairment in re-learning of olfactory behaviors in mice expressing intracellular amyloid-beta protein oligomers.
    J Alzheimers Dis. 2025;108:805-823.
    PubMed     Abstract available


  33. MAO R, Zhao S, Chen J, Wang L, et al
    Identification of novel biomarkers for cognitive function via an integrative analysis.
    J Alzheimers Dis. 2025;108:931-947.
    PubMed     Abstract available


  34. BROWN K, Shutes-David A, Wilson K, Shao Y, et al
    Machine learning-based risk scores are associated with conversion to dementia in Veterans.
    J Alzheimers Dis. 2025;108:873-882.
    PubMed     Abstract available


  35. SIMON ZD, McFarland KN, Golde TE, Chakrabarty P, et al
    Sex-dependent effect of amyloidosis on functional network 'hub' topology is associated with downregulated neuronal gene signatures in the APPswe/PSEN1dE9 double transgenic mouse.
    J Alzheimers Dis. 2025;108:893-913.
    PubMed     Abstract available


  36. SAHIN MZ, Yildirim A
    Gonadal hormones and aquaporin-4: Preclinical insights into glymphatic regulation and amyloid clearance.
    J Alzheimers Dis. 2025;108:461-469.
    PubMed     Abstract available


    October 2025
  37. MICHELUTTI M, Cenacchi V, Lombardo T, Palacino F, et al
    Regional gyrification alterations and metabolic correlates in biologically defined Alzheimer's disease using a multimodal approach.
    J Alzheimers Dis. 2025 Oct 29:13872877251390876. doi: 10.1177/13872877251390876.
    PubMed     Abstract available


  38. BANERJEE A, Yang F, Dutta J, Cacciola A, et al
    Atrophy patterns of deep gray matter nuclei in Alzheimer's disease and frontotemporal dementia.
    J Alzheimers Dis. 2025 Oct 29:13872877251390386. doi: 10.1177/13872877251390386.
    PubMed     Abstract available


  39. KIM M, Kwon H, Sohn S, Lee WJ, et al
    Alzheimer's disease diagnosis and treatment: From pathophysiological insights to therapeutic advances in the era of precision neurology (2025 review).
    J Alzheimers Dis. 2025 Oct 29:13872877251391820. doi: 10.1177/13872877251391820.
    PubMed     Abstract available


  40. SINGH S, Kumar U
    Brain region-specific dopamine receptor changes and astrocyte activation influence tau pathology through CDK5 in Alzheimer's disease models.
    J Alzheimers Dis. 2025 Oct 29:13872877251389961. doi: 10.1177/13872877251389961.
    PubMed     Abstract available


  41. CURY RM, da Silva T, Cezar-Dos-Santos F, Fakih YRC, et al
    A randomized clinical trial of low-dose cannabis extract in Alzheimer's disease.
    J Alzheimers Dis. 2025 Oct 29:13872877251389608. doi: 10.1177/13872877251389608.
    PubMed     Abstract available


  42. JIAO Y, Ding Y, Luo N, Niu M, et al
    MicroRNA biomarkers in cerebrospinal fluid and plasma predicting cognitive decline in Alzheimer's disease.
    J Alzheimers Dis. 2025 Oct 29:13872877251390836. doi: 10.1177/13872877251390836.
    PubMed     Abstract available


  43. CHOI YJ, Oh DJ, Han JW, Kim KW, et al
    Development and validation of a weighted Subjective Memory Complaints Questionnaire (SMCQ-R) for early symptomatic Alzheimer's disease detection.
    J Alzheimers Dis. 2025 Oct 28:13872877251390383. doi: 10.1177/13872877251390383.
    PubMed     Abstract available


  44. SONG W, Gong C, Li Y, Yang D, et al
    Alzheimer's disease pathogenesis and the role of APOE epsilon4 in remodeling functional gradients of the default mode network.
    J Alzheimers Dis. 2025 Oct 27:13872877251389965. doi: 10.1177/13872877251389965.
    PubMed     Abstract available


  45. YANG H, You X, Yue C, Yu X, et al
    Uncovering the cytophenotypic and transcriptomic features of natural killer cells derived from peripheral blood of patients with Alzheimer's disease.
    J Alzheimers Dis. 2025 Oct 27:13872877251390553. doi: 10.1177/13872877251390553.
    PubMed     Abstract available


  46. SAAK TM, Tervo JP, Motter JN, Overdevest JB, et al
    Expanding the scope of olfactory evaluation in Alzheimer's disease and related dementias (ADRD): A narrative review of the role for odor memory and recognition in AD/ADRD.
    J Alzheimers Dis. 2025 Oct 27:13872877251389113. doi: 10.1177/13872877251389113.
    PubMed     Abstract available


  47. ZHANG Y, Dong X, Yang Y, Wang X, et al
    Caregiving burden, disease-related knowledge, and quality of life among primary caregivers in Alzheimer's disease: A cross-sectional study.
    J Alzheimers Dis. 2025 Oct 24:13872877251390494. doi: 10.1177/13872877251390494.
    PubMed     Abstract available


  48. JIN H, He J, Zhang W, Wang Y, et al
    The association between Alzheimer-associated neuronal thread protein (AD7c-NTP) and plasma inflammatory cytokine levels in individuals with cognitive impairment and demographically-matched controls.
    J Alzheimers Dis. 2025 Oct 24:13872877251389239. doi: 10.1177/13872877251389239.
    PubMed     Abstract available


  49. MULLINS CA, Gannaban RB, Kramer A, Shah H, et al
    Early branched-chain amino acid reduction delays the onset of cognitive decline in a mouse model of Alzheimer's disease.
    J Alzheimers Dis. 2025 Oct 24:13872877251389236. doi: 10.1177/13872877251389236.
    PubMed     Abstract available


  50. KETATA I, Ellouz E
    Artificial intelligence-driven eye tracker models for Alzheimer's disease diagnosis: A systematic review and meta-analysis.
    J Alzheimers Dis. 2025 Oct 24:13872877251389145. doi: 10.1177/13872877251389145.
    PubMed     Abstract available


  51. KHALSA DS, Lavretsky H, Reddy MY, Fenn A, et al
    Air pollution and Alzheimer's disease prevention: The science and a prevention plan.
    J Alzheimers Dis. 2025 Oct 24:13872877251386482. doi: 10.1177/13872877251386482.
    PubMed     Abstract available


  52. BEN ZAKEN K, Mesfin S, Bloch N, Samson AO, et al
    Virtual screening of drugs against multiple targets of Alzheimer's disease.
    J Alzheimers Dis. 2025 Oct 23:13872877251387167. doi: 10.1177/13872877251387167.
    PubMed     Abstract available


  53. DRZYMALLA E, Avery C, Palta P, Reiner AP, et al
    Association between neutrophil to lymphocyte ratio and Alzheimer's disease in large biobank cohorts.
    J Alzheimers Dis. 2025 Oct 23:13872877251386813. doi: 10.1177/13872877251386813.
    PubMed     Abstract available


  54. WANG XY, Jia YJ, Zhang J, Chen JF, et al
    Therapeutic potential of 40 Hz flickering light stimulation in Alzheimer's disease: Mechanisms, evidence, and controversies.
    J Alzheimers Dis. 2025 Oct 22:13872877251388664. doi: 10.1177/13872877251388664.
    PubMed     Abstract available


  55. LEE J, Kim YJ, Kim W, Cho S, et al
    Cumulative burden of lifestyle risk factors on Alzheimer's disease in older Korean adults: A nationwide retrospective cohort study.
    J Alzheimers Dis. 2025 Oct 22:13872877251386889. doi: 10.1177/13872877251386889.
    PubMed     Abstract available


  56. LI C, Feng L, Li M, Dai C, et al
    Research progress on the regulation of Nrf2/HO-1 signaling pathway by traditional Chinese medicine in the treatment of Alzheimer's disease.
    J Alzheimers Dis. 2025 Oct 22:13872877251389011. doi: 10.1177/13872877251389011.
    PubMed     Abstract available


  57. SOSA PEREZ S, Urrutia Amable N, Viada Gonzalez CE, Lorenzo-Luaces P, et al
    NeuroEPO plus (NeuralCIM((R))) in Alzheimer's disease: Post-trial observational follow-up study.
    J Alzheimers Dis. 2025 Oct 22:13872877251386885. doi: 10.1177/13872877251386885.
    PubMed     Abstract available


  58. AVENEAU C, Lamy E, Grassin-Delyle S, Sanchez-Ortiz M, et al
    Cerebrospinal fluid acetylcholine is not a reliable diagnostic marker for Alzheimer's disease and dementia with Lewy bodies.
    J Alzheimers Dis. 2025 Oct 22:13872877251387159. doi: 10.1177/13872877251387159.
    PubMed     Abstract available


  59. MUNOZ-MUSAT E, Le Prince G, Delmaire C, Paquet C, et al
    Cerebellar atrophy in biologically confirmed Alzheimer's disease: Associations with amyloidopathy measured by cerebrospinal fluid biomarkers.
    J Alzheimers Dis. 2025 Oct 17:13872877251386085. doi: 10.1177/13872877251386085.
    PubMed     Abstract available


  60. GABRIEL V, Chabran E, Sourty M, Cretin B, et al
    Salience and frontoparietal network impairments across disease stages in dementia with Lewy bodies: A comparative functional MRI study with Alzheimer's disease.
    J Alzheimers Dis. 2025 Oct 17:13872877251386844. doi: 10.1177/13872877251386844.
    PubMed     Abstract available


  61. PEREZ-NAVARRO LM, Lopez-Alvarenga JC
    A molecular renaissance in Alzheimer's disease research: The rise of systems biology and spatial omics.
    J Alzheimers Dis. 2025 Oct 17:13872877251387169. doi: 10.1177/13872877251387169.
    PubMed     Abstract available


  62. BI X, Xiao X, Zhou L, Liu Q, et al
    Exploring multitarget molecular mechanisms of cannabidiol in Alzheimer's disease treatment using molecular simulations and modeling.
    J Alzheimers Dis. 2025 Oct 17:13872877251386440. doi: 10.1177/13872877251386440.
    PubMed     Abstract available


  63. YE H, Zhuang C, Jin Z, Hu Y, et al
    VEGFB is a potential therapeutic target for Alzheimer's disease: Insights from integrative multi-omics analysis.
    J Alzheimers Dis. 2025 Oct 17:13872877251385244. doi: 10.1177/13872877251385244.
    PubMed     Abstract available


  64. RUBENSTEIN E, Tewolde S, Michals A, Fortea J, et al
    Novel predictors of Alzheimer's disease in Down syndrome identified using machine learning.
    J Alzheimers Dis. 2025 Oct 17:13872877251385423. doi: 10.1177/13872877251385423.
    PubMed     Abstract available


  65. CHAITHRA PM, Rakshith BS, Logesh S, Kanthesh BM, et al
    Nutraceuticals intervention in Alzheimer's disease: From farm to pharma.
    J Alzheimers Dis. 2025 Oct 17:13872877251385216. doi: 10.1177/13872877251385216.
    PubMed     Abstract available


  66. ZOU M, Yu H, Zhou R, Lu Y, et al
    Association between dental floss use, dental visits, and a five-year Alzheimer's disease risk prediction score among United States adults aged 65 years and older.
    J Alzheimers Dis. 2025 Oct 16:13872877251386836. doi: 10.1177/13872877251386836.
    PubMed     Abstract available


  67. AIELLO EN, Gendarini C, Cocuzza A, Romandini A, et al
    Semantic and phonemic advantages in Alzheimer's disease and behavioral variant-frontotemporal dementia: Insights from the Fluency Type Index.
    J Alzheimers Dis. 2025 Oct 16:13872877251386438. doi: 10.1177/13872877251386438.
    PubMed     Abstract available


  68. ARRIOLA-INFANTE JE, Garcia-Roldan E, Garcia-Solis D, Lojo-Ramirez JA, et al
    Alternative TMA-93 version demonstrates comparable performance and discriminative accuracy in early Alzheimer's disease.
    J Alzheimers Dis. 2025 Oct 16:13872877251386479. doi: 10.1177/13872877251386479.
    PubMed     Abstract available


  69. BESSER LM, Baig M, Henriquez AM, Tolea M, et al
    Sociodemographic correlates of cognition and Alzheimer's disease and vascular biomarkers among middle to older age participants in the Healthy Brain Initiative.
    J Alzheimers Dis. 2025 Oct 15:13872877251386378. doi: 10.1177/13872877251386378.
    PubMed     Abstract available


  70. KELSEY PT, Selbaek G, Lovheim H, Asvold BO, et al
    Helicobacter pylori and Alzheimer's disease risk: The HUNT study.
    J Alzheimers Dis. 2025 Oct 15:13872877251386015. doi: 10.1177/13872877251386015.
    PubMed     Abstract available


  71. ZHAO M, Yang J, Cheng H, Fan Y, et al
    Altered brain morphometry and its association with cognitive decline and APOE gene in normal people at risk for Alzheimer's disease.
    J Alzheimers Dis. 2025 Oct 10:13872877251384967. doi: 10.1177/13872877251384967.
    PubMed     Abstract available


  72. KENNEMER AA, Gao Z, Davis PB, Kaelber DC, et al
    Timing of neurorehabilitation and subsequent Alzheimer's disease risk in patients with moderate to severe traumatic brain injury: A nationwide retrospective cohort study in the United States.
    J Alzheimers Dis. 2025 Oct 9:13872877251385262. doi: 10.1177/13872877251385262.
    PubMed     Abstract available


  73. HANSON M, Liu Y, Ozawa T, Yin H, et al
    Potential barriers to timely Alzheimer's disease diagnosis and treatment: Tracer delivery and patient travel to amyloid PET scanners in the United States.
    J Alzheimers Dis. 2025 Oct 9:13872877251385118. doi: 10.1177/13872877251385118.
    PubMed     Abstract available


  74. WEISS S, Harris K, Carney OL, Maza VI, et al
    Initial development of the writing to heal app: A structured writing series for caregivers of spouses living with Alzheimer's disease and related dementias.
    J Alzheimers Dis. 2025 Oct 9:13872877251378478. doi: 10.1177/13872877251378478.
    PubMed     Abstract available


  75. TEIPEL S, Singh D, Dubbelman MA, Pan G, et al
    Early detection of Alzheimer's disease: From multiplex assays and imaging to point of care devices and AI-based functional monitoring.
    J Alzheimers Dis. 2025 Oct 7:13872877251383339. doi: 10.1177/13872877251383339.
    PubMed     Abstract available


  76. LYU J, Zhang W, De J, Shan B, et al
    The impact of music-based intervention on cognitive function and brain functional magnetic resonance imaging in people with mild Alzheimer's disease.
    J Alzheimers Dis. 2025 Oct 3:13872877251379419. doi: 10.1177/13872877251379419.
    PubMed     Abstract available


  77. BOONGIRD C, Anothaisintawee T, Tearneukit W, Wongpipathpong W, et al
    Bridging the gap: Efficacy of combined therapies for cognitive, behavioral, and functional outcomes in Alzheimer's disease - results from a systematic review and network meta-analysis.
    J Alzheimers Dis. 2025 Oct 3:13872877251378354. doi: 10.1177/13872877251378354.
    PubMed     Abstract available


  78. CHEN C, Babulal GM
    Longitudinal associations between plasma biomarkers and changes in naturalistic driving behaviors in older adults.
    J Alzheimers Dis. 2025;107:1275-1284.
    PubMed     Abstract available


  79. AGBOJI A
    Navigating life after diagnosis: Insights from people with early-stage dementia.
    J Alzheimers Dis. 2025;107:997-998.
    PubMed     Abstract available


  80. DUCHESNE S, Potvin O, Hudon C, Bocti C, et al
    A brain health framework with application to the study of neurodegeneration.
    J Alzheimers Dis. 2025;107:960-972.
    PubMed     Abstract available


  81. THO CHU TQ, Morimoto K, Kowa H
    Cognitive performance and blood biomarkers: Insights into their relationship and predicting high Amyloid Probability Score in cognitively impaired older adults.
    J Alzheimers Dis. 2025;107:1661-1673.
    PubMed     Abstract available


  82. HALE MR, Langhough R, Basche KE, Betthauser TJ, et al
    Linking silent pause locations in speech to amyloid and tau deposition in cognitively unimpaired individuals.
    J Alzheimers Dis. 2025;107:1481-1497.
    PubMed     Abstract available


  83. SAIDO TC, Iwata N
    The tale of donanemab: God is in the details.
    J Alzheimers Dis. 2025;107:1364-1373.
    PubMed     Abstract available


  84. SPEH A, Boada M, Jessen F, Visser PJ, et al
    Cardiovascular health and cognition in older adults: Variations across recruitment models and European countries in the MOPEAD project.
    J Alzheimers Dis. 2025;107:1530-1538.
    PubMed     Abstract available


  85. WALTERS ME, Small BJ, Andel R, Lerch O, et al
    Differential MRI atrophy profiles and incident dementia: A cross-national comparison.
    J Alzheimers Dis. 2025;107:1539-1554.
    PubMed     Abstract available


  86. JUNG J, Ko H, Kim H, Lee H, et al
    Exposure to ambient carbon monoxide and cognitive decrease in a memory clinic.
    J Alzheimers Dis. 2025;107:1637-1644.
    PubMed     Abstract available


  87. BOCCALINI C, Garibotto V
    Is early-phase amyloid PET ready for use as neurodegeneration marker?
    J Alzheimers Dis. 2025;107:1411-1414.
    PubMed     Abstract available


  88. SALEMME S, Chiari A, Zamboni G, Tondelli M, et al
    Deciphering the A-T+ enigma: Clinical relevance or diagnostic noise?
    J Alzheimers Dis. 2025;107:1404-1405.
    PubMed     Abstract available


    September 2025
  89. TANAKA E, Nihashi T, Kato T, Arahata Y, et al
    Modulation of middle-latency somatosensory evoked magnetic field waveforms associated with the pathophysiological states of Alzheimer's disease.
    J Alzheimers Dis. 2025 Sep 26:13872877251379466. doi: 10.1177/13872877251379466.
    PubMed     Abstract available


  90. HOU H, Yu J, Hao S, Zhang X, et al
    Electroencephalography microstates as biomarkers for screening Alzheimer's disease: Feasibility analysis and a machine learning classification scheme.
    J Alzheimers Dis. 2025 Sep 26:13872877251379072. doi: 10.1177/13872877251379072.
    PubMed     Abstract available


  91. MUKESHA D, Sarter M, Dubray M, Durand F, et al
    Targeted serum metabolomic profiling and machine learning approach in Alzheimer's disease using the Alzheimer's disease diagnostics clinical study (ADDIA) cohort.
    J Alzheimers Dis. 2025 Sep 26:13872877251378653. doi: 10.1177/13872877251378653.
    PubMed     Abstract available


  92. ROJAS-ALVAREZ A, Chung H, Cabrero Castro JE, Umucu E, et al
    Profile and disparities in health outcomes for older adults with dual diagnoses of diabetes and Alzheimer's disease.
    J Alzheimers Dis. 2025 Sep 25:13872877251380260. doi: 10.1177/13872877251380260.
    PubMed     Abstract available


  93. RICO V, Zelinsky M, Ford PJ, Leverenz J, et al
    Recommended approaches to sharing individual research results in Alzheimer's disease research: A multidisciplinary expert Delphi consensus.
    J Alzheimers Dis. 2025 Sep 25:13872877251379076. doi: 10.1177/13872877251379076.
    PubMed     Abstract available


  94. FAIZAN ALI M, Ahmad H, Fawzi Hemida M, Faizan Tahir M, et al
    Aging, Alzheimer's disease, and stroke: A 25-year longitudinal analysis of U.S. mortality trends.
    J Alzheimers Dis. 2025 Sep 24:13872877251380689. doi: 10.1177/13872877251380689.
    PubMed     Abstract available


  95. NASERRAMEZANI Z, Palizvan MR, Ganji A, Ghazavi A, et al
    Synergistic neuroprotection of chitosan-cannabidiol nanoparticles in a rat model of Alzheimer's disease: Amelioration of cognitive deficits and neuroinflammation.
    J Alzheimers Dis. 2025 Sep 24:13872877251379420. doi: 10.1177/13872877251379420.
    PubMed     Abstract available


  96. QI T, Feng Y, Kononenko N, Ising C, et al
    Axonal degeneration and retinal neurovascular dysfunction in the TgF344-AD rat model of Alzheimer's disease.
    J Alzheimers Dis. 2025 Sep 23:13872877251379844. doi: 10.1177/13872877251379844.
    PubMed     Abstract available


  97. BOROJE I, Sanchez-Solino O, Yue EX, Vinikoor-Imler L, et al
    Medication prescriptions among patients with mild cognitive impairment and Alzheimer's disease: A large nationwide electronic health record cohort study.
    J Alzheimers Dis. 2025 Sep 22:13872877251376032. doi: 10.1177/13872877251376032.
    PubMed     Abstract available


  98. YAN Y, Pan Y, Lu S, Kou J, et al
    Gut microbiota-mediated targeting of EHMT2 in individuals of European ancestry: A novel therapeutic approach for Alzheimer's disease.
    J Alzheimers Dis. 2025 Sep 22:13872877251372945. doi: 10.1177/13872877251372945.
    PubMed     Abstract available


  99. LI J, Yi Y, Gao X, Ren Y, et al
    High brain network dynamics mediate audiovisual integration deficits and cognitive impairment in Alzheimer's disease.
    J Alzheimers Dis. 2025 Sep 22:13872877251376717. doi: 10.1177/13872877251376717.
    PubMed     Abstract available


  100. SUBRAMANIAN ML, Sampani K, Ness S, Tuz-Zahra F, et al
    Biomarkers for Alzheimer's disease are upregulated in patients with diabetic retinopathy.
    J Alzheimers Dis. 2025 Sep 22:13872877251378759. doi: 10.1177/13872877251378759.
    PubMed     Abstract available


  101. ONUH VC
    Advancing Alzheimer's disease treatment: A literature review on senolytic intervention.
    J Alzheimers Dis. 2025 Sep 22:13872877251376540. doi: 10.1177/13872877251376540.
    PubMed     Abstract available


  102. GITLIN-LEIGH G, Wilson J, Howard R, Howard R, et al
    Effects of monoclonal antibody therapies on depression in Parkinson's disease and Alzheimer's disease: Systematic review and meta-analysis.
    J Alzheimers Dis. 2025 Sep 19:13872877251378156. doi: 10.1177/13872877251378156.
    PubMed     Abstract available


  103. SU X, Chen H, Cao J, Zhang Y, et al
    The effect of deprivation of whisker stimulation on cognition and synaptic plasticity in male and female Alzheimer's disease mice.
    J Alzheimers Dis. 2025 Sep 19:13872877251379079. doi: 10.1177/13872877251379079.
    PubMed     Abstract available


  104. DONG M, Qian Y, Geng Y, Wang R, et al
    HIF-1alpha-induced microglia-mediated neuroinflammation is involved in Alzheimer's disease: Evidence from single-cell transcriptomic analysis.
    J Alzheimers Dis. 2025 Sep 19:13872877251378007. doi: 10.1177/13872877251378007.
    PubMed     Abstract available


  105. WANG W, Liu H, Chen Y, Xiong Z, et al
    Identifying differential brain structures and genetic mechanisms between Alzheimer's disease and idiopathic normal pressure hydrocephalus.
    J Alzheimers Dis. 2025 Sep 17:13872877251379046. doi: 10.1177/13872877251379046.
    PubMed     Abstract available


  106. MAO C, Zou Y, Wang T, Sha L, et al
    Comparison of diagnostic accuracy of Alzheimer's disease cerebrospinal fluid core biomarkers using INNOTEST, Lumipulse G, and Elecsys assays: Insights from the PUMCH dementia cohort study.
    J Alzheimers Dis. 2025 Sep 17:13872877251379084. doi: 10.1177/13872877251379084.
    PubMed     Abstract available


  107. DENG T, Duan J, Yu W, Deng Z, et al
    Education as a domain-specific moderator: Shaping the impact of cerebral structural changes on clinical manifestations in Alzheimer's disease.
    J Alzheimers Dis. 2025 Sep 17:13872877251379078. doi: 10.1177/13872877251379078.
    PubMed     Abstract available


  108. LIU Y, Chen Y, Chen Z, Wan H, et al
    Tau seeding activity in Alzheimer's disease: Characteristics, factors, and applications.
    J Alzheimers Dis. 2025 Sep 17:13872877251378772. doi: 10.1177/13872877251378772.
    PubMed     Abstract available


  109. KITAYAMA Y, Nakano Y, Hirano S, Hanayama S, et al
    Multimodal neuroimaging related to cerebrospinal fluid biomarkers and cognitive function in Alzheimer's disease.
    J Alzheimers Dis. 2025 Sep 17:13872877251376601. doi: 10.1177/13872877251376601.
    PubMed     Abstract available


  110. LEE J, Kim CW, Kim Y, Lee S, et al
    Environmental noise exposure and a new biomarker of Alzheimer's disease: A pilot study.
    J Alzheimers Dis. 2025 Sep 16:13872877251376920. doi: 10.1177/13872877251376920.
    PubMed     Abstract available


  111. SHAKER A, Ljunggren G, Vossen LE, Religa D, et al
    Impact of socio-economic and patient-centered characteristics on access to Alzheimer's disease medication in primary care: A population-based study in the Stockholm county, Sweden.
    J Alzheimers Dis. 2025 Sep 16:13872877251375900. doi: 10.1177/13872877251375900.
    PubMed     Abstract available


  112. HAALAND B, Dickson SP, Santana AF, Tanzi RE, et al
    Efficacy of AD04, an aluminum-based vaccine adjuvant, in patients with early Alzheimer's disease: Post hoc analysis of AFF006 (NCT01117818), a proof-of-concept, phase 2 randomized controlled trial.
    J Alzheimers Dis. 2025 Sep 15:13872877251375985. doi: 10.1177/13872877251375985.
    PubMed     Abstract available


  113. LI H, Wu Y, Huang T, Sun Y, et al
    Development of a risk prediction model for Alzheimer's disease based on the UK Biobank prospective study.
    J Alzheimers Dis. 2025 Sep 15:13872877251375473. doi: 10.1177/13872877251375473.
    PubMed     Abstract available


  114. CARDOSO S, Montalvo A, Maroco J, Silva D, et al
    Long-term predictive accuracy of the 'mild cognitive impairment due to Alzheimer's disease' criteria.
    J Alzheimers Dis. 2025 Sep 15:13872877251375927. doi: 10.1177/13872877251375927.
    PubMed     Abstract available


  115. CHEN H, Guo Y, Zhang Z, Huang W, et al
    Neurovascular coupling dysfunction associated with cognition and glial fibrillary acidic protein along the Alzheimer's disease continuum.
    J Alzheimers Dis. 2025 Sep 12:13872877251375476. doi: 10.1177/13872877251375476.
    PubMed     Abstract available


  116. XU J, Sun A, Yang Y, Shi Y, et al
    Real-world observations on neuroinflammation-related drug responses in Alzheimer's disease.
    J Alzheimers Dis. 2025 Sep 12:13872877251376291. doi: 10.1177/13872877251376291.
    PubMed     Abstract available


  117. KAKKAR A, Singh H, Singh BK, Kumar A, et al
    Neuroinflammation and Alzheimer's disease: Unravelling the molecular mechanisms.
    J Alzheimers Dis. 2025 Sep 12:13872877251374353. doi: 10.1177/13872877251374353.
    PubMed     Abstract available


  118. FAKOREDE S, Sodiq TA, Ajagbe AO, Adeleke AJ, et al
    Interplay of Glut1 alteration and Alzheimer's disease: A narrative review on glucose transport and energy metabolism.
    J Alzheimers Dis. 2025 Sep 12:13872877251377793. doi: 10.1177/13872877251377793.
    PubMed     Abstract available


  119. ZHOU Y, Su T, Yuan M, Li WL, et al
    A new lens on Alzheimer's disease: Insights into the Edinger-Westphal nucleus and its circuits.
    J Alzheimers Dis. 2025 Sep 11:13872877251372587. doi: 10.1177/13872877251372587.
    PubMed     Abstract available


  120. CHATTERJEE P, Ivanic S, Southon A, McCarthy C, et al
    Real world diagnostic performance of plasma p-tau217 for early-onset Alzheimer's disease in a cognitive disorders tertiary care setting.
    J Alzheimers Dis. 2025 Sep 11:13872877251376694. doi: 10.1177/13872877251376694.
    PubMed     Abstract available


  121. MOTOLESE F, Norata D, Iaccarino G, Sapio E, et al
    Predicting cognitive decline in Alzheimer's disease: A real-life proof-of-principle study on multimodal assessment.
    J Alzheimers Dis. 2025 Sep 10:13872877251376676. doi: 10.1177/13872877251376676.
    PubMed     Abstract available


  122. TARAGANO F, Seinhart D, Epstein P, Sylvestre V, et al
    A real-world study on the safety and efficacy of therapeutic plasma exchange in patients with Alzheimer's disease.
    J Alzheimers Dis. 2025 Sep 10:13872877251375430. doi: 10.1177/13872877251375430.
    PubMed     Abstract available


  123. SCHAFFNER E, Sandoz M, Chatton P, Iglesias K, et al
    Tense production in French-speaking participants with Alzheimer's disease: What about discourse? Contribution of a storytelling-in-sequence task.
    J Alzheimers Dis. 2025 Sep 9:13872877251376028. doi: 10.1177/13872877251376028.
    PubMed     Abstract available


  124. ARSLAN B, Zetterberg H, Ashton NJ
    Integrating kidney function assessment into the clinical interpretation of plasma Alzheimer's disease biomarkers.
    J Alzheimers Dis. 2025 Sep 9:13872877251375101. doi: 10.1177/13872877251375101.
    PubMed     Abstract available


  125. KATSUMI Y
    Alterations of the brain functional organization in young-onset Alzheimer's disease: Is it a matter of "time"?
    J Alzheimers Dis. 2025 Sep 9:13872877251375094. doi: 10.1177/13872877251375094.
    PubMed     Abstract available


  126. HAYES CA, Odden MC, Thorpe RJ Jr
    Application of modified Poisson regression for risk estimation of major neuropathology outcomes: National Alzheimer's coordinating center.
    J Alzheimers Dis. 2025 Sep 9:13872877251375099. doi: 10.1177/13872877251375099.
    PubMed     Abstract available


  127. WANG L, Zuo X, Xu M, Hu Q, et al
    Interaction between gut microbiota and Alzheimer's disease: Re-analysis of the same sample.
    J Alzheimers Dis. 2025 Sep 4:13872877251367359. doi: 10.1177/13872877251367359.
    PubMed     Abstract available


  128. LIU G, Sun Y
    Harnessing nanoparticles for Alzheimer's disease: Innovations in drug delivery and pathology-specific treatments.
    J Alzheimers Dis. 2025 Sep 3:13872877251374149. doi: 10.1177/13872877251374149.
    PubMed     Abstract available


  129. ZHU Y, Chen Q, Chen F, Lu J, et al
    Functional connectivity signatures of olfactory networks linked to cognitive risk: A functional MRI study in subjective cognitive decline at risk for Alzheimer's disease.
    J Alzheimers Dis. 2025 Sep 3:13872877251373017. doi: 10.1177/13872877251373017.
    PubMed     Abstract available


  130. JIANG X, Liu Y, Lu Q, Liu J, et al
    Identification of exosome-related genes in Alzheimer's disease: Evidence from transcriptomic and Mendelian randomization analyses.
    J Alzheimers Dis. 2025 Sep 3:13872877251372065. doi: 10.1177/13872877251372065.
    PubMed     Abstract available


  131. STREIBER AM, Neitzel J, Yaqub A, Vernooij MW, et al
    Arteriosclerosis in the heart-brain axis and Alzheimer's disease plasma markers in the Rotterdam Study.
    J Alzheimers Dis. 2025 Sep 3:13872877251372641. doi: 10.1177/13872877251372641.
    PubMed     Abstract available


  132. SU FJ, Li YC, Shi XC, Yi C, et al
    Visual Cognitive Assessment Test correlates with brain amyloid status in Alzheimer's disease-related mild cognitive impairment.
    J Alzheimers Dis. 2025 Sep 1:13872877251371718. doi: 10.1177/13872877251371718.
    PubMed     Abstract available


  133. KRAMER M, Alekseyenko AV, Mollalo A
    The role of built and social environments in Alzheimer's disease dementia prevalence in the United States: A machine learning approach.
    J Alzheimers Dis. 2025 Sep 1:13872877251372144. doi: 10.1177/13872877251372144.
    PubMed     Abstract available


  134. TANG Q, Zhang X, Zhang C, Lang Q, et al
    Optimized sequential classification models for mild cognitive impairment screening based on handwriting and speech data.
    J Alzheimers Dis. 2025;107:112-127.
    PubMed     Abstract available


  135. STROPE TA, Troutwine B, Hauger BM, Smith KP, et al
    Amyloid-beta protein precursor modulates mitophagy and mitochondrial function through its cellular localization.
    J Alzheimers Dis. 2025;107:277-293.
    PubMed     Abstract available


  136. MOSER VA
    The gap between amyloid pathology and cognition.
    J Alzheimers Dis. 2025;107:46-48.
    PubMed     Abstract available


  137. JIANG D, Yue A, Nan H, Hou J, et al
    Plasma glial fibrillary acidic protein and neurological diseases: A bidirectional Mendelian randomization study.
    J Alzheimers Dis. 2025;107:806-818.
    PubMed     Abstract available


  138. ZHANG J, Wang C, Chang K, Peng T, et al
    A novel traditional Chinese medicine formula restores sleep and cognitive function in APP/PS1 mice by targeting glycolytic pathways and neuroinflammatory responses.
    J Alzheimers Dis. 2025;107:617-627.
    PubMed     Abstract available


    August 2025
  139. CHEN J, Lin B, Seow E, Kim S, et al
    Prediction of infusion capacity to deliver Alzheimer's disease treatments in the United States relative to expected demand.
    J Alzheimers Dis. 2025 Aug 29:13872877251372129. doi: 10.1177/13872877251372129.
    PubMed     Abstract available


  140. LIN H, Huang Z, Lu J, Wang J, et al
    The asymmetry of tau deposition and its correlation with cerebral metabolic asymmetry in Alzheimer's disease.
    J Alzheimers Dis. 2025 Aug 29:13872877251372523. doi: 10.1177/13872877251372523.
    PubMed     Abstract available


  141. CHEN Y, Dong C, Chen J, Li Q, et al
    Clinical observations on treating Alzheimer's disease with umbilical cord blood mononuclear cells.
    J Alzheimers Dis. 2025 Aug 28:13872877251366669. doi: 10.1177/13872877251366669.
    PubMed     Abstract available


  142. JIANG C, Qi J, Zou H, Lopez O, et al
    Impact of antidiabetic therapy on cognitive function in patients with type 2 diabetes and Alzheimer's disease: A comprehensive analysis.
    J Alzheimers Dis. 2025 Aug 25:13872877251365662. doi: 10.1177/13872877251365662.
    PubMed     Abstract available


  143. SAMPATH R, Baskar M
    Biomarker extraction-based Alzheimer's disease stage detection using optimized deep learning approach.
    J Alzheimers Dis. 2025 Aug 19:13872877251360394. doi: 10.1177/13872877251360394.
    PubMed     Abstract available


  144. GIM J
    Revisiting APOE: Insights from rare variants and the expanding landscape of Alzheimer's disease genetics.
    J Alzheimers Dis. 2025 Aug 17:13872877251366662. doi: 10.1177/13872877251366662.
    PubMed     Abstract available


  145. KONISHI K, Spets DS, Fisher P, Aroner S, et al
    Sex differences in the impact of genetic and clinical risk factors for Alzheimer's disease in midlife.
    J Alzheimers Dis. 2025 Aug 17:13872877251366701. doi: 10.1177/13872877251366701.
    PubMed     Abstract available


  146. GHOSH D, Pal S, Lutz M, Luo S, et al
    Ensemble survival analysis for preclinical cognitive decline prediction in Alzheimer's disease using longitudinal biomarkers.
    J Alzheimers Dis. 2025 Aug 14:13872877251365621. doi: 10.1177/13872877251365621.
    PubMed     Abstract available


  147. SHELTON M, Kerns KA, Shirali S, Castora FJ, et al
    Integrating mitochondrial gene expression data to model the effects of respirasome supercomplex formation on reactive oxygen species production in Alzheimer's disease models.
    J Alzheimers Dis. 2025 Aug 13:13872877251362889. doi: 10.1177/13872877251362889.
    PubMed     Abstract available


  148. JIANG F, Wang N, Meng Q
    From APOE to cellular changes: Unraveling the multidimensional mechanisms of blood-brain barrier damage in Alzheimer's disease.
    J Alzheimers Dis. 2025 Aug 13:13872877251360321. doi: 10.1177/13872877251360321.
    PubMed     Abstract available


  149. PFLANZER H, Kerns KA, Knoble J, Gershon BS, et al
    Mitochondrial energy production genes affecting reactive oxygen species and ATP synthesis, inflammatory pathways, and neuron viability are differentially expressed in brains of Alzheimer's disease patients.
    J Alzheimers Dis. 2025 Aug 13:13872877251362884. doi: 10.1177/13872877251362884.
    PubMed     Abstract available


  150. ZHANG X, Sun Z, Wu D, Shi X, et al
    Effects of cerebellar intermittent theta-burst stimulation on patients with Alzheimer's disease: A randomized controlled trial.
    J Alzheimers Dis. 2025 Aug 13:13872877251366656. doi: 10.1177/13872877251366656.
    PubMed     Abstract available


  151. XIE F, Ye Y, Hao J, Liu H, et al
    Surgical advances in the treatment of Alzheimer's disease: A comprehensive review.
    J Alzheimers Dis. 2025 Aug 13:13872877251364397. doi: 10.1177/13872877251364397.
    PubMed     Abstract available


  152. MERVOSH N, Bilici N, Wisniewski T, Devi G, et al
    Reducing ARIA risk in Alzheimer's disease: Real-world impact of APOE genotype-guided slow titration with aducanumab and lecanemab.
    J Alzheimers Dis. 2025 Aug 13:13872877251366657. doi: 10.1177/13872877251366657.
    PubMed     Abstract available


  153. MOTAGHI M, Potvin O, Duchesne S
    Commonalities in cortical neurodegeneration between type 2 diabetes and Alzheimer's disease.
    J Alzheimers Dis. 2025 Aug 10:13872877251365671. doi: 10.1177/13872877251365671.
    PubMed     Abstract available


  154. QI J, He M, Lian T, Wang S, et al
    Correlations of retinal morphology with clinical symptoms, blood-brain barrier, and brain structure in patients with Alzheimer's disease.
    J Alzheimers Dis. 2025 Aug 8:13872877251364736. doi: 10.1177/13872877251364736.
    PubMed     Abstract available


  155. CABAN M, Tran E, Meng A, Wetmore JB, et al
    Planning for the future following receipt of Alzheimer's disease risk estimate among Latinos in New York City.
    J Alzheimers Dis. 2025 Aug 8:13872877251365571. doi: 10.1177/13872877251365571.
    PubMed     Abstract available


  156. WANG H, Liu J, Tian YR, Zhu F, et al
    The effects of Honokiol on the liver of Alzheimer's disease mice by upregulating SIRT3.
    J Alzheimers Dis. 2025 Aug 8:13872877251362185. doi: 10.1177/13872877251362185.
    PubMed     Abstract available


  157. PRATT T, Lee A, Zheng J, Tavacoli F, et al
    Distinct glial functions are associated with Alzheimer's disease based on cell-type- and pathway-specific polygenic risk score analysis.
    J Alzheimers Dis. 2025 Aug 8:13872877251362258. doi: 10.1177/13872877251362258.
    PubMed     Abstract available


  158. ZHAO R, Bai W, Tian Z, Li X, et al
    Cistanche flavonoids activate the Keap1-Nrf2-ARE signaling pathway in improving cognitive dysfunction in Alzheimer's disease: A review.
    J Alzheimers Dis. 2025 Aug 8:13872877251361053. doi: 10.1177/13872877251361053.
    PubMed     Abstract available


  159. ROBINSON JEYAPAUL S, Kombaiya S, Jeya Kumar AK, Stanley VJ, et al
    Ensemble deep learning model for early diagnosis and classification of Alzheimer's disease using MRI scans.
    J Alzheimers Dis. 2025 Aug 8:13872877251359950. doi: 10.1177/13872877251359950.
    PubMed     Abstract available


  160. LV Y, Xiang Y, Fu W, Li B, et al
    Global burden trends of Alzheimer's disease and other dementias attributable to smoking from 1990 to 2021.
    J Alzheimers Dis. 2025 Aug 6:13872877251365284. doi: 10.1177/13872877251365284.
    PubMed     Abstract available


  161. GUO X, Fu H, Qin M, Kan J, et al
    Multi-omics profiling reveals two distinct trajectories in the progression from mild cognitive impairment to Alzheimer's disease.
    J Alzheimers Dis. 2025 Aug 6:13872877251365210. doi: 10.1177/13872877251365210.
    PubMed     Abstract available


  162. KITAGAWA K, Yoshizawa H, Toi S, Todo K, et al
    Utility of combination of Mini-Mental State Examination and Montreal Cognitive Assessment to predict incident Alzheimer's disease dementia in patients at high vascular risks.
    J Alzheimers Dis. 2025 Aug 6:13872877251365629. doi: 10.1177/13872877251365629.
    PubMed     Abstract available


  163. YAO R, Ouyang Z, Xu T, Zhu Y, et al
    Immune system-associated genes in patients with Alzheimer's disease.
    J Alzheimers Dis. 2025 Aug 6:13872877251364396. doi: 10.1177/13872877251364396.
    PubMed     Abstract available


  164. CHEN X, Zhou S, Wang W, Gao Z, et al
    Sex differences in white matter amplitude of low-frequency fluctuation associated with cognitive performance across the Alzheimer's disease continuum.
    J Alzheimers Dis. 2025 Aug 5:13872877251364722. doi: 10.1177/13872877251364722.
    PubMed     Abstract available


  165. XIA Y, Sha L, Tao M, Peng A, et al
    Cognitive and spatial patterns of amyloid-beta burden in Alzheimer's disease with epilepsy.
    J Alzheimers Dis. 2025 Aug 4:13872877251360425. doi: 10.1177/13872877251360425.
    PubMed     Abstract available


  166. CANOVAS R, Doecke JD, Fowler CJ, Fripp J, et al
    Association of plastic-associated chemicals with Alzheimer's disease amyloid-beta and cognitive status.
    J Alzheimers Dis. 2025 Aug 3:13872877251364559. doi: 10.1177/13872877251364559.
    PubMed     Abstract available


  167. PANG R, Wang J, Kanekar S, Karunanayaka P, et al
    Linking genetics to MRI-DTI: HFE polymorphism delays Alzheimer's disease white matter degeneration in APOE4 carriers.
    J Alzheimers Dis. 2025 Aug 3:13872877251363211. doi: 10.1177/13872877251363211.
    PubMed     Abstract available


  168. AYELE BA, Whitehead PL, Pascual J, Gu T, et al
    Exploring the stability of Alzheimer's disease plasma biomarkers stored for extended periods at -20 degrees C: Implications for resource-constrained environments.
    J Alzheimers Dis. 2025 Aug 3:13872877251364899. doi: 10.1177/13872877251364899.
    PubMed     Abstract available


  169. BARBOUR AJ
    Screening antiseizure medications to break the cycle between neuronal hyperexcitability and Alzheimer's disease.
    J Alzheimers Dis. 2025 Aug 3:13872877251364556. doi: 10.1177/13872877251364556.
    PubMed     Abstract available


  170. AKUSHEVICH I, Yashkin A, Tupler LA, Ouyang M, et al
    The absolute and relative concentration-response patterns of exposure to ambient air pollutants and the risk of Alzheimer's disease.
    J Alzheimers Dis. 2025 Aug 1:13872877251362785. doi: 10.1177/13872877251362785.
    PubMed     Abstract available


  171. ZANINI L, D'Antonio F, Di Vita A, Talarico G, et al
    Sensitivity and vagal reactivity to C-tactile-mediated affective touch in mild cognitive impairment due to Alzheimer's disease.
    J Alzheimers Dis. 2025 Aug 1:13872877251362249. doi: 10.1177/13872877251362249.
    PubMed     Abstract available


  172. WOOD KA, Chen X, Ko YA, Wharton W, et al
    National Alzheimer's Coordinating Center cerebral neuropathology and cognitive function in atrial fibrillation.
    J Alzheimers Dis. 2025 Aug 1:13872877251364508. doi: 10.1177/13872877251364508.
    PubMed     Abstract available


  173. ANSCHUETZ A, Schwab K, Harrington CR, Wischik CM, et al
    Proteomic and non-proteomic changes of presynaptic proteins in animal models of Alzheimer's disease: A meta-analysis 2015-2023.
    J Alzheimers Dis. 2025 Aug 1:13872877251362212. doi: 10.1177/13872877251362212.
    PubMed     Abstract available


  174. PARK J, Abner EL, Wang P, Liu C, et al
    Estimation of events in cohort studies based on probability of cognitive impairment.
    J Alzheimers Dis. 2025;106:1097-1107.
    PubMed     Abstract available


  175. PARK YJ, Seo SW, Choi SH, Moon SY, et al
    Machine learning-based prediction of amyloid positivity using early-phase F-18 flutemetamol PET.
    J Alzheimers Dis. 2025;106:1198-1211.
    PubMed     Abstract available



  176. Cyrus A. Raji, MD, PhD, is the recipient of the 2025 Mark A. Smith Alzheimer Award.
    J Alzheimers Dis. 2025;106:1217-1218.
    PubMed    


    July 2025
  177. PRAJAPAT M, Sarma P, Kaur G, Choudhary G, et al
    Therapeutic potential of 6BIO and DKK1-LRP6 inhibitor in Wnt/beta-catenin pathway modulation for amyloid-beta-induced Alzheimer's disease model.
    J Alzheimers Dis. 2025 Jul 30:13872877251362787. doi: 10.1177/13872877251362787.
    PubMed     Abstract available


  178. KUECK PJ, Honea RA, Kemna RE, Burns JM, et al
    Brain-derived neurotrophic factor and its relationship to known biomarkers of Alzheimer's disease.
    J Alzheimers Dis. 2025 Jul 30:13872877251362487. doi: 10.1177/13872877251362487.
    PubMed     Abstract available


  179. KIM J, Yang HJ, Park S, Kim BS, et al
    Gait speed and muscle mass as dual mediators in the link between white matter hyperintensities and Alzheimer's disease.
    J Alzheimers Dis. 2025 Jul 30:13872877251362424. doi: 10.1177/13872877251362424.
    PubMed     Abstract available


  180. MILES LA, Masters CL
    The structural foundations of anti-amyloid-beta immunotherapies: Unravelling antibody-antigen interactions in Alzheimer's disease treatment.
    J Alzheimers Dis. 2025 Jul 30:13872877251361049. doi: 10.1177/13872877251361049.
    PubMed     Abstract available


  181. WANG H, Yang Q, Ge C, Liu J, et al
    Integrated transcriptomic and proteomic analysis identifies FBXW7 as a key regulator of tau homeostasis in Alzheimer's disease.
    J Alzheimers Dis. 2025 Jul 29:13872877251361042. doi: 10.1177/13872877251361042.
    PubMed     Abstract available


  182. IKANGA J, Jean K, Medina P, Patel SS, et al
    Neurodegenerative plasma biomarkers for prediction of hippocampal atrophy in older adults with suspected Alzheimer's disease in Kinshasa, Democratic Republic of Congo.
    J Alzheimers Dis. 2025 Jul 29:13872877251360697. doi: 10.1177/13872877251360697.
    PubMed     Abstract available


  183. SHI L, Tian X, Lu X, Yih B, et al
    Frailty in Alzheimer's disease: A bibliometric analysis of research hotspots, emerging trends, and knowledge structure.
    J Alzheimers Dis. 2025 Jul 28:13872877251362665. doi: 10.1177/13872877251362665.
    PubMed     Abstract available



  184. Cyrus A. Raji, MD, PhD, is the recipient of the 2025 Mark A. Smith Alzheimer Award.
    J Alzheimers Dis. 2025 Jul 28:13872877251361092. doi: 10.1177/13872877251361092.
    PubMed    


  185. XIONG C, Lu R, Bui Q, Popp B, et al
    Person-specific digital measurements of air pollutant exposure and biomarkers of Alzheimer's disease: Findings from a pilot study.
    J Alzheimers Dis. 2025 Jul 27:13872877251362667. doi: 10.1177/13872877251362667.
    PubMed     Abstract available


  186. HSIAO CH, Wu CE, Wang CM, Lin TY, et al
    Intracerebral hemorrhage risk in Alzheimer's disease patients on anticoagulants: A nationwide cohort study.
    J Alzheimers Dis. 2025 Jul 27:13872877251362362. doi: 10.1177/13872877251362362.
    PubMed     Abstract available


  187. ALABDULJABBAR A, Khan SU, Altherwy YN, Almarshad F, et al
    A novel multimodal medical image fusion model for Alzheimer's and glioma disease detection based on hybrid fusion strategies in non-subsampled shearlet transform domain.
    J Alzheimers Dis. 2025 Jul 27:13872877251362498. doi: 10.1177/13872877251362498.
    PubMed     Abstract available


  188. PRABHU SS, Burrage EN, Coblentz T, Ball S, et al
    Mid-life exposure to chronic stress accelerates cerebrovascular dysfunction and upregulates oxidative stress in Alzheimer's disease mice.
    J Alzheimers Dis. 2025 Jul 27:13872877251362204. doi: 10.1177/13872877251362204.
    PubMed     Abstract available


  189. RICH A, Oh H
    Distinctive volumetric associations between plasma p-tau181 and hippocampal formation structures across the Alzheimer's disease continuum.
    J Alzheimers Dis. 2025 Jul 27:13872877251361354. doi: 10.1177/13872877251361354.
    PubMed     Abstract available


  190. CHONG JR, Hye A, Boada M, Svenningsson P, et al
    Cerebrospinal fluid biomarkers of Alzheimer's disease in Lewy body diseases: The performance of fully automated immunoassays.
    J Alzheimers Dis. 2025 Jul 27:13872877251360404. doi: 10.1177/13872877251360404.
    PubMed     Abstract available


  191. MORYS F, Liu L, Senkevich K, Gan-Or Z, et al
    Obesity-related brain atrophy is independent of Alzheimer's disease protein pathways.
    J Alzheimers Dis. 2025 Jul 27:13872877251359680. doi: 10.1177/13872877251359680.
    PubMed     Abstract available


  192. ARAI H, Aiba S, Arai R
    Safety of switching from lecanemab to donanemab in 20 consecutive patients with Alzheimer's disease.
    J Alzheimers Dis. 2025 Jul 24:13872877251361051. doi: 10.1177/13872877251361051.
    PubMed     Abstract available


  193. BENGISU S, Savas M, Ustel DA, Begen SK, et al
    The discriminant ability of the Eating Assessment Tool-10 to detect dysphagia and aspiration according to the stage of Alzheimer's disease.
    J Alzheimers Dis. 2025 Jul 23:13872877251362229. doi: 10.1177/13872877251362229.
    PubMed     Abstract available


  194. WANG X, Wang M, Wang H, Yin G, et al
    Drug repurposing for Alzheimer's disease integrating transcriptome-wide association study and biological network analysis.
    J Alzheimers Dis. 2025 Jul 22:13872877251360009. doi: 10.1177/13872877251360009.
    PubMed     Abstract available


  195. PEREIRA DA SILVA AM, Falcao L, Virgilio F, Rodrigues Menezes I, et al
    Efficacy and APOE epsilon4-stratified risk of donanemab in Alzheimer's disease: A systematic review and meta-analysis of randomized clinical trials.
    J Alzheimers Dis. 2025 Jul 21:13872877251361044. doi: 10.1177/13872877251361044.
    PubMed     Abstract available


  196. YIN M, Ding S, Zhao M, Liu J, et al
    The global, regional, and national burden and attributable risk factors of Alzheimer's disease and other dementias, 1990-2021: A systematic analysis for the Global Burden of Disease Study.
    J Alzheimers Dis. 2025 Jul 21:13872877251360221. doi: 10.1177/13872877251360221.
    PubMed     Abstract available


  197. ALZHRANI AJ, Stockfelt L, Xu Y, Harari F, et al
    Long-term exposure to air pollution and validated cases of Alzheimer's disease and vascular dementia in the Malmo diet and cancer cohort.
    J Alzheimers Dis. 2025 Jul 21:13872877251360225. doi: 10.1177/13872877251360225.
    PubMed     Abstract available


  198. LUO X, Hong H, Wang S, Li K, et al
    Assessment of diffusivity along the perivascular space in early- and late-onset Alzheimer's disease.
    J Alzheimers Dis. 2025 Jul 21:13872877251360416. doi: 10.1177/13872877251360416.
    PubMed     Abstract available


  199. QIU Y, Bao J, Wang T, Shang L, et al
    Global and regional white matter hyperintensities in Alzheimer's disease: Exploring etiologies and cognitive correlates.
    J Alzheimers Dis. 2025 Jul 21:13872877251360239. doi: 10.1177/13872877251360239.
    PubMed     Abstract available


  200. HUANG Y, Xu T, Wang L, Xiang R, et al
    Application of machine learning reveals diagnostic biomarkers related to pyroptosis in Alzheimer's disease and analysis of immune infiltration.
    J Alzheimers Dis. 2025 Jul 20:13872877251360033. doi: 10.1177/13872877251360033.
    PubMed     Abstract available


  201. SENRA H, Costa MC, Pereira I, Agostinho D, et al
    Predicting diagnostic conversion from mild cognitive impairment to Alzheimer's disease: A Bayesian hierarchical model approach using ADNI patient data.
    J Alzheimers Dis. 2025 Jul 20:13872877251360228. doi: 10.1177/13872877251360228.
    PubMed     Abstract available


  202. PASTERIS M, Cakir S, Bellizzi A, Sariyer IK, et al
    Alternative splicing in Alzheimer's disease: Mechanisms, therapeutic implications, and 3D modeling approaches.
    J Alzheimers Dis. 2025 Jul 20:13872877251359633. doi: 10.1177/13872877251359633.
    PubMed     Abstract available


  203. LI Q, Koehler S, Koenig A, Dyrba M, et al
    Associations between digital speech features of automated cognitive tasks and trajectories of brain atrophy and cognitive decline in early Alzheimer's disease.
    J Alzheimers Dis. 2025 Jul 20:13872877251359967. doi: 10.1177/13872877251359967.
    PubMed     Abstract available


  204. WEI C, Wang J, Xue Y, Jiang J, et al
    Characterizing structure-function coupling in subjective memory complaints of preclinical Alzheimer's disease.
    J Alzheimers Dis. 2025 Jul 17:13872877251360259. doi: 10.1177/13872877251360259.
    PubMed     Abstract available


  205. VARANGIS E, Liu J, Miao Y, Zhu X, et al
    Neural flexibility is higher in Alzheimer's disease and predicts Alzheimer's disease transition.
    J Alzheimers Dis. 2025 Jul 17:13872877251360025. doi: 10.1177/13872877251360025.
    PubMed     Abstract available


  206. GE L, Zhu L, Su C, Jin Z, et al
    Exploring causal gut-brain axes in Alzheimer's disease using mediation Mendelian randomization analysis.
    J Alzheimers Dis. 2025 Jul 15:13872877251360004. doi: 10.1177/13872877251360004.
    PubMed     Abstract available


  207. ABBATE C, Gallucci A
    New Alzheimer's association workgroup criteria underestimate syndromes in Alzheimer's disease definition.
    J Alzheimers Dis. 2025 Jul 15:13872877251359642. doi: 10.1177/13872877251359642.
    PubMed     Abstract available


  208. FU Y, Jiang L, Detre J, Wang Z, et al
    Alzheimer's disease classification using mutual information generated graph convolutional network for functional MRI.
    J Alzheimers Dis. 2025 Jul 15:13872877251350306. doi: 10.1177/13872877251350306.
    PubMed     Abstract available


  209. TAHAMI MONFARED AA, Hummel N, Kopiec A, Chandak A, et al
    Integrating intangible costs into societal cost estimates of Alzheimer's disease.
    J Alzheimers Dis. 2025 Jul 13:13872877251351591. doi: 10.1177/13872877251351591.
    PubMed     Abstract available


  210. EDMUNDS KJ, Nelson AR, Brach TL, Glittenberg M, et al
    Depression modifies age-associated [(11)C]PiB-PET amyloid burden in a cohort enriched with risk for Alzheimer's disease.
    J Alzheimers Dis. 2025 Jul 10:13872877251353098. doi: 10.1177/13872877251353098.
    PubMed     Abstract available


  211. GAMM S, Ummel D, Vasil N, Grenier S, et al
    The need to adapt after Alzheimer's disease diagnosis: Coping strategies used to maintain identity and quality of life.
    J Alzheimers Dis. 2025 Jul 7:13872877251351596. doi: 10.1177/13872877251351596.
    PubMed     Abstract available


  212. HOILUND-CARLSEN PF, Alavi A, Costa T, Neve RL, et al
    Is US residence a risk factor for Alzheimer's disease?
    J Alzheimers Dis. 2025 Jul 3:13872877251356682. doi: 10.1177/13872877251356682.
    PubMed     Abstract available


  213. PALEY JL, Scheiffele GD, Li Y, Shaaban CE, et al
    Neighborhood deprivation and mortality among people with Alzheimer's disease and related dementia.
    J Alzheimers Dis. 2025 Jul 2:13872877251352120. doi: 10.1177/13872877251352120.
    PubMed     Abstract available


  214. HSU YH, Huang SM, Kuo LW, Yang JJ, et al
    Diagnostic utility of the item-specific Encoding Deficit Index in relation to medial temporal lobe atrophy in early-stage Alzheimer's disease.
    J Alzheimers Dis. 2025 Jul 2:13872877251351612. doi: 10.1177/13872877251351612.
    PubMed     Abstract available


  215. BOSE C, Hindle A, Smith SC, Strickland J, et al
    Low-dose dietary vorinostat increases brain histone acetylation levels and reduces oxidative stress in an Alzheimer's disease mouse model.
    J Alzheimers Dis. 2025 Jul 1:13872877251352107. doi: 10.1177/13872877251352107.
    PubMed     Abstract available


  216. WALCZAK K, Kolodziejczyk W, Pszczolowska M, Kozlowska M, et al
    Klotho protein in Alzheimer's disease: Diet leading to immortality?
    J Alzheimers Dis. 2025 Jul 1:13872877251350125. doi: 10.1177/13872877251350125.
    PubMed     Abstract available


  217. LIU SK, Cao H, Yang X, Zhou X, et al
    An ABCA1 missense variant decreases cholesterol efflux and confers Alzheimer's disease risk in the Chinese population.
    J Alzheimers Dis. 2025 Jul 1:13872877251350722. doi: 10.1177/13872877251350722.
    PubMed     Abstract available


  218. RICCHI I, Griffa A, Corredor-Jerez R, Richiardi J, et al
    The complementary role of automated brain volumetry to stratify ADNI participants within the ATN framework.
    J Alzheimers Dis. 2025;106:245-258.
    PubMed     Abstract available


  219. LOJO-RAMIREZ JA, Fernandez-Rodriguez P, Guerra-Gomez M, Marin-Cabanas AM, et al
    Evaluation of early-phase (18)F-Florbetaben PET as a surrogate biomarker of neurodegeneration: In-depth comparison with (18)F-FDG PET at group and single patient level.
    J Alzheimers Dis. 2025;106:304-316.
    PubMed     Abstract available


  220. YIN A, Gui Y, Wan L, Cai Q, et al
    p53 SUMOylation promotes neurogenesis defects in APP/PS1 mice.
    J Alzheimers Dis. 2025;106:352-362.
    PubMed     Abstract available


  221. SEKIKAWA A, Higashiyama A, Lopresti BJ, Ihara M, et al
    An inverse association of cerebral amyloid-beta deposition and serum docosahexaenoic acid levels in cognitively normal older adults in Japan.
    J Alzheimers Dis. 2025;106:378-386.
    PubMed     Abstract available


  222. ANDERSEN LSN, Simonsen AH, Vogel A, McWilliam OH, et al
    Isolated elevation of 181p-tau in the cerebrospinal fluid is associated with distinct clinical features: Findings from a Danish memory clinic cohort.
    J Alzheimers Dis. 2025;106:111-119.
    PubMed     Abstract available


  223. ZHAI A, Zou R, Lv T, Yang S, et al
    Genetic association of social participation with cognitive function: A bidirectional Mendelian randomization study.
    J Alzheimers Dis. 2025;106:259-270.
    PubMed     Abstract available


  224. CAI Y, Wang X, Xiang Y, Wang Z, et al
    Codonopsis pilosula polysaccharides alleviate neuronal apoptosis induced by endoplasmic reticulum stress-activated PERK-ATF4-CHOP signaling in APP/PS1 mice.
    J Alzheimers Dis. 2025;106:317-330.
    PubMed     Abstract available


  225. LIU J, Duangjan C, Phan NM, Curran SP, et al
    Loss of WDR23 slows the rate of age-related cognitive decline with elevated amyloid burden.
    J Alzheimers Dis. 2025;106:218-229.
    PubMed     Abstract available


  226. SALVIONI CHIABOTTI P, Nasuti M, Rouaud O, Allali G, et al
    Posterior cortical atrophy in the age of anti-amyloid treatments: An 11-year retrospective study of eligible patients from the Leenaards Memory Center.
    J Alzheimers Dis. 2025;106:512-517.
    PubMed     Abstract available


  227. SINGHRAO SK
    Porphyromonas gingivalis-lipopolysaccharide and amyloid-beta: A dangerous liaison for impairing memory?
    J Alzheimers Dis. 2025;106:537-539.
    PubMed     Abstract available


  228. SUZUMURA S, Sugioka J, Sakurai K, Osawa A, et al
    Finger motor skills and related brain regions in patients with cognitive disorder.
    J Alzheimers Dis. 2025;106:634-645.
    PubMed     Abstract available


  229. ALISHAHI F, Beam CR, Gatz M, Schneider LS, et al
    High precision and cost-effective multiplex quantification of amyloid-beta40, amyloid-beta42, p181Tau, p217Tau, neurofilament light chain, and glial fibrillary acidic protein from plasma and serum.
    J Alzheimers Dis. 2025;106:739-755.
    PubMed     Abstract available


    June 2025
  230. SARAIVA JA, Becker M, Dyrba M, Bolukbas B, et al
    Electroencephalogram features support the retrogenesis hypothesis of Alzheimer's disease: Exploratory comparison of brain changes in aging and childhood.
    J Alzheimers Dis. 2025 Jun 30:13872877251352119. doi: 10.1177/13872877251352119.
    PubMed     Abstract available


  231. SATO K, Niimi Y, Ihara R, Iwata A, et al
    Effect of corrections for renal function on plasma phosphorylated tau performance for Alzheimer's disease.
    J Alzheimers Dis. 2025 Jun 30:13872877251350718. doi: 10.1177/13872877251350718.
    PubMed     Abstract available


  232. WANG G, Chen T, O'Gorman J, Li Y, et al
    Harnessing greater statistical power: Comprehensive evaluation of disease modifying treatment effects across all or multiple post-baseline visits compared to the last visit for Alzheimer's disease clinical trials.
    J Alzheimers Dis. 2025 Jun 30:13872877251352189. doi: 10.1177/13872877251352189.
    PubMed     Abstract available


  233. SHANG ZT, Huang XY, Xiong LL, Xu ZC, et al
    Methanol extract from miracle fruit seeds mitigates Alzheimer's disease and enhance autophagy via suppressing the AKT/mTOR signal pathway.
    J Alzheimers Dis. 2025 Jun 30:13872877251352545. doi: 10.1177/13872877251352545.
    PubMed     Abstract available


  234. ESLICK S, Austin G, Ferguson JJ, Garg ML, et al
    Blood biomarkers of Alzheimer's disease in Australians habitually consuming various plant-based diets.
    J Alzheimers Dis. 2025 Jun 30:13872877251351549. doi: 10.1177/13872877251351549.
    PubMed     Abstract available


  235. KIM S, Wang SM, Kang DW, Kim S, et al
    Impact of type 2 diabetes mellitus on differential cerebellar volume reduction in Alzheimer's disease trajectory.
    J Alzheimers Dis. 2025 Jun 27:13872877251352208. doi: 10.1177/13872877251352208.
    PubMed     Abstract available


  236. JAMISON D, Kadamangudi S, Tumurbaatar B, Zhang WR, et al
    Comparative analysis of brain-derived tau oligomer interactomes in Alzheimer's disease, non-demented with Alzheimer's neuropathology, and primary age-related tauopathy: Implications for neurodegeneration and cognitive resilience.
    J Alzheimers Dis. 2025 Jun 27:13872877251352382. doi: 10.1177/13872877251352382.
    PubMed     Abstract available


  237. ZHANG QN, Yu LK, Zhang XY, Wu Y, et al
    LCN2 of cerebrospinal fluid: A potential biomarker for diagnosis and disease progression in Alzheimer's disease.
    J Alzheimers Dis. 2025 Jun 27:13872877251352411. doi: 10.1177/13872877251352411.
    PubMed     Abstract available


  238. CHEN F, Deng H, Zhang Q, Liu Y, et al
    Utility of machine learning algorithms in classification of progressive cognitive impairment in Alzheimer's disease: A retrospective cohort based on China.
    J Alzheimers Dis. 2025 Jun 27:13872877251352510. doi: 10.1177/13872877251352510.
    PubMed     Abstract available


  239. POPP ZT, Ang TFA, Hwang PH, Au R, et al
    Association between education and rate of cognitive decline among individuals with Alzheimer's disease: A multi-national European observational study.
    J Alzheimers Dis. 2025 Jun 26:13872877251352216. doi: 10.1177/13872877251352216.
    PubMed     Abstract available


  240. WADLEY VG, Zhang Y, Bull T, Barba C, et al
    Daily function outcomes in adults with mild cognitive impairment due to Alzheimer's disease after two years of processing speed training versus a control training protocol.
    J Alzheimers Dis. 2025 Jun 26:13872877251351341. doi: 10.1177/13872877251351341.
    PubMed     Abstract available


  241. XIA X, Duffner LA, Bintener C, Bradshaw A, et al
    Diagnostic and prognostic multimodal prediction models in Alzheimer's disease: A scoping review.
    J Alzheimers Dis. 2025 Jun 26:13872877251351630. doi: 10.1177/13872877251351630.
    PubMed     Abstract available


  242. SIRIWARDHANA C, Carrazana E, Liow K
    Racial and socioeconomic influences on the interplay between Alzheimer's disease-related dementia and cardio-cerebrovascular disease in an aging population.
    J Alzheimers Dis. 2025 Jun 26:13872877251351216. doi: 10.1177/13872877251351216.
    PubMed     Abstract available


  243. GARRAHY JP
    Astrocytic lipidopathy and bioenergetic failure in ApoE4-associated late-onset Alzheimer's disease: A unifying hypothesis.
    J Alzheimers Dis. 2025 Jun 26:13872877251350338. doi: 10.1177/13872877251350338.
    PubMed     Abstract available


  244. KATABATHULA S, Gurney M, Perry G, Davis PB, et al
    Identifying patients with mild cognitive impairment at high risk of transitioning to Alzheimer's disease using routinely collected data.
    J Alzheimers Dis. 2025 Jun 25:13872877251351622. doi: 10.1177/13872877251351622.
    PubMed     Abstract available


  245. WANG W, Davis PB, Qi X, Gurney M, et al
    Associations of semaglutide with Alzheimer's disease-related dementias in patients with type 2 diabetes: A real-world target trial emulation study.
    J Alzheimers Dis. 2025 Jun 24:13872877251351329. doi: 10.1177/13872877251351329.
    PubMed     Abstract available


  246. ASANTE J JR, Nagel CL, Barger SW
    Prescription-based association of P-glycoprotein substrates with Alzheimer's disease risk: A nested case-control study.
    J Alzheimers Dis. 2025 Jun 23:13872877251351629. doi: 10.1177/13872877251351629.
    PubMed     Abstract available


  247. TIAN J, Meka SS, Wang T, Guo L, et al
    Vulnerability of mitochondrial OXPHOS complexes in the arcuate nucleus of the hypothalamus of Alzheimer's disease.
    J Alzheimers Dis. 2025 Jun 22:13872877251352209. doi: 10.1177/13872877251352209.
    PubMed     Abstract available


  248. GONG J, Li S, Han X, Wang P, et al
    Autoantibodies in Alzheimer's disease: Multifaceted roles and therapeutic horizons.
    J Alzheimers Dis. 2025 Jun 22:13872877251350292. doi: 10.1177/13872877251350292.
    PubMed     Abstract available


  249. NAKAMURA K, Tagai K, Shinotoh H, Hirano S, et al
    Concurrent Alzheimer's disease pathologies in Lewy body diseases affect cognition and glucose metabolism in the posterior cingulate gyrus: A multimodal PET study.
    J Alzheimers Dis. 2025 Jun 20:13872877251351220. doi: 10.1177/13872877251351220.
    PubMed     Abstract available


  250. HOILUND-CARLSEN PF, Barrio JR
    History repeats itself: A new trivializing term for a potentially life-threatening side effect of antibody Alzheimer's disease therapy.
    J Alzheimers Dis. 2025 Jun 19:13872877251350295. doi: 10.1177/13872877251350295.
    PubMed     Abstract available


  251. LIN PJ, Riley AG, Synnott PG, Frangiosa TL, et al
    Health utilities in Alzheimer's disease: A survey of patients and caregivers in the United States.
    J Alzheimers Dis. 2025 Jun 19:13872877251350381. doi: 10.1177/13872877251350381.
    PubMed     Abstract available


  252. CHENG M, Wei YD, Zheng X, Gao XR, et al
    Bibliometric analysis of the interplay between Alzheimer's disease and type 2 diabetes mellitus: Trends, hotspots, and emerging research areas.
    J Alzheimers Dis. 2025 Jun 17:13872877251351042. doi: 10.1177/13872877251351042.
    PubMed     Abstract available


  253. JOHNSON IP, Peterson TM, Gudsnuk K, Keene CD, et al
    Presence of Alzheimer's disease variants in circular RNA of PSEN1 and PSEN2.
    J Alzheimers Dis. 2025 Jun 16:13872877251350112. doi: 10.1177/13872877251350112.
    PubMed     Abstract available


  254. MICHAEL GC
    Knowledge and attitudes about Alzheimer's disease in Nigerian geriatric outpatients: The role of primary care professionals.
    J Alzheimers Dis. 2025 Jun 16:13872877251350293. doi: 10.1177/13872877251350293.
    PubMed     Abstract available


  255. ZAWAR I, Kapur J
    Seizing the link: Exploring the potential association between anti-seizure medications and Alzheimer's disease.
    J Alzheimers Dis. 2025 Jun 16:13872877251350291. doi: 10.1177/13872877251350291.
    PubMed     Abstract available


  256. VANNINI P, Zamboni G
    To know or to not know: The importance of assessing awareness of cognitive function in the early stages of Alzheimer's disease.
    J Alzheimers Dis. 2025 Jun 16:13872877251350138. doi: 10.1177/13872877251350138.
    PubMed     Abstract available


  257. MARIZZONI M, Coppola L, Festari C, Luongo D, et al
    Circulating short chain fatty acids in Alzheimer's disease: A cross-sectional observational study.
    J Alzheimers Dis. 2025 Jun 12:13872877251337773. doi: 10.1177/13872877251337773.
    PubMed     Abstract available


  258. WANG DW, Qin XT, Wang G, Liu J, et al
    Effect of comprehensive geriatric assessment intervention on serum S100beta levels and clinical outcomes in patients with Alzheimer's disease.
    J Alzheimers Dis. 2025 Jun 10:13872877251344544. doi: 10.1177/13872877251344544.
    PubMed     Abstract available


  259. KNOX KM, Davidson S, Lehmann LM, Skinner E, et al
    Alzheimer's disease-associated genotypes differentially influence chronic evoked seizure outcomes and antiseizure medicine efficacy in aged mice.
    J Alzheimers Dis. 2025 Jun 3:13872877251343321. doi: 10.1177/13872877251343321.
    PubMed     Abstract available


  260. YU K, Jiang R, Zhou D, Zhao Z, et al
    Therapeutic targets for Alzheimer's disease: Proteome-wide Mendelian randomization and colocalization analyses.
    J Alzheimers Dis. 2025 Jun 2:13872877251344572. doi: 10.1177/13872877251344572.
    PubMed     Abstract available


  261. KIM HN, Jang WH, Kang NS, Kim S, et al
    Pterosin D-activated protein kinase A mitigates Alzheimer's disease in 5xFAD mice.
    J Alzheimers Dis. 2025 Jun 2:13872877251344627. doi: 10.1177/13872877251344627.
    PubMed     Abstract available


  262. YANG D, Hou N, Jia M
    Multicomponent exercise interventions for older adults with Alzheimer's disease: A systematic review and meta-analytical perspective.
    J Alzheimers Dis. 2025 Jun 2:13872877251346989. doi: 10.1177/13872877251346989.
    PubMed     Abstract available


  263. PEREIRA ME, de Souza JV, Gomar GG, Kruk IL, et al
    Glutathione peroxidase activity in Alzheimer's disease patients: A systematic review and meta-analysis.
    J Alzheimers Dis. 2025 Jun 2:13872877251346981. doi: 10.1177/13872877251346981.
    PubMed     Abstract available


  264. LI L, Wang Y, Feng Q, Ma C, et al
    Role of astroglia and microglia in Alzheimer's disease and multiple therapeutic interventions.
    J Alzheimers Dis. 2025 Jun 2:13872877251335572. doi: 10.1177/13872877251335572.
    PubMed     Abstract available


  265. ALKAM T, Tarshizi E, Van Benschoten AH
    Large language models for Alzheimer's disease drug discovery.
    J Alzheimers Dis. 2025 Jun 2:13872877251346890. doi: 10.1177/13872877251346890.
    PubMed     Abstract available


  266. WANG Z, Wang Q, Fu C, Li X, et al
    The fall-dementia connection: Synergistic effects of falls with genetic and health risk factors.
    J Alzheimers Dis. 2025;105:990-999.
    PubMed     Abstract available


  267. LI J, Zhang F, Eisel UL
    Adverse events associated with lecanemab: A disproportionality analysis of data from the FDA adverse event reporting system.
    J Alzheimers Dis. 2025;105:849-859.
    PubMed     Abstract available


  268. SAEZ-CALVERAS N, Ishii M
    Hydrate to keep the amyloid away.
    J Alzheimers Dis. 2025;105:759-761.
    PubMed     Abstract available


    May 2025
  269. LOFFREDO L, Alfano AR, Ettorre E, Desideri G, et al
    Effect of the probiotic Escherichia coli Nissle 1917 on serum levels of NADPH oxidase-2 and lipopolysaccharide in patients with Alzheimer's disease.
    J Alzheimers Dis. 2025 May 27:13872877251345157. doi: 10.1177/13872877251345157.
    PubMed     Abstract available


  270. GUZMAN-VELEZ E, Aguillon D, Rivera-Hernandez A, Baena AY, et al
    Association among cardiorespiratory fitness, plasma biomarkers of pathology and astrocyte reactivity, and cognition in autosomal-dominant Alzheimer's disease.
    J Alzheimers Dis. 2025 May 27:13872877251344327. doi: 10.1177/13872877251344327.
    PubMed     Abstract available


  271. LIANG J, Wang Q, Wang J, Shao Y, et al
    Individual electric field in cortical white matter is correlated with cognitive improvement in patients with mild cognitive impairment due to Alzheimer's disease after repetitive transcranial magnetic stimulation treatment.
    J Alzheimers Dis. 2025 May 27:13872877251344599. doi: 10.1177/13872877251344599.
    PubMed     Abstract available


  272. LU P, Chen M, Chen L, Lin F, et al
    Translational computerized clinical decision support systems for Alzheimer's disease: A systematic review.
    J Alzheimers Dis. 2025 May 25:13872877251343241. doi: 10.1177/13872877251343241.
    PubMed     Abstract available


  273. SACU S, Slattery CF, Friston KJ, Paterson RW, et al
    Neural mechanisms of disease pathology and cognition in young-onset Alzheimer's disease variants.
    J Alzheimers Dis. 2025 May 22:13872877251344325. doi: 10.1177/13872877251344325.
    PubMed     Abstract available


  274. PANDEY JP, Kimball C, Nietert PJ
    Epistatic effects of immunoglobulin KM (kappa marker) allotypes and APOE epsilon4 allele on the risk of Alzheimer's disease.
    J Alzheimers Dis. 2025 May 22:13872877251343315. doi: 10.1177/13872877251343315.
    PubMed     Abstract available


  275. LIU H, Li Y, Sun Z, Xu X, et al
    Altered hemispheres lateralization of brain functional gradients in Alzheimer's disease.
    J Alzheimers Dis. 2025 May 22:13872877251339761. doi: 10.1177/13872877251339761.
    PubMed     Abstract available


  276. MENG X, Gong Y, Xiao F, Cao Z, et al
    Curcumin's multi-target mechanisms in the treatment of Alzheimer's disease and creative modification techniques.
    J Alzheimers Dis. 2025 May 21:13872877251344188. doi: 10.1177/13872877251344188.
    PubMed     Abstract available


  277. ISHIMARU D, Satake Y, Kanemoto H, Taomoto D, et al
    Thieves in the delusions of theft in patients with Alzheimer's disease living alone: A case series.
    J Alzheimers Dis. 2025 May 21:13872877251343313. doi: 10.1177/13872877251343313.
    PubMed     Abstract available


  278. LI Y, Yao YL, Wu Y
    Causal relationships between plasma proteins and Alzheimer's disease using bidirectional Mendelian randomization.
    J Alzheimers Dis. 2025 May 21:13872877251345151. doi: 10.1177/13872877251345151.
    PubMed     Abstract available


  279. MIYASHITA A, Obinata A, Hara N, Mitsumori R, et al
    Association of rare APOE missense variants with Alzheimer's disease in the Japanese population.
    J Alzheimers Dis. 2025 May 21:13872877251340710. doi: 10.1177/13872877251340710.
    PubMed     Abstract available


  280. LANDRY A, Elsliger S, Gaudet J, Al-Shamaa S, et al
    Psychological impact of biomarker-assisted diagnosis of Alzheimer's disease.
    J Alzheimers Dis. 2025 May 21:13872877251341587. doi: 10.1177/13872877251341587.
    PubMed     Abstract available


  281. NONG Y, Kim JS, Jia L, Arancio O, et al
    The interaction between neurotransmitter receptor activity and amyloid-beta pathology in Alzheimer's disease.
    J Alzheimers Dis. 2025 May 19:13872877251342273. doi: 10.1177/13872877251342273.
    PubMed     Abstract available


  282. GIAQUINTO F, Iaia M, Rizzi E, Macchitella L, et al
    Cognitive training for Alzheimer's disease and other forms of dementia: Insights from a systematic review and Bayesian meta-analysis.
    J Alzheimers Dis. 2025 May 13:13872877251334795. doi: 10.1177/13872877251334795.
    PubMed     Abstract available


  283. QIN Q, Xia X, Qu J, Guan Z, et al
    Blood biomarkers of amyloid and tau pathologies, brain degeneration, inflammation, and oxidative stress in early- and late-onset Alzheimer's disease.
    J Alzheimers Dis. 2025 May 8:13872877251340955. doi: 10.1177/13872877251340955.
    PubMed     Abstract available


  284. CUMBO E, Migliore D
    Differential effects of antidepressants on cognition in Alzheimer's disease with depression: A sub-group analysis of an open-label, observational study.
    J Alzheimers Dis. 2025 May 7:13872877251340084. doi: 10.1177/13872877251340084.
    PubMed     Abstract available


  285. NYONGESA CA, Hogarth M, Pa J
    Artificial intelligence-driven natural language processing for identifying linguistic patterns in Alzheimer's disease and mild cognitive impairment: A study of lexical, syntactic, and cohesive features of speech through picture description tasks.
    J Alzheimers Dis. 2025 May 7:13872877251339756. doi: 10.1177/13872877251339756.
    PubMed     Abstract available


  286. ZHANG J, Liu T, Wu H, Wei J, et al
    Identification of NDUFV2, NDUFS7, OPA1, and NDUFA1 as biomarkers for Alzheimer's disease: Insights from oxidative stress and mitochondrial dysfunction in the hippocampus.
    J Alzheimers Dis. 2025 May 7:13872877251339771. doi: 10.1177/13872877251339771.
    PubMed     Abstract available


  287. VON GAL A, Papa D, D'Auria M, Piccardi L, et al
    Disruptive resting state networks characterizing depressive comorbidity in Alzheimer's disease and mild cognitive impairment.
    J Alzheimers Dis. 2025 May 6:13872877251337770. doi: 10.1177/13872877251337770.
    PubMed     Abstract available


  288. WANG T, Jiang H, Zheng R, Zhang C, et al
    Trends and research focus on autophagy in Alzheimer's disease (2003-2023): A bibliometric study.
    J Alzheimers Dis. 2025 May 6:13872877251336442. doi: 10.1177/13872877251336442.
    PubMed     Abstract available


  289. KORIATH CA, Perneczky R
    Obesity and Alzheimer's disease dementia: Examining inflammatory links to cognitive decline and neuropsychiatric symptoms.
    J Alzheimers Dis. 2025 May 6:13872877251338467. doi: 10.1177/13872877251338467.
    PubMed     Abstract available


  290. WU R, Guo J, Liu Y, Huang S, et al
    Angiogenesis promotion of the transplantation of human amniotic mesenchymal stem cells via the Ang-1/Tie-2 signaling pathways in Alzheimer's disease model.
    J Alzheimers Dis. 2025 May 5:13872877251338687. doi: 10.1177/13872877251338687.
    PubMed     Abstract available


  291. SANDBERG A, Puttagunta S, Duval N, Fleming H, et al
    Immunocal((R)), a cysteine-rich whey protein, rescues reelin and reduces amyloid plaque burden in a transgenic amyloid-beta protein precursor (hAbetaPP(SweInd)) mouse model of Alzheimer's disease.
    J Alzheimers Dis. 2025 May 5:13872877251338323. doi: 10.1177/13872877251338323.
    PubMed     Abstract available


  292. NAGATA T, Nakajima S, Kito S, Shinagawa S, et al
    Correlations between agitation and other neuropsychiatric symptoms in each stage of Alzheimer's disease: A re-analysis of CATIE-AD.
    J Alzheimers Dis. 2025 May 5:13872877251340402. doi: 10.1177/13872877251340402.
    PubMed     Abstract available


  293. ITO K, Washimi Y, Kato T, Suzuki K, et al
    (18)F-FDG PET for the differential diagnosis of Alzheimer's disease and frontotemporal lobar degeneration: A multicenter prospective study in Japan.
    J Alzheimers Dis. 2025 May 5:13872877251338691. doi: 10.1177/13872877251338691.
    PubMed     Abstract available


  294. LI MJ, Lan MN, Du YX, Liu Y, et al
    EPRCN exerts neuroprotective function by regulating gut microbiota and restoring gut immune homeostasis in Alzheimer's disease model mice.
    J Alzheimers Dis. 2025 May 5:13872877251339762. doi: 10.1177/13872877251339762.
    PubMed     Abstract available


  295. MO D, Li X, He J, Lin X, et al
    Chronic gingivitis increases the risk of early-onset Alzheimer's disease.
    J Alzheimers Dis. 2025 May 4:13872877251336259. doi: 10.1177/13872877251336259.
    PubMed     Abstract available


  296. VOGELS L, Mohammadi R, Schoonhoven M, Birbil SI, et al
    Modeling Alzheimer's disease: Bayesian copula graphical model from demographic, cognitive, and neuroimaging data.
    J Alzheimers Dis. 2025 May 4:13872877251337944. doi: 10.1177/13872877251337944.
    PubMed     Abstract available


  297. YANG YH, Chang HW, Chien CF, Hour TC, et al
    Investigating the effects of 40 Hz sound stimulation on Alzheimer's disease pathways: Modulation of amyloid-beta42 secretion, tau phosphorylation, phagocytosis, and autophagy.
    J Alzheimers Dis. 2025 May 4:13872877251339774. doi: 10.1177/13872877251339774.
    PubMed     Abstract available


  298. BAO W, Bi H, Chao L, Jiang Y, et al
    Identifying the mediating role of brain atrophy on the relationship between DNA damage repair pathway and Alzheimer's disease: A Mendelian randomization analysis and mediation analysis.
    J Alzheimers Dis. 2025 May 2:13872877251333811. doi: 10.1177/13872877251333811.
    PubMed     Abstract available


  299. URSO D, Introna A, Gnoni V, Giugno A, et al
    Donanemab eligibility in early Alzheimer's disease: A real-world study.
    J Alzheimers Dis. 2025 May 1:13872877251331243. doi: 10.1177/13872877251331243.
    PubMed     Abstract available


  300. LOBUE C, Stopschinski BE, Calveras NS, Salter A, et al
    A preliminary study on plasma markers across cognitive stages and links to a history of mild traumatic brain injury.
    J Alzheimers Dis. 2025;105:49-55.
    PubMed     Abstract available


  301. HOILUND-CARLSEN PF, Werner TJ, Alavi A
    The unsafe profile of lecanemab.
    J Alzheimers Dis. 2025;105:62-64.
    PubMed     Abstract available


  302. LABONTE J, Sugarman MA, Pettway E, Zetterberg H, et al
    Sex differences on tau, astrocytic, and neurodegenerative plasma biomarkers.
    J Alzheimers Dis. 2025;105:443-452.
    PubMed     Abstract available


  303. ZHAI Y, Lu K, Yuan Y, Zhang Z, et al
    Semaglutide improves cognitive function and neuroinflammation in APP/PS1 transgenic mice by activating AMPK and inhibiting TLR4/NF-kappaB pathway.
    J Alzheimers Dis. 2025;105:416-432.
    PubMed     Abstract available


  304. BARTOLINI E, Di Crosta A, La Malva P, Marin A, et al
    Gamma oscillation modulation for cognitive impairment: A systematic review.
    J Alzheimers Dis. 2025;105:331-350.
    PubMed     Abstract available


  305. COOPER JK
    Differences between East and West may affect dementia studies: Thoughts from the KSA dementia prevalence study.
    J Alzheimers Dis. 2025;105:368-369.
    PubMed     Abstract available


    April 2025
  306. HEINZE T, Tuchtenhagen M, Knuppel S, Weber D, et al
    EPIC-Potsdam sub-cohort study: The early role of trace elements, oxidative stress, and anthropometrics in Alzheimer's disease and dementia onset.
    J Alzheimers Dis. 2025 Apr 23:13872877251333726. doi: 10.1177/13872877251333726.
    PubMed     Abstract available


  307. ZHANG W, Teng F, Lan X, Liu P, et al
    A novel finding relates to the involvement of ATF3/DOCK8 in Alzheimer's disease pathogenesis.
    J Alzheimers Dis. 2025 Apr 23:13872877251336266. doi: 10.1177/13872877251336266.
    PubMed     Abstract available


  308. JEONG H, Kim D, Na S, Kim B, et al
    Repeated neuromodulation with low-intensity focused ultrasound in patients with Alzheimer's disease.
    J Alzheimers Dis. 2025 Apr 23:13872877251333614. doi: 10.1177/13872877251333614.
    PubMed     Abstract available


  309. WEI S, Li C, Li W, Yuan F, et al
    Glial changes and gene expression in Alzheimer's disease from snRNA-Seq and spatial transcriptomics.
    J Alzheimers Dis. 2025 Apr 23:13872877251330320. doi: 10.1177/13872877251330320.
    PubMed     Abstract available


  310. HE F, Shi WJ, Liu W, Fan JX, et al
    A mass-producible macaque model displays a durable Alzheimer-like cognitive deficit and hallmark amyloid-beta/tau/neurofilament light chain pathologies.
    J Alzheimers Dis. 2025 Apr 23:13872877251334316. doi: 10.1177/13872877251334316.
    PubMed     Abstract available


  311. SINGH-REILLY N, Graff-Radford J, Li D, Mielke MM, et al
    Abeta(42/40) and p-tau 181 as disease biomarkers in atypical Alzheimer's disease.
    J Alzheimers Dis. 2025 Apr 23:13872877251333450. doi: 10.1177/13872877251333450.
    PubMed     Abstract available


  312. GHANBARIAN E, Khorsand B, Petersen KK, Nallapu BT, et al
    Cerebrospinal fluid inflammatory cytokines as prognostic indicators for cognitive decline across Alzheimer's disease spectrum.
    J Alzheimers Dis. 2025 Apr 22:13872877251335915. doi: 10.1177/13872877251335915.
    PubMed     Abstract available


  313. KSHIRSAGAR S, Deshmukh H, Reddy AP, Reddy AP, et al
    Grounding as a complementary intervention for Alzheimer's disease: Mechanisms, evidence, and potential therapeutic applications.
    J Alzheimers Dis. 2025 Apr 22:13872877251334666. doi: 10.1177/13872877251334666.
    PubMed     Abstract available


  314. CHEN HM, Shen K, Ji L, McGrath C, et al
    Patterns and trends in the burden of Alzheimer's disease and related dementias in China (1990-2021) and predictions to 2040.
    J Alzheimers Dis. 2025 Apr 22:13872877251333108. doi: 10.1177/13872877251333108.
    PubMed     Abstract available


  315. STAMATELOS P, Beratis IN, Hatzaki P, Economou A, et al
    Mild cognitive impairment, Alzheimer's disease dementia, and predictors of driving cessation: A 7-year longitudinal prospective study.
    J Alzheimers Dis. 2025 Apr 22:13872877251333705. doi: 10.1177/13872877251333705.
    PubMed     Abstract available


  316. WANG S, Ni J, Wei M, Li T, et al
    Impact of obesity on neuropsychiatric symptoms in Alzheimer's disease: Insights from the ADNI cohort.
    J Alzheimers Dis. 2025 Apr 22:13872877251331974. doi: 10.1177/13872877251331974.
    PubMed     Abstract available


  317. JAMAL R, Shaikh MA, Taleuzzaman M, Haque Z, et al
    Key biomarkers in Alzheimer's disease: Insights for diagnosis and treatment strategies.
    J Alzheimers Dis. 2025 Apr 21:13872877251330500. doi: 10.1177/13872877251330500.
    PubMed     Abstract available


  318. MALEK J, Levchenko A, Robinson JO, Fong J, et al
    Dilemmas in diagnosing Alzheimer's disease: The peril and promise of self-fulfilling prophecies.
    J Alzheimers Dis. 2025 Apr 21:13872877251331236. doi: 10.1177/13872877251331236.
    PubMed     Abstract available


  319. KIM H, Kulshreshtha A, Alonso A, Goldstein FC, et al
    The association between pulse wave velocity and cerebrospinal fluid biomarkers for Alzheimer's disease.
    J Alzheimers Dis. 2025 Apr 21:13872877251331235. doi: 10.1177/13872877251331235.
    PubMed     Abstract available


  320. SUN J, Teng F, Cao Y, Pei H, et al
    Peripheral blood immune cell phenotypes and Alzheimer's disease: A mediation Mendelian randomization study.
    J Alzheimers Dis. 2025 Apr 15:13872877251330503. doi: 10.1177/13872877251330503.
    PubMed     Abstract available


  321. ASHMAWY RE, Okesanya OJ, Ukoaka BM, Daniel FM, et al
    Exploring the efficacy and safety of lecanemab in the management of early Alzheimer's disease: A systematic review of clinical evidence.
    J Alzheimers Dis. 2025 Apr 15:13872877251331640. doi: 10.1177/13872877251331640.
    PubMed     Abstract available


  322. SEGIET N, Poczatek G, Drzazga J, Laskowska-Wronarowicz A, et al
    Effectiveness of structured cognitive intervention among patients diagnosed with late-onset Alzheimer's disease: Report from a pilot study.
    J Alzheimers Dis. 2025 Apr 15:13872877251331184. doi: 10.1177/13872877251331184.
    PubMed     Abstract available


  323. SAAOUD F, Liu L, Xu K, Lu Y, et al
    Alzheimer's disease as an auto-innate immune pathology with potential cell trans-differentiation and enhanced trained immunity in 3xTg-AD mouse model.
    J Alzheimers Dis. 2025 Apr 15:13872877251329583. doi: 10.1177/13872877251329583.
    PubMed     Abstract available


  324. PARKS AL, Thacker A, Dohan D, Gomez LAR, et al
    A qualitative study of people with Alzheimer's disease in a memory clinic considering lecanemab treatment.
    J Alzheimers Dis. 2025 Apr 10:13872877251329519. doi: 10.1177/13872877251329519.
    PubMed     Abstract available


  325. TONG H, Petyuk VA, Sendtner M, Sood A, et al
    Alzheimer's disease-related cortical proteins modify the association of brain insulin signaling with cognitive decline.
    J Alzheimers Dis. 2025 Apr 4:13872877251319463. doi: 10.1177/13872877251319463.
    PubMed     Abstract available


  326. KARKKAINEN V, Saari T, Hannonen S, Rusanen M, et al
    Altered tear fluid protein expression in persons with mild Alzheimer's disease in proteins involved in oxidative stress, protein synthesis, and energy metabolism.
    J Alzheimers Dis. 2025 Apr 4:13872877251326868. doi: 10.1177/13872877251326868.
    PubMed     Abstract available


  327. MARTINEZ JE, Bocanegra Y, Baena A, Langella S, et al
    Religious stress coping is associated with lower entorhinal tau pathology and better memory performance in autosomal dominant Alzheimer's disease.
    J Alzheimers Dis. 2025 Apr 3:13872877251331569. doi: 10.1177/13872877251331569.
    PubMed     Abstract available


  328. CORDEIRO AMT, Singulani MP, Talib LL, Forlenza OV, et al
    Down syndrome and Alzheimer's disease: Oxidative stress in the neurodegenerative process.
    J Alzheimers Dis. 2025 Apr 3:13872877251326291. doi: 10.1177/13872877251326291.
    PubMed     Abstract available


  329. DEVERKA PA, Arias JJ, Lin GA, Zwerling J, et al
    Alzheimer's disease blood-based biomarker testing: A stakeholder-informed assessment of coverage considerations.
    J Alzheimers Dis. 2025 Apr 1:13872877251329394. doi: 10.1177/13872877251329394.
    PubMed     Abstract available


  330. WANG Y, Wu Z, Zheng Y, Wang H, et al
    Unraveling the genetic underpinnings of mitochondrial traits and associated circulating inflammatory proteins in Alzheimer's disease: Mitochondrial HtrA2-T cell CD5 negative axis.
    J Alzheimers Dis. 2025 Apr 1:13872877251329517. doi: 10.1177/13872877251329517.
    PubMed     Abstract available


  331. ASADA T, Kakuma T, Tanaka M, Araki W, et al
    A statistical method for predicting amyloid-beta deposits from severity, extend, and ratio indices of the (99m)Tc-ECD SPECT.
    J Alzheimers Dis. 2025;104:1281-1289.
    PubMed     Abstract available


  332. WANG J, Wang DZ, Li BH, Yang S, et al
    Elevated circulating cathepsin S levels are associated with cognitive decline and neurodegeneration in a cohort of patients reporting memory complaints.
    J Alzheimers Dis. 2025;104:1147-1153.
    PubMed     Abstract available


  333. BECKER C, Herschung L, Gomm W, Haenisch B, et al
    Dementia diagnosis and prescription of antidementia drugs: An analysis of German claims data (2006-2016).
    J Alzheimers Dis. 2025;104:698-708.
    PubMed     Abstract available


  334. XU S, Fan Y, Mao C, Hu Z, et al
    Multimodal magnetic resonance imaging analysis of early mild cognitive impairment.
    J Alzheimers Dis. 2025;104:1013-1027.
    PubMed     Abstract available


  335. FURUYA Y, Sato K, Niimi Y, Ihara R, et al
    Cognitive function instrument-based anosognosia to predict amyloid status.
    J Alzheimers Dis. 2025;104:995-1000.
    PubMed     Abstract available


    March 2025
  336. GONG C, Song W, Zhu Z, Yang D, et al
    APOE epsilon4 influences the dynamic functional connectivity variability and cognitive performance in Alzheimer's disease.
    J Alzheimers Dis. 2025 Mar 28:13872877251322687. doi: 10.1177/13872877251322687.
    PubMed     Abstract available


  337. VANNINEN A, Erkkila L, Kokkola T, Selander T, et al
    Effect of ventricular volume on cerebrospinal fluid Alzheimer's disease biomarkers in patients with idiopathic normal pressure hydrocephalus.
    J Alzheimers Dis. 2025 Mar 28:13872877251329081. doi: 10.1177/13872877251329081.
    PubMed     Abstract available


  338. BELFORT T, Nogueira ML, Gaigher J, Rangel R, et al
    Comparing patterns of impairment in social cognition between young-onset and late-onset Alzheimer's disease.
    J Alzheimers Dis. 2025 Mar 28:13872877251323046. doi: 10.1177/13872877251323046.
    PubMed     Abstract available


  339. RUAN T, Ling Y, Wu C, Niu Y, et al
    Abnormal epigenetic modification of lysosome and lipid regulating genes in Alzheimer's disease.
    J Alzheimers Dis. 2025 Mar 28:13872877251322955. doi: 10.1177/13872877251322955.
    PubMed     Abstract available


  340. SHEN Y, Nie Q, Xiang W, Chen S, et al
    The relationship between Alzheimer's disease and intracerebral hemorrhage based on Mendelian randomization.
    J Alzheimers Dis. 2025 Mar 28:13872877251323294. doi: 10.1177/13872877251323294.
    PubMed     Abstract available


  341. XUE RJ, Gao PY, Chen YM, Liu Y, et al
    Associations between plasma complement C1q and cerebrospinal fluid biomarkers of Alzheimer's disease pathology in cognitively intact adults: The CABLE study.
    J Alzheimers Dis. 2025 Mar 26:13872877251322808. doi: 10.1177/13872877251322808.
    PubMed     Abstract available


  342. WANG S, Luo G, Sun G, Zhang M, et al
    A polymorphism in the BIN1 gene influences its expression and is associated with the risk of Alzheimer's disease: An integrated analysis.
    J Alzheimers Dis. 2025 Mar 26:13872877251326273. doi: 10.1177/13872877251326273.
    PubMed     Abstract available


  343. HOWARD KA, Massimo LM, Witrick B, Zhang L, et al
    Investigation of risk of Alzheimer's disease diagnosis and survival based on variation to life experiences used to operationalize cognitive reserve.
    J Alzheimers Dis. 2025 Mar 26:13872877251326818. doi: 10.1177/13872877251326818.
    PubMed     Abstract available


  344. ROBERTS H, Fang Y, Quinn K, Hill T, et al
    Lifespan of male and female APP/PS1 and APP(NL-F/NL-F) mouse models of Alzheimer's disease.
    J Alzheimers Dis. 2025 Mar 26:13872877251325878. doi: 10.1177/13872877251325878.
    PubMed     Abstract available


  345. JEONG S, Lin L, Leone AP, Hsu YH, et al
    Type 2 diabetes and late-onset Alzheimer's disease and related dementia: A longitudinal cohort study integrating polygenic risk score.
    J Alzheimers Dis. 2025 Mar 25:13872877251326107. doi: 10.1177/13872877251326107.
    PubMed     Abstract available


  346. SCHAEFER SY, Reed AM, Duff K
    Validating a brief performance-based measure of cognition and daily functioning in amnestic mild cognitive impairment and mild Alzheimer's disease.
    J Alzheimers Dis. 2025 Mar 25:13872877251320379. doi: 10.1177/13872877251320379.
    PubMed     Abstract available


  347. SLADE B, Williams B, Engelbrecht R, Ciorciari J, et al
    Improving executive functioning and reducing the risk of Alzheimer's disease with music therapy: A narrative review of potential neural mechanisms.
    J Alzheimers Dis. 2025 Mar 24:13872877251327762. doi: 10.1177/13872877251327762.
    PubMed     Abstract available


  348. DE RIJKE TJ, Vasseur D, van der Flier WM, Minkman MM, et al
    Exploring interdisciplinary perspectives on the implementation of personalized medicine and patient-orchestrated care in Alzheimer's disease: A qualitative study within the ABOARD research project.
    J Alzheimers Dis. 2025 Mar 21:13872877251326166. doi: 10.1177/13872877251326166.
    PubMed     Abstract available


  349. SORDU P, Alaylioglu M, Samanci B, Bulu E, et al
    Cerebrospinal fluid HSP90AA1, HSPA4, and STUB1/CHIP levels in Alzheimer's disease, mild cognitive impairment, and frontotemporal dementia.
    J Alzheimers Dis. 2025 Mar 21:13872877251329540. doi: 10.1177/13872877251329540.
    PubMed     Abstract available


  350. KRAAKE S, Luppa M, Saur D, Dietzel J, et al
    Social functioning in individuals with Alzheimer's disease and the situation of caregivers.
    J Alzheimers Dis. 2025 Mar 21:13872877251326029. doi: 10.1177/13872877251326029.
    PubMed     Abstract available


  351. WILLIAMS JP, Zhu Y, Singh RK, Beyene K, et al
    The effect of anti-seizure medications on Alzheimer's disease (AD) risk and AD-related symptoms: A scoping review.
    J Alzheimers Dis. 2025 Mar 21:13872877251324663. doi: 10.1177/13872877251324663.
    PubMed     Abstract available


  352. ARRIOLA-INFANTE JE, Garcia-Roldan E, Garcia-Solis D, Marin-Cabanas AM, et al
    TMA-93 (binding by images): Cutoffs optimization based on Alzheimer's disease biomarkers.
    J Alzheimers Dis. 2025 Mar 21:13872877251325759. doi: 10.1177/13872877251325759.
    PubMed     Abstract available


  353. MACIVER MB, Pearce RA
    Reduced GABA(A, slow) synaptic inhibition in Alzheimer's disease.
    J Alzheimers Dis. 2025 Mar 21:13872877251328940. doi: 10.1177/13872877251328940.
    PubMed     Abstract available


  354. YANG B, Teymur A, Tang C, Wu T, et al
    V-set and immunoglobulin domain containing 4 as a potential predictor of Alzheimer's disease and advanced aging.
    J Alzheimers Dis. 2025 Mar 21:13872877251329463. doi: 10.1177/13872877251329463.
    PubMed     Abstract available


  355. RICHTER N, Breidenbach L, Schmieschek MH, Heiss WD, et al
    Alzheimer-typical temporo-parietal atrophy and hypoperfusion are associated with a more significant cholinergic impairment in amnestic neurodegenerative syndromes.
    J Alzheimers Dis. 2025 Mar 21:13872877251324080. doi: 10.1177/13872877251324080.
    PubMed     Abstract available


  356. LI F, Zheng M, Jia J
    Validate association of gene loci and establish genetic risk prediction models for late-onset Alzheimer's disease in Chinese populations.
    J Alzheimers Dis. 2025 Mar 21:13872877251326283. doi: 10.1177/13872877251326283.
    PubMed     Abstract available


  357. XU X, Mo X, Zhang W, Liu D, et al
    Local and distant atrophy mediate the relationship between tau pathology and cognition in temporoparietal region in Alzheimer's disease.
    J Alzheimers Dis. 2025 Mar 21:13872877251322539. doi: 10.1177/13872877251322539.
    PubMed     Abstract available


  358. ABDULLAH L, Zhou Z, Hall J, Petersen M, et al
    Association of Alzheimer's disease biomarkers with low premorbid intellectual functioning in a multi-ethnic community-dwelling cohort: A cross-sectional study of HABS-HD.
    J Alzheimers Dis. 2025 Mar 21:13872877251322966. doi: 10.1177/13872877251322966.
    PubMed     Abstract available


  359. VASILEVA-METODIEV SZ, Spargo D, Klein EG, Quevenco FC, et al
    Diagnostic journey and management of patients with mild cognitive impairment and Alzheimer's disease dementia: A multinational, real-world survey.
    J Alzheimers Dis. 2025 Mar 20:13872877251322978. doi: 10.1177/13872877251322978.
    PubMed     Abstract available


  360. AYAZ G, Sordu P, Kucuksezer UC, Hanagasi H, et al
    Association of glycoprotein 1b and miR-26a-5p levels with platelet function in Alzheimer's disease.
    J Alzheimers Dis. 2025 Mar 20:13872877251326204. doi: 10.1177/13872877251326204.
    PubMed     Abstract available


  361. HU D, Chen M, Li X, Daley S, et al
    ApoE epsilon4-dependent Alteration of CXCR3 (+) CD127(+) CD4(+) T cells associates with elevated plasma neurofilament light chain in Alzheimer's disease.
    J Alzheimers Dis. 2025 Mar 20:13872877251320123. doi: 10.1177/13872877251320123.
    PubMed     Abstract available


  362. KATONOVA A, Andel R, Jurasova V, Veverova K, et al
    Associations of KLOTHO-VS heterozygosity and alpha-Klotho protein with cerebrospinal fluid Alzheimer's disease biomarkers.
    J Alzheimers Dis. 2025 Mar 20:13872877251326199. doi: 10.1177/13872877251326199.
    PubMed     Abstract available


  363. FUSEYA K, Mimura Y, Nakajima S, Mimura M, et al
    A systematic review and meta-analysis on the characteristics of transcranial magnetic stimulation treatment protocols for patients with Alzheimer's disease.
    J Alzheimers Dis. 2025 Mar 20:13872877251325887. doi: 10.1177/13872877251325887.
    PubMed     Abstract available


  364. WIMO A, Handels R, Blennow K, Kirsebom KB, et al
    Cost-effectiveness of diagnosing and treating patients with early Alzheimer's disease with anti-amyloid treatment in a clinical setting.
    J Alzheimers Dis. 2025 Mar 20:13872877251323231. doi: 10.1177/13872877251323231.
    PubMed     Abstract available


  365. ALAMI M, Zerif E, Khalil A, Hajji N, et al
    Neuroprotective effects of SGLT2 inhibitors empagliflozin and dapagliflozin on Abeta(1-42)-induced neurotoxicity and neuroinflammation in cellular models of Alzheimer's disease.
    J Alzheimers Dis. 2025 Mar 20:13872877251329474. doi: 10.1177/13872877251329474.
    PubMed     Abstract available


  366. GUI S, Zeng F, Wu Z, Nonaka S, et al
    Lipopolysaccharides from Porphyromonas gingivalis indirectly induce neuronal GSK3beta-dependent synaptic defects and cause cognitive decline in a low-amyloid-beta-concentration environment in Alzheimer's disease.
    J Alzheimers Dis. 2025 Mar 20:13872877251326879. doi: 10.1177/13872877251326879.
    PubMed     Abstract available


  367. LALIVE HM, Griffa A, Pini L, Rouaud O, et al
    Biomarkers do not paint the whole picture: The role of clinical expertise and advanced neuroimaging for Alzheimer's disease diagnosis.
    J Alzheimers Dis. 2025 Mar 20:13872877251328953. doi: 10.1177/13872877251328953.
    PubMed     Abstract available


  368. MEWS MA, Naj AC, Griswold AJ, Below JE, et al
    Brain and blood transcriptome-wide association studies identify five novel genes associated with Alzheimer's disease.
    J Alzheimers Dis. 2025 Mar 20:13872877251326288. doi: 10.1177/13872877251326288.
    PubMed     Abstract available


  369. CHEN YH, Wang ZB, Liu XP, Mao ZQ, et al
    Cerebrospinal fluid LMO4 as a synaptic biomarker linked to Alzheimer's disease pathology and cognitive decline.
    J Alzheimers Dis. 2025 Mar 19:13872877251326286. doi: 10.1177/13872877251326286.
    PubMed     Abstract available


  370. LEI S, Liu Y
    Identifying microglia-derived NFKBIA as a potential contributor to the pathogenesis of Alzheimer's disease and age-related macular degeneration.
    J Alzheimers Dis. 2025 Mar 19:13872877251326267. doi: 10.1177/13872877251326267.
    PubMed     Abstract available


  371. SIMMATIS LE, Russo EE, Steininger T, Riddell H, et al
    EEG biomarkers for Alzheimer's disease: A novel automated pipeline for detecting and monitoring disease progression.
    J Alzheimers Dis. 2025 Mar 18:13872877251327754. doi: 10.1177/13872877251327754.
    PubMed     Abstract available


  372. DZIANOK P, Wojciechowski J, Wolak T, Kublik E, et al
    Alzheimer's disease-like features in resting state EEG/fMRI of cognitively intact and healthy middle-aged APOE/PICALM risk carriers.
    J Alzheimers Dis. 2025 Mar 17:13872877251317489. doi: 10.1177/13872877251317489.
    PubMed     Abstract available


  373. ZHANG Z, Cui L, Huang L, Guan YH, et al
    Development and validation of the Chinese Naming Test (CNT): Diagnostic efficacy and correlation with Alzheimer's disease biomarkers.
    J Alzheimers Dis. 2025 Mar 17:13872877251324100. doi: 10.1177/13872877251324100.
    PubMed     Abstract available


  374. LU Y, Li D, Yu Y, Wang Q, et al
    Cerebrospinal fluid VGF is associated with the onset and progression of Alzheimer's disease.
    J Alzheimers Dis. 2025 Mar 17:13872877251323002. doi: 10.1177/13872877251323002.
    PubMed     Abstract available


  375. ZEISS CJ, Huttner A, Nairn AC, Arnsten A, et al
    The neuropathologic basis for translational biomarker development in the macaque model of late-onset Alzheimer's disease.
    J Alzheimers Dis. 2025 Mar 17:13872877251323787. doi: 10.1177/13872877251323787.
    PubMed     Abstract available


  376. YANG Y, Li Y, Chen Y
    Changes in transcriptional regulation in the temporal lobe in patients with Alzheimer's disease.
    J Alzheimers Dis. 2025 Mar 17:13872877251322536. doi: 10.1177/13872877251322536.
    PubMed     Abstract available


  377. ZHANG C, Tai Y, Kong M, Jia P, et al
    Synergistic associations of amyloid-beta and phosphorylated tau with tau aggregation and cognitive decline in Alzheimer's disease.
    J Alzheimers Dis. 2025 Mar 17:13872877251322196. doi: 10.1177/13872877251322196.
    PubMed     Abstract available


  378. LIN YJ, Liu Y, Sheng ZH, Fu Y, et al
    The associations of cerebrospinal fluid ApoE and C1q with Alzheimer's disease biomarkers.
    J Alzheimers Dis. 2025 Mar 17:13872877251320419. doi: 10.1177/13872877251320419.
    PubMed     Abstract available


  379. ISHIKAWA-TAKATA K, Fujiwara K, Tanaka T, Nakamura K, et al
    Associations of dietary protein and amino acid intakes with disability-adjusted life years for Alzheimer's disease in Japanese people.
    J Alzheimers Dis. 2025 Mar 14:13872877251319535. doi: 10.1177/13872877251319535.
    PubMed     Abstract available


  380. PIERCE ME, Logue M, Sherva R, Miller M, et al
    Association of Alzheimer's disease genetic risk with age-dependent changes in plasma amyloid-beta(42:40) in Veterans.
    J Alzheimers Dis. 2025 Mar 14:13872877251321183. doi: 10.1177/13872877251321183.
    PubMed     Abstract available


  381. WANG D, Scalici A, Wang Y, Lin H, et al
    Frequency of variants in Mendelian Alzheimer's disease genes within the Alzheimer's Disease Sequencing Project.
    J Alzheimers Dis. 2025 Mar 14:13872877251320375. doi: 10.1177/13872877251320375.
    PubMed     Abstract available


  382. TREMBLAY C, Shakir N, Zhang N, Adler CH, et al
    Associations between neuropsychiatric symptoms and pathology in clinicopathologically defined Alzheimer's disease, Alzheimer's disease with Lewy bodies, and dementia with Lewy bodies.
    J Alzheimers Dis. 2025 Mar 14:13872877251320670. doi: 10.1177/13872877251320670.
    PubMed     Abstract available


  383. ALVES L, Hashiguchi D, Loss CM, van Praag H, et al
    Vascular dysfunction in Alzheimer's disease: Exploring the potential of aerobic and resistance exercises as therapeutic strategies.
    J Alzheimers Dis. 2025 Mar 13:13872877251321118. doi: 10.1177/13872877251321118.
    PubMed     Abstract available


  384. BARRETT-YOUNG A, Reuben A, Caspi A, Cheyne K, et al
    Measures of retinal health successfully capture risk for Alzheimer's disease and related dementias at midlife.
    J Alzheimers Dis. 2025 Mar 3:13872877251321114. doi: 10.1177/13872877251321114.
    PubMed     Abstract available


  385. SHARDELL M, Chen C
    Genetic geroscience and Alzheimer's disease: The pleiotropy is the point!
    J Alzheimers Dis. 2025 Mar 3:13872877251321182. doi: 10.1177/13872877251321182.
    PubMed     Abstract available


  386. ZEGARRA-VALDIVIA JA, Shany-Ur T, Rijpma MG, Callahan P, et al
    Validation of the Cognitive-Emotional Perspective Taking test in patients with neurodegeneration.
    J Alzheimers Dis. 2025 Mar 3:13872877251317683. doi: 10.1177/13872877251317683.
    PubMed     Abstract available


  387. MORITO T, Watamura N, Sasaguri H, Tomita T, et al
    Experimental basis for generating nonhuman primate models of frontotemporal dementia and Alzheimer's disease.
    J Alzheimers Dis. 2025 Mar 2:13872877251321116. doi: 10.1177/13872877251321116.
    PubMed     Abstract available


  388. WANG SY, Huang ZH, Duan R, Fu XX, et al
    IL-34/TREM2 modulates microglia-mediated inflammation and provides neuroprotection in a mouse model of sporadic Alzheimer's disease.
    J Alzheimers Dis. 2025 Mar 2:13872877251320418. doi: 10.1177/13872877251320418.
    PubMed     Abstract available


  389. YANG J, Ding H, Li Y, Ang TFA, et al
    Association of mid-age Life's Essential 8 score with digital cognitive performance and incident Alzheimer's disease: The Framingham Heart Study.
    J Alzheimers Dis. 2025 Mar 2:13872877251317734. doi: 10.1177/13872877251317734.
    PubMed     Abstract available


  390. BOHN L, Zheng Y, McFall GP, Andrew MK, et al
    Frailty in motion: Amnestic mild cognitive impairment and Alzheimer's disease cohorts display heterogeneity in multimorbidity classification and longitudinal transitions.
    J Alzheimers Dis. 2025 Mar 2:13872877251319547. doi: 10.1177/13872877251319547.
    PubMed     Abstract available


  391. KIM JW, Byun MS, Yi D, Jung JH, et al
    Daily fluid intake and brain amyloid deposition: A cohort study.
    J Alzheimers Dis. 2025;104:138-149.
    PubMed     Abstract available


  392. YANG Q, Yang H, Long W, Zuo S, et al
    Rapid cognitive assessment: Accuracy and discriminant validity of Mini-Cog and process-based Clock Drawing Test.
    J Alzheimers Dis. 2025;104:200-208.
    PubMed     Abstract available


  393. SALMAN Y, Huyghe L, Quenon L, Ghysens O, et al
    Autopsy-proven patient with corticobasal degeneration presenting with visuo-constructive disorders as initial symptoms: How advanced MRI sequences can help clinical practice.
    J Alzheimers Dis. 2025;104:158-172.
    PubMed     Abstract available


  394. PARK SA, An YS, Park YJ, Lee JY, et al
    Comparative analysis of Elecsys and ELISA for differentiating amyloid-PET status in a Korean memory clinic based on cerebrospinal fluid biomarkers.
    J Alzheimers Dis. 2025;104:232-244.
    PubMed     Abstract available


  395. KUMAR WS, Bhutare SR, Sinha N, Issac TG, et al
    Bayesian network modeling of statistical dependency within cognitive domains and clinical dementia severity ratings for Western and Indian cohorts.
    J Alzheimers Dis. 2025;104:221-231.
    PubMed     Abstract available


  396. LIGUORI C
    Obstructive sleep apnea is a common diagnosis in patients admitted at the memory clinic: Please screen for it!
    J Alzheimers Dis. 2025;104:40-42.
    PubMed     Abstract available


  397. D'ANTONIO F, Vivacqua G, Serrentino M, Nalepa M, et al
    Salivary biomarkers for the molecular diagnosis of dementia with Lewy bodies.
    J Alzheimers Dis. 2025;104:452-462.
    PubMed     Abstract available


  398. HAJJAR SH, Alsaad SM, AlFouzan MA, Rohaiem SN, et al
    Dementia prevalence within the Kingdom of Saudi Arabia National Guard Health System (2015-2023): An exploratory epidemiological study.
    J Alzheimers Dis. 2025;104:488-497.
    PubMed     Abstract available


  399. ZHU S, Ni J, Long S, Teng Y, et al
    Androgen deprivation therapy and dementia risk: An updated and dose-response meta-analysis.
    J Alzheimers Dis. 2025;104:547-562.
    PubMed     Abstract available


  400. JANG JW, Lee SH, Kim T, Lee E, et al
    Hearing loss and the risk of dementia: A longitudinal analysis of the Korean National Health Insurance Service Senior Cohort.
    J Alzheimers Dis. 2025;104:364-373.
    PubMed     Abstract available


  401. MAYAN I, Roth H, Ghosh D, Whitson HE, et al
    Genetic and biomarker disclosure process in a memory and aging study.
    J Alzheimers Dis. 2025;104:312-318.
    PubMed     Abstract available


    February 2025
  402. CHRISTIMANN G, Rocha G, Sattler JAG
    Bioactive compounds and dietary patterns in Alzheimer's disease.
    J Alzheimers Dis. 2025 Feb 26:13872877251319048. doi: 10.1177/13872877251319048.
    PubMed     Abstract available


  403. RENTOUMI V, Vassiliou E, Pittaras N, Demiraj A, et al
    Linguistic cues for automatic assessment of Alzheimer's disease across languages.
    J Alzheimers Dis. 2025 Feb 25:13872877251319401. doi: 10.1177/13872877251319401.
    PubMed     Abstract available


  404. BRADEN-KUHLE PN, Lacy VA, Brice KN, Bertrand ME, et al
    A Mediterranean-style diet protects against cognitive and behavioral deficits, adiposity, and Alzheimer's disease-related markers, compared to a macronutrient-matched typical American diet in C57BL/6J mice.
    J Alzheimers Dis. 2025 Feb 25:13872877251319467. doi: 10.1177/13872877251319467.
    PubMed     Abstract available


  405. STOJANOVIC M, Millar PR, McKay NS, Aschenbrenner AJ, et al
    The associations between attentional control, episodic memory, and Alzheimer's disease biomarkers of tau and neurodegeneration.
    J Alzheimers Dis. 2025 Feb 24:13872877251316801. doi: 10.1177/13872877251316801.
    PubMed     Abstract available


  406. ALHARBI AA, Alatwi HE, Albulaihe H, Algarzae NK, et al
    Alzheimer's disease in the Kingdom of Saudi Arabia: Current perspectives and genetic insights.
    J Alzheimers Dis. 2025 Feb 24:13872877251316122. doi: 10.1177/13872877251316122.
    PubMed     Abstract available


  407. RANDLOVA K, Pazitny P, Kandilaki D
    Institutionalization of persons with Alzheimer's disease in the Czech and Slovak Republics.
    J Alzheimers Dis. 2025 Feb 24:13872877251317987. doi: 10.1177/13872877251317987.
    PubMed     Abstract available


  408. WANG H, Qin N, Maimaitiaili D, Wu J, et al
    Transcranial electrical stimulation as a therapeutic strategy for Alzheimer's disease: Current uses and challenges.
    J Alzheimers Dis. 2025 Feb 24:13872877251315777. doi: 10.1177/13872877251315777.
    PubMed     Abstract available


  409. GAO X, Sun Z, Hu J, Li Y, et al
    Identification of the enzymatic cleavage relationship between anti-aging protein alpha-Klotho and Alzheimer's disease biomarker BACE1.
    J Alzheimers Dis. 2025 Feb 24:13872877251317730. doi: 10.1177/13872877251317730.
    PubMed     Abstract available


  410. LIN SW, Hsu YH, Yang JJ, Tu MC, et al
    A higher vertebrobasilar pulsatility index is associated with lower parietal perfusion in Alzheimer's disease.
    J Alzheimers Dis. 2025 Feb 24:13872877251314140. doi: 10.1177/13872877251314140.
    PubMed     Abstract available


  411. DONG YT, Luo X, Zhang LL, Gong YM, et al
    Genetic colocalization of cathepsins H, D, and L1 with Alzheimer's disease: Implications for biomarker and therapeutic target discovery.
    J Alzheimers Dis. 2025 Feb 21:13872877251314058. doi: 10.1177/13872877251314058.
    PubMed     Abstract available


  412. FIALA M, Hammock BD, Hwang SH, Whitelegge J, et al
    Inhibitors of soluble epoxide hydrolase and cGAS/STING repair defects in amyloid-beta clearance underlying vascular complications of Alzheimer's disease.
    J Alzheimers Dis. 2025 Feb 17:13872877241305965. doi: 10.1177/13872877241305965.
    PubMed     Abstract available


  413. WEISS JN, Eber D
    Earlier diagnosis of Alzheimer's disease by dynamic light scattering spectroscopy.
    J Alzheimers Dis. 2025 Feb 16:13872877251319352. doi: 10.1177/13872877251319352.
    PubMed     Abstract available


  414. CHEN ZQ, Wang MT, Tan CR, Huang S, et al
    Clinical relevance of plasma ADAM-17 with cognition and neurodegeneration in Alzheimer's disease.
    J Alzheimers Dis. 2025 Feb 16:13872877251317659. doi: 10.1177/13872877251317659.
    PubMed     Abstract available


  415. MICHELUTTI M, Urso D, Tafuri B, Gnoni V, et al
    Structural covariance network patterns linked to neuropsychiatric symptoms in biologically defined Alzheimer's disease: Insights from the mild behavioral impairment checklist.
    J Alzheimers Dis. 2025 Feb 16:13872877251316794. doi: 10.1177/13872877251316794.
    PubMed     Abstract available


  416. CLAUS JJ, Rosbergen MT, Roshchupkin GV, Ikram MA, et al
    Validation of a novel neuroimaging signature for dementia and clinical Alzheimer's disease in the population-based Rotterdam study.
    J Alzheimers Dis. 2025 Feb 16:13872877251315044. doi: 10.1177/13872877251315044.
    PubMed     Abstract available


  417. KASAHARA H, Ikeda M, Makioka K, Nakamura T, et al
    White matter lesions rather than amyloid-beta burden are associated with cognitive decline in Alzheimer's disease.
    J Alzheimers Dis. 2025 Feb 16:13872877251316516. doi: 10.1177/13872877251316516.
    PubMed     Abstract available


  418. PAN N, Liu S, Ge X, Zheng Y, et al
    Association of hippocampal atrophy with tau pathology of temporal regions in preclinical Alzheimer's disease.
    J Alzheimers Dis. 2025 Feb 16:13872877251314785. doi: 10.1177/13872877251314785.
    PubMed     Abstract available


  419. XAVIER C, Pinto N
    Navigating the blurred boundary: Neuropathologic changes versus clinical symptoms in Alzheimer's disease, and its consequences for research in genetics.
    J Alzheimers Dis. 2025 Feb 16:13872877251317543. doi: 10.1177/13872877251317543.
    PubMed     Abstract available


  420. ONIFADE IA, Umar HI, Aborode AT, Awaji AA, et al
    In silico study of selected alkaloids as dual inhibitors of beta- and gamma-secretases for Alzheimer's disease.
    J Alzheimers Dis. 2025 Feb 16:13872877241313049. doi: 10.1177/13872877241313049.
    PubMed     Abstract available


  421. NETSYK O, Korol SV, Li JP, Birnir B, et al
    GABA-activated slow spontaneous inhibitory postsynaptic currents are decreased in dorsal hippocampal dentate gyrus granule cells in an aged mouse model of Alzheimer's disease.
    J Alzheimers Dis. 2025 Feb 16:13872877251317608. doi: 10.1177/13872877251317608.
    PubMed     Abstract available


  422. SHENG ZH, Liu JY, Ma JY, Mi YC, et al
    Frailty increases the risk of Alzheimer's disease in non-demented individuals: A longitudinal cohort study.
    J Alzheimers Dis. 2025 Feb 16:13872877241309081. doi: 10.1177/13872877241309081.
    PubMed     Abstract available


  423. CAI C, Kato T, Arahata Y, Takeda A, et al
    Altered functional connectivity between primary visual cortex and cerebellum in Alzheimer's disease.
    J Alzheimers Dis. 2025 Feb 16:13872877241303849. doi: 10.1177/13872877241303849.
    PubMed     Abstract available


  424. WILLIAMS LA, Terhorst L, Williams IC, Skidmore E, et al
    Perceived risk of Alzheimer's disease: Insights into the Black and African American male perspective.
    J Alzheimers Dis. 2025 Feb 9:13872877251317151. doi: 10.1177/13872877251317151.
    PubMed     Abstract available


  425. WEN C, Gan JH, Liu S, Lu H, et al
    Enlarged perivascular spaces correlate with blood-brain barrier leakage and cognitive impairment in Alzheimer's disease.
    J Alzheimers Dis. 2025 Feb 9:13872877251317220. doi: 10.1177/13872877251317220.
    PubMed     Abstract available


  426. SILVA RPDS, Barbosa BJAP
    Exploring the potential of acupuncture as a complementary treatment for Alzheimer's disease: Pushing the boundaries forward.
    J Alzheimers Dis. 2025 Feb 9:13872877251316572. doi: 10.1177/13872877251316572.
    PubMed     Abstract available


  427. TAWEEPHOL T, Pongpitakmetha T, Booncharoen K, Khieukhajee J, et al
    Short communication: Evaluating roles of plasma glial fibrillary acidic protein as Alzheimer's disease biomarker in real-world multi-center memory clinics in Thailand.
    J Alzheimers Dis. 2025 Feb 9:13872877251316546. doi: 10.1177/13872877251316546.
    PubMed     Abstract available


  428. LU C, Zhou J
    Analysis of the causal relationship between five chosen factors and early-onset Alzheimer's disease: A Mendelian randomization study.
    J Alzheimers Dis. 2025 Feb 9:13872877241310248. doi: 10.1177/13872877241310248.
    PubMed     Abstract available


  429. NDUKWE K, Serrano PA, Rockwell P, Xie L, et al
    Brain-penetrant histone deacetylase inhibitor RG2833 improves spatial memory in females of an Alzheimer's disease rat model.
    J Alzheimers Dis. 2025 Feb 9:13872877251314777. doi: 10.1177/13872877251314777.
    PubMed     Abstract available


  430. TIAN Q, Dong Q, Su Z, Liu Y, et al
    Association of body weight and serum uric acid with Alzheimer's disease biomarkers and cognitive impairment.
    J Alzheimers Dis. 2025 Feb 9:13872877251315011. doi: 10.1177/13872877251315011.
    PubMed     Abstract available


  431. PRIGATANO GP, Braga LW, McElvogue M, Coddaire K, et al
    Motor correlates of finger tapping variability in subjective memory complaints, mild cognitive impairment and probable Alzheimer's disease.
    J Alzheimers Dis. 2025 Feb 7:13872877241312984. doi: 10.1177/13872877241312984.
    PubMed     Abstract available


  432. GUO R, Li D, Li F, Ji L, et al
    Effects of whole-head 810 nm near-infrared therapy on cognitive and neuropsychiatric symptoms in Alzheimer's disease: A pilot study.
    J Alzheimers Dis. 2025 Feb 5:13872877251313819. doi: 10.1177/13872877251313819.
    PubMed     Abstract available


  433. RAMIREZ-GOMEZ J, Dalal S, Devara D, Sharma B, et al
    MicroRNA-based recent research developments in Alzheimer's disease.
    J Alzheimers Dis. 2025 Feb 2:13872877241313397. doi: 10.1177/13872877241313397.
    PubMed     Abstract available


  434. KHALED M, Al-Jamal H, Matar D, Ibrahim A, et al
    Unveiling the link between APOE epsilon4, environmental factors, and Alzheimer's disease in North Lebanon: A case-control study.
    J Alzheimers Dis. 2025 Feb 2:13872877241307307. doi: 10.1177/13872877241307307.
    PubMed     Abstract available


  435. YANG X, Wang J, Jia X, Yang Y, et al
    Microglial polarization in Alzheimer's disease: Mechanisms, implications, and therapeutic opportunities.
    J Alzheimers Dis. 2025 Feb 2:13872877241313223. doi: 10.1177/13872877241313223.
    PubMed     Abstract available


  436. S M, Roy D, Menon AJ, G S, et al
    Exploring predementia: Understanding the characteristics of subjective cognitive decline plus from India.
    J Alzheimers Dis. 2025;103:966-973.
    PubMed     Abstract available


  437. GE W, Yan Y, Hu Y, Lin S, et al
    Unveiling the safety profile of lecanemab: A comprehensive analysis of adverse events using FDA adverse event reporting system data.
    J Alzheimers Dis. 2025;103:844-855.
    PubMed     Abstract available


  438. LI D, An B, Men L, Glittenberg M, et al
    The association of high-density lipoprotein cargo proteins with brain volume in older adults in the Atherosclerosis Risk in Communities (ARIC).
    J Alzheimers Dis. 2025;103:724-734.
    PubMed     Abstract available


  439. WANG Y, Zhu L, He K, Cui L, et al
    Urinary formic acid is associated with cerebral amyloid deposition and glucose metabolism in memory clinic patients.
    J Alzheimers Dis. 2025;103:1102-1111.
    PubMed     Abstract available


    January 2025
  440. ZHANG E, Dai F, Tao L, Chen Y, et al
    Immune cells: Mediators in the metabolites and Alzheimer's disease.
    J Alzheimers Dis. 2025 Jan 29:13872877241313140. doi: 10.1177/13872877241313140.
    PubMed     Abstract available


  441. ZHANG L, An H, Zhen R, Zhang T, et al
    Di Huang Yi Zhi Fang improves cognitive function in APP/PS1 mice by inducing neuronal mitochondrial autophagy through the PINK1-parkin pathway.
    J Alzheimers Dis. 2025 Jan 28:13872877241299832. doi: 10.1177/13872877241299832.
    PubMed     Abstract available


  442. ROVETA F, Rubino E, Marcinno A, Grassini A, et al
    Diagnostic performance of plasma biomarkers for Alzheimer's disease using a fully automated platform: A real-world clinical study.
    J Alzheimers Dis. 2025 Jan 26:13872877241313145. doi: 10.1177/13872877241313145.
    PubMed     Abstract available


  443. ASHFORD JW
    The VA Million Veteran Program, Alzheimer's disease, and genetics: Important steps forward but many steps still to go on the march to control dementia and Alzheimer's disease.
    J Alzheimers Dis. 2025 Jan 26:13872877241313398. doi: 10.1177/13872877241313398.
    PubMed     Abstract available


  444. SIRIWARDHANA C, Carrazana E, Liow K
    Survival disparities among Alzheimer's disease patients in Hawaii.
    J Alzheimers Dis. 2025 Jan 26:13872877251314144. doi: 10.1177/13872877251314144.
    PubMed     Abstract available


  445. GALVIN JE, Kleiman MJ, Estes PW, Harris HM, et al
    Cognivue Clarity((R)) characterizes amyloid status and preclinical Alzheimer's disease in biomarker confirmed cohorts in the Bio-Hermes Study.
    J Alzheimers Dis. 2025 Jan 26:13872877251314117. doi: 10.1177/13872877251314117.
    PubMed     Abstract available


  446. GILLMAN A, Bourgeat P, Cox T, Villemagne VL, et al
    Digital detector PET/CT increases Centiloid measures of amyloid in Alzheimer's disease: A head-to-head comparison of cameras.
    J Alzheimers Dis. 2025 Jan 26:13872877241313063. doi: 10.1177/13872877241313063.
    PubMed     Abstract available


  447. TOLEA MI, Rosenfeld A, Roy SV, Besser LM, et al
    Gait, balance, and physical performance as markers of early Alzheimer's disease and related dementia risk.
    J Alzheimers Dis. 2025 Jan 26:13872877241313144. doi: 10.1177/13872877241313144.
    PubMed     Abstract available


  448. SHAO J, Youngblood H, Yang L
    Targeting SPI1 to mitigate amyloid-beta pathology in Alzheimer's disease.
    J Alzheimers Dis. 2025 Jan 26:13872877251316593. doi: 10.1177/13872877251316593.
    PubMed     Abstract available


  449. CROOKE PS 3RD, Tossberg JT, Aune TM
    Increased unedited Alu RNA patterns found in cortex extracellular vesicles in Alzheimer's disease resemble hippocampus vasculature Alu RNA editing patterns but not cortex Alu RNA editing patterns.
    J Alzheimers Dis. 2025 Jan 26:13872877241313054. doi: 10.1177/13872877241313054.
    PubMed     Abstract available


  450. PETKUS AJ, Sonti AN, Montoya L, Rowe B, et al
    Sequence of decline on the NIH-toolbox cognitive battery in a predominantly Latino sample with autosomal dominant Alzheimer's disease.
    J Alzheimers Dis. 2025 Jan 26:13872877241312934. doi: 10.1177/13872877241312934.
    PubMed     Abstract available


  451. FU XX, Wei B, Huang ZH, Duan R, et al
    Modulation of mitochondrial functions contributes to the protection of lamotrigine against Alzheimer's disease.
    J Alzheimers Dis. 2025 Jan 21:13872877251314847. doi: 10.1177/13872877251314847.
    PubMed     Abstract available


  452. YANG H, Ning Y, Chen M, Jia J, et al
    SGLT2 inhibition, circulating biomarkers, and Alzheimer's disease: A Mendelian randomization study.
    J Alzheimers Dis. 2025 Jan 21:13872877241309674. doi: 10.1177/13872877241309674.
    PubMed     Abstract available


  453. WANG Z, Liang Q, Lin Z, Li H, et al
    Potential role of formononetin as a novel natural agent in Alzheimer's disease and osteoporosis comorbidity.
    J Alzheimers Dis. 2025 Jan 19:13872877241299104. doi: 10.1177/13872877241299104.
    PubMed     Abstract available


  454. KJAERGAARD D, Simonsen AH, Waldemar G, Nielsen TR, et al
    Ethnic and racial influences on blood biomarkers for Alzheimer's disease: A systematic review.
    J Alzheimers Dis. 2025 Jan 15:13872877241299047. doi: 10.1177/13872877241299047.
    PubMed     Abstract available


  455. DAVID S, Costa AS, Hohenfeld C, Romanzetti S, et al
    Modulating effects of fitness and physical activity on Alzheimer's disease: Implications from a six-month randomized controlled sports intervention.
    J Alzheimers Dis. 2025 Jan 15:13872877241303764. doi: 10.1177/13872877241303764.
    PubMed     Abstract available


  456. TAUFEEQ M, Choudhury A, Hussain A, Alajmi MF, et al
    Discovering potential ERK1 inhibitors from natural products for therapeutic targeting of Alzheimer's disease.
    J Alzheimers Dis. 2025 Jan 15:13872877241309592. doi: 10.1177/13872877241309592.
    PubMed     Abstract available


  457. YANG W, Yu W, Lv Y
    Neuroprotective effects of chitinase-1 and calcitonin gene-related peptide on Alzheimer's disease by promoting lysosomal function.
    J Alzheimers Dis. 2025 Jan 15:13872877241307257. doi: 10.1177/13872877241307257.
    PubMed     Abstract available


  458. LI Y, Sanjay AB, Manchella M, Mishra A, et al
    Effect of genetic and vascular risk factors on rates of cognitive decline in early-onset and late-onset Alzheimer's disease.
    J Alzheimers Dis. 2025 Jan 12:13872877241307321. doi: 10.1177/13872877241307321.
    PubMed     Abstract available


  459. RUIZ-URIBE NE, Manser P, Butcher B, Li Y, et al
    Cross-sectional and prognostic associations of baseline [(18)F]GTP1 tau PET signal and white matter lesion volumes for cognitive and functional decline in prodromal-to-mild Alzheimer's disease.
    J Alzheimers Dis. 2025 Jan 12:13872877241302497. doi: 10.1177/13872877241302497.
    PubMed     Abstract available


  460. XING H, Kant S, Kanuparthy M, Harris D, et al
    Impaired cerebral microvascular reactivity and endothelial SK channel activity in a streptozotocin-treated mouse model of Alzheimer's disease.
    J Alzheimers Dis. 2025 Jan 10:13872877241309120. doi: 10.1177/13872877241309120.
    PubMed     Abstract available


  461. HAN X, Li Y, Wang J, Liu X, et al
    Associations between lifelong cognitive reserve, Alzheimer's disease-related plasma biomarkers, and cognitive function in dementia-free older adults: A population-based study.
    J Alzheimers Dis. 2025 Jan 10:13872877241306448. doi: 10.1177/13872877241306448.
    PubMed     Abstract available


  462. XU F, Shi J
    Insulin signaling and oxidative stress: Bridging the gap between type 2 diabetes mellitus and Alzheimer's disease.
    J Alzheimers Dis. 2025 Jan 10:13872877241307404. doi: 10.1177/13872877241307404.
    PubMed     Abstract available


  463. SHAH J, Krell-Roesch J, Forzani E, Knopman DS, et al
    Predicting cognitive decline from neuropsychiatric symptoms and Alzheimer's disease biomarkers: A machine learning approach to a population-based data.
    J Alzheimers Dis. 2025 Jan 10:13872877241306654. doi: 10.1177/13872877241306654.
    PubMed     Abstract available


  464. WAN T, Wang C
    SMOC2 promotes microglia activity and neuroinflammation in Alzheimer's disease.
    J Alzheimers Dis. 2025 Jan 10:13872877241307337. doi: 10.1177/13872877241307337.
    PubMed     Abstract available


  465. MATSUNAGA M, Tanihara S, He Y, Yatsuya H, et al
    Sex-specific association of comorbid heart failure on mortality after Alzheimer's disease diagnosis in older adults aged 75 years and above: A health insurance claims data analysis in Japan.
    J Alzheimers Dis. 2025 Jan 10:13872877241305813. doi: 10.1177/13872877241305813.
    PubMed     Abstract available


  466. DA SILVA PINTO GM, de Souza Crepalde LO, Scalli ACAM, de Oliveira MPB, et al
    Body composition differences in older adults with and without Alzheimer's disease: A systematic review and meta-analysis of observational studies.
    J Alzheimers Dis. 2025 Jan 10:13872877241304603. doi: 10.1177/13872877241304603.
    PubMed     Abstract available


  467. ALGHAMDI A, de Vos S, Bos JH, Schuiling-Veninga CC, et al
    A matched case-control study on polypharmacy and co-medications one year before drug treatment for Alzheimer's disease.
    J Alzheimers Dis. 2025 Jan 10:13872877241305799. doi: 10.1177/13872877241305799.
    PubMed     Abstract available


  468. LI S, Wang Y, Liang X, Li Y, et al
    Autophagy intersection: Unraveling the role of the SNARE complex in lysosomal fusion in Alzheimer's disease.
    J Alzheimers Dis. 2025 Jan 9:13872877241307403. doi: 10.1177/13872877241307403.
    PubMed     Abstract available


  469. BARKER-HALISKI M
    Seizing the opportunity to therapeutically address neuronal hyperexcitability in Alzheimer's disease.
    J Alzheimers Dis. 2025 Jan 9:13872877241305740. doi: 10.1177/13872877241305740.
    PubMed     Abstract available


  470. SU S, Huang R, Liu Y
    The effects of transcranial direct current stimulation on global cognition in patients with Alzheimer's disease: An update meta-analysis.
    J Alzheimers Dis. 2025 Jan 9:13872877241298303. doi: 10.1177/13872877241298303.
    PubMed     Abstract available


  471. WANG X, Chen L, Li W, He Z, et al
    Association of dipeptidyl peptidase-4 with Alzheimer's disease: A new therapeutic prospect.
    J Alzheimers Dis. 2025 Jan 8:13872877241304673. doi: 10.1177/13872877241304673.
    PubMed     Abstract available


  472. GRAU-JURADO P, Mostafaei S, Xu H, Mo M, et al
    Medications and cognitive decline in Alzheimer's disease: Cohort cluster analysis of 15,428 patients.
    J Alzheimers Dis. 2025 Jan 8:13872877241307870. doi: 10.1177/13872877241307870.
    PubMed     Abstract available


  473. GOODING DC, Van Hulle CA, Zuelsdorff M, Lewis JP, et al
    Perceptions about preclinical Alzheimer's disease biomarker collection procedure influences willingness to participate: Findings from an ethnoracially diverse study.
    J Alzheimers Dis. 2025 Jan 8:13872877241307255. doi: 10.1177/13872877241307255.
    PubMed     Abstract available


  474. WANG P, Dong YL, Li SS, Jin Y, et al
    Integrating network pharmacology and component analysis to investigate the potential mechanisms of Sheng-Hui-Yi-Zhi decoction in the treatment of Alzheimer's disease.
    J Alzheimers Dis. 2025 Jan 8:13872877241305744. doi: 10.1177/13872877241305744.
    PubMed     Abstract available


  475. MERRITT VC, Zhang R, Sherva R, Ly MT, et al
    Curation and validation of electronic medical record-based dementia diagnoses in the VA Million Veteran Program.
    J Alzheimers Dis. 2025;103:180-193.
    PubMed     Abstract available


  476. IMPERIALE D, Atzori C, Angeloro DP, Murgioni A, et al
    Real-life reliability of plasma pTau181, Abeta(42)/Abeta(40), and pTau181/Abeta(42) measured by Lumipulse G600II in predicting cerebrospinal fluid amyloid status.
    J Alzheimers Dis. 2025;103:305-315.
    PubMed     Abstract available


  477. ENGEL MG, Narayan S, Cui MH, Branch CA, et al
    Intranasal long R3 insulin-like growth factor-1 treatment promotes amyloid plaque remodeling in cerebral cortex but fails to preserve cognitive function in male 5XFAD mice.
    J Alzheimers Dis. 2025;103:113-126.
    PubMed     Abstract available


  478. CHEN X, Lin C, He C, Li K, et al
    Icariin improves learning and memory function by enhancing HRD1-mediated ubiquitination of amyloid precursor protein in APP/PS1 mice.
    J Alzheimers Dis. 2025;103:616-626.
    PubMed     Abstract available


  479. WITBRACHT M, Xu Y, Morgan OB, Salazar CR, et al
    Research Attitudes Questionnaire scores and retention in a recruitment registry.
    J Alzheimers Dis. 2025;103:406-418.
    PubMed     Abstract available


  480. HEDDERICH DM, Opfer R, Kruger J, Spies L, et al
    Clinical validation of artificial intelligence-based single-subject morphometry without normative reference database.
    J Alzheimers Dis. 2025;103:542-551.
    PubMed     Abstract available


  481. WEINSTEIN AM, Fang F, Chang CH, Cohen A, et al
    Multimodal neuroimaging biomarkers and subtle cognitive decline in a population-based cohort without dementia.
    J Alzheimers Dis. 2025;103:570-581.
    PubMed     Abstract available


  482. LIM YY, Mills A, Norfolk M, Rosenich E, et al
    Factors influencing rates of unsupervised assessment of short-term learning in cognitively unimpaired adults.
    J Alzheimers Dis. 2025;103:441-451.
    PubMed     Abstract available


  483. JAHANI I, Jahani A, Delrobaei M, Khadem A, et al
    Classifying cognitive impairment based on FDG-PET and combined T1-MRI and rs-fMRI: An ADNI study.
    J Alzheimers Dis. 2025;103:452-464.
    PubMed     Abstract available


  484. WEINSTEIN AM, Gogniat MA, Butters MA
    The importance of cognitive correlates of plasma amyloid-beta 42/40.
    J Alzheimers Dis. 2025;103:353-355.
    PubMed     Abstract available


    December 2024
  485. BENNETT CG, Guttmann RP, Hackney ME, Amin R, et al
    Impacts of adapted dance on mood and physical function among persons living with Alzheimer's disease.
    J Alzheimers Dis. 2024 Dec 23:13872877241298529. doi: 10.1177/13872877241298529.
    PubMed     Abstract available


  486. HORSTKOTTER D
    Alzheimer's disease prediction and prevention in a public health perspective: Ethical considerations and collaborations beyond the biomedical paradigm.
    J Alzheimers Dis. 2024 Dec 23:13872877241308299. doi: 10.1177/13872877241308299.
    PubMed     Abstract available


  487. VIGNOLO J, Jacus JP, Darnaud T, Cuervo-Lombard CV, et al
    Exploratory study of French healthcare workers' experiences of anosognosia in Alzheimer's disease and related disorders.
    J Alzheimers Dis. 2024 Dec 19:13872877241307045. doi: 10.1177/13872877241307045.
    PubMed     Abstract available


  488. BOADA M, Neve A, Das B, Wojtowicz J, et al
    Long-term safety of gantenerumab in participants with Alzheimer's disease: A phase III, open-label extension study (SCarlet RoAD).
    J Alzheimers Dis. 2024 Dec 16:13872877241303644. doi: 10.1177/13872877241303644.
    PubMed     Abstract available


  489. GARCIA-LLUCH G, Marseglia A, Royo LM, Albiach JP, et al
    Associations between antidiabetic medications and cerebrospinal fluid biomarkers of Alzheimer's disease.
    J Alzheimers Dis. 2024 Dec 16:13872877241304995. doi: 10.1177/13872877241304995.
    PubMed     Abstract available


  490. PLUTA R, Kocki J, Bogucki J, Bogucka-Kocka A, et al
    Apolipoprotein (APOA1, APOE, CLU) genes expression in the CA3 region of the hippocampus in an ischemic model of Alzheimer's disease with survival up to 2 years.
    J Alzheimers Dis. 2024 Dec 16:13872877241303950. doi: 10.1177/13872877241303950.
    PubMed     Abstract available


  491. NAZARETH CCG, Scalli ACAM, de Oliveira MPB, Gomes AFS, et al
    Differences in lean mass and sarcopenia between individuals with Alzheimer's disease and those without dementia: A systematic review and meta-analysis of observational studies.
    J Alzheimers Dis. 2024 Dec 16:13872877241299051. doi: 10.1177/13872877241299051.
    PubMed     Abstract available


  492. LI D, Liu X, Yu J, Zhang Y, et al
    Item response theory for the color-picture version of Boston naming test in a Chinese sample with neurodegenerative diseases.
    J Alzheimers Dis. 2024 Dec 16:13872877241305820. doi: 10.1177/13872877241305820.
    PubMed     Abstract available


  493. OKAFOR M, Yang Z, Vickers KL, Sanders K, et al
    Technology literacy and access to digital resources for remote assessment among adults enrolled in Alzheimer's disease research.
    J Alzheimers Dis. 2024 Dec 11:13872877241297496. doi: 10.1177/13872877241297496.
    PubMed     Abstract available


  494. MAKI Y, Ubuka T, Yamane Y
    The importance of non-pharmacological interventions to improve cognitive reserve prior to the administration of a drug against the causative agent of Alzheimer's disease.
    J Alzheimers Dis. 2024 Dec 5:13872877241301806. doi: 10.1177/13872877241301806.
    PubMed     Abstract available


  495. SMITH ML, Wilson AD, Knebl J, Hilsabeck RC, et al
    Utilization and perceived usefulness of monitoring technology for family caregivers of people living with Alzheimer's disease and related dementias.
    J Alzheimers Dis. 2024 Dec 5:13872877241300078. doi: 10.1177/13872877241300078.
    PubMed     Abstract available


  496. ZENG J, Gao Z, Xiong X, Hou X, et al
    The effects of two Alzheimer's disease related genes APOE and MAPT in healthy young adults: An attentional blink study.
    J Alzheimers Dis. 2024 Dec 5:13872877241299124. doi: 10.1177/13872877241299124.
    PubMed     Abstract available


  497. ANGELOPOULOU E, Papageorgiou SG
    Telemedicine in Alzheimer's disease and other dementias: Where we are?
    J Alzheimers Dis. 2024 Dec 5:13872877241298295. doi: 10.1177/13872877241298295.
    PubMed     Abstract available


  498. ZHANG P, Liu Y, Jin X, Hu Z, et al
    Alzheimer's disease-like pathology induced by Porphyromonas gingivalis in middle-aged mice is mediated by NLRP3 inflammasome via the microbiota-gut-brain axis.
    J Alzheimers Dis. 2024 Dec 5:13872877241302498. doi: 10.1177/13872877241302498.
    PubMed     Abstract available


  499. XU L, Chen K, Mueller KD, Liss J, et al
    Articulatory precision from connected speech as a marker of cognitive decline in Alzheimer's disease risk-enriched cohorts.
    J Alzheimers Dis. 2024 Dec 5:13872877241300149. doi: 10.1177/13872877241300149.
    PubMed     Abstract available


  500. BARNES DE, Balderson BH, Shulman L, Rosenberg DE, et al
    The Systematic Multi-domain Alzheimer's Risk Reduction Trial (SMARRT) intervention: A personalized approach to dementia risk reduction.
    J Alzheimers Dis. 2024 Dec 3:13872877241296161. doi: 10.1177/13872877241296161.
    PubMed     Abstract available


  501. TAO M, Cui L, Du Y, Liu X, et al
    Analysis of eye movement features in patients with Alzheimer's disease based on intelligent eye movement analysis and evaluation system.
    J Alzheimers Dis. 2024 Dec 1:13872877241297416. doi: 10.1177/13872877241297416.
    PubMed     Abstract available


  502. SHIR D, Shiner T, Bregman N
    Anti-amyloid treatments for Alzheimer's disease: A study on physicians' perspectives.
    J Alzheimers Dis. 2024;102:627-632.
    PubMed     Abstract available


  503. CANEVELLI M, Ancidoni A, Valletta M, Toccaceli Blasi M, et al
    Reporting of comorbidities and health status of participants in clinical trials testing amyloid- and tau-targeting monoclonal antibodies for Alzheimer's disease: A systematic review.
    J Alzheimers Dis. 2024;102:587-596.
    PubMed     Abstract available


  504. KISELICA AM, Atkinas KJ, Han SD, Diaz-Orueta U, et al
    Reactions of clinical neuropsychologists to the Alzheimer's Association workgroup's draft diagnostic and staging criteria for Alzheimer's disease.
    J Alzheimers Dis. 2024;102:877-884.
    PubMed     Abstract available


  505. OLIVER A, Wildschut T, Redhead ES, Parker MO, et al
    Benefits of nostalgic landmarks for people living with Alzheimer's disease.
    J Alzheimers Dis. 2024;102:683-702.
    PubMed     Abstract available


  506. ANDRES P, Flores-Vazquez JF, Enriquez-Geppert S
    Associating faces with names and meals as a biomarker of early AD in cognitively healthy individuals.
    J Alzheimers Dis. 2024;102:639-641.
    PubMed     Abstract available


  507. SOINIEMI L, Solje E, Suominen AL, Kanninen KM, et al
    The association between oral diseases and neurodegenerative disorders.
    J Alzheimers Dis. 2024;102:577-586.
    PubMed     Abstract available


  508. PEETHAMBARAN MALLIKA A
    Tri-culture modeling of neuroinflammation, neurodegeneration, and neuroprotection.
    J Alzheimers Dis. 2024;102:742-744.
    PubMed     Abstract available


  509. GAN J, Zeng Y, Huang G, Wang XD, et al
    The updated prevalence and risk factors of dementia in old adults in China: A cross-sectional study.
    J Alzheimers Dis. 2024;102:1209-1223.
    PubMed     Abstract available


    November 2024
  510. BENKE T, Karagiannis G
    Memory anosognosia in early Alzheimer's disease: A memory clinic study.
    J Alzheimers Dis. 2024 Nov 29:13872877241302423. doi: 10.1177/13872877241302423.
    PubMed     Abstract available


  511. CASTELLANI RJ
    Biomarker-only diagnosis of Alzheimer's disease: Not ready for prime time.
    J Alzheimers Dis. 2024 Nov 29:13872877241301805. doi: 10.1177/13872877241301805.
    PubMed     Abstract available


  512. JUDAY TR, Holub A, Mattke S, Betts KA, et al
    Real-world diagnostic, referral, and treatment patterns in early Alzheimer's disease among community-based practices in the United States.
    J Alzheimers Dis. 2024 Nov 29:13872877241297128. doi: 10.1177/13872877241297128.
    PubMed     Abstract available


  513. BECHI GABRIELLI G, D'Antonio F, Di Vita A, Margiotta R, et al
    Mind's eye in the Alzheimer's disease spectrum continuum.
    J Alzheimers Dis. 2024 Nov 29:13872877241299134. doi: 10.1177/13872877241299134.
    PubMed     Abstract available


  514. UNERI A, McArdle CJ, Deng Z, Barth SH, et al
    DJ-1-mediated repression of the RNA-binding protein FMRP is predicted to impact known Alzheimer's disease-related protein networks.
    J Alzheimers Dis. 2024 Nov 29:13872877241291175. doi: 10.1177/13872877241291175.
    PubMed     Abstract available


  515. MALIK R, Beaton D, Ahmed J, Nho K, et al
    A DAT1 gene and APOE epsilon4 interaction is associated with apathy and structural brain changes in mild cognitive impairment and Alzheimer's disease.
    J Alzheimers Dis. 2024 Nov 29:13872877241299785. doi: 10.1177/13872877241299785.
    PubMed     Abstract available


  516. AKHTAR SN, Tran TD, Chen YH, Lu Q, et al
    Spatial and planar profiling of Rac1/Cdc42 signaling in Alzheimer's disease brain.
    J Alzheimers Dis. 2024 Nov 29:13872877241291076. doi: 10.1177/13872877241291076.
    PubMed     Abstract available


  517. RAO S, Forns J, Danysh HE, Calingaert B, et al
    Natural history and clinical outcomes in patients with Alzheimer's disease-related psychosis by antipsychotic treatment status in the United States.
    J Alzheimers Dis. 2024 Nov 27:13872877241297361. doi: 10.1177/13872877241297361.
    PubMed     Abstract available


  518. BERNARD MA, Boutajangout A, Debure L, Ahmed W, et al
    The relationship between anxiety and levels of Alzheimer's disease plasma biomarkers.
    J Alzheimers Dis. 2024 Nov 27:13872877241295324. doi: 10.1177/13872877241295324.
    PubMed     Abstract available


  519. PRABHA S, Sajad M, Anjum F, Hassan MI, et al
    Investigating gene expression datasets of hippocampus tissue to discover Alzheimer's disease-associated molecular markers.
    J Alzheimers Dis. 2024 Nov 27:13872877241297335. doi: 10.1177/13872877241297335.
    PubMed     Abstract available


  520. ORJUELA AL, Pecchio M, Cruz-Mora J, Emani LS, et al
    The role of carotenoids from red mamey fruit (Pouteria sapota) against amyloid-beta monomers in Alzheimer's disease: Computational analysis and ADMET prediction.
    J Alzheimers Dis. 2024 Nov 26:13872877241291172. doi: 10.1177/13872877241291172.
    PubMed     Abstract available


  521. BAGHERI S, Rashno M, Salehi I, Karimi SA, et al
    Protective effects of geraniol in a male rat model of Alzheimer's disease: A behavioral, biochemical, and histological study.
    J Alzheimers Dis. 2024 Nov 25:13872877241290695. doi: 10.1177/13872877241290695.
    PubMed     Abstract available


  522. FERRARO PM, Filippi L, Ponzano M, Signori A, et al
    Clinical and biological underpinnings of longitudinal atrophy pattern progression in Alzheimer's disease.
    J Alzheimers Dis. 2024 Nov 25:13872877241299843. doi: 10.1177/13872877241299843.
    PubMed     Abstract available


  523. LIU W, Chen S, Rao X, Chen X, et al
    Exploring the role of miR-125b-5p as a pro-inflammatory factor in Alzheimer's disease pathology.
    J Alzheimers Dis. 2024 Nov 25:13872877241297178. doi: 10.1177/13872877241297178.
    PubMed     Abstract available


  524. GAO Z, Zhu W, Li Y, Ye W, et al
    Identification and cognitive function prediction of Alzheimer's disease based on multivariate pattern analysis of hippocampal volumes.
    J Alzheimers Dis. 2024 Nov 25:13872877241296130. doi: 10.1177/13872877241296130.
    PubMed     Abstract available


  525. PAN H, Wang G, Bi Z, Lai C, et al
    Identification of key neutrophil extracellular trap genes in Alzheimer's disease.
    J Alzheimers Dis. 2024 Nov 25:13872877241295374. doi: 10.1177/13872877241295374.
    PubMed     Abstract available


  526. WEISS JN
    Dynamic light scattering of the eye in the diagnosis of Alzheimer's disease.
    J Alzheimers Dis. 2024 Nov 25:13872877241301802. doi: 10.1177/13872877241301802.
    PubMed     Abstract available


  527. SHIBATA H, Uchida Y, Kan H, Sakurai K, et al
    Deep-learning assessment of hippocampal magnetic susceptibility in Alzheimer's disease.
    J Alzheimers Dis. 2024 Nov 25:13872877241300278. doi: 10.1177/13872877241300278.
    PubMed     Abstract available


  528. SANTOS VD, Costa AC, Junior NC, Delaere FJ, et al
    Virtual reality interventions and their effects on the cognition of individuals with Alzheimer's disease: A systematic review and meta-analysis.
    J Alzheimers Dis. 2024 Nov 25:13872877241299037. doi: 10.1177/13872877241299037.
    PubMed     Abstract available


  529. KOLLING LJ, Chimenti MS, Marcinkiewcz CA
    Spatial differences in gene expression across the dorsal raphe nucleus in a model of early Alzheimer's disease.
    J Alzheimers Dis. 2024 Nov 25:13872877241299119. doi: 10.1177/13872877241299119.
    PubMed     Abstract available


  530. XIYANG Y, Gao J, Ding M, Ren X, et al
    Exacerbated mitochondrial dynamic abnormalities without evident tau pathology in rapidly progressive Alzheimer's disease.
    J Alzheimers Dis. 2024 Nov 25:13872877241295403. doi: 10.1177/13872877241295403.
    PubMed     Abstract available


  531. BUONGIORNO M, Sanchez-Benavides G, Marzal-Espi C, Giraldo DM, et al
    Blood-brain barrier permeable beta-blockers association with Alzheimer's disease cerebrospinal fluid biomarkers levels in non-demented individuals.
    J Alzheimers Dis. 2024 Nov 25:13872877241293812. doi: 10.1177/13872877241293812.
    PubMed     Abstract available


  532. MARTINEZ-LOPEZ S, Tabone M, Clemente-Velasco S, Gonzalez-Soltero MDR, et al
    A systematic review of lifestyle-based interventions for managing Alzheimer's disease: Insights from randomized controlled trials.
    J Alzheimers Dis. 2024 Nov 25:13872877241292829. doi: 10.1177/13872877241292829.
    PubMed     Abstract available


  533. PAJAVAND AM, Grothe MJ, De Schotten MT, Giorgi FS, et al
    Structural white matter connectivity differences independent of gray matter loss in mild cognitive impairment with neuropsychiatric symptoms: Early indicators of Alzheimer's disease using network-based statistics.
    J Alzheimers Dis. 2024 Nov 22:13872877241288710. doi: 10.1177/13872877241288710.
    PubMed     Abstract available


  534. WANG LY, Hu H, Sheng ZH, Hu HY, et al
    Associations among healthy lifestyle characteristics, neuroinflammation, and cerebrospinal fluid core biomarkers of Alzheimer's disease in cognitively intact adults: The CABLE study.
    J Alzheimers Dis. 2024 Nov 19:13872877241291969. doi: 10.1177/13872877241291969.
    PubMed     Abstract available


  535. KARKKAINEN V, Hannonen S, Rusanen M, Lehtola JM, et al
    Tear fluid reflects the altered protein expressions of Alzheimer's disease patients in proteins involved in protein repair and clearance system or the regulation of cytoskeleton.
    J Alzheimers Dis. 2024 Nov 18:13872877241295315. doi: 10.1177/13872877241295315.
    PubMed     Abstract available


  536. RIGHI D, Manco C, Pardini M, Stufano A, et al
    Investigating interleukin-8 in Alzheimer's disease: A comprehensive review.
    J Alzheimers Dis. 2024 Nov 18:13872877241298973. doi: 10.1177/13872877241298973.
    PubMed     Abstract available


  537. SHAO K, Chen X, Yu X, Yang J, et al
    Functional connectivity changes in two cortico-hippocampal networks of Alzheimer's disease continuum and their correlations with cognition: A SILCODE study.
    J Alzheimers Dis. 2024 Nov 15:13872877241291236. doi: 10.1177/13872877241291236.
    PubMed     Abstract available


  538. KE C, Shan S, Yu J, Wei X, et al
    Acupuncture for patients with Alzheimer's disease: An evidence map of randomized controlled trials, systematic reviews, and meta-analysis.
    J Alzheimers Dis. 2024 Nov 14:13872877241295400. doi: 10.1177/13872877241295400.
    PubMed     Abstract available


  539. AGBOJI A, Freeman S, Banner D, Armstrong J, et al
    The prevalence and risk factors of apathy among the Canadian long-term care residents with Alzheimer's disease and related dementias.
    J Alzheimers Dis. 2024 Nov 14:JAD240370. doi: 10.3233/JAD-240370.
    PubMed     Abstract available


  540. SCHEINMAN SB, Dong H
    The impact of sex on memory during aging and Alzheimer's disease progression: Epigenetic mechanisms.
    J Alzheimers Dis. 2024 Nov 14:13872877241288709. doi: 10.1177/13872877241288709.
    PubMed     Abstract available


  541. CHAO SP, Lin WC, Lu CH, Wu HC, et al
    Changes in plasma biomarkers differentiate clinical stages of Alzheimer's disease using immunomagnetic reduction assays.
    J Alzheimers Dis. 2024 Nov 13:JAD240690. doi: 10.3233/JAD-240690.
    PubMed     Abstract available


  542. SCHROEDER KM, Afonso AS, Wang H, Grace S, et al
    Demographics, comorbidities, and comedications in newly diagnosed patients with Alzheimer's disease and related dementias: Findings from United States Medicare claims data.
    J Alzheimers Dis. 2024 Nov 13:JAD231488. doi: 10.3233/JAD-231488.
    PubMed     Abstract available


  543. BEHL S, Slomkowski M, Chen D, Chang D, et al
    Brexpiprazole for the treatment of agitation associated with dementia due to Alzheimer's disease: A 12-week, active-treatment, extension trial.
    J Alzheimers Dis. 2024 Nov 13:JAD240491. doi: 10.3233/JAD-240491.
    PubMed     Abstract available


  544. LEWIS JM, Harris DA, Kosmatka J, Mikrut E, et al
    Single step capture and assessment of multiple plasma extracellular vesicle biomarkers in Alzheimer's disease detection.
    J Alzheimers Dis. 2024 Nov 13:13872877241291964. doi: 10.1177/13872877241291964.
    PubMed     Abstract available


  545. MOSS DE, Perez RG
    The phospho-tau cascade, basal forebrain neurodegeneration, and dementia in Alzheimer's disease: Anti-neurodegenerative benefits of acetylcholinesterase inhibitors.
    J Alzheimers Dis. 2024 Nov 12:13872877241289602. doi: 10.1177/13872877241289602.
    PubMed     Abstract available


  546. SUZUKI H, Tagai K, Ono M, Shimizu H, et al
    Distinct tau pathologies in the nucleus basalis of Meynert between early-onset and late-onset Alzheimer's disease patients revealed by positron emission tomography.
    J Alzheimers Dis. 2024 Nov 11:13872877241297382. doi: 10.1177/13872877241297382.
    PubMed     Abstract available


  547. MAYR E, Rotter J, Kuhrt H, Winter K, et al
    Detection of molecular markers of ferroptosis in human Alzheimer's disease brains.
    J Alzheimers Dis. 2024 Nov 11:13872877241296563. doi: 10.1177/13872877241296563.
    PubMed     Abstract available


  548. PAN M, Lai D, Unverzagt F, Apostolova L, et al
    Genetic variants for Alzheimer's disease and comorbid conditions.
    J Alzheimers Dis. 2024 Nov 10:13872877241289054. doi: 10.1177/13872877241289054.
    PubMed     Abstract available


  549. MAHAJAN K, Sharma S, Gautam RK, Goyal R, et al
    Insights on therapeutic approaches of natural anti-Alzheimer's agents in the management of Alzheimer's disease: A future perspective.
    J Alzheimers Dis. 2024 Nov 10:13872877241296557. doi: 10.1177/13872877241296557.
    PubMed     Abstract available


  550. AAZAD AA, Choudhury A, Hussain A, AlAjmi MF, et al
    Exploring phytochemical inhibitors of protein kinase C alpha for therapeutic targeting of Alzheimer's disease.
    J Alzheimers Dis. 2024 Nov 10:13872877241289620. doi: 10.1177/13872877241289620.
    PubMed     Abstract available


  551. REN C, Wang WQ, Li HH, Li BY, et al
    Valuing the importance of sex differences in prodromal Alzheimer's disease based on structural magnetic resonance imaging.
    J Alzheimers Dis. 2024 Nov 8:13872877241289790. doi: 10.1177/13872877241289790.
    PubMed     Abstract available


  552. GARCIA-ALBERCA JM, De La Guia P, Gris E, Mendoza S, et al
    Real-world assessment of caregiver preference and compliance to treatment with twice-weekly versus daily rivastigmine patches in Alzheimer's disease.
    J Alzheimers Dis. 2024 Nov 5:13872877241292018. doi: 10.1177/13872877241292018.
    PubMed     Abstract available


  553. DEJAKAISAYA H, Lin R, Harutyunyan A, Chan J, et al
    Effect of ceftriaxone on the glutamate-glutamine cycle and seizure susceptibility of Tg2576 mouse model of Alzheimer's disease.
    J Alzheimers Dis. 2024 Nov 3:13872877241289053. doi: 10.1177/13872877241289053.
    PubMed     Abstract available


  554. CHEN X, Hu F, Chi Q, Rao C, et al
    The study of Alzheimer's disease risk diagnosis based on natural killer cell marker genes in the multi-omics data.
    J Alzheimers Dis. 2024 Nov 3:13872877241295316. doi: 10.1177/13872877241295316.
    PubMed     Abstract available


  555. GESSI S, Mirandola P, Merighi S
    Keep neuroinflammation in mind when addressing Alzheimer's disease: A microglia perspective.
    J Alzheimers Dis. 2024 Nov 3:13872877241290693. doi: 10.1177/13872877241290693.
    PubMed     Abstract available


  556. ABDELRAOUF K, Farrag HS, El-Ganzuri MA, El-Sayed WM, et al
    A new bithiophene inhibited amyloid-beta accumulation and enhanced cognitive function in the hippocampus of aluminum-induced Alzheimer's disease in adult rats.
    J Alzheimers Dis. 2024 Nov 3:13872877241295405. doi: 10.1177/13872877241295405.
    PubMed     Abstract available


  557. ZHAO Y, Villasante-Tezanos A, Miranda-Morales EG, Pappolla MA, et al
    Discovery of novel metabolic biomarkers in blood serum for diagnosis of Alzheimer's disease.
    J Alzheimers Dis. 2024;102:237-253.
    PubMed     Abstract available


  558. MATIAS-GUIU JA, Alvarez-Sabin J, Botia E, Casado-Naranjo I, et al
    Perceptions of key informant neurologists before implementing anti-amyloid drugs in the Spanish departments of neurology.
    J Alzheimers Dis. 2024;102:207-217.
    PubMed     Abstract available


  559. PAPOTTI B, Palumbo M, Adorni MP, Elviri L, et al
    Influence of APOE4 genotype on PCSK9-lipids association in cerebrospinal fluid and serum of patients in the Alzheimer's disease continuum.
    J Alzheimers Dis. 2024;102:162-172.
    PubMed     Abstract available


  560. JURASOVA V, Andel R, Katonova A, Nolan R, et al
    Is KIBRA polymorphism associated with memory performance and cognitive impairment in Alzheimer's disease?
    J Alzheimers Dis. 2024;102:218-227.
    PubMed     Abstract available


  561. KHAN SU, Albanyan A, Bilal M, Ullah S, et al
    A genetic programming Rician noise reduction and explainable deep learning model for Alzheimer's diseases severity prediction.
    J Alzheimers Dis. 2024;102:129-142.
    PubMed     Abstract available


  562. ISHII K, Yamada T, Hanaoka K, Kaida H, et al
    Regional differences in glucose metabolic decline and tau deposition in the Alzheimer's continuum brain.
    J Alzheimers Dis. 2024;102:228-236.
    PubMed     Abstract available


  563. ZHANG Z, Sheng Z, Liu J, Zhang D, et al
    The association of the triglyceride-glucose index with Alzheimer's disease and its potential mechanisms.
    J Alzheimers Dis. 2024;102:77-88.
    PubMed     Abstract available


  564. GAO Z, Dorney I, Davis PB, Kaelber DC, et al
    Association between selective serotonin reuptake inhibitors and mortality following COVID-19 among patients with Alzheimer's disease.
    J Alzheimers Dis. 2024;102:99-109.
    PubMed     Abstract available


  565. SERRA L, Bonarota S, Di Domenico C, Caruso G, et al
    The funnel effect of reserves prompted by leisure activities across the Alzheimer's disease continuum.
    J Alzheimers Dis. 2024;102:181-194.
    PubMed     Abstract available


  566. KANG L, Zhang X, Guan J, Huang K, et al
    Early Alzheimer's disease diagnosis via handwriting with self-attention mechanisms.
    J Alzheimers Dis. 2024;102:173-180.
    PubMed     Abstract available


  567. BEDER N, Belkhelfa M, Leklou H
    Involvement of inflammasomes in the pathogenesis of Alzheimer's disease.
    J Alzheimers Dis. 2024;102:11-29.
    PubMed     Abstract available


  568. BESSER LM, Fuentes AJ, Zhang JN, O'Shea DM, et al
    Intersectionality of gender with social determinants of health and asymptomatic Alzheimer's disease neuropathology.
    J Alzheimers Dis. 2024;102:110-118.
    PubMed     Abstract available


  569. CALVO N, McFall GP, Ramana S, Galper M, et al
    Associated risk and resilience factors of Alzheimer's disease in women with early bilateral oophorectomy: Data from the UK Biobank.
    J Alzheimers Dis. 2024;102:119-128.
    PubMed     Abstract available


  570. LECLERC H, Lee AK, Kunicki ZJ, Alber J, et al
    Added value of inflammatory plasma biomarkers to pathologic biomarkers in predicting preclinical Alzheimer's disease.
    J Alzheimers Dis. 2024;102:89-98.
    PubMed     Abstract available


  571. ABDULLAH L, Zhang F, Hall J, O'Bryant S, et al
    Neurofilament light and cognition in community-dwelling non-Hispanic Blacks.
    J Alzheimers Dis. 2024;102:60-66.
    PubMed     Abstract available


  572. LIN Y, Kuo SH
    The emerging role of the cerebellum in neurodegeneration linked to cognitive impairment.
    J Alzheimers Dis. 2024;102:30-32.
    PubMed     Abstract available


  573. LIU Z, Hu B, Tang J, Liu X, et al
    Frontiers and hotspots evolution between air pollution and Alzheimer's disease: A bibliometric analysis from 2013 to 2023.
    J Alzheimers Dis. 2024;102:257-274.
    PubMed     Abstract available


  574. CHEN H, Wang L, Chen F, Sun W, et al
    Performance of the Benton Judgment of Line Orientation test across patients with different types of dementia.
    J Alzheimers Dis. 2024;102:437-448.
    PubMed     Abstract available


  575. DOS SANTOS JR, Catalao CHR, Vulczak A, Azzolini AECS, et al
    Voluntary wheel running decreases amyloidogenic pathway and rescues cognition and mitochondrial energy metabolism in middle-aged female 3xTg-AD mouse model of Alzheimer's disease.
    J Alzheimers Dis. 2024;102:424-436.
    PubMed     Abstract available


  576. TANG M, Guo JJ, Guo RX, Xu SJ, et al
    Progress of research and application of non-pharmacologic intervention in Alzheimer's disease.
    J Alzheimers Dis. 2024;102:275-294.
    PubMed     Abstract available


  577. ZHANG X, Lv R, Sun Y, Liu TC, et al
    The safety and effectiveness of 40 Hz gamma-tACS in Alzheimer's disease: A meta-analysis.
    J Alzheimers Dis. 2024;102:295-307.
    PubMed     Abstract available


  578. FINDLEY CA, McFadden SA, Hill T, Peck MR, et al
    Sexual dimorphism, altered hippocampal glutamatergic neurotransmission, and cognitive impairment in APP knock-in mice.
    J Alzheimers Dis. 2024;102:491-505.
    PubMed     Abstract available


  579. CIESLA M, Toro-Serey C, Jannati A, Banks RE, et al
    Detecting functional impairment with the Digital Clock and Recall.
    J Alzheimers Dis. 2024;102:329-337.
    PubMed     Abstract available


  580. COOK N, Driscoll I, Gaitan JM, Glittenberg M, et al
    Amyloid-beta positivity is less prevalent in cognitively unimpaired KLOTHO KL-VS heterozygotes.
    J Alzheimers Dis. 2024;102:480-490.
    PubMed     Abstract available


    September 2024
  581. CHAN CK, Lane KA, Gao S, Adeoye-Olatunde OA, et al
    Referral Sources Across Racial and Ethnic Groups at Alzheimer's Disease Research Centers.
    J Alzheimers Dis. 2024 Sep 30. doi: 10.3233/JAD-240485.
    PubMed     Abstract available


  582. WANG N, Tai HC, Tzeng IS
    Non-Pharmacological Exercise Randomized Controlled Trials in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Sep 20. doi: 10.3233/JAD-240418.
    PubMed     Abstract available


  583. DEL TREDICI K, Schon M, Feldengut S, Ghebremedhin E, et al
    Early CA2 Tau Inclusions Do Not Distinguish an Age-Related Tauopathy from Early Alzheimer's Disease.
    J Alzheimers Dis. 2024 Sep 18. doi: 10.3233/JAD-240483.
    PubMed     Abstract available


  584. MATTKE S, Tang Y, Hanson M, von Arnim CAF, et al
    Current Capacity for Diagnosing Alzheimer's Disease in Germany and Implications for Wait Times.
    J Alzheimers Dis. 2024 Sep 17. doi: 10.3233/JAD-240728.
    PubMed     Abstract available


  585. LIU XL, Yeerlan J, Liu Z, Bai Y, et al
    Past, Present, and Future of Liver-Brain Axis in Alzheimer's Disease: A Bibliometric Review.
    J Alzheimers Dis. 2024 Sep 17. doi: 10.3233/JAD-240688.
    PubMed     Abstract available


  586. NOWELL J, Raza S, Livingston NR, Sivanathan S, et al
    Do Tau Deposition and Glucose Metabolism Dissociate in Alzheimer's Disease Trajectory?
    J Alzheimers Dis. 2024 Sep 17. doi: 10.3233/JAD-240434.
    PubMed     Abstract available


  587. BABULAL GM, Zha W, Trani JF, Guerra JL, et al
    Identifying Gaps and Barriers in Alzheimer's Disease and Related Dementia Research and Management in Low- and Middle-Income Countries: A Survey of Health Professionals and Researchers.
    J Alzheimers Dis. 2024 Sep 16. doi: 10.3233/JAD-240650.
    PubMed     Abstract available


  588. UTYRO O, Wloczkowska-Lapinska O, Jakubowski H
    Association of GLOD4 with Alzheimer's Disease in Humans and Mice.
    J Alzheimers Dis. 2024 Sep 16. doi: 10.3233/JAD-240512.
    PubMed     Abstract available


  589. RAJAMAKI B, Braithwaite B, Hartikainen S, Tolppanen AM, et al
    Identifying Comorbidity Patterns in People with and without Alzheimer's Disease Using Latent Dirichlet Allocation.
    J Alzheimers Dis. 2024 Sep 16. doi: 10.3233/JAD-240490.
    PubMed     Abstract available


  590. ABI-GHANEM C, Salinero AE, Smith RM, Kelly RD, et al
    Effects of Menopause and High Fat Diet on Metabolic Outcomes in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2024 Sep 16. doi: 10.3233/JAD-231332.
    PubMed     Abstract available


  591. MENDEZ-BARRIO C, Medina-Rodriguez M, Mendoza-Vazquez G, Garcia-Roldan E, et al
    Prodromal Alzheimer's Disease: Global Cognition, Cue Efficiency, and Cerebrospinal Fluid Neurofilament Light Values Predict Short-Term Conversion to Dementia.
    J Alzheimers Dis. 2024 Sep 14. doi: 10.3233/JAD-240689.
    PubMed     Abstract available


  592. PARK J, Oh JP, Ku K, Jin Y, et al
    Preventing Donepezil-Induced Adverse Effects Through N-acetylcysteine Co-Administration.
    J Alzheimers Dis. 2024 Sep 13. doi: 10.3233/JAD-240709.
    PubMed     Abstract available


  593. MANAKKADAN A, Krishnan D, Rui Xia Ang S, Sajikumar S, et al
    Slow Release of Hydrogen Sulfide in CA1 Hippocampal Neurons Rescues Long-Term Synaptic Plasticity and Associativity in an Amyloid-beta Induced Model of Alzheimer's Disease.
    J Alzheimers Dis. 2024 Sep 13. doi: 10.3233/JAD-240456.
    PubMed     Abstract available


  594. SCHICKTANZ S, Alpinar-Segawa Z, Ulitsa N, Perry J, et al
    Moving Towards Ethical-Practical Recommendations for Alzheimer's Disease Prediction: Addressing Interindividual, Interprofessional, and Societal Aspects.
    J Alzheimers Dis. 2024 Sep 13. doi: 10.3233/JAD-231137.
    PubMed     Abstract available


  595. VYHNALEK M, Laczo M, Laczo J
    Diagnosis of Alzheimer's Disease in Clinical Practice: Time to Incorporate Biomarkers?
    J Alzheimers Dis. 2024 Sep 12. doi: 10.3233/JAD-240660.
    PubMed     Abstract available


  596. WANG T, Yan S, Shan Y, Xing Y, et al
    Altered Neuronal Activity Patterns of the Prefrontal Cortex in Alzheimer's Disease After Transcranial Alternating Current Stimulation: A Resting-State fMRI Study.
    J Alzheimers Dis. 2024 Sep 12. doi: 10.3233/JAD-240400.
    PubMed     Abstract available


  597. SPENCER FSE, Elsworthy RJ, Breen L, Bishop J, et al
    The Relationship Between Physical Activity and Non-Modifiable Risk Factors on Alzheimer's Disease and Brain Health Markers: A UK Biobank Study.
    J Alzheimers Dis. 2024 Sep 12. doi: 10.3233/JAD-240269.
    PubMed     Abstract available


  598. WANG Q, Fu M, Gao L, Yuan X, et al
    A Drug Repositioning Approach Reveals Ergotamine May Be a Potential Drug for the Treatment of Alzheimer's Disease.
    J Alzheimers Dis. 2024 Sep 12. doi: 10.3233/JAD-240235.
    PubMed     Abstract available


  599. SELIGMANN B, Camiolo S, Hernandez M, Yeakley JM, et al
    Molecular Gene Expression Testing to Identify Alzheimer's Disease with High Accuracy from Fingerstick Blood.
    J Alzheimers Dis. 2024 Sep 11. doi: 10.3233/JAD-240174.
    PubMed     Abstract available


  600. BOLSHAKOV AP, Gerasimov K, Dobryakova YV
    Alzheimer's Disease: An Attempt of Total Recall.
    J Alzheimers Dis. 2024 Sep 7. doi: 10.3233/JAD-240620.
    PubMed     Abstract available


  601. LIU S, Maruff P, Fedyashov V, Masters CL, et al
    A Data-Driven Cognitive Composite Sensitive to Amyloid-beta for Preclinical Alzheimer's Disease.
    J Alzheimers Dis. 2024 Sep 6. doi: 10.3233/JAD-231319.
    PubMed     Abstract available


  602. BUTLER T, Tey SR, Galvin JE, Perry G, et al
    Endocrine Dyscrasia in the Etiology and Therapy of Alzheimer's Disease.
    J Alzheimers Dis. 2024 Sep 4. doi: 10.3233/JAD-240334.
    PubMed     Abstract available


  603. GUO H, Sun S, Yang Y, Ma R, et al
    A Novel Score to Predict Individual Risk for Future Alzheimer's Disease: A Longitudinal Study of the ADNI Cohort.
    J Alzheimers Dis. 2024 Sep 3. doi: 10.3233/JAD-240532.
    PubMed     Abstract available


  604. GUO F, Tan MS, Hu H, Ou YN, et al
    sTREM2 Mediates the Correlation Between BIN1 Gene Polymorphism and Tau Pathology in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Sep 3. doi: 10.3233/JAD-240372.
    PubMed     Abstract available


  605. CARDOSO R, Teunissen CE, Oliveira CR
    Enhancing Alzheimer's Disease Diagnosis and Care by Focusing on Plasma Biomarkers for Identifying Mild Cognitive Impairment.
    J Alzheimers Dis. 2024 Sep 2. doi: 10.3233/JAD-240724.
    PubMed     Abstract available


  606. ZHANG X, You J, Qao Q, Qi X, et al
    Correlation Between the Fractional Amplitude of Low-Frequency Fluctuation and Cognitive Defects in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Sep 2. doi: 10.3233/JAD-231040.
    PubMed     Abstract available


    August 2024
  607. KRESHPA W, Raffa S, Girtler N, Brugnolo A, et al
    Limbic Network Derangement Mediates Unawareness of Apathy in Mild Cognitive Impairment due to Alzheimer's Disease: Clues from [18F]FDG PET Voxel-Wise Analysis.
    J Alzheimers Dis. 2024 Aug 31. doi: 10.3233/JAD-240430.
    PubMed     Abstract available


  608. ZHAO H, Yuan H, Wang E
    Causal Effects of Kidney Function and Chronic Kidney Disease on Alzheimer's Disease by Analyzing Large-Scale Genome-Wide Association Study Datasets.
    J Alzheimers Dis. 2024 Aug 30. doi: 10.3233/JAD-240807.
    PubMed     Abstract available


  609. GIUDICESSI A, McDowell CP, Martinez JE, Baena A, et al
    Cognitive Outcomes in Autosomal-Dominant Alzheimer's Disease: A Comprehensive Review from a Colombian Kindred with the Presenilin-1 E280A Mutation.
    J Alzheimers Dis. 2024 Aug 30. doi: 10.3233/JAD-240360.
    PubMed     Abstract available


  610. HANYU H, Koyama Y, Umekida K, Watanabe S, et al
    Path Integration Detects Prodromal Alzheimer's Disease and Predicts Cognitive Decline.
    J Alzheimers Dis. 2024 Aug 30. doi: 10.3233/JAD-240347.
    PubMed     Abstract available


  611. CHEN Y, Ji X, Bao Z
    Identification of the Shared Gene Signatures Between Alzheimer's Disease and Diabetes-Associated Cognitive Dysfunction by Bioinformatics Analysis Combined with Biological Experiment.
    J Alzheimers Dis. 2024 Aug 29. doi: 10.3233/JAD-240353.
    PubMed     Abstract available


  612. MACCIONI RB, Prieto R
    Understanding the Human Being from a Quantum Perspective: Lessons to Elucidate Alzheimer's Disease Pathogenesis.
    J Alzheimers Dis. 2024 Aug 28. doi: 10.3233/JAD-240864.
    PubMed    


  613. NAGATA T, Nakajima S, Kito S, Shinagawa S, et al
    The Association Between Distinct Delusional Ideations and Depressive Symptoms in Alzheimer's Disease: A Re-Analysis of CATIE-AD.
    J Alzheimers Dis. 2024 Aug 28. doi: 10.3233/JAD-240702.
    PubMed     Abstract available


  614. GUTIERREZ J, Kurz C, Sandoval C, Edmonds R, et al
    Impact of Preanalytical Procedures on Complement Biomarkers in Cerebrospinal Fluid and Plasma from Controls and Alzheimer's Disease Patients.
    J Alzheimers Dis. 2024 Aug 28. doi: 10.3233/JAD-240287.
    PubMed     Abstract available


  615. HUYNH ALH, Wang Y, Ma L, Low YLC, et al
    A Comparison of an Australian Observational Longitudinal Alzheimer's Disease Cohort to Community-Based Australian Data.
    J Alzheimers Dis. 2024 Aug 28. doi: 10.3233/JAD-240241.
    PubMed     Abstract available


  616. SOUZA NAP, Simoes Neto JP, Dourado MCN
    The Relationship Between Decision-Making Capacity and Awareness in People with Young-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2024 Aug 26. doi: 10.3233/JAD-231324.
    PubMed     Abstract available


  617. GIAQUINTO F, Lorenzini P, Salvi E, Carnevale G, et al
    The Profile of the Italian Centers for Cognitive Disorders and Dementia in the Context of New Drugs in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Aug 24. doi: 10.3233/JAD-240594.
    PubMed     Abstract available


  618. SUN W, Chen Y, Yang Y, Wang P, et al
    Characteristics and Transcriptomic Analysis of Cholinergic Neurons Derived from Induced Pluripotent Stem Cells with APP Mutation in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Aug 24. doi: 10.3233/JAD-240299.
    PubMed     Abstract available


  619. SILVA-RUDBERG JA, Mecca AP
    Diffusion Imaging of Gray Matter Microstructure in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Aug 23. doi: 10.3233/JAD-240673.
    PubMed     Abstract available


  620. PERREIRA KM, Hotz VJ, Duke NN, Aiello AE, et al
    The Add Health Parent Study: A Biosocial Resource for the Study of Multigenerational Racial/Ethnic Disparities in Alzheimer's Disease and Alzheimer's Disease-Related Dementias.
    J Alzheimers Dis. 2024 Aug 23. doi: 10.3233/JAD-240201.
    PubMed     Abstract available


  621. WEI W, Jiang Y, Hu G, He Y, et al
    Recent Advances of Mitochondrial Alterations in Alzheimer's Disease: A Perspective of Mitochondrial Basic Events.
    J Alzheimers Dis. 2024 Aug 23. doi: 10.3233/JAD-240092.
    PubMed     Abstract available


  622. CHEN J, Yang J, Shen D, Wang X, et al
    A Predictive Model of the Progression to Alzheimer's Disease in Patients with Mild Cognitive Impairment Based on the MRI Enlarged Perivascular Spaces.
    J Alzheimers Dis. 2024 Aug 22. doi: 10.3233/JAD-240523.
    PubMed     Abstract available


  623. JANN K, Cen S, Santos M, Aksman L, et al
    Effect of Genetic Risk on the Relationship Between rs-fMRI Complexity and Tau and Amyloid PET in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Aug 22. doi: 10.3233/JAD-240459.
    PubMed     Abstract available


  624. NATARAJ A, Kala A, Pena SLP, Jezek K, et al
    Impaired Dynamics of Positional and Contextual Neural Coding in an Alzheimer's Disease Rat Model.
    J Alzheimers Dis. 2024 Aug 22. doi: 10.3233/JAD-231386.
    PubMed     Abstract available


  625. UH K, Monarch K, Reese ED, Rodriguez K, et al
    Impaired Skeletal Development by Disruption of Presenilin-1 in Pigs and Generation of Novel Pig Models for Alzheimer's Disease.
    J Alzheimers Dis. 2024 Aug 21. doi: 10.3233/JAD-231297.
    PubMed     Abstract available


  626. QI H, Zhu X, Ren Y, Zhang X, et al
    A Study of Assisted Screening for Alzheimer's Disease Based on Handwriting and Gait Analysis.
    J Alzheimers Dis. 2024 Aug 17. doi: 10.3233/JAD-240362.
    PubMed     Abstract available


  627. NEVE A, Das B, Wojtowicz J, Huang Z, et al
    Long-Term Safety of Gantenerumab in Participants with Alzheimer's Disease: A Phase III, Double-Blind, and Open-Label Extension Study (Marguerite RoAD).
    J Alzheimers Dis. 2024 Aug 17. doi: 10.3233/JAD-240221.
    PubMed     Abstract available


  628. AVELAR-PEREIRA B, Phillips CM, Hosseini SMH
    Convergence of Accelerated Brain Volume Decline in Normal Aging and Alzheimer's Disease Pathology.
    J Alzheimers Dis. 2024 Aug 17. doi: 10.3233/JAD-231458.
    PubMed     Abstract available


  629. ILARDI CR, Menichelli A, Michelutti M, Cattaruzza T, et al
    On the Clinimetrics of the Montreal Cognitive Assessment: Cutoff Analysis in Patients with Mild Cognitive Impairment due to Alzheimer's Disease.
    J Alzheimers Dis. 2024 Aug 12. doi: 10.3233/JAD-240339.
    PubMed     Abstract available


  630. KOHLER K, Macheda T, Hobbs MM, Maisel MT, et al
    Exposure to Lead in Drinking Water Causes Cognitive Impairment via an Alzheimer's Disease Gene-Dependent Mechanism in Adult Mice.
    J Alzheimers Dis. 2024 Aug 8. doi: 10.3233/JAD-240640.
    PubMed     Abstract available


  631. DUITS FH, Nilsson J, Zetterberg H, Blennow K, et al
    Serial Cerebrospinal Fluid Sampling Reveals Trajectories of Potential Synaptic Biomarkers in Early Stages of Alzheimer's Disease.
    J Alzheimers Dis. 2024 Aug 8. doi: 10.3233/JAD-240610.
    PubMed     Abstract available


  632. KALTSA M, Tsolaki A, Lazarou I, Mittas I, et al
    Assessing the Linguistic Capacity Across Alzheimer's Disease and Its Preclinical Stages: Evidence from Narrative Macrostructure in Elderly Speakers of Greek.
    J Alzheimers Dis. 2024 Aug 8. doi: 10.3233/JAD-240496.
    PubMed     Abstract available


  633. L'ESPERANCE OJ, McGhee J, Davidson G, Niraula S, et al
    Functional Connectivity Favors Aberrant Visual Network c-Fos Expression Accompanied by Cortical Synapse Loss in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2024 Aug 7. doi: 10.3233/JAD-240776.
    PubMed     Abstract available


  634. WING JJ, Rajczyk JI, Burke JF
    Geographic Variation of Prevalence of Alzheimer's Disease and Related Dementias in Central Appalachia.
    J Alzheimers Dis. 2024 Aug 7. doi: 10.3233/JAD-240528.
    PubMed     Abstract available


  635. GRANT WB
    A Brief History of the Progress in Our Understanding of Genetics and Lifestyle, Especially Diet, in the Risk of Alzheimer's Disease.
    J Alzheimers Dis. 2024 Aug 6. doi: 10.3233/JAD-240658.
    PubMed     Abstract available


  636. BUCHMAN AS, Yu L, Oveisgharan S, Zammit AR, et al
    Parkinson's Disease and Other Alzheimer's Disease and Related Dementia Pathologies and the Progression of Parkinsonism in Older Adults.
    J Alzheimers Dis. 2024 Aug 6. doi: 10.3233/JAD-240593.
    PubMed     Abstract available


  637. RUSTAMZADEH A, Tafakhori A, Ariaei A, Heydari M, et al
    Targeting Caspases 3/6 and Cathepsins L/B May Decrease Laminopathy-Induced Apoptosis in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Aug 5. doi: 10.3233/JAD-240413.
    PubMed     Abstract available


  638. ORIA RB, Smith CJ, Ashford JW, Vitek MP, et al
    Pros and Cons of APOE4 Homozygosity and Effects on Neuroplasticity, Malnutrition, and Infections in Early Life Adversity, Alzheimer's Disease, and Alzheimer's Prevention.
    J Alzheimers Dis. 2024 Aug 1. doi: 10.3233/JAD-240888.
    PubMed     Abstract available


  639. HAN BL, Ma LZ, Han SL, Mi YC, et al
    Explore the Role of Frailty as a Contributor to the Association Between AT(N) Profiles and Cognition in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Aug 1. doi: 10.3233/JAD-231489.
    PubMed     Abstract available


    July 2024
  640. IBAN-ARIAS R, Wang SH, Soares Dias Portela A, Yang EJ, et al
    Exposure to the World Center Particulate Matter Alters the Gut-Brain Axis in Early Onset Alzheimer's Disease Mice.
    J Alzheimers Dis. 2024 Jul 30. doi: 10.3233/JAD-240635.
    PubMed     Abstract available


  641. WANG H, Li J, Tu W, Wang Z, et al
    Identification of Blood Biomarkers Related to Energy Metabolism and Construction of Diagnostic Prediction Model Based on Three Independent Alzheimer's Disease Cohorts.
    J Alzheimers Dis. 2024 Jul 29. doi: 10.3233/JAD-240301.
    PubMed     Abstract available


  642. KASHIBAYASHI T, Kanemoto H, Takahashi R, Fujito R, et al
    Neural Basis of Agitated Behaviors in Patients with Amnestic Mild Cognitive Impairment and Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jul 27. doi: 10.3233/JAD-240256.
    PubMed     Abstract available


  643. BOCCARDI V, Ruggiero C, Cecchetti R, Mecocci P, et al
    Geroscience and the Fight Against Alzheimer's Disease: Between Myth and Reality.
    J Alzheimers Dis. 2024 Jul 26. doi: 10.3233/JAD-240582.
    PubMed     Abstract available


  644. WANG W, Zhao F, Torres S, Harris PLR, et al
    Space-Like Irradiation Exacerbated Cognitive Deficits and Amyloid Pathology in CRND8 Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jul 26. doi: 10.3233/JAD-240570.
    PubMed     Abstract available


  645. LEE JH, Jia J, Ji Y, Kandiah N, et al
    A Framework for Best Practices and Readiness in the Advent of Anti-Amyloid Therapy for Early Alzheimer's Disease in Asia.
    J Alzheimers Dis. 2024 Jul 23. doi: 10.3233/JAD-240684.
    PubMed     Abstract available


  646. LIU Y, Xu W, Yang P, Liu X, et al
    Revealing Molecular Patterns of Alzheimer's Disease Risk Gene Expression Signatures in COVID-19 Brains.
    J Alzheimers Dis. 2024 Jul 23. doi: 10.3233/JAD-240609.
    PubMed     Abstract available


  647. AVILA J
    Delaying Brain Aging or Decreasing Tau Levels as Strategies to Prevent Alzheimer's Disease: In Memoriam of Mark A. Smith.
    J Alzheimers Dis. 2024 Jul 20. doi: 10.3233/JAD-240500.
    PubMed     Abstract available


  648. LIU Y, He B, Du K, Zheng J, et al
    Periphery Biomarkers Predicting Conversion of Type 2 Diabetes to Pre-Alzheimer-Like Cognitive Decline: A Multicenter Follow-Up Study.
    J Alzheimers Dis. 2024 Jul 19. doi: 10.3233/JAD-240455.
    PubMed     Abstract available


  649. BUTTERFIELD DA
    Activation of the Neuronal Cell Cycle in Brains in Amnestic Mild Cognitive Impairment: Early Involvement in the Progression of Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jul 12. doi: 10.3233/JAD-240615.
    PubMed     Abstract available


  650. MANDAL PK, Maroon JC, Samkaria A, Arora Y, et al
    Iron Chelators and Alzheimer's Disease Clinical Trials.
    J Alzheimers Dis. 2024 Jul 12. doi: 10.3233/JAD-240605.
    PubMed     Abstract available


  651. AMARAL-CARVALHO V, Bento Lima-Silva T, Inacio Mariano L, Cruz de Souza L, et al
    Improved Accuracy of the Addenbrooke's Cognitive Examination-Revised in the Diagnosis of Mild Cognitive Impairment, Mild Dementia Due to Alzheimer's Disease and Behavioral Variant Frontotemporal Dementia Using Mokken Scale Analysis.
    J Alzheimers Dis. 2024 Jul 12. doi: 10.3233/JAD-240554.
    PubMed     Abstract available


  652. WANG RT, Sun Z, Tan CC, Tan L, et al
    Dynamic Features of Body Mass Index in Late Life Predict Cognitive Trajectories and Alzheimer's Disease: A Longitudinal Study.
    J Alzheimers Dis. 2024 Jul 12. doi: 10.3233/JAD-240292.
    PubMed     Abstract available


  653. BOCTI C
    Is Simpler Always Better? The Case for Going Beyond the Amyloid Hypothesis in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jul 9. doi: 10.3233/JAD-240488.
    PubMed     Abstract available


  654. ELMAN JA, Schork NJ, Rangan AV
    Exploring the Genetic Heterogeneity of Alzheimer's Disease: Evidence for Genetic Subtypes.
    J Alzheimers Dis. 2024 Jul 8. doi: 10.3233/JAD-231252.
    PubMed     Abstract available


  655. REIVE BS, Lau V, Sanchez-Lafuente CL, Henri-Bhargava A, et al
    The Inflammation-Induced Dysregulation of Reelin Homeostasis Hypothesis of Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jul 5. doi: 10.3233/JAD-240088.
    PubMed     Abstract available


  656. PORTAL B, Sodergren M, Pares I Borrell T, Giraud R, et al
    Early Astrocytic Dysfunction Is Associated with Mistuned Synapses as well as Anxiety and Depressive-Like Behavior in the AppNL-F Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jul 4. doi: 10.3233/JAD-231461.
    PubMed     Abstract available



  657. Erratum to: Tubastatin A/ACY-1215 Improves Cognition in Alzheimer's Disease Transgenic Mice.
    J Alzheimers Dis. 2024 Jul 2. doi: 10.3233/JAD-249014.
    PubMed    


    June 2024
  658. JIN H, Yang Q, Chen G, Zhang W, et al
    Effects of Hepatorenal Function on Urinary Alzheimer-Associated Neuronal Thread Protein: A Laboratory-Based Cross-Sectional Study Among the Older Chinese Population.
    J Alzheimers Dis. 2024 Jun 29. doi: 10.3233/JAD-240148.
    PubMed     Abstract available


  659. ZHANG YH, Zhao P, Gao HL, Zhong ML, et al
    Screening Targets and Therapeutic Drugs for Alzheimer's Disease Based on Deep Learning Model and Molecular Docking.
    J Alzheimers Dis. 2024 Jun 29. doi: 10.3233/JAD-231389.
    PubMed     Abstract available



  660. Erratum to: Insulin-Related Biomarkers in Cerebrospinal Fluid in Mild Cognitive Impairment and Alzheimer's Disease: A Systematic Review.
    J Alzheimers Dis. 2024 Jun 28. doi: 10.3233/JAD-249011.
    PubMed    


  661. GARCIA-MARTINEZ M, Pozueta-Cantudo A, Lage C, Martinez-Dubarbie F, et al
    LAM Test: A New Cognitive Marker for Early Detection in Preclinical Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jun 28. doi: 10.3233/JAD-240067.
    PubMed     Abstract available


  662. ZHUANG X, Cordes D, Bender AR, Nandy R, et al
    Classifying Alzheimer's Disease Neuropathology Using Clinical and MRI Measurements.
    J Alzheimers Dis. 2024 Jun 28. doi: 10.3233/JAD-231321.
    PubMed     Abstract available


  663. PUZZO D
    Beyond Amyloid-beta: Reevaluating Its Physiological Role to Find Safe Therapies Against Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jun 27. doi: 10.3233/JAD-240406.
    PubMed     Abstract available


  664. COIMBRA JRM, Resende R, Custodio JBA, Salvador JAR, et al
    BACE1 Inhibitors for Alzheimer's Disease: Current Challenges and Future Perspectives.
    J Alzheimers Dis. 2024 Jun 22. doi: 10.3233/JAD-240146.
    PubMed     Abstract available


  665. SAKHAROVA T, Mao S, Osadchuk M
    Updated Models of Alzheimer's Disease with Deep Neural Networks.
    J Alzheimers Dis. 2024 Jun 21. doi: 10.3233/JAD-240183.
    PubMed     Abstract available


  666. PERRY G, Castellani R
    Alzheimer's Disease: Are We There Yet?
    J Alzheimers Dis. 2024 Jun 20. doi: 10.3233/JAD-249012.
    PubMed    


  667. LOBUE C, McClintock SM, Chiang HS, Helphrey J, et al
    A Critical Review of Noninvasive Brain Stimulation Technologies in Alzheimer's Dementia and Primary Progressive Aphasia.
    J Alzheimers Dis. 2024 Jun 20. doi: 10.3233/JAD-240230.
    PubMed     Abstract available


  668. HU Y, Wang X, Zhao Z, Liu M, et al
    The Downregulation of ITGAX Exacerbates Amyloid-beta Plaque Deposition in Alzheimer's Disease by Increasing Polarization of M1 Microglia.
    J Alzheimers Dis. 2024 Jun 20. doi: 10.3233/JAD-240118.
    PubMed     Abstract available


  669. GARERI P, Cotroneo AM, Montella R, Gaglianone M, et al
    Citicoline: A Cholinergic Precursor with a Pivotal Role in Dementia and Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jun 15. doi: 10.3233/JAD-240497.
    PubMed     Abstract available


  670. DESAI S, Chen IY, Hom C, Doran E, et al
    Insomnia Symptoms Are Associated with Measures of Functional Deterioration and Dementia Status in Adults with Down Syndrome at High Risk for Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jun 14. doi: 10.3233/JAD-220750.
    PubMed     Abstract available


  671. CABALLERO HS, McFall GP, Gee M, MacDonald S, et al
    Cognitive Speed in Neurodegenerative Disease: Comparing Mean Rate and Inconsistency Within and Across the Alzheimer's and Lewy Body Spectra in the COMPASS-ND Study.
    J Alzheimers Dis. 2024 Jun 12. doi: 10.3233/JAD-240210.
    PubMed     Abstract available


  672. CHEN X, Walton K, Brodaty H, Chalton K, et al
    Polyphenols and Diets as Current and Potential Nutrition Senotherapeutics in Alzheimer's Disease: Findings from Clinical Trials.
    J Alzheimers Dis. 2024 Jun 12. doi: 10.3233/JAD-231222.
    PubMed     Abstract available


  673. CANDEIAS E, Pereira-Santos AR, Empadinhas N, Cardoso SM, et al
    The Gut-Brain Axis in Alzheimer's and Parkinson's Diseases: The Catalytic Role of Mitochondria.
    J Alzheimers Dis. 2024 Jun 8. doi: 10.3233/JAD-240524.
    PubMed     Abstract available


  674. SHAMSI A, Furkan M, Khan MS, Yadav DK, et al
    Computational Screening of Repurposed Drugs for HMG-CoA Synthase 2 in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jun 8. doi: 10.3233/JAD-240376.
    PubMed     Abstract available


  675. CHANDLER JM, Ye W, Mi X, Doty EG, et al
    Potential Impact of Slowing Disease Progression in Early Symptomatic Alzheimer's Disease on Patient Quality of Life, Caregiver Time, and Total Societal Costs: Estimates Based on Findings from GERAS-US Study.
    J Alzheimers Dis. 2024 Jun 8. doi: 10.3233/JAD-231166.
    PubMed     Abstract available


  676. LALIVE HM, Griffa A, Carlier S, Nasuti M, et al
    Amnestic Syndrome in Memory Clinics: Similar Morphological Brain Patterns in Older Adults with and without Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jun 7. doi: 10.3233/JAD-240026.
    PubMed     Abstract available


  677. CHEN YH, Wang ZB, Liu XP, Mao ZQ, et al
    Plasma Insulin Predicts Early Amyloid-beta Pathology Changes in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jun 5. doi: 10.3233/JAD-240289.
    PubMed     Abstract available


  678. LI D, Xie Q, Xie J, Ni M, et al
    Cerebrospinal Fluid Proteomics Identifies Potential Biomarkers for Early-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jun 5. doi: 10.3233/JAD-240022.
    PubMed     Abstract available


  679. LI JG, Mutreja Y, Servili M, Leone A, et al
    The Anti-Neuroinflammatory Effect of Extra-Virgin Olive Oil in the Triple Transgenic Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jun 4. doi: 10.3233/JAD-240374.
    PubMed     Abstract available



  680. Erratum to: Self-Reported Late-Life Hypertension Is Associated with a Healthy Cognitive Status and Reduced Alzheimer's Disease Pathology Burden.
    J Alzheimers Dis. 2024 Jun 3. doi: 10.3233/JAD-249010.
    PubMed    


  681. SUN CK, Guo F, Ou YN, Zhang MZ, et al
    Association Between Carotid Plaque and Alzheimer's Disease Cerebrospinal Fluid Biomarkers and Cognitive Function in Cognitively Intact Adults: The CABLE Study.
    J Alzheimers Dis. 2024 Jun 1. doi: 10.3233/JAD-240131.
    PubMed     Abstract available


  682. LIANG X, Wang Y, Li S, Fan J, et al
    Enhancing Rab7 Activity by Inhibiting TBC1D5 Expression Improves Mitophagy in Alzheimer's Disease Models.
    J Alzheimers Dis. 2024 Jun 1. doi: 10.3233/JAD-231300.
    PubMed     Abstract available


  683. FUKUI Y, Tadokoro K, Hamada M, Asada K, et al
    A Novel Peptidome Technology for the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease by Selected Reaction Monitoring.
    J Alzheimers Dis. 2024 Jun 1. doi: 10.3233/JAD-230915.
    PubMed     Abstract available


    May 2024
  684. TAYLOR J, Jaros M, Chen C, Harrison J, et al
    Plasma pTau181 Predicts Clinical Progression in a Phase 2 Randomized Controlled Trial of the 11beta-HSD1 Inhibitor Xanamem(R) for Mild Alzheimer's Disease.
    J Alzheimers Dis. 2024 May 31. doi: 10.3233/JAD-231456.
    PubMed     Abstract available


  685. CANTERO-FORTIZ Y, Cano A, Boada M
    Unraveling the Tau Puzzle: A Brief Discussion on Biomarkers in Alzheimer's Disease.
    J Alzheimers Dis. 2024 May 30. doi: 10.3233/JAD-240055.
    PubMed     Abstract available


  686. ZHAO A, Balcer LJ, Himali JJ, O'Donnell A, et al
    Association of Loneliness with Functional Connectivity MRI, Amyloid-beta PET, and Tau PET Neuroimaging Markers of Vulnerability for Alzheimer's Disease.
    J Alzheimers Dis. 2024 May 28. doi: 10.3233/JAD-231425.
    PubMed     Abstract available


  687. ILBOUDO Y, Yoshiji S, Lu T, Butler-Laporte G, et al
    Vitamin D, Cognition, and Alzheimer's Disease: Observational and Two-Sample Mendelian Randomization Studies.
    J Alzheimers Dis. 2024 May 27. doi: 10.3233/JAD-221223.
    PubMed     Abstract available


  688. DUCHESNE S, Rousseau LS, Belzile-Marsolais F, Welch LA, et al
    A Scoping Review of Alzheimers Disease Hypotheses: An Array of Uni- and Multi-Factorial Theories.
    J Alzheimers Dis. 2024 May 24. doi: 10.3233/JAD-230772.
    PubMed     Abstract available


  689. GENG Z, Wu Y, Liu J, Zhan Y, et al
    A Study on the Effect of Executive Control Network Functional Connection on the Therapeutic Efficacy of Repetitive Transcranial Magnetic Stimulation in Alzheimer's Disease.
    J Alzheimers Dis. 2024 May 24. doi: 10.3233/JAD-231449.
    PubMed     Abstract available


  690. AGUILAR BJ, Jasuja GK, Li X, Shishova E, et al
    Prevalence of Mild Cognitive Impairment and Alzheimer's Disease Identified in Veterans in the United States.
    J Alzheimers Dis. 2024 May 23. doi: 10.3233/JAD-240027.
    PubMed     Abstract available


  691. HERMES S, Cady J, Armentrout S, O'Connor J, et al
    Epistatic Features and Machine Learning Improve Alzheimer's Disease Risk Prediction Over Polygenic Risk Scores.
    J Alzheimers Dis. 2024 May 23. doi: 10.3233/JAD-230236.
    PubMed     Abstract available


  692. STARMANS NLP, Kappelle LJ, Muller M, Staals J, et al
    Blood Pressure Variability and Plasma Biomarkers of Neuronal Injury and Alzheimer's Disease: A Clinic-Based Study of Patients with Diseases Along the Heart-Brain Axis.
    J Alzheimers Dis. 2024 May 21. doi: 10.3233/JAD-240119.
    PubMed     Abstract available


  693. CHAI YL, Strohm L, Zhu Y, Chia RSL, et al
    Extracellular Vesicle-Enriched miRNA-Biomarkers Show Improved Utility for Detecting Alzheimer's Disease Dementia and Medial Temporal Atrophy.
    J Alzheimers Dis. 2024 May 21. doi: 10.3233/JAD-230572.
    PubMed     Abstract available


  694. NING M, An L, Dong L, Zhu R, et al
    Causal Associations Between Gut Microbiota, Gut Microbiota-Derived Metabolites, and Alzheimer's Disease: A Multivariable Mendelian Randomization Study.
    J Alzheimers Dis. 2024 May 20. doi: 10.3233/JAD-240082.
    PubMed     Abstract available


  695. PRZYBYSZEWSKI AW, Chudzik A
    How to Cure Alzheimer's Disease.
    J Alzheimers Dis. 2024 May 18. doi: 10.3233/JAD-240231.
    PubMed     Abstract available


  696. GAMM S, Ummel D, Vasil N, Grenier S, et al
    Getting Insight to the Lived Emotional Experience of People with Alzheimer's Disease Shortly After Diagnosis: A Phenomenological Approach.
    J Alzheimers Dis. 2024 May 18. doi: 10.3233/JAD-231403.
    PubMed     Abstract available


  697. ZENG B, Tang C, Wang J, Yang Q, et al
    Pharmacologic and Nutritional Interventions for Early Alzheimer's Disease: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.
    J Alzheimers Dis. 2024 May 17. doi: 10.3233/JAD-240161.
    PubMed     Abstract available


  698. PLUTA R, Bogucka-Kocka A, Bogucki J, Kocki J, et al
    Apoptosis, Autophagy, and Mitophagy Genes in the CA3 Area in an Ischemic Model of Alzheimer's Disease with 2-Year Survival.
    J Alzheimers Dis. 2024 May 16. doi: 10.3233/JAD-240401.
    PubMed     Abstract available


  699. COSTANTINI E, Carrarini C, Calisi D, De Rosa M, et al
    Search in the Periphery for Potential Inflammatory Biomarkers of Dementia with Lewy Bodies and Alzheimer's Disease.
    J Alzheimers Dis. 2024 May 16. doi: 10.3233/JAD-231471.
    PubMed     Abstract available


  700. KURIHARA M, Kondo S, Ohse K, Nojima H, et al
    Relationship Between Cerebrospinal Fluid Alzheimer's Disease Biomarker Values Measured via Lumipulse Assays and Conventional ELISA: Single-Center Experience and Systematic Review.
    J Alzheimers Dis. 2024 May 15. doi: 10.3233/JAD-240185.
    PubMed     Abstract available


  701. WEGNER P, Balabin H, Ay MC, Bauermeister S, et al
    Semantic Harmonization of Alzheimer's Disease Datasets Using AD-Mapper.
    J Alzheimers Dis. 2024 May 15. doi: 10.3233/JAD-240116.
    PubMed     Abstract available


  702. NAKAYA M, Sato N, Matsuda H, Maikusa N, et al
    Assessment of Gray Matter Microstructural Alterations in Alzheimer's Disease by Free Water Imaging.
    J Alzheimers Dis. 2024 May 15. doi: 10.3233/JAD-231416.
    PubMed     Abstract available


  703. STAM CJ, de Haan W
    Network Hyperexcitability in Early-Stage Alzheimer's Disease: Evaluation of Functional Connectivity Biomarkers in a Computational Disease Model.
    J Alzheimers Dis. 2024 May 15. doi: 10.3233/JAD-230825.
    PubMed     Abstract available


  704. MCINTIRE LB
    Prognostic Power? Do the Plasma Biomarkers, Neurofilament Light and Phospho-Tau 181, Improve Prediction of Progression to Alzheimer's Disease Using a Machine Learning Approach in the ADNI Cohort?
    J Alzheimers Dis. 2024 May 14. doi: 10.3233/JAD-240126.
    PubMed     Abstract available


  705. IRFAN B, Ankouni G, Reader J, Seraji-Bozorgzad N, et al
    Alzheimer's Disease and Related Dementias in Muslim Women: Recommendations for Culturally Sensitive Care.
    J Alzheimers Dis. 2024 May 13. doi: 10.3233/JAD-240064.
    PubMed     Abstract available


  706. ZAKRZEWSKI JJ, Davis JD, Gemelli ZT, Korthauer LE, et al
    Understanding Health Beliefs and Health Behaviors in Older Adults at Risk for Alzheimer's Disease.
    J Alzheimers Dis. 2024 May 13. doi: 10.3233/JAD-230977.
    PubMed     Abstract available


  707. SATO K, Niimi Y, Ihara R, Suzuki K, et al
    Simplifying Alzheimer's Disease Monitoring: A Novel Machine-Learning Approach to Estimate the Clinical Dementia Rating Sum of Box Changes Using the Mini-Mental State Examination and Functional Activities Questionnaire.
    J Alzheimers Dis. 2024 May 11. doi: 10.3233/JAD-231426.
    PubMed     Abstract available


  708. CHONG JSX, Tan YJ, Koh AJ, Ting SKS, et al
    Plasma Neurofilament Light Relates to Divergent Default and Salience Network Connectivity in Alzheimer's Disease and Behavioral Variant Frontotemporal Dementia.
    J Alzheimers Dis. 2024 May 11. doi: 10.3233/JAD-231251.
    PubMed     Abstract available


  709. GUO ZX, Liu F, Wang FY, Ou YN, et al
    CAIDE Score, Alzheimer's Disease Pathology, and Cognition in Cognitively Normal Adults: The CABLE Study.
    J Alzheimers Dis. 2024 May 10. doi: 10.3233/JAD-240005.
    PubMed     Abstract available


  710. MCLAREN AMR, Kawaja MD
    Olfactory Dysfunction and Alzheimer's Disease: A Review.
    J Alzheimers Dis. 2024 May 10. doi: 10.3233/JAD-231377.
    PubMed     Abstract available


  711. WU C, Ruan T, Yuan Y, Xu C, et al
    Alterations in Synaptic Connectivity and Synaptic Transmission in Alzheimer's Disease with High Physical Activity.
    J Alzheimers Dis. 2024 May 10. doi: 10.3233/JAD-240123.
    PubMed     Abstract available


  712. ZUPANIC E, Emersic A, Wimo A, Winblad B, et al
    Slovenian Memory Clinic Organization with the Introduction of Potential New Alzheimer's Disease Treatment.
    J Alzheimers Dis. 2024 May 9. doi: 10.3233/JAD-240190.
    PubMed     Abstract available


  713. XIE L, Raj Y, Varathan P, He B, et al
    Deep Trans-Omic Network Fusion for Molecular Mechanism of Alzheimer's Disease.
    J Alzheimers Dis. 2024 May 9. doi: 10.3233/JAD-240098.
    PubMed     Abstract available


  714. ZHU M, Liu Y, Chen C, Chen H, et al
    TLR4/Rac1/NLRP3 Pathway Mediates Amyloid-beta-Induced Neuroinflammation in Alzheimer's Disease.
    J Alzheimers Dis. 2024 May 8. doi: 10.3233/JAD-240012.
    PubMed     Abstract available


  715. GIRALDO-BERRIO D, Jimenez-Del-Rio M, Velez-Pardo C
    Sildenafil Reverses the Neuropathological Alzheimer's Disease Phenotype in Cholinergic-Like Neurons Carrying the Presenilin 1 E280A Mutation.
    J Alzheimers Dis. 2024 May 8. doi: 10.3233/JAD-231169.
    PubMed     Abstract available


    April 2024
  716. XU J, Chen Y, Shi Y, Sun A, et al
    Associations Between Neuroinflammation-Related Conditions and Alzheimer's Disease: A Study of US Insurance Claims Data.
    J Alzheimers Dis. 2024 Apr 30. doi: 10.3233/JAD-231286.
    PubMed     Abstract available


  717. WU B, Chen M, Meng L, Tian Q, et al
    Osteoclasts Link Dysregulated Peripheral Degradation Processes and Accelerated Progression in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Apr 29. doi: 10.3233/JAD-240096.
    PubMed     Abstract available


  718. LI Y, Yang Z, Zhang Y, Liu F, et al
    Genetic Screening of Patients with Sporadic Alzheimer's Disease and Frontotemporal Lobar Degeneration in the Chinese Population.
    J Alzheimers Dis. 2024 Apr 29. doi: 10.3233/JAD-231361.
    PubMed     Abstract available


  719. GALE SA
    Language and Meaning: Asymptomatic Alzheimer's Disease in the Clinic and Society.
    J Alzheimers Dis. 2024 Apr 27. doi: 10.3233/JAD-240195.
    PubMed     Abstract available


  720. OHNO M
    A Strategy for Allowing Earlier Diagnosis and Rigorous Evaluation of BACE1 Inhibitors in Preclinical Alzheimer's Disease.
    J Alzheimers Dis. 2024 Apr 27. doi: 10.3233/JAD-231451.
    PubMed     Abstract available


  721. HORVATH A, Quinlan P, Eckerstrom C, Aberg ND, et al
    The Associations Between Serum Insulin-like Growth Factor-I, Brain White Matter Volumes, and Cognition in Mild Cognitive Impairment and Alzheimer's Disease.
    J Alzheimers Dis. 2024 Apr 27. doi: 10.3233/JAD-231026.
    PubMed     Abstract available



  722. Erratum to: Loss in PKC Epsilon Causes Downregulation of MnSOD and BDNF Expression in Neurons of Alzheimer's Disease Hippocampus.
    J Alzheimers Dis. 2024 Apr 26. doi: 10.3233/JAD-249008.
    PubMed    


  723. UM YH, Wang SM, Kang DW, Kim S, et al
    Impact of Apolipoprotein E4 on the Locus Coeruleus Functional Connectivity in Preclinical Alzheimer's Disease.
    J Alzheimers Dis. 2024 Apr 26. doi: 10.3233/JAD-240065.
    PubMed     Abstract available


  724. ELGHANAM Y, Purja S, Kim EY
    Biomarkers as Endpoints in Clinical Trials for Alzheimer's Disease.
    J Alzheimers Dis. 2024 Apr 26. doi: 10.3233/JAD-240008.
    PubMed     Abstract available


  725. DURAN T, Gaussoin SA, Latham LA, Rundle MM, et al
    Examining a Preclinical Alzheimer's Cognitive Composite for Telehealth Administration for Reliability Between In-Person and Remote Cognitive Testing with Neuroimaging Biomarkers.
    J Alzheimers Dis. 2024 Apr 26. doi: 10.3233/JAD-231435.
    PubMed     Abstract available


  726. GARCIA-CARLOS CA, Basurto-Islas G, Perry G, Mondragon-Rodriguez S, et al
    Meta-Analysis in Transgenic Alzheimer's Disease Mouse Models Reveals Opposite Brain Network Effects of Amyloid-beta and Phosphorylated Tau Proteins.
    J Alzheimers Dis. 2024 Apr 26. doi: 10.3233/JAD-231365.
    PubMed     Abstract available


  727. MEMON A, Moore JA, Kang C, Ismail Z, et al
    Visual Functions Are Associated with Biomarker Changes in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Apr 26. doi: 10.3233/JAD-231084.
    PubMed     Abstract available


  728. LIU M, Ma N, Yang X, Sun M, et al
    The Association of Circulating Glucagon-Like Peptide-1 with Cognitive Functions and Biomarkers in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Apr 25. doi: 10.3233/JAD-240001.
    PubMed     Abstract available


  729. NGO S, Jackson AJ, Manivannan M, Young JC, et al
    Real World Financial Mismanagement in Alzheimer's Disease, Frontotemporal Dementia, and Primary Progressive Aphasia.
    J Alzheimers Dis. 2024 Apr 24. doi: 10.3233/JAD-231021.
    PubMed     Abstract available


  730. HUANG Z
    Evidence that Alzheimer's Disease Is a Disease of Competitive Synaptic Plasticity Gone Awry.
    J Alzheimers Dis. 2024 Apr 21. doi: 10.3233/JAD-240042.
    PubMed     Abstract available


  731. DUFF K, Hammers DB, Koppelmans V, King JB, et al
    Short-Term Practice Effects on Cognitive Tests Across the Late Life Cognitive Spectrum and How They Compare to Biomarkers of Alzheimer's Disease.
    J Alzheimers Dis. 2024 Apr 21. doi: 10.3233/JAD-231392.
    PubMed     Abstract available


  732. CHU Y, Xie Q, Meng R, Leng B, et al
    Evaluation of the Quality and Readability of Online Information about Alzheimer's Disease in China.
    J Alzheimers Dis. 2024 Apr 21. doi: 10.3233/JAD-231339.
    PubMed     Abstract available


  733. CETINSOY O, Anyanwu I, Krishnanand H, Natarajan G, et al
    Gene Association Study of the Urokinase Plasminogen Activator and Its Receptor Gene in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Apr 20. doi: 10.3233/JAD-231383.
    PubMed     Abstract available


  734. KIM D, Jamrasi P, Li X, Ahn S, et al
    Effects of Exercise on Urinary AD7c-NTP (Alzheimer-Associated Neuronal Thread Protein) Levels and Cognitive Function Among Active Korean Elderly: A Randomized Controlled Trial.
    J Alzheimers Dis. 2024 Apr 20. doi: 10.3233/JAD-230946.
    PubMed     Abstract available


  735. BUTLER T, Wang X, Chiang G, Xi K, et al
    Reduction in Constitutively Activated Auditory Brainstem Microglia in Aging and Alzheimer's Disease.
    J Alzheimers Dis. 2024 Apr 19. doi: 10.3233/JAD-231312.
    PubMed     Abstract available


  736. KIM M, Song YS, Han K, Bae YJ, et al
    Impaired Glymphatic Flow on Diffusion Tensor MRI as a Marker of Neurodegeneration in Alzheimer's Disease: Correlation with Gray Matter Volume Loss and Cognitive Decline Independent of Cerebral Amyloid Deposition.
    J Alzheimers Dis. 2024 Apr 19. doi: 10.3233/JAD-231131.
    PubMed     Abstract available


  737. CAI J, Xie D, Kong F, Zhai Z, et al
    Effect and Mechanism of Rapamycin on Cognitive Deficits in Animal Models of Alzheimer's Disease: A Systematic Review and Meta-analysis of Preclinical Studies.
    J Alzheimers Dis. 2024 Apr 17. doi: 10.3233/JAD-231249.
    PubMed     Abstract available


  738. SIGHINOLFI G, Mitolo M, Pizzagalli F, Stanzani-Maserati M, et al
    Sulcal Morphometry Predicts Mild Cognitive Impairment Conversion to Alzheimer's Disease.
    J Alzheimers Dis. 2024 Apr 17. doi: 10.3233/JAD-231192.
    PubMed     Abstract available


  739. CHANDRASEKARAN G, Xie SX
    Improving Regression Analysis with Imputation in a Longitudinal Study of Alzheimer's Disease.
    J Alzheimers Dis. 2024 Apr 17. doi: 10.3233/JAD-231047.
    PubMed     Abstract available


  740. DAS S
    Omics Approaches in Alzheimer's Disease Research.
    J Alzheimers Dis. 2024 Apr 16. doi: 10.3233/JAD-240272.
    PubMed    


  741. TAHAMI MONFARED AA, Khachatryan A, Hummel N, Kopiec A, et al
    Assessing Quality of Life, Economic Burden, and Independence Across the Alzheimer's Disease Continuum Using Patient-Caregiver Dyad Surveys.
    J Alzheimers Dis. 2024 Apr 16. doi: 10.3233/JAD-231259.
    PubMed     Abstract available


  742. CHOI YY, Lee JJ, Te Nijenhuis J, Choi KY, et al
    Multi-Ethnic Norms for Volumes of Subcortical and Lobar Brain Structures Measured by Neuro I: Ethnicity May Improve the Diagnosis of Alzheimer's Disease1.
    J Alzheimers Dis. 2024 Apr 16. doi: 10.3233/JAD-231182.
    PubMed     Abstract available


  743. YOO HS, Kim HK, Lee JH, Chun JH, et al
    Association of Basal Forebrain Volume with Amyloid, Tau, and Cognition in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Apr 16. doi: 10.3233/JAD-230975.
    PubMed     Abstract available


  744. KHALED M, Al-Jamal H, Tajer L, El-Mir R, et al
    Alzheimer's Disease in Lebanon: Exploring Genetic and Environmental Risk Factors-A Comprehensive Review.
    J Alzheimers Dis. 2024 Apr 12. doi: 10.3233/JAD-231432.
    PubMed     Abstract available


  745. ETEKOCHAY MO, Amaravadhi AR, Gonzalez GV, Atanasov AG, et al
    Unveiling New Strategies Facilitating the Implementation of Artificial Intelligence in Neuroimaging for the Early Detection of Alzheimer's Disease.
    J Alzheimers Dis. 2024 Apr 12. doi: 10.3233/JAD-231135.
    PubMed     Abstract available


  746. DORADO-MARTINEZ C, Montiel-Flores E, Ordonez-Librado JL, Gutierrez-Valdez AL, et al
    Histological and Memory Alterations in an Innovative Alzheimer's Disease Animal Model by Vanadium Pentoxide Inhalation.
    J Alzheimers Dis. 2024 Apr 12. doi: 10.3233/JAD-230818.
    PubMed     Abstract available


  747. BINI J
    The Importance of PET Imaging to Understanding Whole-Body Cortisol Metabolism in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Apr 11. doi: 10.3233/JAD-231463.
    PubMed     Abstract available


  748. BECKERS E, Riphagen JM, Van Egroo M, Bennett DA, et al
    Sparse Asymmetry in Locus Coeruleus Pathology in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Apr 11. doi: 10.3233/JAD-231328.
    PubMed     Abstract available


  749. SACHDEVA P, Narayanan KB, Sinha JK, Gupta S, et al
    Recent Advances in Drug Delivery Systems Targeting Insulin Signalling for the Treatment of Alzheimer's Disease.
    J Alzheimers Dis. 2024 Apr 6. doi: 10.3233/JAD-231181.
    PubMed     Abstract available


  750. WIDJAYA MA, Lee SD, Cheng WC, Wu BT, et al
    Effects of Exercise Training on Immune-Related Genes and Pathways in the Cortex of Animal Models of Alzheimer's Disease: A Systematic Review.
    J Alzheimers Dis. 2024 Apr 5. doi: 10.3233/JAD-230803.
    PubMed     Abstract available


  751. ACQUARONE E, Argyrousi EK, Arancio O, Watterson DM, et al
    The 5HT2b Receptor in Alzheimer's Disease: Increased Levels in Patient Brains and Antagonist Attenuation of Amyloid and Tau Induced Dysfunction.
    J Alzheimers Dis. 2024 Apr 3. doi: 10.3233/JAD-240063.
    PubMed     Abstract available


  752. AREA-GOMEZ E, Schon EA
    Towards a Unitary Hypothesis of Alzheimer's Disease Pathogenesis.
    J Alzheimers Dis. 2024 Apr 3. doi: 10.3233/JAD-231318.
    PubMed     Abstract available


  753. DAUAR MT, Picard C, Labonte A, Breitner J, et al
    Contactin 5 and Apolipoproteins Interplay in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Apr 3. doi: 10.3233/JAD-231003.
    PubMed     Abstract available


    March 2024
  754. BRAGAZZI NL, Boulares A, Garbarino S
    Could the Historical Transition from Segmented to Monophasic Sleep Explain the Modern Insurgence of Alzheimer's Disease and Related Dementias?
    J Alzheimers Dis. 2024 Mar 30. doi: 10.3233/JAD-240154.
    PubMed     Abstract available


  755. MORENO-RODRIGUEZ M, Perez SE, Martinez-Gardeazabal J, Manuel I, et al
    Frontal Cortex Lipid Alterations During the Onset of Alzheimer's Disease.
    J Alzheimers Dis. 2024 Mar 30. doi: 10.3233/JAD-231485.
    PubMed     Abstract available


  756. MUELLER SG
    Traumatic Brain Injury and Post-Traumatic Stress Disorder and Their Influence on Development and Pattern of Alzheimer's Disease Pathology in Later Life.
    J Alzheimers Dis. 2024 Mar 29. doi: 10.3233/JAD-231183.
    PubMed     Abstract available


  757. MATTSSON P, Cselenyi Z, Forsberg Moren A, Freund-Levi Y, et al
    High Contrast PET Imaging of Subcortical and Allocortical Amyloid-beta in Early Alzheimer's Disease Using [11C]AZD2184.
    J Alzheimers Dis. 2024 Mar 29. doi: 10.3233/JAD-231013.
    PubMed     Abstract available


  758. ROBINSON AC, Bin Rizwan T, Davidson YS, Minshull J, et al
    Self-Reported Late-Life Hypertension Is Associated with a Healthy Cognitive Status and Reduced Alzheimer's Disease Pathology Burden.
    J Alzheimers Dis. 2024 Mar 25. doi: 10.3233/JAD-231429.
    PubMed     Abstract available


  759. VIJAYAN M, Reddy PH
    Unveiling the Role of Novel miRNA PC-5P-12969 in Alleviating Alzheimer's Disease.
    J Alzheimers Dis. 2024 Mar 25. doi: 10.3233/JAD-231281.
    PubMed     Abstract available


  760. GELFO F, Petrosini L, Mandolesi L, Landolfo E, et al
    Land/Water Aerobic Activities: Two Sides of the Same Coin. A Comparative Analysis on the Effects in Cognition of Alzheimer's Disease.
    J Alzheimers Dis. 2024 Mar 25. doi: 10.3233/JAD-231279.
    PubMed     Abstract available


  761. LOVE RWB
    Aniracetam: An Evidence-Based Model for Preventing the Accumulation of Amyloid-beta Plaques in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Mar 25. doi: 10.3233/JAD-231247.
    PubMed     Abstract available


  762. LI Y, Xu X, Wang P, Chen X, et al
    Association of Cancer History with Lifetime Risk of Dementia and Alzheimer's Disease.
    J Alzheimers Dis. 2024 Mar 22. doi: 10.3233/JAD-231223.
    PubMed     Abstract available


  763. MATTKE S, Jun H, Chu S, Hanson M, et al
    Disparities in Access to Diagnostic Evaluation for Alzheimer's Disease in Individuals Dually Eligible for Medicare and Medicaid: A Modeling Study.
    J Alzheimers Dis. 2024 Mar 22. doi: 10.3233/JAD-231134.
    PubMed     Abstract available


  764. ZHANG M, Qu Y, Li Q, Gu C, et al
    Correlation Between Prefrontal Functional Connectivity and the Degree of Cognitive Impairment in Alzheimer's Disease: A Functional Near-Infrared Spectroscopy Study.
    J Alzheimers Dis. 2024 Mar 21. doi: 10.3233/JAD-230648.
    PubMed     Abstract available


  765. CUMMINGS J
    "Landscape of Phase 2 Trials in Alzheimer's Disease": Perspective on Adaptive Trials.
    J Alzheimers Dis. 2024 Mar 20. doi: 10.3233/JAD-240145.
    PubMed     Abstract available


  766. SHUI L, Shibata D, Chan KCG, Zhang W, et al
    Longitudinal Relationship Between Brain Atrophy Patterns, Cognitive Decline, and Cerebrospinal Fluid Biomarkers in Alzheimer's Disease Explored by Orthonormal Projective Non-Negative Matrix Factorization.
    J Alzheimers Dis. 2024 Mar 20. doi: 10.3233/JAD-231149.
    PubMed     Abstract available


  767. POLIS B, Samson AO
    Addressing the Discrepancies Between Animal Models and Human Alzheimer's Disease Pathology: Implications for Translational Research.
    J Alzheimers Dis. 2024 Mar 19. doi: 10.3233/JAD-240058.
    PubMed     Abstract available


  768. ZHONG P, Cao Q, Yan Z
    Distinct and Convergent Alterations of Entorhinal Cortical Circuits in Two Mouse Models for Alzheimer's Disease and Related Disorders.
    J Alzheimers Dis. 2024 Mar 14. doi: 10.3233/JAD-231413.
    PubMed     Abstract available


  769. SOARES MARTINS T, Ferreira M, Magalhaes S, Leandro K, et al
    FTIR Spectroscopy and Blood-Derived Extracellular Vesicles Duo in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Mar 14. doi: 10.3233/JAD-231239.
    PubMed     Abstract available


  770. ALJASSABI A, Zieneldien T, Kim J, Regmi D, et al
    Alzheimer's Disease Immunotherapy: Current Strategies and Future Prospects.
    J Alzheimers Dis. 2024 Mar 14. doi: 10.3233/JAD-231163.
    PubMed     Abstract available


  771. ZHANG X, Gomez L, Below JE, Naj AC, et al
    An X Chromosome Transcriptome Wide Association Study Implicates ARMCX6 in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Mar 14. doi: 10.3233/JAD-231075.
    PubMed     Abstract available


  772. SHEN Z, Yang X, Lan Y, Chen G, et al
    The Neuro-Inflammatory Microenvironment: An Important Regulator of Stem Cell Survival in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Mar 13. doi: 10.3233/JAD-231159.
    PubMed     Abstract available


  773. RAMADAN FA, Arani G, Jafri A, Thompson T, et al
    Mendelian Randomization of Blood Metabolites Suggests Circulating Glutamine Protects Against Late-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2024 Mar 13. doi: 10.3233/JAD-231063.
    PubMed     Abstract available


  774. BROOKS WH
    Polyamine Dysregulation and Nucleolar Disruption in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Mar 12. doi: 10.3233/JAD-231184.
    PubMed     Abstract available


  775. CAO J, Tang Y, Chen S, Yu S, et al
    The Hippocampal Subfield Volume Reduction and Plasma Biomarker Changes in Mild Cognitive Impairment and Alzheimer's Disease.
    J Alzheimers Dis. 2024 Mar 12. doi: 10.3233/JAD-231114.
    PubMed     Abstract available


  776. TRIEU C, van Harten AC, Leeuwis AE, Exalto LG, et al
    Alzheimer's Disease and Cognitive Decline in Patients with Cardiovascular Diseases Along the Heart-Brain Axis.
    J Alzheimers Dis. 2024 Mar 12. doi: 10.3233/JAD-231096.
    PubMed     Abstract available


  777. ZHAI M, Zhang Y, Yan D, Wang Y, et al
    Genetic Insights into the Association and Causality Between Blood Metabolites and Alzheimer's Disease.
    J Alzheimers Dis. 2024 Mar 12. doi: 10.3233/JAD-230985.
    PubMed     Abstract available


  778. CESANA BM, Bergh S, Ciccone A, Cognat E, et al
    Predictors of Nursing Home Placement in a Cohort of European People with Alzheimer's Disease and Other Dementia Cases Enrolled in SCU-B or Non SCU-B Centers: The RECage Study.
    J Alzheimers Dis. 2024 Mar 12. doi: 10.3233/JAD-230878.
    PubMed     Abstract available


  779. CABRERA-LEON Y, Baez PG, Fernandez-Lopez P, Suarez-Araujo CP, et al
    Neural Computation-Based Methods for the Early Diagnosis and Prognosis of Alzheimer's Disease Not Using Neuroimaging Biomarkers: A Systematic Review.
    J Alzheimers Dis. 2024 Mar 10. doi: 10.3233/JAD-231271.
    PubMed     Abstract available


  780. TERAO I, Kodama W
    Comparative Efficacy, Tolerability, and Acceptability of Donanemab, Lecanemab, Aducanumab, Melatonin, and Aerobic Exercise for a Short Time on Cognitive Function in Mild Cognitive Impairment and Mild Alzheimer's Disease: A Systematic Review and Networ
    J Alzheimers Dis. 2024 Mar 6. doi: 10.3233/JAD-230911.
    PubMed     Abstract available


  781. MANDAL PK
    Pro-Oxidants and Antioxidants Imbalance in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Mar 4. doi: 10.3233/JAD-240217.
    PubMed    



  782. Retraction to: Potential Mechanisms Linking Cholesterol to Alzheimer's Disease-like Pathology in Rabbit Brain, Hippocampal Organotypic Slices, and Skeletal Muscle.
    J Alzheimers Dis. 2024 Mar 1. doi: 10.3233/JAD-239016.
    PubMed    


  783. GOHEL D, Zhang P, Gupta AK, Li Y, et al
    Sildenafil as a Candidate Drug for Alzheimer's Disease: Real-World Patient Data Observation and Mechanistic Observations from Patient-Induced Pluripotent Stem Cell-Derived Neurons.
    J Alzheimers Dis. 2024 Mar 1. doi: 10.3233/JAD-231391.
    PubMed     Abstract available


  784. YANG J, Liu X, Oveisgharan S, Zammit AR, et al
    Inferring Alzheimer's Disease Pathologic Traits from Clinical Measures in Living Adults.
    J Alzheimers Dis. 2024 Mar 1. doi: 10.3233/JAD-230639.
    PubMed     Abstract available


    February 2024
  785. WANG CS, Chen PS, Tsai TY, Hou NT, et al
    Cognitive Effect of Transcranial Direct Current Stimulation on Left Dorsolateral Prefrontal Cortex in Mild Alzheimer's Disease: A Randomized, Double-Blind, Cross-Over Small-Scale Exploratory Study.
    J Alzheimers Dis. 2024 Feb 28. doi: 10.3233/JAD-240002.
    PubMed     Abstract available


  786. LI S, Lan X, Liu Y, Zhou J, et al
    Unlocking the Potential of Repetitive Transcranial Magnetic Stimulation in Alzheimer's Disease: A Meta-Analysis of Randomized Clinical Trials to Optimize Intervention Strategies.
    J Alzheimers Dis. 2024 Feb 28. doi: 10.3233/JAD-231031.
    PubMed     Abstract available


  787. LU TV, Grill JD, Gillen DL
    Study Partner Type and Adverse Event Reporting in Mild-to-Moderate Alzheimer's Disease Clinical Trials.
    J Alzheimers Dis. 2024 Feb 26. doi: 10.3233/JAD-231283.
    PubMed     Abstract available


  788. SIGURDSSON EM
    Tau Immunotherapies for Alzheimer's Disease and Related Tauopathies: Status of Trials and Insights from Preclinical Studies.
    J Alzheimers Dis. 2024 Feb 26. doi: 10.3233/JAD-231238.
    PubMed     Abstract available


  789. GARCIA-ALBERCA JM, de Rojas I, Sanchez-Mejias E, Garrido-Martin D, et al
    An Insertion Within SIRPbeta1 Shows a Dual Effect Over Alzheimer's Disease Cognitive Decline Altering the Microglial Response.
    J Alzheimers Dis. 2024 Feb 26. doi: 10.3233/JAD-231150.
    PubMed     Abstract available


  790. CHI HC, Ma LZ, Wang ZB, Sheng ZH, et al
    Associations of Frailty with Neuropsychiatric Symptoms of Alzheimer's Disease: A Longitudinal Study.
    J Alzheimers Dis. 2024 Feb 26. doi: 10.3233/JAD-231111.
    PubMed     Abstract available


  791. ROSSI E, Marrosu F, Saba L
    Music Therapy as a Complementary Treatment in Patients with Dementia Associated to Alzheimer's Disease: A Systematic Review.
    J Alzheimers Dis. 2024 Feb 26. doi: 10.3233/JAD-230852.
    PubMed     Abstract available


  792. NJOMBORO P, Lekhutlile T
    The Effect of Apathy and Depressive Syndromes on Functional Outcomes in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Feb 26. doi: 10.3233/JAD-230426.
    PubMed     Abstract available


  793. VERWAERDE P, Estrella C, Burlet S, Barrier M, et al
    First-In-Human Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of AZP2006, A Synthetic Compound for the Treatment of Alzheimer's Disease and Related Diseases.
    J Alzheimers Dis. 2024 Feb 26. doi: 10.3233/JAD-220883.
    PubMed     Abstract available


  794. KUMARI S, Kaur P, Singh AK, Ashar MS, et al
    Quantification of COX-2 Level in Alzheimer's Disease Patients to Develop Potential Blood-Based Biomarker for Early Diagnosis and Therapeutic Target.
    J Alzheimers Dis. 2024 Feb 24. doi: 10.3233/JAD-231445.
    PubMed     Abstract available


  795. KAVOOSI S, Shahraki A, Sheervalilou R
    Identification of microRNA-mRNA Regulatory Networks with Therapeutic Values in Alzheimer's Disease by Bioinformatics Analysis.
    J Alzheimers Dis. 2024 Feb 24. doi: 10.3233/JAD-230966.
    PubMed     Abstract available


  796. SABBIR MG
    Cholinergic Receptor Muscarinic 1 Co-Localized with Mitochondria in Cultured Dorsal Root Ganglion Neurons, and Its Deletion Disrupted Mitochondrial Ultrastructure in Peripheral Neurons: Implications in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Feb 24. doi: 10.3233/JAD-230883.
    PubMed     Abstract available


  797. CULIBRK RA, Ebbert KA, Yeisley DJ, Chen R, et al
    Impact of Suramin on Key Pathological Features of Sporadic Alzheimer's Disease-Derived Forebrain Neurons.
    J Alzheimers Dis. 2024 Feb 24. doi: 10.3233/JAD-230600.
    PubMed     Abstract available


  798. KAMEYAMA H, Tagai K, Takasaki E, Kashibayashi T, et al
    Examining Frontal Lobe Asymmetry and Its Potential Role in Aggressive Behaviors in Early Alzheimer's Disease.
    J Alzheimers Dis. 2024 Feb 23. doi: 10.3233/JAD-231306.
    PubMed     Abstract available


  799. VAISHNAV N, Gonzalez R, Karunungan K, Tyler A, et al
    Creating an Unprotected Class: Addressing Legal Risks in the Era of Biologically-Defined Alzheimer's Disease.
    J Alzheimers Dis. 2024 Feb 23. doi: 10.3233/JAD-230067.
    PubMed     Abstract available


  800. ADAMS JA, Uryash A, Lopez JR
    Harnessing Passive Pulsatile Shear Stress for Alzheimer's Disease Prevention and Intervention.
    J Alzheimers Dis. 2024 Feb 22. doi: 10.3233/JAD-231010.
    PubMed     Abstract available


  801. RAPOS PEREIRA F, George N, Dalla Barba G, Dubois B, et al
    The Memory Binding Test Detects Early Subtle Episodic Memory Decline in Preclinical Alzheimer's Disease: A Longitudinal Study.
    J Alzheimers Dis. 2024 Feb 22. doi: 10.3233/JAD-230921.
    PubMed     Abstract available


  802. COGRAM P, Garduno BM, Ren B, Xu X, et al
    First International Conference on Unconventional Animal Models of Alzheimer's Disease and Aging.
    J Alzheimers Dis. 2024 Feb 20. doi: 10.3233/JAD-249004.
    PubMed     Abstract available


  803. ACHARYA NK, Grossman HC, Clifford PM, Levin EC, et al
    A Chronic Increase in Blood-Brain Barrier Permeability Facilitates Intraneuronal Deposition of Exogenous Bloodborne Amyloid-Beta1-42 Peptide in the Brain and Leads to Alzheimer's Disease-Relevant Cognitive Changes in a Mouse Model.
    J Alzheimers Dis. 2024 Feb 20. doi: 10.3233/JAD-231028.
    PubMed     Abstract available


  804. CZUCZWAR SAJ, Kocki J, Miziak B, Bogucki J, et al
    Alpha-, Beta-, and Gamma-Secretase, Amyloid Precursor Protein, and Tau Protein Genes in the Hippocampal CA3 Subfield in an Ischemic Model of Alzheimer's Disease with Survival up to 2 Years.
    J Alzheimers Dis. 2024 Feb 19. doi: 10.3233/JAD-231333.
    PubMed     Abstract available


  805. RAJABLI F, Seixas AA, Akgun B, Adams LD, et al
    African Ancestry Individuals with Higher Educational Attainment are Resilient to Alzheimer's Disease Measured by pTau181.
    J Alzheimers Dis. 2024 Feb 19. doi: 10.3233/JAD-231116.
    PubMed     Abstract available


  806. SUN H, Li P, Gao L, Yang J, et al
    Altered Motor Activity Patterns within 10-Minute Timescale Predict Incident Clinical Alzheimer's Disease.
    J Alzheimers Dis. 2024 Feb 19. doi: 10.3233/JAD-230928.
    PubMed     Abstract available


  807. NELSON D, Thompson KJ, Wang L, Wang Z, et al
    Pericyte Control of Gene Expression in the Blood-Brain Barrier Endothelium: Implications for Alzheimer's Disease.
    J Alzheimers Dis. 2024 Feb 19. doi: 10.3233/JAD-230907.
    PubMed     Abstract available


  808. GILLS JL, Bubu OM
    Obstructive Sleep Apnea and Alzheimer's Disease Pathology: Is Sleep Architecture the Missing Key?
    J Alzheimers Dis. 2024 Feb 14. doi: 10.3233/JAD-231385.
    PubMed     Abstract available


  809. KIM SA, Maeda M, Murata F, Fujii T, et al
    Impact of Concurrent Visual and Hearing Impairment on Incident Alzheimer's Disease: The LIFE Study.
    J Alzheimers Dis. 2024 Feb 14. doi: 10.3233/JAD-230806.
    PubMed     Abstract available


  810. JU IG, Lee S, Kim SH, Im H, et al
    Trichosanthis Semen Exerts Neuroprotective Effects in Alzheimer's Disease Models by Inhibiting Amyloid-beta Accumulation and Regulating the Akt and ERK Signaling Pathways.
    J Alzheimers Dis. 2024 Feb 13. doi: 10.3233/JAD-231124.
    PubMed     Abstract available


  811. LI Z, Fan Z, Zhang Q
    The Associations of Phosphorylated Tau 181 and Tau 231 Levels in Plasma and Cerebrospinal Fluid with Cognitive Function in Alzheimer's Disease: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2024 Feb 7. doi: 10.3233/JAD-230799.
    PubMed     Abstract available


  812. GEPHINE L, Roux CM, Freret T, Boulouard M, et al
    Vulnerability of Spatial Pattern Separation in 5xFAD Alzheimer's Disease Mouse Model.
    J Alzheimers Dis. 2024 Feb 2. doi: 10.3233/JAD-231112.
    PubMed     Abstract available


  813. DE LA MONTE SM, Tong M
    Agent Orange Herbicidal Toxin-Initiation of Alzheimer-Type Neurodegeneration.
    J Alzheimers Dis. 2024 Feb 2. doi: 10.3233/JAD-230881.
    PubMed     Abstract available


  814. GIULIETTI MV, Fabbietti P, Spatuzzi R, Vespa A, et al
    Effects of Mindfulness Based Interventions in Adults and Older Adults Caregivers of Patients with Early Stage Alzheimer's Disease: A Randomized Pilot Study.
    J Alzheimers Dis. 2024 Feb 2. doi: 10.3233/JAD-230284.
    PubMed     Abstract available


    January 2024
  815. MONE P, De Luca A, Kansakar U, Santulli G, et al
    Leukocytes and Endothelial Cells Participate in the Pathogenesis of Alzheimer's Disease: Identifying New Biomarkers Mirroring Metabolic Alterations.
    J Alzheimers Dis. 2024 Jan 31. doi: 10.3233/JAD-231464.
    PubMed     Abstract available


  816. ZHANG X, Haeri M, Swerdlow RH, Wang N, et al
    Loss of Adaptive DNA Breaks in Alzheimer's Disease Brains.
    J Alzheimers Dis. 2024 Jan 31. doi: 10.3233/JAD-231303.
    PubMed     Abstract available


  817. SIBLE IJ, Nation DA
    Blood Pressure Variability and Plasma Alzheimer's Disease Biomarkers in the SPRINT Trial.
    J Alzheimers Dis. 2024 Jan 31. doi: 10.3233/JAD-230930.
    PubMed     Abstract available


  818. NOORI A, Jayakumar R, Moturi V, Li Z, et al
    Alzheimer DataLENS: An Open Data Analytics Portal for Alzheimer's Disease Research.
    J Alzheimers Dis. 2024 Jan 31. doi: 10.3233/JAD-230884.
    PubMed     Abstract available


  819. WHEELER KV, Irimia A, Braskie MN
    Using Neuroimaging to Study Cerebral Amyloid Angiopathy and Its Relationship to Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jan 31. doi: 10.3233/JAD-230553.
    PubMed     Abstract available


  820. JIAO L, Jing Z, Zhang W, Su X, et al
    Codon Pattern and Context Analysis in Genes Triggering Alzheimer's Disease and Latent Tau Protein Aggregation Post-Anesthesia Exhibited Unique Molecular Patterns Associated with Functional Aspects.
    J Alzheimers Dis. 2024 Jan 30. doi: 10.3233/JAD-231142.
    PubMed     Abstract available


  821. NG PY, Zhang C, Li H, Baker DJ, et al
    Senescence Targeting Methods Impact Alzheimer's Disease Features in 3xTg Mice.
    J Alzheimers Dis. 2024 Jan 30. doi: 10.3233/JAD-230465.
    PubMed     Abstract available


  822. CABAN-HOLT A, Cuccaro ML, Lloyd SL, Starks TD, et al
    Attitudes and Perceptions about Brain Donation Among African Americans: Implications for Recruitment into Alzheimer's Disease Research.
    J Alzheimers Dis. 2024 Jan 29. doi: 10.3233/JAD-230461.
    PubMed     Abstract available


  823. BELKHELFA M, Bekrar S, Rezaig L, Beder N, et al
    Neuroinflammatory Responses Occur in Brain Lesions During Alzheimer's Disease: Postmortem Case Report.
    J Alzheimers Dis. 2024 Jan 23. doi: 10.3233/JAD-230910.
    PubMed     Abstract available


  824. WEI G, Tian X, Yang H, Luo Y, et al
    Adjunct Methods for Alzheimer's Disease Detection: A Review of Auditory Evoked Potentials.
    J Alzheimers Dis. 2024 Jan 23. doi: 10.3233/JAD-230822.
    PubMed     Abstract available


  825. TAKASE H, Hamanaka G, Hoshino T, Ohtomo R, et al
    Transcriptomic Profiling Reveals Neuroinflammation in the Corpus Callosum of a Transgenic Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jan 22. doi: 10.3233/JAD-231049.
    PubMed     Abstract available


  826. OKINAKA Y, Shinagawa Y, Claussen C, Gul S, et al
    RNA Analysis of Circulating Leukocytes in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jan 22. doi: 10.3233/JAD-230874.
    PubMed     Abstract available


  827. SAEED A, Alharazi T, Alshaghdali K, Rezgui R, et al
    Targeting GluR3 in Depression and Alzheimer's Disease: Novel Compounds and Therapeutic Prospects.
    J Alzheimers Dis. 2024 Jan 22. doi: 10.3233/JAD-230821.
    PubMed     Abstract available


  828. VILLEMAGNE VL, Dore V, Chong L, Kassiou M, et al
    Brain 11beta-Hydroxysteroid Dehydrogenase Type 1 Occupancy by Xanamem Assessed by PET in Alzheimer's Disease and Cognitively Normal Individuals.
    J Alzheimers Dis. 2024 Jan 19. doi: 10.3233/JAD-220542.
    PubMed     Abstract available


  829. ZHOU J, Zhao M, Yang Z, Chen L, et al
    Exploring the Value of MRI Measurement of Hippocampal Volume for Predicting the Occurrence and Progression of Alzheimer's Disease Based on Artificial Intelligence Deep Learning Technology and Evidence-Based Medicine Meta-Analysis.
    J Alzheimers Dis. 2024 Jan 18. doi: 10.3233/JAD-230733.
    PubMed     Abstract available


  830. GORHAM IK, Reid DM, Sun J, Zhou Z, et al
    Blood-Based mtDNA Quantification Indicates Population-Specific Differences Associated with Alzheimer's Disease-Related Risk.
    J Alzheimers Dis. 2024 Jan 16. doi: 10.3233/JAD-230880.
    PubMed     Abstract available


  831. KURANO M, Saito Y, Yatomi Y
    Comprehensive Analysis of Metabolites in Postmortem Brains of Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jan 13. doi: 10.3233/JAD-230942.
    PubMed     Abstract available


  832. CHEN M, Wang F, Lei H, Yang Z, et al
    In Silico Insights into Micro-Mechanism Understanding of Extracts of Taxus Chinensis Fruits Against Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jan 12. doi: 10.3233/JAD-231066.
    PubMed     Abstract available


  833. FORT-AZNAR L, Molina-Porcel L, Ramos-Campoy O, Esteller D, et al
    Misfolded alpha-Synuclein in Autosomal Dominant Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jan 12. doi: 10.3233/JAD-230919.
    PubMed     Abstract available


  834. SMITH HS, Robinson JO, Levchenko A, Pereira S, et al
    Research Participants' Perspectives on Precision Diagnostics for Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jan 12. doi: 10.3233/JAD-230609.
    PubMed     Abstract available


  835. HAN Y, Huang C, Pan Y, Gu X, et al
    Single Cell Sequencing Technology and Its Application in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jan 8. doi: 10.3233/JAD-230861.
    PubMed     Abstract available


  836. WU LY, Chong JR, Chong JPC, Hilal S, et al
    Serum Placental Growth Factor as a Marker of Cerebrovascular Disease Burden in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jan 8. doi: 10.3233/JAD-230811.
    PubMed     Abstract available


  837. ZHANG C, Lei X, Ma W, Long J, et al
    Diagnosis Framework for Probable Alzheimer's Disease and Mild Cognitive Impairment Based on Multi-Dimensional Emotion Features.
    J Alzheimers Dis. 2024 Jan 5. doi: 10.3233/JAD-230703.
    PubMed     Abstract available


  838. STONE J, Mitrofanis J, Johnstone DM, Robinson SR, et al
    The Catastrophe of Intracerebral Hemorrhage Drives the Capillary-Hemorrhage Dementias, Including Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jan 5. doi: 10.3233/JAD-231202.
    PubMed     Abstract available


  839. SAFIEH M, Liraz O, Ovadia M, Michaelson D, et al
    The Role of Impaired Receptor Trafficking in Mediating the Pathological Effects of APOE4 in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jan 5. doi: 10.3233/JAD-230514.
    PubMed     Abstract available


  840. FAN X, Cai Y, Zhao L, Liu W, et al
    Machine Learning-Derived MRI-Based Neurodegeneration Biomarker for Alzheimer's Disease: A Multi-Database Validation Study.
    J Alzheimers Dis. 2024 Jan 4. doi: 10.3233/JAD-230574.
    PubMed     Abstract available


  841. VALENTIN-ESCALERA J, Leclerc M, Calon F
    High-Fat Diets in Animal Models of Alzheimer's Disease: How Can Eating Too Much Fat Increase Alzheimer's Disease Risk?
    J Alzheimers Dis. 2024 Jan 4. doi: 10.3233/JAD-230118.
    PubMed     Abstract available


  842. SELLES MC, Oliveira MM
    The Oxytocin Puzzle: Unlocking Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jan 3. doi: 10.3233/JAD-231127.
    PubMed     Abstract available


  843. LI J, Yang M, Wei R, Cao Y, et al
    The Predictive Ability of Blood Neurofilament Light Chain in Predicting Cognitive Decline in the Alzheimer's Disease Continuum: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2024 Jan 2. doi: 10.3233/JAD-231080.
    PubMed     Abstract available


  844. NADEAU PA, Jobin B, Boller B
    Erratum to: Diagnostic Sensitivity and Specificity of Cognitive Tests for Mild Cognitive Impairment and Alzheimer's Disease in Patients with Down Syndrome: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2024;97:521.
    PubMed    



  845. The Journal of Alzheimer's Disease Is Happy to Announce the Appointment of Paula I. Moreira, PhD, as Co-Editor-in-Chief of the Journal.
    J Alzheimers Dis. 2024;97:1.
    PubMed    


  846. ANGELIDOU IA, Stocker H, Beyreuther K, Teichmann B, et al
    Validation of the "Perceptions Regarding pRE-Symptomatic Alzheimer's Disease Screening" (PRE-ADS) Questionnaire in the German Population: Attitudes, Motivations, and Barriers to Pre-Symptomatic Dementia Screening.
    J Alzheimers Dis. 2024;97:309-325.
    PubMed     Abstract available


  847. ZENG Y, Cao S, Pang K, Tang J, et al
    Causal Association Between Sepsis and Neurodegenerative Diseases: A Bidirectional Two-Sample Mendelian Randomization Study.
    J Alzheimers Dis. 2024;97:229-237.
    PubMed     Abstract available


  848. DE SIMONE MS, Spalletta G, Vecchio D, Bassi A, et al
    The Role of the Anterior Thalamic Nuclei in the Genesis of Memory Disorders in Alzheimer's Disease: An Exploratory Study.
    J Alzheimers Dis. 2024;97:507-519.
    PubMed     Abstract available


  849. ALSHAHERI DURAZO A, Weigand AJ, Bangen KJ, Membreno R, et al
    Type 2 Diabetes Moderates the Association Between Amyloid and 1-Year Change in Everyday Functioning in Older Veterans.
    J Alzheimers Dis. 2024;97:219-228.
    PubMed     Abstract available


  850. LOBUE C, Stopschinski BE, Saez Calveras N, Douglas PM, et al
    Blood Markers in Relation to a History of Traumatic Brain Injury Across Stages of Cognitive Impairment in a Diverse Cohort.
    J Alzheimers Dis. 2024;97:345-358.
    PubMed     Abstract available


  851. GUO Y, Sun Y, Li M, Qi WY, et al
    Amyloid Pathology Modulates the Associations of Neuropsychiatric Symptoms with Cognitive Impairments and Neurodegeneration in Non-Demented Elderly.
    J Alzheimers Dis. 2024;97:471-484.
    PubMed     Abstract available


  852. LAPEYRE L, Piret J, Rheaume C, Pons V, et al
    Herpes Simplex Virus 1 Infection Does Not Increase Amyloid-beta Pathology in APP/PS1 Mice.
    J Alzheimers Dis. 2024;97:171-178.
    PubMed     Abstract available


  853. MARTIN J, Reid N, Ward DD, King S, et al
    Investigating Sex Differences in Risk and Protective Factors in the Progression of Mild Cognitive Impairment to Dementia: A Systematic Review.
    J Alzheimers Dis. 2024;97:101-119.
    PubMed     Abstract available


  854. YANG M, Gan J, Liu S, Yang Y, et al
    Associations Between Plasma Orexin-A Level and Constipation in Cognitive Impairment.
    J Alzheimers Dis. 2024;97:409-419.
    PubMed     Abstract available


  855. KIM REY, Lee M, Kang DW, Wang SM, et al
    Increased Likelihood of Dementia with Coexisting Atrophy of Multiple Regions of Interest.
    J Alzheimers Dis. 2024;97:259-271.
    PubMed     Abstract available


  856. NA S, Lee C, Ho S, Hong YJ, et al
    A Longitudinal Study on Memory Enhancement in Subjective Cognitive Decline Patients: Clinical and Neuroimaging Perspectives.
    J Alzheimers Dis. 2024;97:193-204.
    PubMed     Abstract available


  857. POSSEMIS N, Ter Huurne D, Banning L, Gruters A, et al
    The Reliability and Clinical Validation of Automatically-Derived Verbal Memory Features of the Verbal Learning Test in Early Diagnostics of Cognitive Impairment.
    J Alzheimers Dis. 2024;97:179-191.
    PubMed     Abstract available


  858. BRUNO JL, Shaw JS, Hosseini SMH
    Toward Personalized Cognitive Training in Older Adults: A Pilot Investigation of the Effects of Baseline Performance and Age on Cognitive Training Outcomes.
    J Alzheimers Dis. 2024;97:327-343.
    PubMed     Abstract available


  859. DE LA PERRELLE L
    Health Care Is Not Enough to Prevent Dementia.
    J Alzheimers Dis. 2024;97:951-952.
    PubMed     Abstract available


  860. DIGMA LA, Winer JR, Greicius MD
    Substantial Doubt Remains about the Efficacy of Anti-Amyloid Antibodies.
    J Alzheimers Dis. 2024;97:567-572.
    PubMed     Abstract available


  861. FRENTZ I, van Arendonk J, Leeuwis AE, Vernooij MW, et al
    Interaction Between Arteriosclerosis and Amyloid-beta on Cognitive Function.
    J Alzheimers Dis. 2024;97:953-961.
    PubMed     Abstract available


  862. MATERS J, van der Steen JT, de Vugt ME, Bakker C, et al
    Palliative Care in Nursing Home Residents with Young-Onset Dementia: Professional and Family Caregiver Perspectives.
    J Alzheimers Dis. 2024;97:573-586.
    PubMed     Abstract available


  863. SCHRODER VE, Skrozic A, Erz D, Kaysen A, et al
    Programme Dementia Prevention (pdp): A Nationwide Program for Personalized Prevention in Luxembourg.
    J Alzheimers Dis. 2024;97:791-804.
    PubMed     Abstract available


  864. DINGLE SE, Milte CM, Daly RM, Torres SJ, et al
    Attitudes and Considerations for Multidomain Lifestyle Approaches to Dementia Prevention: A Qualitative Study.
    J Alzheimers Dis. 2024;97:939-949.
    PubMed     Abstract available


  865. KOSEL F, Hartley MR, Franklin TB
    Aberrant Cortical Activity in 5xFAD Mice in Response to Social and Non-Social Olfactory Stimuli.
    J Alzheimers Dis. 2024;97:659-677.
    PubMed     Abstract available


  866. REHMAN H, Ang TFA, Tao Q, Espenilla AL, et al
    Comparison of Commonly Measured Plasma and Cerebrospinal Fluid Proteins and Their Significance for the Characterization of Cognitive Impairment Status.
    J Alzheimers Dis. 2024;97:621-633.
    PubMed     Abstract available


  867. REN J, Yu Y, Wang Y, Dong Y, et al
    Association Between Urinary Glyphosate Exposure and Cognitive Impairment in Older Adults from NHANES 2013-2014.
    J Alzheimers Dis. 2024;97:609-620.
    PubMed     Abstract available


  868. MAZZOLA P, Zanetti M, Ferraguzzi G, Villa ML, et al
    Shifting the Paradigm of Nursing Home Care for People with Dementia: The Italian Experience of Il Paese Ritrovato and the Impact of SARS-CoV-2.
    J Alzheimers Dis. 2024;97:741-752.
    PubMed     Abstract available


  869. BRITZ J, Ojo E, Haque N, Dhukhwa A, et al
    Sex-Dependent Effects of Chronic Circadian Disruption in AbetaPP/PS1 Mice.
    J Alzheimers Dis. 2024;97:855-870.
    PubMed     Abstract available


  870. GURJAR P, Khan AA, Alanazi AM, Vasil'ev VG, et al
    Molecular Dissection of Herpes Simplex Virus Type 1 to Elucidate Molecular Mechanisms Behind Latency and Comparison of Its Codon Usage Patterns with Genes Modulated During Alzheimer's Disease as a Part of Host-Pathogen Interaction.
    J Alzheimers Dis. 2024;97:1111-1123.
    PubMed     Abstract available


  871. SCHWINNE M, Alonso A, Roberts BR, Hickle S, et al
    The Association of Alzheimer's Disease-Related Blood-Based Biomarkers with Cognitive Screening Test Performance in the Congolese Population in Kinshasa.
    J Alzheimers Dis. 2024;97:1353-1363.
    PubMed     Abstract available


  872. ASIAMAH EA, Feng B, Guo R, Yaxing X, et al
    The Contributions of the Endolysosomal Compartment and Autophagy to APOEvarepsilon4 Allele-Mediated Increase in Alzheimer's Disease Risk.
    J Alzheimers Dis. 2024;97:1007-1031.
    PubMed     Abstract available


  873. PLASSMAN BL, Ford CB, Smith VA, DePasquale N, et al
    Elevated Amyloid-beta PET Scan and Cognitive and Functional Decline in Mild Cognitive Impairment and Dementia of Uncertain Etiology.
    J Alzheimers Dis. 2024;97:1161-1171.
    PubMed     Abstract available


  874. ROBILLARD JM, Masellis M, Martin SE, Khachaturian AS, et al
    The Return of Biomarker Results in Research: Balancing Complexity, Precision, and Ethical Responsibility.
    J Alzheimers Dis. 2024;97:1083-1090.
    PubMed     Abstract available


  875. PANZAVOLTA A, Cerami C, Marcone A, Zamboni M, et al
    Diagnostic Performance of Socio-Emotional Informant-Based Questionnaires for the Clinical Detection of the Behavioral Variant of Frontotemporal Dementia.
    J Alzheimers Dis. 2024;97:1249-1260.
    PubMed     Abstract available


  876. OKAHASHI S, Noguchi T, Ishihara M, Osawa A, et al
    Dyadic Art Appreciation and Self-Expression Program (NCGG-ART) for People with Dementia or Mild Cognitive Impairment and Their Family Caregivers: A Feasibility Study.
    J Alzheimers Dis. 2024;97:1435-1448.
    PubMed     Abstract available


  877. DU P, Zhang X, Lian X, Holscher C, et al
    O-GlcNAcylation and Its Roles in Neurodegenerative Diseases.
    J Alzheimers Dis. 2024;97:1051-1068.
    PubMed     Abstract available


  878. SHANG L, Dong L, Huang X, Chu S, et al
    Comorbidity of Dementia: A Cross-Sectional Study of PUMCH Dementia Cohort.
    J Alzheimers Dis. 2024;97:1313-1322.
    PubMed     Abstract available


  879. ALEGRET M, Garcia-Gutierrez F, Munoz N, Espinosa A, et al
    FACEmemory(R), an Innovative Online Platform for Episodic Memory Pre-Screening: Findings from the First 3,000 Participants.
    J Alzheimers Dis. 2024;97:1173-1187.
    PubMed     Abstract available


  880. MARIN-MARIN L, Renau-Lagranja J, Avila C, Costumero V, et al
    Depression and Agitation Factors Are Related to Regional Brain Atrophy and Faster Longitudinal Cognitive Decline in Mild Cognitive Impairment.
    J Alzheimers Dis. 2024;97:1341-1351.
    PubMed     Abstract available


  881. TSENG YT, Chang YL, Chiu YS
    Assessment of Language Function in Older Mandarin-Speaking Adults with Mild Cognitive Impairment using Multifaceted Language Tests.
    J Alzheimers Dis. 2024;97:1189-1209.
    PubMed     Abstract available


  882. KARAYIANNIS CC, Srikanth V, Beare R, Mehta H, et al
    Type 2 Diabetes and Biomarkers of Brain Structure, Perfusion, Metabolism, and Function in Late Mid-Life: A Multimodal Discordant Twin Study.
    J Alzheimers Dis. 2024;97:1223-1233.
    PubMed     Abstract available


  883. ZAWISLAK-FORNAGIEL K, Ledwon D, Bugdol M, Grazynska A, et al
    Quantitative EEG Spectral and Connectivity Analysis for Cognitive Decline in Amnestic Mild Cognitive Impairment.
    J Alzheimers Dis. 2024;97:1235-1247.
    PubMed     Abstract available


  884. FERINI-STRAMBI L
    Which Are the Most Reliable Sleep Parameters that Predict Cognitive Decline and Alzheimer's Disease?
    J Alzheimers Dis. 2024;97:1641-1643.
    PubMed     Abstract available


  885. KANG J, Park M, Kim T
    Vitamin D Reduces GABA-Positive Astrocytes in the 5xFAD Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2024;97:1939-1950.
    PubMed     Abstract available


  886. GROECHEL RC, Liu AC, Koton S, Kucharska-Newton AM, et al
    Associations Between Mid-Life Psychosocial Measures and Estimated Late Life Amyloid Burden: The Atherosclerosis Risk in Communities (ARIC)-PET Study.
    J Alzheimers Dis. 2024;97:1901-1911.
    PubMed     Abstract available


  887. BACHAND AM, Dell LD
    Can Incorrect Analysis of Time-Dependent Exposure Explain Associations between PM2.5 Exposure and Risk of Dementia?
    J Alzheimers Dis. 2024;97:1931-1937.
    PubMed     Abstract available


  888. VERMEULEN RJ, Roudijk B, Govers TM, Rovers MM, et al
    Prognostic Information on Progression to Dementia: Quantification of the Impact on Quality of Life.
    J Alzheimers Dis. 2024;97:1829-1840.
    PubMed     Abstract available


  889. HARRIS JL, Wang X, Christian SK, Novikova L, et al
    Traumatic Brain Injury Alters the Trajectory of Age-Related Mitochondrial Change.
    J Alzheimers Dis. 2024;97:1793-1806.
    PubMed     Abstract available


  890. VALENCIA-OLVERA AC, Balu D, Moore A, Shah M, et al
    APOE2 Heterozygosity Reduces Hippocampal Soluble Amyloid-beta42 Levels in Non-Hyperlipidemic Mice.
    J Alzheimers Dis. 2024;97:1629-1639.
    PubMed     Abstract available


  891. ZHANG S, Ai H, Wang J, Liu T, et al
    Reduced Prefrontal-Thalamic Theta Flow During Working Memory Retrieval in APP/PS1 Mice.
    J Alzheimers Dis. 2024;97:1737-1749.
    PubMed     Abstract available


  892. DAI Y, Hsu YC, Fernandes BS, Zhang K, et al
    Disentangling Accelerated Cognitive Decline from the Normal Aging Process and Unraveling Its Genetic Components: A Neuroimaging-Based Deep Learning Approach.
    J Alzheimers Dis. 2024;97:1807-1827.
    PubMed     Abstract available


  893. HEIKKINEN AL, Paajanen TI, Hanninen T, Tikkanen V, et al
    Neuropsychological Profiles, Etiologies, and Medical Comorbidities in Early-Onset Dementia and Cognitive Impairment: A Memory Outpatient Clinic Cohort Study.
    J Alzheimers Dis. 2024;97:1765-1776.
    PubMed     Abstract available


  894. VESTIN E, Bostrom G, Olsson J, Elgh F, et al
    Herpes Simplex Viral Infection Doubles the Risk of Dementia in a Contemporary Cohort of Older Adults: A Prospective Study.
    J Alzheimers Dis. 2024;97:1841-1850.
    PubMed     Abstract available


  895. ARMSTRONG MJ, Barnes LL
    Under-Diagnosis of Dementia with Lewy Bodies in Individuals Racialized as Black: Hypotheses Regarding Potential Contributors.
    J Alzheimers Dis. 2024;97:1571-1580.
    PubMed     Abstract available


  896. CUI X, Wang J, Wu B, Zhao Q, et al
    Interventions for Persons with Young-Onset Dementia and Their Families: A Scoping Review.
    J Alzheimers Dis. 2024;97:1519-1531.
    PubMed     Abstract available


  897. FINCH CE, Burstein SM
    Dementia in the Ancient Greco-Roman World Was Minimally Mentioned.
    J Alzheimers Dis. 2024;97:1581-1588.
    PubMed     Abstract available


  898. SIAFARIKAS N
    Neuropsychiatric and Cognitive Symptoms: Two Sides of the Same Coin?
    J Alzheimers Dis. 2024;98:75-78.
    PubMed     Abstract available


  899. MATSUZONO K, Mashiko T, Koide R, Yoshizumi H, et al
    Comparison of Prognosis and Cognitive Function of Holistic Neurological Disease: Tochigi Neurological Disease Cohort Study.
    J Alzheimers Dis. 2024;98:275-285.
    PubMed     Abstract available


  900. NALLAPU BT, Petersen KK, Lipton RB, Davatzikos C, et al
    Plasma Biomarkers as Predictors of Progression to Dementia in Individuals with Mild Cognitive Impairment.
    J Alzheimers Dis. 2024;98:231-246.
    PubMed     Abstract available


  901. PRABHAKARAN D, Grant C, Pedraza O, Caselli R, et al
    Machine Learning Predicts Conversion from Normal Aging to Mild Cognitive Impairment Using Medical History, APOE Genotype, and Neuropsychological Assessment.
    J Alzheimers Dis. 2024;98:83-94.
    PubMed     Abstract available


  902. ROSS JP, Post SG, Scheinfeld L
    Lucidity in the Deeply Forgetful: A Scoping Review.
    J Alzheimers Dis. 2024;98:3-11.
    PubMed     Abstract available


  903. PUTIGNANO S, Forgione L, Fusco M, Giacummo A, et al
    Early Detection Screening of Cognitive Decline in Patients Over 60 Years: ELDERCARE Study.
    J Alzheimers Dis. 2024;98:145-150.
    PubMed     Abstract available


  904. BALLENGER J, George DR, Whitehouse PJ
    Digging Deeper: What Can We Really Learn about Dementia from History?
    J Alzheimers Dis. 2024;98:417-419.
    PubMed     Abstract available


  905. ORR ME
    A Need for Refined Senescence Biomarkers and Measures of Senolytics in the Brain.
    J Alzheimers Dis. 2024;98:411-415.
    PubMed     Abstract available


  906. SHIMADA H, Doi T, Tsutsumimoto K, Makino K, et al
    Elevated Risk of Dementia Diagnosis in Older Adults with Low Frequencies and Durations of Social Conversation.
    J Alzheimers Dis. 2024;98:659-669.
    PubMed     Abstract available


  907. ZHANG XX, Wang HR, Meng-Wei, Hu YZ, et al
    Association of Vitamin D Levels with Risk of Cognitive Impairment and Dementia: A Systematic Review and Meta-Analysis of Prospective Studies.
    J Alzheimers Dis. 2024;98:373-385.
    PubMed     Abstract available


  908. WANG J, Leong IT, Johnson MK, Pei Y, et al
    What Matters to Chinese and Korean American Dementia Caregivers: Navigating Cultural Influences in Dementia Care from Caregivers' Perspectives.
    J Alzheimers Dis. 2024;98:519-538.
    PubMed     Abstract available


  909. VERA R, Hong N, Jiang B, Liang G, et al
    Effects of Intranasal Dantrolene Nanoparticles on Brain Concentration and Behavior in PS19 Tau Transgenic Mice.
    J Alzheimers Dis. 2024;98:549-562.
    PubMed     Abstract available


  910. GREENBLATT CL, Lathe R
    Vaccines and Dementia: Part II. Efficacy of BCG and Other Vaccines Against Dementia.
    J Alzheimers Dis. 2024;98:361-372.
    PubMed     Abstract available


  911. WANG Y, Wang S, Wu J, Liu X, et al
    Causal Association Between Allergic Diseases and Dementia: Evidence from Multivariate Mendelian Randomization Study.
    J Alzheimers Dis. 2024;98:505-517.
    PubMed     Abstract available


  912. PARKER DC, Whitson HE, Smith PJ, Kraus VB, et al
    Anti-CMV IgG Seropositivity is Associated with Plasma Biomarker Evidence of Amyloid-beta Accumulation.
    J Alzheimers Dis. 2024;98:593-600.
    PubMed     Abstract available


  913. HAN SL, Ou YN, Han BL, Guo HH, et al
    Total Tau Protein Mediates the Association of Ischemic Cerebrovascular Disease with Cognitive Decline.
    J Alzheimers Dis. 2024;98:1133-1143.
    PubMed     Abstract available


  914. COGUT V, McNeely TL, Bussian TJ, Graves SI, et al
    Caloric Restriction Improves Spatial Learning Deficits in Tau Mice.
    J Alzheimers Dis. 2024;98:925-940.
    PubMed     Abstract available


  915. TSENG WI, Hsu YC, Huang LK, Hong CT, et al
    Brain Age Is Associated with Cognitive Outcomes of Cholinesterase Inhibitor Treatment in Patients with Mild Cognitive Impairment.
    J Alzheimers Dis. 2024;98:1095-1106.
    PubMed     Abstract available


  916. MARTINEZ-DUBARBIE F, Lopez-Garcia S, Lage C, Di Molfetta G, et al
    Plasma Phosphorylated Tau 231 Increases at One-Year Intervals in Cognitively Unimpaired Subjects.
    J Alzheimers Dis. 2024;98:1029-1042.
    PubMed     Abstract available


  917. O'SHEA DM, Camacho S, Ezzeddine R, Besser L, et al
    The Mediating Role of Cortical Atrophy on the Relationship between the Resilience Index and Cognitive Function: Findings from the Healthy Brain Initiative.
    J Alzheimers Dis. 2024;98:1017-1027.
    PubMed     Abstract available


  918. PODGER L, Stewart WF, Serrano D, Lipton RB, et al
    Application of a Novel Endpoint Staging Framework: Proof of Concept in the AMBAR Study.
    J Alzheimers Dis. 2024;98:1079-1094.
    PubMed     Abstract available


  919. CEYZERIAT K, Jaques E, Gloria Y, Badina A, et al
    Low-Dose Radiation Therapy Impacts Microglial Inflammatory Response without Modulating Amyloid Load in Female TgF344-AD Rats.
    J Alzheimers Dis. 2024;98:1001-1016.
    PubMed     Abstract available


  920. PAPADIMITRIOU A, Dawson AZ, Thorgerson A, Bhandari S, et al
    Understanding the Relationship Between Wealth and Cognitive Function by Race/Ethnicity Among Older United States Adults with Diabetes.
    J Alzheimers Dis. 2024;98:1145-1155.
    PubMed     Abstract available


  921. SANCHEZ-SOBLECHERO A, Lopez-Garcia S, Lage C, Fernandez-Matarrubia M, et al
    Where Should I Draw the Line: PET-Driven, Data-Driven, or Manufacturer Cut-Off?
    J Alzheimers Dis. 2024;98:957-967.
    PubMed     Abstract available


  922. BERGAMINO M, Keeling E, McElvogue M, Schaefer SY, et al
    White Matter Microstructure Analysis in Subjective Memory Complaints and Cognitive Impairment: Insights from Diffusion Kurtosis Imaging and Free-Water DTI.
    J Alzheimers Dis. 2024;98:863-884.
    PubMed     Abstract available



  923. Erratum to: Ubiquitin Specific Protease 13 Regulates Tau Accumulation and Clearance in Models of Alzheimer's Disease.
    J Alzheimers Dis. 2024;98:1543-1546.
    PubMed    


  924. JANBEK J, Laursen TM, Frimodt-Moller N, Magyari M, et al
    Risk of Major Types of Dementias Following Hospital-Diagnosed Infections and Autoimmune Diseases.
    J Alzheimers Dis. 2024;98:1503-1514.
    PubMed     Abstract available


  925. CHEN Y, Su Y, Wu J, Chen K, et al
    Combining Blood-Based Biomarkers and Structural MRI Measurements to Distinguish Persons with and without Significant Amyloid Plaques.
    J Alzheimers Dis. 2024;98:1415-1426.
    PubMed     Abstract available


  926. GALANKIN TL, Bespalov AY, Moebius HY
    Clusterization of Behavioral and Psychological Symptoms of Dementia as Assessed by Neuropsychiatric Inventory: A Case Against the Use of Principal Component Analysis.
    J Alzheimers Dis. 2024;98:1483-1491.
    PubMed     Abstract available


  927. HOJJATI SH, Chiang GC, Butler TA, de Leon M, et al
    Remote Associations Between Tau and Cortical Amyloid-beta Are Stage-Dependent.
    J Alzheimers Dis. 2024;98:1467-1482.
    PubMed     Abstract available


  928. CALDERON-GARCIDUENAS L, Ayala A, Mukherjee PS
    2024 United States Elections: Air Pollution, Neurodegeneration, Neuropsychiatric, and Neurodevelopmental Disorders. Who Cares?
    J Alzheimers Dis. 2024;98:1277-1282.
    PubMed     Abstract available


  929. SYED RA, Hayat M, Qaiser H, Uzair M, et al
    Aging-Related Protein Alterations in the Brain.
    J Alzheimers Dis. 2024;99.
    PubMed     Abstract available


  930. ALROUJI M, Yasmin S, Furkan M, Alhumaydhi FA, et al
    Unveiling the Molecular Interactions Between Human Transferrin and Limonene: Natural Compounds in Alzheimer's Disease Therapeutics.
    J Alzheimers Dis. 2024;99:333-343.
    PubMed     Abstract available


  931. MORROW CB, Pontone GM
    Exploring Psychosis in Neurodegenerative Dementia: Connecting Symptoms to Neurobiology.
    J Alzheimers Dis. 2024;99:101-103.
    PubMed     Abstract available


  932. CRESSOT C, Vrillon A, Lilamand M, Francisque H, et al
    Psychosis in Neurodegenerative Dementias: A Systematic Comparative Review.
    J Alzheimers Dis. 2024;99:85-99.
    PubMed     Abstract available


  933. ESPAY AJ, Herrup K, Imbimbo BP, Kepp KP, et al
    Recalibrating the Risk-Benefit Profiles of Lecanemab and Donanemab: Scales, Immunoreactivity, and Changes in Amyloid-beta42.
    J Alzheimers Dis. 2024;99:877-881.
    PubMed     Abstract available


  934. TAVARES-JUNIOR JWL, Ciurleo GCV, Feitosa EAAF, Oria RB, et al
    The Clinical Aspects of COVID and Alzheimer's Disease: A Round-Up of Where Things Stand and Are Headed.
    J Alzheimers Dis. 2024;99:1159-1171.
    PubMed     Abstract available


  935. SUGANUMA T, Hatori S, Chen CK, Hori S, et al
    Caffeoylquinic Acid Mitigates Neuronal Loss and Cognitive Decline in 5XFAD Mice Without Reducing the Amyloid-beta Plaque Burden.
    J Alzheimers Dis. 2024;99:1285-1301.
    PubMed     Abstract available


  936. WANG T, Zhang W, Maclin JMA, Xu H, et al
    Novel Panel of Long Noncoding RNAs as Diagnostic Biomarkers for Amnestic Mild Cognitive Impairment in Peripheral Blood.
    J Alzheimers Dis. 2024;99:1385-1396.
    PubMed     Abstract available


  937. XIONG R, Li B, Yu H, Fan T, et al
    Urolithin A Inhibits Anterior Basolateral Amygdala to Ventral Hippocampal CA1 Circuit to Ameliorate Amyloid-beta-Impaired Social Ability.
    J Alzheimers Dis. 2024;99:1303-1316.
    PubMed     Abstract available


  938. LEE CS, Ferguson AN, Gibbons LE, Walker R, et al
    Eye Adult Changes in Thought (Eye ACT) Study: Design and Report on the Inaugural Cohort.
    J Alzheimers Dis. 2024;100:309-320.
    PubMed     Abstract available


  939. MENG H, Lv X, Zhang R, Feng Y, et al
    Occurrence and Risk Factors for Cognitive Decline Shared by Couples: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2024;100:29-40.
    PubMed     Abstract available


  940. GIBBONS LE, Mobley T, Mayeda ER, Lee CS, et al
    How Generalizable Are Findings from a Community-Based Prospective Cohort Study? Extending Estimates from the Adult Changes in Thought Study to Its Source Population.
    J Alzheimers Dis. 2024;100:163-174.
    PubMed     Abstract available


  941. SHI Q, Liu WS, Liu F, Zeng YX, et al
    The Etiology of Rapidly Progressive Dementia: A 3-Year Retrospective Study in a Tertiary Hospital in China.
    J Alzheimers Dis. 2024;100:77-85.
    PubMed     Abstract available


  942. SANNEMANN L, Bartels C, Brosseron F, Buerger K, et al
    Symptomatic Clusters Related to Amyloid Positivity in Cognitively Unimpaired Individuals.
    J Alzheimers Dis. 2024;100:193-205.
    PubMed     Abstract available


  943. ZUKOWSKI LA, Brinkerhoff SA, Levin I, Herter TM, et al
    Amyloid-beta Deposition Predicts Grocery Shopping Performance in Older Adults Without Cognitive Impairment.
    J Alzheimers Dis. 2024;100:53-75.
    PubMed     Abstract available



  944. Robert Rissman, PhD, is the recipient of the 2024 Alzheimer Award.
    J Alzheimers Dis. 2024;100:377-378.
    PubMed    


  945. KRIZANOVIC N, Jokisch M, Jockel KH, Schmidt B, et al
    Sex-Specific Differences in Serum Kallikrein-8 (KLK8): An Exploratory Study.
    J Alzheimers Dis. 2024;100:495-507.
    PubMed     Abstract available


  946. HOWARD E, Moody JN, Prieto S, Hayes JP, et al
    Higher Cerebrospinal Fluid Levels of Amyloid-beta40 Following Traumatic Brain Injury Relate to Confrontation Naming Performance.
    J Alzheimers Dis. 2024;100:539-550.
    PubMed     Abstract available


  947. HE Q, Wang W, Xiong Y, Tao C, et al
    Potential Biomarkers in Cerebrospinal Fluid and Plasma for Dementia.
    J Alzheimers Dis. 2024;100:603-611.
    PubMed     Abstract available


  948. LOEFFLER DA
    Approaches for Increasing Cerebral Efflux of Amyloid-beta in Experimental Systems.
    J Alzheimers Dis. 2024;100:379-411.
    PubMed     Abstract available


  949. LENG F, Hinz R, Gentleman S, Dani M, et al
    Combined Neuroinflammation and Amyloid PET Markers in Predicting Disease Progression in Cognitively Impaired Subjects.
    J Alzheimers Dis. 2024;100:973-986.
    PubMed     Abstract available


  950. FRANK B, Walsh M, Hurley L, Groh J, et al
    Cognition Mediates the Association Between Cerebrospinal Fluid Biomarkers of Amyloid and P-Tau and Neuropsychiatric Symptoms.
    J Alzheimers Dis. 2024;100:1055-1073.
    PubMed     Abstract available


  951. FU J, Wei Q, Chen X, Lai X, et al
    Analysis of the Association Between Pathogen Exposure and the Risk of Dementia.
    J Alzheimers Dis. 2024;100:961-972.
    PubMed     Abstract available


  952. SCHWERTHOFFER D, Haselwarter T, Grimmer T
    Obstructive Sleep Apnea Among Patients with Mild Cognitive Impairment.
    J Alzheimers Dis. 2024;100:809-823.
    PubMed     Abstract available


  953. YU W, Zhuang S, Zhan M, Chen Y, et al
    Deubiquitinating Enzyme USP19 Regulates Ferroptosis and Mitochondrial Damage in SH-SY5Y Cells by Targeting the NOX4 Protein.
    J Alzheimers Dis. 2024;100:799-808.
    PubMed     Abstract available


  954. DENG C, Cai Q, Zhang J, Chang K, et al
    Generation and Characterization of a Novel Knockin Mouse Model Expressing PSEN1 D385A: Implications for Investigating Herbal Drug Effects in gamma-Secretase Activity.
    J Alzheimers Dis. 2024;100:825-841.
    PubMed     Abstract available


  955. MACE RA, Lyons C, Cohen JE, Ritchie C, et al
    Optimizing the Implementation of a Lifestyle Dementia Prevention Intervention for Older Patients in an Academic Healthcare System.
    J Alzheimers Dis. 2024;100:1237-1259.
    PubMed     Abstract available


  956. LEPPING RJ, Hess BJ, Taylor JM, Hanson-Abromeit D, et al
    Inconsistent Music-Based Intervention Reporting in Dementia Studies: A Systematic Mapping Review.
    J Alzheimers Dis. 2024;100:1145-1159.
    PubMed     Abstract available


  957. MARIN A, Turk KW, Schiloski K, Vives-Rodriguez A, et al
    The Use of Event Related Potentials to Predict Amyloid PET Status Among Patients from a Memory Disorders Clinic.
    J Alzheimers Dis. 2024;100:1195-1208.
    PubMed     Abstract available


  958. FROMM D, Dalton SG, Brick A, Olaiya G, et al
    The Case of the Cookie Jar: Differences in Typical Language Use in Dementia.
    J Alzheimers Dis. 2024;100:1417-1434.
    PubMed     Abstract available


  959. CORREIA SC, Perry G, Moreira PI
    Fueling Alzheimer's Disease: Where Does Immunometabolism Stand?
    J Alzheimers Dis. 2024;100.
    PubMed     Abstract available


  960. PETERSEN ME, Zhang F, Hall JR, Julovich D, et al
    Characterization of Ptau181 Among a Diverse Community-Based Cohort: A HABS-HD Study.
    J Alzheimers Dis. 2024;100.
    PubMed     Abstract available


  961. ARENDASH GW, Lin X, Cao C
    Enhanced Brain Clearance of Tau and Amyloid-beta in Alzheimer's Disease Patients by Transcranial Radiofrequency Wave Treatment: A Central Role of Vascular Endothelial Growth Factor (VEGF).
    J Alzheimers Dis. 2024;100.
    PubMed     Abstract available


  962. POUDEL P, Frost SM, Eslick S, Sohrabi HR, et al
    Hyperspectral Retinal Imaging as a Non-Invasive Marker to Determine Brain Amyloid Status.
    J Alzheimers Dis. 2024;100.
    PubMed     Abstract available


  963. GOGOLA A, Cohen AD, Snitz B, Minhas D, et al
    Implementation and Assessment of Tau Thresholds in Non-Demented Individuals as Predictors of Cognitive Decline in Tau Imaging Studies.
    J Alzheimers Dis. 2024;100.
    PubMed     Abstract available


  964. LEINENGA G, Padmanabhan P, Gotz J
    Improving Cognition Without Clearing Amyloid: Effects of Tau and Ultrasound Neuromodulation.
    J Alzheimers Dis. 2024;100.
    PubMed     Abstract available


  965. PERRY G
    JAD's Glorious 100 Volumes.
    J Alzheimers Dis. 2024;100.
    PubMed    


  966. ALLDRED MJ, Pidikiti H, Ibrahim KW, Lee SH, et al
    Hippocampal CA1 Pyramidal Neurons Display Sublayer and Circuitry Dependent Degenerative Expression Profiles in Aged Female Down Syndrome Mice.
    J Alzheimers Dis. 2024;100.
    PubMed     Abstract available


  967. ZHANG J, Zhang Y, Zhang Y, Yao J, et al
    The Association of Brain Insulin Resistance with Anesthesia/Surgery-Induced Cognitive Deterioration Is Female-Specific in 5XFAD Transgenic Mice.
    J Alzheimers Dis. 2024;101:183-195.
    PubMed     Abstract available


  968. LASTUKA A, Bliss E, Breshock MR, Iannucci VC, et al
    Societal Costs of Dementia: 204 Countries, 2000-2019.
    J Alzheimers Dis. 2024;101:277-292.
    PubMed     Abstract available


  969. ZHANG Y, Li Y, Song S, Li Z, et al
    Predicting Conversion Time from Mild Cognitive Impairment to Dementia with Interval-Censored Models.
    J Alzheimers Dis. 2024;101:147-157.
    PubMed     Abstract available


  970. SATERNOS H, Hamlett ED, Guzman S, Head E, et al
    Unique Pathology in the Locus Coeruleus of Individuals with Down Syndrome.
    J Alzheimers Dis. 2024;101:541-561.
    PubMed     Abstract available


  971. ALLE MC, Joseph C, Antoine P
    Involuntary Autobiographical Memory in Alzheimer's Disease: A Double-Edged Way of Remembering the Past?
    J Alzheimers Dis. 2024;101:961-969.
    PubMed     Abstract available


  972. SAIDO TC
    Obituary for the late Yasuo Ihara.
    J Alzheimers Dis. 2024;101:1027-1028.
    PubMed    


  973. PEREIRA HR, Diogo VS, Prata D, Ferreira HA, et al
    Detecting Amyloid Positivity Using Morphometric Magnetic Resonance Imaging.
    J Alzheimers Dis. 2024;101:1293-1305.
    PubMed     Abstract available


  974. LINGENBERG A, Herrmann FR, Armand S, Peron J, et al
    Forget About Memory: Disentangling the Amnestic Syndrome in Idiopathic Normal Pressure Hydrocephalus.
    J Alzheimers Dis. 2024;101:1205-1216.
    PubMed     Abstract available


  975. BECKMANN MN
    Did Reagan Decline?
    J Alzheimers Dis. 2024;101:1261-1266.
    PubMed     Abstract available


  976. WANG J, Xu L, Chen X, Wu J, et al
    Correlation Analysis of ApoB, ApoA1, and ApoB/ApoA1 with Cortical Morphology in Patients with Memory Complaints.
    J Alzheimers Dis. 2024;101:1137-1150.
    PubMed     Abstract available


  977. SATO K, Niimi Y, Ihara R, Iwata A, et al
    Adverse Events as a Cause of Unblinding of Allocated Arms in Anti-Amyloid Therapy Trials: A Meta-Analysis of the Predictive Value.
    J Alzheimers Dis. 2024;101:1127-1132.
    PubMed     Abstract available


  978. HAMEDANI M, Caneva S, Mancardi GL, Ali PA, et al
    Toward Quantitative Neurology: Sensors to Assess Motor Deficits in Dementia.
    J Alzheimers Dis. 2024;101:1083-1106.
    PubMed     Abstract available


  979. MOREIRA PI, Avila J, Galimberti D, Pappolla MA, et al
    Therapeutic Trials in Alzheimer's Disease: Where Are We Now?
    J Alzheimers Dis. 2024;101.
    PubMed    


  980. SAYFULLAEVA J, McLoughlin J, Kwakowsky A
    Hormone Replacement Therapy and Alzheimer's Disease: Current State of Knowledge and Implications for Clinical Use.
    J Alzheimers Dis. 2024;101.
    PubMed     Abstract available


  981. CROOK H, Edison P
    Incretin Mimetics as Potential Disease Modifying Treatment for Alzheimer's Disease.
    J Alzheimers Dis. 2024;101.
    PubMed     Abstract available


  982. BROWN A, Bayley PJ
    The Therapeutic Potential of Yoga for Alzheimer's Disease: A Critical Review.
    J Alzheimers Dis. 2024;101.
    PubMed     Abstract available


  983. ROBERTS JA, Varma VR, Jones A, Thambisetty M, et al
    Drug Repurposing for Effective Alzheimer's Disease Medicines: Existing Methods and Novel Pharmacoepidemiological Approaches.
    J Alzheimers Dis. 2024;101.
    PubMed     Abstract available


  984. PAPPOLLA MA, Martins RN, Poeggeler B, Omar RA, et al
    Oxidative Stress in Alzheimer's Disease: The Shortcomings of Antioxidant Therapies.
    J Alzheimers Dis. 2024;101.
    PubMed     Abstract available


  985. TUSZYNSKI MH
    Growth Factor Gene Therapy for Alzheimer's Disease.
    J Alzheimers Dis. 2024;101.
    PubMed     Abstract available


  986. TAHMI M, Benitez R, Luchsinger JA
    Metformin as a Potential Prevention Strategy for Alzheimer's Disease and Alzheimer's Disease Related Dementias.
    J Alzheimers Dis. 2024;101.
    PubMed     Abstract available


  987. SUN MK, Alkon DL
    Treating Alzheimer's Disease: Focusing on Neurodegenerative Consequences.
    J Alzheimers Dis. 2024;101.
    PubMed     Abstract available


  988. PAPPOLLA MA, Refolo L, Sambamurti K, Zambon D, et al
    Hypercholesterolemia and Alzheimer's Disease: Unraveling the Connection and Assessing the Efficacy of Lipid-Lowering Therapies.
    J Alzheimers Dis. 2024;101.
    PubMed     Abstract available


  989. TRIUMBARI EKA, Chiaravalloti A, Schillaci O, Mercuri NB, et al
    Positron Emission Tomography/Computed Tomography Imaging in Therapeutic Clinical Trials in Alzheimer's Disease: An Overview of the Current State of the Art of Research.
    J Alzheimers Dis. 2024;101.
    PubMed     Abstract available


  990. VINA J, Borras C, Mas-Bargues C
    Genistein, A Phytoestrogen, Delays the Transition to Dementia in Prodromal Alzheimer's Disease Patients.
    J Alzheimers Dis. 2024;101.
    PubMed     Abstract available


  991. HOILUND-CARLSEN PF, Alavi A, Barrio JR
    PET/CT/MRI in Clinical Trials of Alzheimer's Disease.
    J Alzheimers Dis. 2024;101.
    PubMed     Abstract available


  992. NOORDA K, Noorda K, Sabbagh MN, Bertelson J, et al
    Amyloid-Directed Antibodies: Past, Present, and Future.
    J Alzheimers Dis. 2024;101.
    PubMed     Abstract available


  993. GABUZYAN R, Lee C, Nygaard HB
    Ketogenic Approaches for the Treatment of Alzheimer's Disease.
    J Alzheimers Dis. 2024;101.
    PubMed     Abstract available


  994. DU B, Chen K, Wang W, Lei P, et al
    Targeting Metals in Alzheimer's Disease: An Update.
    J Alzheimers Dis. 2024;101.
    PubMed     Abstract available


  995. MEIJER L, Chretien E, Ravel D
    Leucettinib-21, a DYRK1A Kinase Inhibitor as Clinical Drug Candidate for Alzheimer's Disease and Down Syndrome.
    J Alzheimers Dis. 2024;101.
    PubMed     Abstract available


  996. DE LA MONTE SM
    Conquering Insulin Network Dysfunctions in Alzheimer's Disease: Where Are We Today?
    J Alzheimers Dis. 2024;101.
    PubMed     Abstract available


  997. YASSINE HN, Carrasco AS, Badie DS
    Designing Newer Omega-3 Supplementation Trials for Cognitive Outcomes: A Systematic Review Guided Analysis.
    J Alzheimers Dis. 2024;101.
    PubMed     Abstract available


  998. KUCK MJ, Begde A, Hawkins K, Hogervorst E, et al
    Alzheimer's Disease and (Phyto) Estrogen Treatment: Modification of Effects by Age, Type of Treatment, and Duration of Use.
    J Alzheimers Dis. 2024;101.
    PubMed     Abstract available


  999. MORATO X, Tartari JP, Pytel V, Boada M, et al
    Pharmacodynamic and Clinical Effects of Ginkgo Biloba Extract EGb 761 and Its Phytochemical Components in Alzheimer's Disease.
    J Alzheimers Dis. 2024;101.
    PubMed     Abstract available


  1000. ALGHAMDI M, Braidy N
    Supplementation with NAD+ Precursors for Treating Alzheimer's Disease: A Metabolic Approach.
    J Alzheimers Dis. 2024;101.
    PubMed     Abstract available


  1001. ALGHAMDI M, Braidy N
    Functional Magnetic Resonance Imaging in Alzheimer's Disease Drug Trials: A Mini-Review.
    J Alzheimers Dis. 2024;101.
    PubMed     Abstract available


  1002. WATKINS EA, Vassar R
    BACE Inhibitor Clinical Trials for Alzheimer's Disease.
    J Alzheimers Dis. 2024;101.
    PubMed     Abstract available


  1003. LI H, Xiang Q, Ren R, Wang G, et al
    Acupuncture as a Complementary Therapy for Alzheimer's Disease.
    J Alzheimers Dis. 2024;101.
    PubMed     Abstract available


  1004. FELDMAN HH, Messer K, Qiu Y, Sabbagh M, et al
    Varoglutamstat: Inhibiting Glutaminyl Cyclase as a Novel Target of Therapy in Early Alzheimer's Disease.
    J Alzheimers Dis. 2024;101.
    PubMed     Abstract available


  1005. CURRAIS A, Raschke W, Maher P
    CMS121, a Novel Drug Candidate for the Treatment of Alzheimer's Disease and Age-Related Dementia.
    J Alzheimers Dis. 2024;101.
    PubMed     Abstract available


  1006. THITILERTDECHA P, Brimson JM
    CT1812, a Small Molecule Sigma-2 Receptor Antagonist for Alzheimer's Disease Treatment: A Systematic Review of Available Clinical Data.
    J Alzheimers Dis. 2024;101.
    PubMed     Abstract available


  1007. MORRONI F, Caccamo A
    Advances and Challenges in Gene Therapy for Alzheimer's Disease.
    J Alzheimers Dis. 2024;101.
    PubMed     Abstract available


  1008. STEINBACH MJ, Denburg NL
    Melatonin in Alzheimer's Disease: Literature Review and Therapeutic Trials.
    J Alzheimers Dis. 2024;101.
    PubMed     Abstract available


  1009. EYOB E, Shaw JS, Bakker A, Munro C, et al
    A Randomized-Controlled Trial Targeting Cognition in Early Alzheimer's Disease by Improving Sleep with Trazodone (REST).
    J Alzheimers Dis. 2024;101.
    PubMed     Abstract available


  1010. VASHISTH K, Sharma S, Ghosh S, Babu MA, et al
    Immunotherapy in Alzheimer's Disease: Current Status and Future Directions.
    J Alzheimers Dis. 2024;101.
    PubMed     Abstract available


  1011. BENUSSI A, Borroni B
    Brain Stimulation in Alzheimer's Disease Trials.
    J Alzheimers Dis. 2024;101.
    PubMed     Abstract available


    December 2023
  1012. AHMED T, Zhang P, Kumar K
    Equilibrium of Dietary Patterns Between Alzheimer's Disease Patients and Healthy People: A Comprehensive Analysis Using Multiple Factor Analysis and Classification Modeling.
    J Alzheimers Dis. 2023 Dec 30. doi: 10.3233/JAD-230634.
    PubMed     Abstract available


  1013. RICCI F, Martorana A, Bonomi CG, Serafini C, et al
    Effect of Vascular Risk Factors on Blood-Brain Barrier and Cerebrospinal Fluid Biomarkers Along the Alzheimer's Disease Continuum: A Retrospective Observational Study.
    J Alzheimers Dis. 2023 Dec 29. doi: 10.3233/JAD-230792.
    PubMed     Abstract available


  1014. ALMKVIST O, Larsson M, Graff C
    Odor Identification Across Time in Mutation Carriers and Non-Carriers in Autosomal-Dominant Alzheimer's Disease.
    J Alzheimers Dis. 2023 Dec 29. doi: 10.3233/JAD-230618.
    PubMed     Abstract available


  1015. ZHANG E, Dai F
    Diagnostic Model for Alzheimer's Disease Based on PANoptosis-Related Genes.
    J Alzheimers Dis. 2023 Dec 28. doi: 10.3233/JAD-231103.
    PubMed     Abstract available


  1016. WEINBERG MS, He Y, Kivisakk P, Arnold SE, et al
    Effect of Metformin on Plasma and Cerebrospinal Fluid Biomarkers in Non-Diabetic Older Adults with Mild Cognitive Impairment Related to Alzheimer's Disease.
    J Alzheimers Dis. 2023 Dec 27. doi: 10.3233/JAD-230899.
    PubMed     Abstract available


  1017. FAN X, Li H, Liu L, Zhang K, et al
    Early Diagnosing and Transformation Prediction of Alzheimer's Disease Using Multi-Scaled Self-Attention Network on Structural MRI Images with Occlusion Sensitivity Analysis.
    J Alzheimers Dis. 2023 Dec 27. doi: 10.3233/JAD-230705.
    PubMed     Abstract available


  1018. MIYANO T, Ayukawa Y, Anada T, Takahashi I, et al
    Association Between Reduced Posterior Occlusal Contact and Alzheimer's Disease Onset in Older Japanese Adults: Results from the LIFE Study.
    J Alzheimers Dis. 2023 Dec 27. doi: 10.3233/JAD-230449.
    PubMed     Abstract available


  1019. MORIN P, Aguilar BJ, Li X, Chen J, et al
    Alzheimer's Disease Stage Transitions Among United States Veterans.
    J Alzheimers Dis. 2023 Dec 23. doi: 10.3233/JAD-230850.
    PubMed     Abstract available


  1020. MAHZARNIA A, Lutz MW, Badea A
    A Continuous Extension of Gene Set Enrichment Analysis Using the Likelihood Ratio Test Statistics Identifies Vascular Endothelial Growth Factor as a Candidate Pathway for Alzheimer's Disease via ITGA5.
    J Alzheimers Dis. 2023 Dec 23. doi: 10.3233/JAD-230934.
    PubMed     Abstract available


  1021. GE Y, AlObaidi AS, Kuchel GA, Bartley JM, et al
    Dysfunctional Bladder Morphology and Functional Impairments Are Identified in the Alzheimer's Disease APPNL-G-F/NL-G-F Murine Model.
    J Alzheimers Dis. 2023 Dec 23. doi: 10.3233/JAD-230547.
    PubMed     Abstract available


  1022. ROBINSON CG, Coleman T, Buciuc M, Singh NA, et al
    Behavioral and Neuropsychiatric Differences Across Two Atypical Alzheimer's Disease Variants: Logopenic Progressive Aphasia and Posterior Cortical Atrophy.
    J Alzheimers Dis. 2023 Dec 22. doi: 10.3233/JAD-230652.
    PubMed     Abstract available


  1023. EL HAFFAF LM, Ronat L, Cannizzaro A, Hanganu A, et al
    Associations Between Hyperactive Neuropsychiatric Symptoms and Brain Morphology in Mild Cognitive Impairment and Alzheimer's Disease.
    J Alzheimers Dis. 2023 Dec 22. doi: 10.3233/JAD-220857.
    PubMed     Abstract available


  1024. LI KY, Lin BT, Hsu ST, Chien CF, et al
    Quetiapine Oral Solution in Alzheimer's Disease: Efficacy and Dosage Insights from a Real-World Retrospective Study.
    J Alzheimers Dis. 2023 Dec 20. doi: 10.3233/JAD-231007.
    PubMed     Abstract available


  1025. LOJO-RAMIREZ JA, Guerra-Gomez M, Marin-Cabanas AM, Fernandez-Rodriguez P, et al
    Correlation Between Amyloid PET Imaging and Discordant Cerebrospinal Fluid Biomarkers Results in Patients with Suspected Alzheimer's Disease.
    J Alzheimers Dis. 2023 Dec 19. doi: 10.3233/JAD-230744.
    PubMed     Abstract available


  1026. KEIZER HG, Brands R, Oosting RS, Seinen W, et al
    The Carnitine Palmitoyl-Transferase 2 Cascade Hypothesis for Alzheimer's Disease.
    J Alzheimers Dis. 2023 Dec 18. doi: 10.3233/JAD-230991.
    PubMed     Abstract available


  1027. PARK YS, Joo HJ, Jang YS, Jeon H, et al
    Socioeconomic Status and Dementia Risk Among Intensive Care Unit Survivors: Using National Health Insurance Cohort in Korea.
    J Alzheimers Dis. 2023 Dec 18. doi: 10.3233/JAD-230715.
    PubMed     Abstract available


  1028. BAPAT R, Ma D, Duong TQ
    Predicting Four-Year's Alzheimer's Disease Onset Using Longitudinal Neurocognitive Tests and MRI Data Using Explainable Deep Convolutional Neural Networks.
    J Alzheimers Dis. 2023 Dec 16. doi: 10.3233/JAD-230893.
    PubMed     Abstract available


  1029. JANG YJ, Choi MG, Yoo BJ, Lee KJ, et al
    Interaction Between a High-Fat Diet and Tau Pathology in Mice: Implications for Alzheimer's Disease.
    J Alzheimers Dis. 2023 Dec 11. doi: 10.3233/JAD-230927.
    PubMed     Abstract available


  1030. MALOTAUX V, Colmant L, Quenon L, Huyghe L, et al
    Suspecting Non-Alzheimer's Pathologies and Mixed Pathologies: A Comparative Study Between Brain Metabolism and Tau Images.
    J Alzheimers Dis. 2023 Dec 11. doi: 10.3233/JAD-230696.
    PubMed     Abstract available


  1031. UKRAINTSEVA S, Duan H, Holmes R, Bagley O, et al
    Patterns of Aging Changes in Bodyweight May Predict Alzheimer's Disease.
    J Alzheimers Dis. 2023 Dec 11. doi: 10.3233/JAD-220998.
    PubMed     Abstract available


  1032. ANSCHUETZ A, Schwab K, Harrington CR, Wischik CM, et al
    A Meta-Analysis on Presynaptic Changes in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Dec 8. doi: 10.3233/JAD-231034.
    PubMed     Abstract available


  1033. DA X, Hempel E, Ou Y, Rowe OE, et al
    Noninvasive Gamma Sensory Stimulation May Reduce White Matter and Myelin Loss in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Dec 8. doi: 10.3233/JAD-230506.
    PubMed     Abstract available


  1034. NGUYEN SA, Oughli HA, Lavretsky H
    Use of Complementary and Integrative Medicine for Alzheimer's Disease and Cognitive Decline.
    J Alzheimers Dis. 2023 Dec 7. doi: 10.3233/JAD-230710.
    PubMed     Abstract available


  1035. SCHMUED L, Maloney B, Schmued C, Lahiri DK, et al
    Treatment with 1, 10 Phenanthroline-5-Amine Reduced Amyloid Burden in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2023 Dec 7. doi: 10.3233/JAD-221285.
    PubMed     Abstract available


    November 2023
  1036. HAO N, Bai X, Hu A, Zhao G, et al
    Assessing the Global, Regional, and National Impact of High Body Mass Index on Alzheimer's Disease and Other Dementias Between 1990 and 2019.
    J Alzheimers Dis. 2023 Nov 30. doi: 10.3233/JAD-230827.
    PubMed     Abstract available


  1037. LI Y, Chen X, Zhou M, Feng S, et al
    Microglial TLR4/NLRP3 Inflammasome Signaling in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Nov 30. doi: 10.3233/JAD-230273.
    PubMed     Abstract available


  1038. CARPI M, Fernandes M, Mercuri NB, Liguori C, et al
    Sleep Biomarkers for Predicting Cognitive Decline and Alzheimer's Disease: A Systematic Review of Longitudinal Studies.
    J Alzheimers Dis. 2023 Nov 29. doi: 10.3233/JAD-230933.
    PubMed     Abstract available


  1039. WANG Y, Jiang R, Li M, Wang Z, et al
    Characteristics of T Cells in Single-Cell Datasets of Peripheral Blood and Cerebrospinal Fluid in Alzheimer's Disease Patients.
    J Alzheimers Dis. 2023 Nov 27. doi: 10.3233/JAD-230784.
    PubMed     Abstract available


  1040. ZHANG X, Wu P, Zhao Y
    COVID-19 in Relation to Alzheimer's Disease: Mendelian Randomization Analyses Add to Multiple Lines of Evidence.
    J Alzheimers Dis. 2023 Nov 24. doi: 10.3233/JAD-231151.
    PubMed     Abstract available


  1041. CHU C, Low YLC, Ma L, Wang Y, et al
    How Can We Use Mathematical Modeling of Amyloid-beta in Alzheimer's Disease Research and Clinical Practices?
    J Alzheimers Dis. 2023 Nov 24. doi: 10.3233/JAD-230938.
    PubMed     Abstract available


  1042. KAWARABAYASHI T, Nakamura T, Miyashita K, Segawa T, et al
    Clinical Evaluation of Cerebrospinal Fluid p217tau and Neurofilament Light Chain Levels in Patients with Alzheimer's Disease or Other Neurological Diseases.
    J Alzheimers Dis. 2023 Nov 23. doi: 10.3233/JAD-230419.
    PubMed     Abstract available


  1043. MELENDEZ JC, Satorres E, Pitarque A, Escudero J, et al
    Transcranial Direct Current Stimulation Intervention in Alzheimer's Disease and Its Follow-Up.
    J Alzheimers Dis. 2023 Nov 22. doi: 10.3233/JAD-230826.
    PubMed     Abstract available


  1044. WANG X, Huang R, Huang B, Li X, et al
    S1PR2 Regulates Autophagy Through the AKT/mTOR Pathway to Promote Pathological Damage in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Nov 22. doi: 10.3233/JAD-230533.
    PubMed     Abstract available


  1045. JOHNSON CE, Duncan MJ, Murphy MP
    Sex and Sleep Disruption as Contributing Factors in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Nov 22. doi: 10.3233/JAD-230527.
    PubMed     Abstract available


  1046. SPAMPINATO MV, Ulber JL, Fayyaz H, Sullivan A, et al
    Neuropsychiatric Symptoms and In Vivo Alzheimer's Biomarkers in Mild Cognitive Impairment.
    J Alzheimers Dis. 2023 Nov 22. doi: 10.3233/JAD-220835.
    PubMed     Abstract available


  1047. WHITE JP, Schembri A, Prenn-Gologranc C, Ondrus M, et al
    Sensitivity of Individual and Composite Test Scores from the Cogstate Brief Battery to Mild Cognitive Impairment and Dementia Due to Alzheimer's Disease.
    J Alzheimers Dis. 2023 Nov 21. doi: 10.3233/JAD-230352.
    PubMed     Abstract available


  1048. LEWIS JE, McDaniel HR, Woolger JM, Khan SA, et al
    The Characterization of the Th1/Th2 Ratio in Moderate-Severe Alzheimer's Disease Patients and Its Response to an Aloe Polymannose-Based Dietary Supplement.
    J Alzheimers Dis. 2023 Nov 20. doi: 10.3233/JAD-230659.
    PubMed     Abstract available


  1049. MONLLOR P, Kumar P, Lloret MA, Ftara A, et al
    Multifactorial Causation of Alzheimer's Disease Due to COVID-19.
    J Alzheimers Dis. 2023 Nov 20. doi: 10.3233/JAD-230396.
    PubMed     Abstract available


  1050. EL KADIRI W, Perrignon-Sommet M, Delpont B, Graber M, et al
    Changes in Taste Perception in Patients with Minor and Major Cognitive Impairment Linked to Alzheimer's Disease Recorded by Gustatory Evoked Potentials.
    J Alzheimers Dis. 2023 Nov 20. doi: 10.3233/JAD-230270.
    PubMed     Abstract available


  1051. TETZLOFF KA, Duffy JR, Clark HM, Pham NTT, et al
    Amyloid and Tau PET Positivity in Progressive Agrammatic Aphasia and Apraxia of Speech.
    J Alzheimers Dis. 2023 Nov 20. doi: 10.3233/JAD-230912.
    PubMed     Abstract available


  1052. ZHANG F, Petersen M, Johnson L, Hall J, et al
    Comorbidities Incorporated to Improve Prediction for Prevalent Mild Cognitive Impairment and Alzheimer's Disease in the HABS-HD Study.
    J Alzheimers Dis. 2023 Nov 18. doi: 10.3233/JAD-230755.
    PubMed     Abstract available


  1053. DING P, Gurney M, Perry G, Xu R, et al
    Association of COVID-19 with Risk and Progression of Alzheimer's Disease: Non-Overlapping Two-Sample Mendelian Randomization Analysis of 2.6 Million Subjects.
    J Alzheimers Dis. 2023 Nov 18. doi: 10.3233/JAD-230632.
    PubMed     Abstract available


  1054. GIUNTI E, Collu R, Daley S, Querfurth H, et al
    Reduction of Phosphorylated Tau in Alzheimer's Disease Induced Pluripotent Stem Cell-Derived Neuro-Spheroids by Rho-Associated Coiled-Coil Kinase Inhibitor Fasudil.
    J Alzheimers Dis. 2023 Nov 18. doi: 10.3233/JAD-230551.
    PubMed     Abstract available


  1055. LIU YB, Wang XJ, Tan L, Tan CC, et al
    PICALM Variation Moderates the Relationships of APOE varepsilon4 with Alzheimer's Disease Cerebrospinal Biomarkers and Memory Function Among Non-Demented Population.
    J Alzheimers Dis. 2023 Nov 18. doi: 10.3233/JAD-230516.
    PubMed     Abstract available


  1056. LAI D, Zhang M, Li R, Zhang C, et al
    Identifying Genes Associated with Alzheimer's Disease Using Gene-Based Polygenic Risk Score.
    J Alzheimers Dis. 2023 Nov 18. doi: 10.3233/JAD-230510.
    PubMed     Abstract available


  1057. BOZKURT AS, Yilmaz SG
    Ferroptotic Potency of ISM1 Expression in the Drug-Induced Alzheimer's Disease-Like Phenotype Under the Influence of Betulin.
    J Alzheimers Dis. 2023 Nov 17. doi: 10.3233/JAD-230940.
    PubMed     Abstract available


  1058. LI JQ, Zhong XL, Song JH, Chi S, et al
    Associations Between TREML2 Gene Variants and Alzheimer's Disease: Biomarkers, Neuroimage, and Cognition.
    J Alzheimers Dis. 2023 Nov 17. doi: 10.3233/JAD-230936.
    PubMed     Abstract available


  1059. LOPES BOSCHETTI JC, Soares KL, Carvalho GR, Filho ACV, et al
    CGAs-Rich Conilon Coffee Consumption Improves Cognition and Reduces Oxidative Stress in Elderly with Alzheimer's Disease: A Pilot Study.
    J Alzheimers Dis. 2023 Nov 17. doi: 10.3233/JAD-230843.
    PubMed     Abstract available


  1060. YANG Z, Banks SJ, Ritter AR, Cummings JL, et al
    Microglial Imaging in Alzheimer's Disease and Its Relationship to Brain Amyloid: A Human 18F-GE180 PET Study.
    J Alzheimers Dis. 2023 Nov 17. doi: 10.3233/JAD-230631.
    PubMed     Abstract available


  1061. WU W, Shen A, Lee I, Miranda-Morales EG, et al
    Changes of tRNA-Derived Fragments by Alzheimer's Disease in Cerebrospinal Fluid and Blood Serum.
    J Alzheimers Dis. 2023 Nov 17. doi: 10.3233/JAD-230412.
    PubMed     Abstract available


  1062. ZENG XX, Zeng JB
    Systems Medicine as a Strategy to Deal with Alzheimer's Disease.
    J Alzheimers Dis. 2023 Nov 16. doi: 10.3233/JAD-230739.
    PubMed     Abstract available


  1063. TAO S, Fan W, Liu J, Wang T, et al
    NLRP3 Inflammasome: An Emerging Therapeutic Target for Alzheimer's Disease.
    J Alzheimers Dis. 2023 Nov 16. doi: 10.3233/JAD-230567.
    PubMed     Abstract available


  1064. CERNOTOVA D, Hruzova K, Levcik D, Svoboda J, et al
    Linking Social Cognition, Parvalbumin Interneurons, and Oxytocin in Alzheimer's Disease: An Update.
    J Alzheimers Dis. 2023 Nov 16. doi: 10.3233/JAD-230333.
    PubMed     Abstract available


  1065. SNYTNIKOVA O, Telegina D, Savina E, Tsentalovich Y, et al
    Quantitative Metabolomic Analysis of the Rat Hippocampus: Effects of Age and of the Development of Alzheimer's Disease-Like Pathology.
    J Alzheimers Dis. 2023 Nov 13. doi: 10.3233/JAD-230706.
    PubMed     Abstract available


  1066. FERNANDO MG, Silva R, Fernando WMADB, de Silva HA, et al
    Effect of Virgin Coconut Oil Supplementation on Cognition of Individuals with Mild-to-Moderate Alzheimer's Disease in Sri Lanka (VCO-AD Study): A Randomized Placebo-Controlled Trial.
    J Alzheimers Dis. 2023 Nov 13. doi: 10.3233/JAD-230670.
    PubMed     Abstract available


  1067. MATSUMOTO H, Tagai K, Endo H, Matsuoka K, et al
    Association of Tooth Loss with Alzheimer's Disease Tau Pathologies Assessed by Positron Emission Tomography.
    J Alzheimers Dis. 2023 Nov 11. doi: 10.3233/JAD-230581.
    PubMed     Abstract available


  1068. FREDERIKSEN KS, Lanctot KL, Weidner W, Hahn-Pedersen JH, et al
    A Literature Review on the Burden of Alzheimer's Disease on Care Partners.
    J Alzheimers Dis. 2023 Nov 11. doi: 10.3233/JAD-230487.
    PubMed     Abstract available


  1069. SHINAGAWA H, Ohuchi K, Goto Y, Hashimoto K, et al
    Vacuolar Protein-Sorting Proteins Are Reduced Even Before Cognitive Decline in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2023 Nov 10. doi: 10.3233/JAD-230686.
    PubMed     Abstract available


  1070. AZAMI H, Daftarifard E, Humeau-Heurtier A, Fernandez A, et al
    Assessment and Comparison of Nonlinear Measures in Resting-State Magnetoencephalograms in Alzheimer's Disease and Mild Cognitive Impairment.
    J Alzheimers Dis. 2023 Nov 10. doi: 10.3233/JAD-230544.
    PubMed     Abstract available


  1071. LY M, Yu GZ, Chwa WJ, Raji CA, et al
    Paving the Way for Alzheimer's Disease Prevention: A Systematic Review of Global Open-Access Neuroimaging Datasets in Healthy Individuals.
    J Alzheimers Dis. 2023 Nov 6. doi: 10.3233/JAD-230738.
    PubMed     Abstract available


  1072. LI K, Rashid T, Li J, Honnorat N, et al
    Postmortem Brain Imaging in Alzheimer's Disease and Related Dementias: The South Texas Alzheimer's Disease Research Center Repository.
    J Alzheimers Dis. 2023 Nov 6. doi: 10.3233/JAD-230389.
    PubMed     Abstract available


  1073. MANI S, Dubey R, Lai IC, Babu MA, et al
    Oxidative Stress and Natural Antioxidants: Back and Forth in the Neurological Mechanisms of Alzheimer's Disease.
    J Alzheimers Dis. 2023 Nov 2. doi: 10.3233/JAD-220700.
    PubMed     Abstract available


  1074. PERRON J, Scramstad C, Hyun Ko J
    Analysis of Costs for Imaging-Assisted Pharmaceutical Intervention in Alzheimer's Disease with Lecanemab: Snapshot of the First 3 Years.
    J Alzheimers Dis. 2023 Nov 1. doi: 10.3233/JAD-230633.
    PubMed     Abstract available


    October 2023
  1075. FUJISAWA C, Umegaki H, Sugimoto T, Nakashima H, et al
    Relationship Between Non-Cognitive Intrinsic Capacity and Activities of Daily Living According to Alzheimer's Disease Stage.
    J Alzheimers Dis. 2023 Oct 30. doi: 10.3233/JAD-230786.
    PubMed     Abstract available


  1076. YANG J, Shi X, Wang Y, Ma M, et al
    Multi-Target Neuroprotection of Thiazolidinediones on Alzheimer's Disease via Neuroinflammation and Ferroptosis.
    J Alzheimers Dis. 2023 Oct 30. doi: 10.3233/JAD-230593.
    PubMed     Abstract available


  1077. SALHI L, Al Taep Y, Salmon E, Van Hede D, et al
    How Periodontitis or Periodontal Bacteria Can Influence Alzheimer's Disease Features? A Systematic Review of Pre-Clinical Studies.
    J Alzheimers Dis. 2023 Oct 30. doi: 10.3233/JAD-230478.
    PubMed     Abstract available


  1078. GRANT WB, Blake SM
    Diet's Role in Modifying Risk of Alzheimer's Disease: History and Present Understanding.
    J Alzheimers Dis. 2023 Oct 28. doi: 10.3233/JAD-230418.
    PubMed     Abstract available


  1079. DONG Y, Hou T, Li Y, Liu R, et al
    Plasma Amyloid-beta, Total Tau, and Neurofilament Light Chain Across the Alzheimer's Disease Clinical Spectrum: A Population-Based Study.
    J Alzheimers Dis. 2023 Oct 26. doi: 10.3233/JAD-230932.
    PubMed     Abstract available


  1080. ALROUJI M, Majrashi TA, Alhumaydhi FA, Zari A, et al
    Unveiling Phytoconstituents with Inhibitory Potential Against Tyrosine-Protein Kinase Fyn: A Comprehensive Virtual Screening Approach Targeting Alzheimer's Disease.
    J Alzheimers Dis. 2023 Oct 26. doi: 10.3233/JAD-230828.
    PubMed     Abstract available


  1081. INGANNATO A, Bessi V, Chiari A, Salvatori D, et al
    GRN Missense Variants and Familial Alzheimer's Disease: Two Case Reports.
    J Alzheimers Dis. 2023 Oct 21. doi: 10.3233/JAD-230689.
    PubMed     Abstract available


  1082. BEN KHEDHER MR, Haddad M, Fulop T, Laurin D, et al
    Implication of Circulating Extracellular Vesicles-Bound Amyloid-beta42 Oligomers in the Progression of Alzheimer's Disease.
    J Alzheimers Dis. 2023 Oct 11. doi: 10.3233/JAD-230823.
    PubMed     Abstract available


  1083. HOANG MT, Kareholt I, Schon P, von Koch L, et al
    The Impact of Educational Attainment and Income on Long-Term Care for Persons with Alzheimer's Disease and Other Dementias: A Swedish Nationwide Study.
    J Alzheimers Dis. 2023 Oct 11. doi: 10.3233/JAD-230388.
    PubMed     Abstract available


  1084. TZENG IS
    Examination of Matching Methods, Sparse Effects, and Limitations in a Nationwide Database Study on Alzheimer's Disease.
    J Alzheimers Dis. 2023 Oct 9. doi: 10.3233/JAD-230701.
    PubMed     Abstract available


  1085. LEE A, Shan D, Castle D, Rajji TK, et al
    Landscape of Phase II Trials in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Oct 9. doi: 10.3233/JAD-230660.
    PubMed     Abstract available


  1086. BUCHMAN AS, Leurgans SE, Kim N, Agrawal S, et al
    Alzheimer's Disease Pathology Outside of the Cerebrum Is Related to a Higher Odds of Dementia.
    J Alzheimers Dis. 2023 Oct 9. doi: 10.3233/JAD-230223.
    PubMed     Abstract available


  1087. JIANG J, Hong Y, Li W, Wang A, et al
    Chain Mediation Analysis of the Effects of Nutrition and Cognition on the Association of Apolipoprotein E varepsilon4 with Neuropsychiatric Symptoms in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Oct 6. doi: 10.3233/JAD-230577.
    PubMed     Abstract available


  1088. XUE W, He W, Yan M, Zhao H, et al
    Exploring Shared Biomarkers of Myocardial Infarction and Alzheimer's Disease via Single-Cell/Nucleus Sequencing and Bioinformatics Analysis.
    J Alzheimers Dis. 2023 Oct 6. doi: 10.3233/JAD-230559.
    PubMed     Abstract available


  1089. XIA S, Chen H, Tang T
    Risk of Death from Alzheimer's Disease Associated with Brain Tumor, Glioma, and Glioblastoma.
    J Alzheimers Dis. 2023 Oct 6. doi: 10.3233/JAD-230554.
    PubMed     Abstract available


  1090. LI A, Du J, Cai Y, Chen X, et al
    Body Mass Index Decrease Has a Distinct Association with Alzheimer's Disease Pathophysiology in APOE varepsilon4 Carriers and Non-Carriers.
    J Alzheimers Dis. 2023 Oct 6. doi: 10.3233/JAD-230446.
    PubMed     Abstract available


  1091. BIAN Z, Hu X, Liu X, Yu H, et al
    Protective Effects of Rivaroxaban on White Matter Integrity and Remyelination in a Mouse Model of Alzheimer's Disease Combined with Cerebral Hypoperfusion.
    J Alzheimers Dis. 2023 Oct 6. doi: 10.3233/JAD-230413.
    PubMed     Abstract available


  1092. ROACH JC, Rapozo MK, Hara J, Glusman G, et al
    A Remotely Coached Multimodal Lifestyle Intervention for Alzheimer's Disease Ameliorates Functional and Cognitive Outcomes.
    J Alzheimers Dis. 2023 Oct 6. doi: 10.3233/JAD-230403.
    PubMed     Abstract available


  1093. KIM M, Yi D, Byun MS, Ahn H, et al
    Development of a Cognitive Composite for Preclinical Alzheimer's Disease in Korean Older Adults.
    J Alzheimers Dis. 2023 Oct 5. doi: 10.3233/JAD-230263.
    PubMed     Abstract available


  1094. AKUSHEVICH I, Yashkin A, Ukraintseva S, Yashin AI, et al
    The Construction of a Multidomain Risk Model of Alzheimer's Disease and Related Dementias.
    J Alzheimers Dis. 2023 Oct 5. doi: 10.3233/JAD-221292.
    PubMed     Abstract available


  1095. KETCHUM FB, Erickson CM, Basche KE, Chin NA, et al
    Informing Disclosure: Efficacy of a Brief Educational Intervention on Research Participants' Knowledge about Alzheimer's Disease Biomarkers.
    J Alzheimers Dis. 2023 Oct 3. doi: 10.3233/JAD-230732.
    PubMed     Abstract available


  1096. BREDESEN DE, Toups K, Hathaway A, Gordon D, et al
    Precision Medicine Approach to Alzheimer's Disease: Rationale and Implications.
    J Alzheimers Dis. 2023 Oct 3. doi: 10.3233/JAD-230467.
    PubMed     Abstract available


  1097. UKRAINTSEVA S, Duan M, Simanek AM, Holmes R, et al
    Vaccination Against Pneumonia May Provide Genotype-Specific Protection Against Alzheimer's Disease.
    J Alzheimers Dis. 2023 Oct 3. doi: 10.3233/JAD-230088.
    PubMed     Abstract available


  1098. LIU CC, Wang QH, Xin JY, Liu YH, et al
    Association of Adipokines with Alzheimer's Disease in a Chinese Cohort.
    J Alzheimers Dis. 2023 Oct 3. doi: 10.3233/JAD-220860.
    PubMed     Abstract available


    September 2023
  1099. BARBA L, Otto M, Abu-Rumeileh S
    The Underestimated Relevance of Alzheimer's Disease Copathology in Amyotrophic Lateral Sclerosis.
    J Alzheimers Dis. 2023 Sep 30. doi: 10.3233/JAD-230900.
    PubMed     Abstract available


  1100. GONZALEZ-MADRID A, Calfio C, Gonzalez A, Luttges V, et al
    Toward Prevention and Reduction of Alzheimer's Disease.
    J Alzheimers Dis. 2023 Sep 30. doi: 10.3233/JAD-230454.
    PubMed     Abstract available


  1101. LIU Y, Shen Y
    Applications of Nanoparticles in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Sep 30. doi: 10.3233/JAD-230098.
    PubMed     Abstract available


  1102. HUANG Y, Driedonks TAP, Cheng L, Turchinovich A, et al
    Small RNA Profiles of Brain Tissue-Derived Extracellular Vesicles in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Sep 28. doi: 10.3233/JAD-230872.
    PubMed     Abstract available


  1103. GUILLIOT S, Gauthier S, Touchon J, Soto ME, et al
    Lithium, a Treatment Option for Alzheimer's Disease? A Review of Existing Evidence and Discussion on Future Perspectives.
    J Alzheimers Dis. 2023 Sep 28. doi: 10.3233/JAD-230568.
    PubMed     Abstract available


  1104. POLIN C, Gelle T, Auditeau E, Adou C, et al
    Repetitive Behaviors in Alzheimer's Disease: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2023 Sep 28. doi: 10.3233/JAD-230380.
    PubMed     Abstract available


  1105. DALY T
    Improving Clinical Trials of Antioxidants in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Sep 28. doi: 10.3233/JAD-230308.
    PubMed     Abstract available


  1106. IKANGA J, Hickle S, Schwinne M, Epenge E, et al
    Association Between Hippocampal Volume and African Neuropsychology Memory Tests in Adult Individuals with Probable Alzheimer's Disease in Democratic Republic of Congo.
    J Alzheimers Dis. 2023 Sep 28. doi: 10.3233/JAD-230206.
    PubMed     Abstract available


  1107. ROGERS JT, Cahill CM
    Iron Responsiveness to Lysosomal Disruption: A Novel Pathway to Alzheimer's Disease.
    J Alzheimers Dis. 2023 Sep 25. doi: 10.3233/JAD-230953.
    PubMed     Abstract available


  1108. BRAMEN JE, Siddarth P, Popa ES, Kress GT, et al
    Impact of Eating a Carbohydrate-Restricted Diet on Cortical Atrophy in a Cross-Section of Amyloid Positive Patients with Alzheimer's Disease: A Small Sample Study.
    J Alzheimers Dis. 2023 Sep 22. doi: 10.3233/JAD-230458.
    PubMed     Abstract available


  1109. CHOW TE, Veziris CR, Mundada N, Martinez-Arroyo AI, et al
    Medial Temporal Lobe Tau Aggregation Relates to Divergent Cognitive and Emotional Empathy Abilities in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Sep 22. doi: 10.3233/JAD-230367.
    PubMed     Abstract available


  1110. QEADAN F, McCunn A, Tingey B, Price R, et al
    Exploring the Association Between Opioid Use Disorder and Alzheimer's Disease and Dementia Among a National Sample of the U.S. Population.
    J Alzheimers Dis. 2023 Sep 21. doi: 10.3233/JAD-230714.
    PubMed     Abstract available


  1111. DINNERSTEIN E
    Erratum to: The Time for Combination Therapy Research in Alzheimer's Disease is Now.
    J Alzheimers Dis. 2023 Sep 20. doi: 10.3233/JAD-239010.
    PubMed    


  1112. SUN Y, Moghekar A, Soldan A, Pettigrew C, et al
    Cerebrospinal Fluid Alzheimer's Disease Biomarker Patterns of Change Prior to the Onset of Mild Cognitive Impairment.
    J Alzheimers Dis. 2023 Sep 20. doi: 10.3233/JAD-230807.
    PubMed     Abstract available


  1113. ALKON DL, Sun MK, Tuchman AJ, Thompson RE, et al
    Advanced Alzheimer's Disease Patients Show Safe, Significant, and Persistent Benefit in 6-Month Bryostatin Trial.
    J Alzheimers Dis. 2023 Sep 19. doi: 10.3233/JAD-230868.
    PubMed     Abstract available


  1114. LEIBY AC, Scambray KA, Nguyen HL, Basith F, et al
    Characterizing Limbic-Predominant Age-Related TDP-43 Encephalopathy Without Alzheimer's Disease and Lewy Body Dementia in the Oldest Old: A Case Series.
    J Alzheimers Dis. 2023 Sep 19. doi: 10.3233/JAD-230238.
    PubMed     Abstract available


  1115. LARDELLI M, Baer L, Hin N, Allen A, et al
    The Use of Zebrafish in Transcriptome Analysis of the Early Effects of Mutations Causing Early Onset Familial Alzheimer's Disease and Other Inherited Neurodegenerative Conditions.
    J Alzheimers Dis. 2023 Sep 16. doi: 10.3233/JAD-230522.
    PubMed     Abstract available


  1116. ZHANG Y, Xue Y, Wang L, Han Z, et al
    rs56405341 Variant Associates with Expression of C4orf33 and C4orf33 Was Downregulated in Alzheimer's Disease and Progressive Supranuclear Palsy.
    J Alzheimers Dis. 2023 Sep 16. doi: 10.3233/JAD-230327.
    PubMed     Abstract available


  1117. MERLO S, Costa L, Chiechio S, Busceti CL, et al
    Increased Heat Pain Tolerance but Hyperalgesia to Tonic Inflammatory Pain in the CRND8 Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2023 Sep 16. doi: 10.3233/JAD-230148.
    PubMed     Abstract available


  1118. BLUSZTAJN JK, Aytan N, Rajendiran T, Mellott TJ, et al
    Cerebral Gray and White Matter Monogalactosyl Diglyceride Levels Rise with the Progression of Alzheimer's Disease.
    J Alzheimers Dis. 2023 Sep 14. doi: 10.3233/JAD-230543.
    PubMed     Abstract available


  1119. PARRENO TORRES A, Roncero-Parra C, Borja AL, Mateo-Sotos J, et al
    Inter-Hospital Advanced and Mild Alzheimer's Disease Classification Based on Electroencephalogram Measurements via Classical Machine Learning Algorithms.
    J Alzheimers Dis. 2023 Sep 14. doi: 10.3233/JAD-230525.
    PubMed     Abstract available


  1120. SAKURAI K, Kaneda D, Morimoto S, Uchida Y, et al
    Asymmetric Cerebral Peduncle Atrophy: A Simple Diagnostic Clue for Distinguishing Frontotemporal Lobar Degeneration from Alzheimer's Disease.
    J Alzheimers Dis. 2023 Sep 14. doi: 10.3233/JAD-230441.
    PubMed     Abstract available


  1121. NIK AKHTAR S, Lu Q
    RhoA-LIMK Signaling Axis Reveals Rostral-Caudal Plane and Spatial Dysregulation in the Brain of Alzheimer's Disease Mouse Models.
    J Alzheimers Dis. 2023 Sep 14. doi: 10.3233/JAD-230408.
    PubMed     Abstract available


  1122. O'BRYANT SE, Zhang F, Johnson LA, Hall J, et al
    Precision Medicine for Preventing Alzheimer's Disease: Analysis of the ADAPT Study.
    J Alzheimers Dis. 2023 Sep 14. doi: 10.3233/JAD-230317.
    PubMed     Abstract available


  1123. YANG Y, Li M, Leng B, Yao R, et al
    Alzheimer's Disease Biomarkers and Complement Proteins Mediate the Impact of Sleep Fragmentation on Cognitive Impairment in Obstructive Sleep Apnea Patients Without Dementia.
    J Alzheimers Dis. 2023 Sep 14. doi: 10.3233/JAD-221288.
    PubMed     Abstract available


  1124. TANG H, Sun Y, Fachim HA, Cheung TKD, et al
    Elevated Expression of Two Pore Potassium Channel THIK-1 in Alzheimer's Disease: An Inflammatory Mechanism.
    J Alzheimers Dis. 2023 Sep 12. doi: 10.3233/JAD-230616.
    PubMed     Abstract available


  1125. WITUCKI L, Borowczyk K, Suszynska-Zajczyk J, Warzych E, et al
    Deletion of the Homocysteine Thiolactone Detoxifying Enzyme Bleomycin Hydrolase, in Mice, Causes Memory and Neurological Deficits and Worsens Alzheimer's Disease-Related Behavioral and Biochemical Traits in the 5xFAD Model of Alzheimer's Disease.
    J Alzheimers Dis. 2023 Sep 12. doi: 10.3233/JAD-230578.
    PubMed     Abstract available


  1126. GUIEYSSE T, Lamothe R, Houot M, Razafimahatratra S, et al
    Detecting Anosognosia from the Prodromal Stage of Alzheimer's Disease.
    J Alzheimers Dis. 2023 Sep 12. doi: 10.3233/JAD-230552.
    PubMed     Abstract available


  1127. FERNANDES C, Montalvo G, Caligiuri M, Pertsinakis M, et al
    Handwriting Changes in Alzheimer's Disease: A Systematic Review.
    J Alzheimers Dis. 2023 Sep 12. doi: 10.3233/JAD-230438.
    PubMed     Abstract available


  1128. XU X, Wang H, Zhang QY, Meng XY, et al
    Dissecting Mitochondrial Mechanisms of Alzheimer's Disease Using Gene Dependency Network and Its Implications for Discovering Nutrients Combatting the Disease.
    J Alzheimers Dis. 2023 Sep 12. doi: 10.3233/JAD-230366.
    PubMed     Abstract available


  1129. LARDELLI M
    An Alternative View of Familial Alzheimer's Disease Genetics.
    J Alzheimers Dis. 2023 Sep 12. doi: 10.3233/JAD-230313.
    PubMed     Abstract available


  1130. DE LA MONTE SM
    Malignant Brain Aging: The Formidable Link Between Dysregulated Signaling Through Mechanistic Target of Rapamycin Pathways and Alzheimer's Disease (Type 3 Diabetes).
    J Alzheimers Dis. 2023 Sep 11. doi: 10.3233/JAD-230555.
    PubMed     Abstract available


  1131. FORTEL I, Zhan L, Ajilore O, Wu Y, et al
    Disrupted Excitation-Inhibition Balance in Cognitively Normal Individuals at Risk of Alzheimer's Disease.
    J Alzheimers Dis. 2023 Sep 11. doi: 10.3233/JAD-230035.
    PubMed     Abstract available


  1132. DAVIDSON S, Allenback G, Decourt B, Sabbagh MN, et al
    Type 2 Diabetes Comorbidity and Cognitive Decline in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2023 Sep 9. doi: 10.3233/JAD-230489.
    PubMed     Abstract available


  1133. FUKUDA H, Kanzaki H, Murata F, Maeda M, et al
    Disease Burden and Progression in Patients with New-Onset Mild Cognitive Impairment and Alzheimer's Disease Identified from Japanese Claims Data: Evidence from the LIFE Study.
    J Alzheimers Dis. 2023 Sep 9. doi: 10.3233/JAD-230471.
    PubMed     Abstract available


  1134. ZIYAD SR, Altulyan M, Alharbi M
    SHMAD: A Smart Health Care System to Monitor Alzheimer's Disease Patients.
    J Alzheimers Dis. 2023 Sep 9. doi: 10.3233/JAD-230402.
    PubMed     Abstract available


  1135. NAKAMURA Y, Narita K, Kim R, Nishiyama K, et al
    Long-Term Safety, Tolerability, and Efficacy of a Transdermal Donepezil Patch in Patients with Severe Alzheimer's Disease.
    J Alzheimers Dis. 2023 Sep 9. doi: 10.3233/JAD-230386.
    PubMed     Abstract available


  1136. VERDE F, Aiello EN, Adobbati L, Poletti B, et al
    Coexistence of Amyotrophic Lateral Sclerosis and Alzheimer's Disease: Case Report and Review of the Literature.
    J Alzheimers Dis. 2023 Sep 7. doi: 10.3233/JAD-230562.
    PubMed     Abstract available


  1137. DU Y, Chen X, Zhang B, Jin X, et al
    Identification of Copper Metabolism Related Biomarkers, Polygenic Prediction Model, and Potential Therapeutic Agents in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Sep 5. doi: 10.3233/JAD-230565.
    PubMed     Abstract available


  1138. LEHMANN DJ, Elshorbagy A, Hurley MJ
    Many Paths to Alzheimer's Disease: A Unifying Hypothesis Integrating Biological, Chemical, and Physical Risk Factors.
    J Alzheimers Dis. 2023 Sep 5. doi: 10.3233/JAD-230295.
    PubMed     Abstract available


  1139. KOPPELMANS V, Ruitenberg MFL, Schaefer SY, King JB, et al
    Delayed and More Variable Unimanual and Bimanual Finger Tapping in Alzheimer's Disease: Associations with Biomarkers and Applications for Classification.
    J Alzheimers Dis. 2023 Sep 4. doi: 10.3233/JAD-221297.
    PubMed     Abstract available


  1140. ADEWALE BA, Coker MM, Ogunniyi A, Kalaria RN, et al
    Biomarkers and Risk Assessment of Alzheimer's Disease in Low- and Middle-Income Countries.
    J Alzheimers Dis. 2023 Sep 4. doi: 10.3233/JAD-221030.
    PubMed     Abstract available


  1141. MAKRI M, Gkioka M, Moraitou D, Fidani L, et al
    Attitudes, Motivations, and Barriers to Pre-Symptomatic Alzheimer's Disease Screening: Development and Validation of the 'Perceptions regarding pRE-symptomatic Alzheimer's Disease Screening' (PRE-ADS) Questionnaire.
    J Alzheimers Dis. 2023 Sep 1. doi: 10.3233/JAD-220954.
    PubMed     Abstract available


    August 2023
  1142. LI Z, Wu H, Ji Y, Shi Z, et al
    Toward Reagent-Free Discrimination of Alzheimer's Disease Using Blood Plasma Spectral Digital Biomarkers and Machine Learning.
    J Alzheimers Dis. 2023 Aug 28. doi: 10.3233/JAD-230248.
    PubMed     Abstract available


  1143. GEZEN-AK D, Dursun E
    Vitamin D, a Secosteroid Hormone and Its Multifunctional Receptor, Vitamin D Receptor, in Alzheimer's Type Neurodegeneration.
    J Alzheimers Dis. 2023 Aug 28. doi: 10.3233/JAD-230214.
    PubMed     Abstract available


  1144. ZHANG J, Liu Q, Zhang H, Dai M, et al
    Uncovering the System Vulnerability and Criticality of Human Brain Under Dynamical Neuropathological Events in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Aug 28. doi: 10.3233/JAD-230027.
    PubMed     Abstract available


  1145. FAZLOLLAHI A, Lee S, Coleman F, McCann E, et al
    Increased Resolution of Structural MRI at 3T Improves Estimation of Regional Cortical Degeneration in Individual Dementia Patients Using Surface Thickness Maps.
    J Alzheimers Dis. 2023 Aug 28. doi: 10.3233/JAD-230030.
    PubMed     Abstract available


  1146. UCHIDA Y, Onda K, Hou Z, Troncoso JC, et al
    Microstructural Neurodegeneration of the Entorhinal-Hippocampus Pathway along the Alzheimer's Disease Continuum.
    J Alzheimers Dis. 2023 Aug 25. doi: 10.3233/JAD-230452.
    PubMed     Abstract available


  1147. WU Y, Eisel ULM
    Microglia-Astrocyte Communication in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Aug 25. doi: 10.3233/JAD-230199.
    PubMed     Abstract available


  1148. SCHORK NJ, Elman JA
    Pathway-Specific Polygenic Risk Scores Correlate with Clinical Status and Alzheimer's Disease-Related Biomarkers.
    J Alzheimers Dis. 2023 Aug 25. doi: 10.3233/JAD-230548.
    PubMed     Abstract available


  1149. BEI J, Miranda-Morales EG, Gan Q, Qiu Y, et al
    Circulating Exosomes from Alzheimer's Disease Suppress Vascular Endothelial-Cadherin Expression and Induce Barrier Dysfunction in Recipient Brain Microvascular Endothelial Cell.
    J Alzheimers Dis. 2023 Aug 25. doi: 10.3233/JAD-230347.
    PubMed     Abstract available


  1150. SATTAROV R, Toresson H, Orbjorn C, Mattsson-Carlgren N, et al
    Direct Conversion of Fibroblast into Neurons for Alzheimer's Disease Research: A Systematic Review.
    J Alzheimers Dis. 2023 Aug 25. doi: 10.3233/JAD-230119.
    PubMed     Abstract available


  1151. HEIDARZADEH N, Ratte S
    'Eye-Tracking' with Words for Alzheimer's Disease Detection: Time Alignment of Words Enunciation with Image Regions During Image Description Tasks.
    J Alzheimers Dis. 2023 Aug 25. doi: 10.3233/JAD-220711.
    PubMed     Abstract available


  1152. LI J, Mountz EJ, Mizuno A, Shah AM, et al
    Functional Asymmetry During Working Memory and Its Association with Markers of Alzheimer's Disease in Cognitively Normal Older Adults.
    J Alzheimers Dis. 2023 Aug 24. doi: 10.3233/JAD-230379.
    PubMed     Abstract available


  1153. RAMOS C, Madrigal C, Aguirre-Acevedo DC, Giraldo-Chica M, et al
    Psychological Status of the Participants in Alzheimer's Prevention Initiative Autosomal Dominant Alzheimer's Disease Colombia.
    J Alzheimers Dis. 2023 Aug 24. doi: 10.3233/JAD-220941.
    PubMed     Abstract available


  1154. JIANG J, Wang A, Liu Y, Yao Z, et al
    Spatiotemporal Characteristics of Regional Brain Perfusion Associated with Neuropsychiatric Symptoms in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2023 Aug 23. doi: 10.3233/JAD-230499.
    PubMed     Abstract available


  1155. KIM DY, Kim JS, Seo YS, Park WY, et al
    Evaluation of Efficacy and Safety Using Low Dose Radiation Therapy with Alzheimer's Disease: A Protocol for Multicenter Phase II Clinical Trial.
    J Alzheimers Dis. 2023 Aug 23. doi: 10.3233/JAD-230241.
    PubMed     Abstract available


  1156. ABYADEH M, Yadav VK, Kaya A
    Common Molecular Signatures Between Coronavirus Infection and Alzheimer's Disease Reveal Targets for Drug Development.
    J Alzheimers Dis. 2023 Aug 22. doi: 10.3233/JAD-230684.
    PubMed     Abstract available


  1157. JANN K, Boudreau J, Albrecht D, Cen SY, et al
    FMRI Complexity Correlates with Tau-PET and Cognitive Decline in Late-Onset and Autosomal Dominant Alzheimer's Disease.
    J Alzheimers Dis. 2023 Aug 18. doi: 10.3233/JAD-220851.
    PubMed     Abstract available


  1158. MAMELAK M
    The Alzheimer's Disease Brain, Its Microvasculature, and NADPH Oxidase.
    J Alzheimers Dis. 2023 Aug 14. doi: 10.3233/JAD-230415.
    PubMed     Abstract available


  1159. KATISKO K, Kruger J, Soppela H, Hartikainen P, et al
    Psychopharmacological Medication Use in Frontotemporal Dementia at the Time of Diagnosis: Comparison with Alzheimer's Disease.
    J Alzheimers Dis. 2023 Aug 12. doi: 10.3233/JAD-230494.
    PubMed     Abstract available


  1160. KOBRO-FLATMOEN A, Hormann TM, Gouras G
    Intracellular Amyloid-beta in the Normal Rat Brain and Human Subjects and Its relevance for Alzheimer's Disease.
    J Alzheimers Dis. 2023 Aug 10. doi: 10.3233/JAD-230349.
    PubMed     Abstract available


  1161. YANG H, Wang W, Jia L, Qin W, et al
    Erratum to: The Effect of Chronic Cerebral Hypoperfusion on Blood-Brain Barrier Permeability in a Transgenic Alzheimer's Disease Mouse Model (PS1V97L).
    J Alzheimers Dis. 2023 Aug 8. doi: 10.3233/JAD-239007.
    PubMed    


  1162. WANG X, Sundermann EE, Buckley RF, Reas ET, et al
    Sex Differences in the Associations of Obesity with Tau, Amyloid PET, and Cognitive Outcomes in Preclinical Alzheimer's Disease: Cross-Sectional A4 Study.
    J Alzheimers Dis. 2023 Aug 7. doi: 10.3233/JAD-230466.
    PubMed     Abstract available


  1163. KENKPEN AK, Storey JJ, Olson ER, Guden TE, et al
    Developing Connections Between LINC00298 RNA and Alzheimer's Disease Through Mapping Its Interactome and Through Biochemical Characterization.
    J Alzheimers Dis. 2023 Aug 7. doi: 10.3233/JAD-230057.
    PubMed     Abstract available


  1164. HARRIS K, Ling Y, Bukhbinder AS, Chen L, et al
    The Impact of Routine Vaccinations on Alzheimer's Disease Risk in Persons 65 Years and Older: A Claims-Based Cohort Study using Propensity Score Matching.
    J Alzheimers Dis. 2023 Aug 7. doi: 10.3233/JAD-221231.
    PubMed     Abstract available


  1165. CONTI E, Grana D, Angiulli F, Karantzoulis A, et al
    TSPO Modulates Oligomeric Amyloid-beta-Induced Monocyte Chemotaxis: Relevance for Neuroinflammation in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Aug 5. doi: 10.3233/JAD-230239.
    PubMed     Abstract available


  1166. CAI HY, Yang D, Qiao J, Yang JT, et al
    Erratum to: A GLP-1/GIP Dual Receptor Agonist DA4-JC Effectively Attenuates Cognitive Impairment and Pathology in the APP/PS1/Tau Model of Alzheimer's Disease.
    J Alzheimers Dis. 2023 Aug 2. doi: 10.3233/JAD-239006.
    PubMed    


  1167. QAISER H, Uzair M, Al-Regaiey K, Rafiq S, et al
    Role of Thioredoxin System in Regulating Cellular Redox Status in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Aug 1. doi: 10.3233/JAD-230394.
    PubMed     Abstract available


  1168. MENDEZ MF
    Can Speaking More Than One Language Help Prevent Alzheimer's Disease?
    J Alzheimers Dis. 2023 Aug 1. doi: 10.3233/JAD-230285.
    PubMed     Abstract available


  1169. SONG S, Asken B, Armstrong MJ, Yang Y, et al
    Predicting Progression to Clinical Alzheimer's Disease Dementia Using the Random Survival Forest.
    J Alzheimers Dis. 2023 Aug 1. doi: 10.3233/JAD-230208.
    PubMed     Abstract available


  1170. BACHMAN SL, Blankenship JM, Busa M, Serviente C, et al
    Capturing Measures That Matter: The Potential Value of Digital Measures of Physical Behavior for Alzheimer's Disease Drug Development.
    J Alzheimers Dis. 2023 Aug 1. doi: 10.3233/JAD-230152.
    PubMed     Abstract available


  1171. BAUMARD J
    Is Shadowing Behavior Caused by Body Representation Disorders and Apraxia?
    J Alzheimers Dis. 2023 Aug 1. doi: 10.3233/JAD-230731.
    PubMed     Abstract available


    July 2023
  1172. LA BARBERA L, D'Amelio M
    Alzheimer's Disease and Sex-Dependent Alterations in the Striatum: A Lesson from a Mouse Model.
    J Alzheimers Dis. 2023 Jul 28. doi: 10.3233/JAD-230681.
    PubMed     Abstract available


  1173. LIN Y, Hu T, Cheng L, Chen Y, et al
    Causal Effects of Plasma Haptoglobin Levels on Alzheimer's Disease: A Two-Sample Mendelian Randomization Study.
    J Alzheimers Dis. 2023 Jul 26. doi: 10.3233/JAD-230159.
    PubMed     Abstract available


  1174. LEITAO ADG, Spencer B, Sarsoza F, Ngolab J, et al
    Hippocampal Reduction of alpha-Synuclein via RNA Interference Improves Neuropathology in Alzheimer's Disease Mice.
    J Alzheimers Dis. 2023 Jul 25. doi: 10.3233/JAD-230232.
    PubMed     Abstract available


  1175. VICENTE MC, Paneghini JL, Stabile AM, Amorim M, et al
    Inhibition of Pro-Inflammatory Microglia with Minocycline Improves Cognitive and Sleep-Wake Dysfunction Under Respiratory Stress in a Sporadic Model for Alzheimer's Disease.
    J Alzheimers Dis. 2023 Jul 25. doi: 10.3233/JAD-230151.
    PubMed     Abstract available


  1176. NADEAU PA, Jobin B, Boller B
    Diagnostic Sensitivity and Specificity of Cognitive Tests for Mild Cognitive Impairment and Alzheimer's Disease in Patients with Down Syndrome: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2023 Jul 25. doi: 10.3233/JAD-220991.
    PubMed     Abstract available


  1177. VOSSEL K
    Putting the Brakes on Accelerated Cognitive Decline in Alzheimer's Disease with Epileptic Activity.
    J Alzheimers Dis. 2023 Jul 24. doi: 10.3233/JAD-230613.
    PubMed     Abstract available


  1178. WHITE LR, Corrada MM, Kawas CH, Cholerton BA, et al
    Neuropathologic Changes of Alzheimer's Disease and Related Dementias: Relevance to Future Prevention.
    J Alzheimers Dis. 2023 Jul 24. doi: 10.3233/JAD-230331.
    PubMed     Abstract available


  1179. NOWRANGI MA, Outen JD, Kim J, Avramopoulos D, et al
    Neuropsychiatric Symptoms of Alzheimer's Disease: An Anatomic-Genetic Framework for Treatment Development.
    J Alzheimers Dis. 2023 Jul 24. doi: 10.3233/JAD-221247.
    PubMed     Abstract available



  1180. Henning Tiemeier, MD, PhD, and Rosanne Freak-Poli, PhD, are the recipients of the 2023 Alzheimer Award.
    J Alzheimers Dis. 2023 Jul 20. doi: 10.3233/JAD-239005.
    PubMed    


  1181. LI J, Zeng Q, Luo X, Li K, et al
    Decoupling of Regional Cerebral Blood Flow and Brain Function Along the Alzheimer's Continuum.
    J Alzheimers Dis. 2023 Jul 20. doi: 10.3233/JAD-230503.
    PubMed     Abstract available


  1182. LOPEZ-MARTOS D, Brugulat-Serrat A, Canas-Martinez A, Canals-Gispert L, et al
    Reference Data for Attentional, Executive, Linguistic, and Visual Processing Tests Obtained from Cognitively Healthy Individuals with Normal Alzheimer's Disease Cerebrospinal Fluid Biomarker Levels.
    J Alzheimers Dis. 2023 Jul 20. doi: 10.3233/JAD-230290.
    PubMed     Abstract available


  1183. KILPATRICK LA, Siddarth P, Krause-Sorio B, Milillo MM, et al
    Impact of Yoga Versus Memory Enhancement Training on Hippocampal Connectivity in Older Women at Risk for Alzheimer's Disease.
    J Alzheimers Dis. 2023 Jul 19. doi: 10.3233/JAD-221159.
    PubMed     Abstract available


  1184. STALLARD E, Kociolek A, Jin Z, Ryu H, et al
    Validation of a Multivariate Prediction Model of the Clinical Progression of Alzheimer's Disease in a Community-Dwelling Multiethnic Cohort.
    J Alzheimers Dis. 2023 Jul 19. doi: 10.3233/JAD-220811.
    PubMed     Abstract available


  1185. YU Y, Xia X, Meng X, Li D, et al
    Plasma Phosphorylated Tau181 and Amyloid-beta42 in Dementia with Lewy Bodies Compared with Alzheimer's Disease and Cognitively Healthy People.
    J Alzheimers Dis. 2023 Jul 18. doi: 10.3233/JAD-230085.
    PubMed     Abstract available


  1186. HARTLEY SL, Fleming V, Schworer EK, Peven J, et al
    Timing of Alzheimer's Disease by Intellectual Disability Level in Down Syndrome.
    J Alzheimers Dis. 2023 Jul 17. doi: 10.3233/JAD-230200.
    PubMed     Abstract available


  1187. PUENTES-DIAZ N, Chaparro D, Reyes-Marquez V, Morales-Morales D, et al
    Computational Evaluation of the Potential Pharmacological Activity of Salen-Type Ligands in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Jul 15. doi: 10.3233/JAD-230542.
    PubMed     Abstract available


  1188. OLMOS-VILLASENOR R, Sepulveda-Silva C, Julio-Ramos T, Fuentes-Lopez E, et al
    Phonological and Semantic Fluency in Alzheimer's Disease: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2023 Jul 15. doi: 10.3233/JAD-221272.
    PubMed     Abstract available


  1189. CHENG C, Yang C, Jia C, Wang Q, et al
    The Role of Cerebellum in Alzheimer's Disease: A Forgotten Research Corner.
    J Alzheimers Dis. 2023 Jul 14. doi: 10.3233/JAD-230381.
    PubMed     Abstract available


  1190. CHUM PP, Bishara MA, Solis SR, Behringer EJ, et al
    Cerebrovascular miRNAs Track Early Development of Alzheimer's Disease and Target Molecular Markers of Angiogenesis and Blood Flow Regulation.
    J Alzheimers Dis. 2023 Jul 14. doi: 10.3233/JAD-230300.
    PubMed     Abstract available


  1191. CHEN R, Morris BJ, Donlon TA, Ross GW, et al
    Incidence of Alzheimer's Disease in Men with Late-Life Hypertension Is Ameliorated by FOXO3 Longevity Genotype.
    J Alzheimers Dis. 2023 Jul 14. doi: 10.3233/JAD-230350.
    PubMed     Abstract available


  1192. XU Y, Vasiljevic E, Deming YK, Jonaitis EM, et al
    Effect of Pathway-Specific Polygenic Risk Scores for Alzheimer's Disease (AD) on Rate of Change in Cognitive Function and AD-Related Biomarkers Among Asymptomatic Individuals.
    J Alzheimers Dis. 2023 Jul 14. doi: 10.3233/JAD-230097.
    PubMed     Abstract available


  1193. TIO ES, Hohman TJ, Milic M, Bennett DA, et al
    Testing a Polygenic Risk Score for Morphological Microglial Activation in Alzheimer's Disease and Aging.
    J Alzheimers Dis. 2023 Jul 10. doi: 10.3233/JAD-230434.
    PubMed     Abstract available


  1194. KUDO S, Funayama M, Kurose S, Shimizu Y, et al
    Shadowing Behavior May Be Associated with an Inability to Recognize the External World: A Case Report of Shadowing in a Patient with Posterior Cortical Atrophy.
    J Alzheimers Dis. 2023 Jul 10. doi: 10.3233/JAD-230257.
    PubMed     Abstract available


  1195. MIGUEL L, Gervais J, Nicolas G, Lecourtois M, et al
    SorLA Protective Function Is Restored by Improving SorLA Protein Maturation in a Subset of Alzheimer's Disease-Associated SORL1 Missense Variants.
    J Alzheimers Dis. 2023 Jul 8. doi: 10.3233/JAD-230211.
    PubMed     Abstract available


  1196. YANG Y, Lv J, Bai H, Ren L, et al
    Periodontal Status and Saliva Metabolic Signature in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2023 Jul 7. doi: 10.3233/JAD-230291.
    PubMed     Abstract available


  1197. XIA ZD, Ma RX, Wen JF, Zhai YF, et al
    Pathogenesis, Animal Models, and Drug Discovery of Alzheimer's Disease.
    J Alzheimers Dis. 2023 Jul 5. doi: 10.3233/JAD-230326.
    PubMed     Abstract available


  1198. MAO M, Wang C, Hou T, Han X, et al
    Ventricular Electrocardiographic Signatures Associated with Dementia and Plasma Alzheimer's Disease Biomarkers in Older Adults: A Population-Based Study.
    J Alzheimers Dis. 2023 Jul 5. doi: 10.3233/JAD-230056.
    PubMed     Abstract available


  1199. ZHANG HQ, Chau ACM, Shea YF, Chiu PK, et al
    Disrupted Structural White Matter Network in Alzheimer's Disease Continuum, Vascular Dementia, and Mixed Dementia: A Diffusion Tensor Imaging Study.
    J Alzheimers Dis. 2023 Jul 3. doi: 10.3233/JAD-230341.
    PubMed     Abstract available


    June 2023
  1200. CAI HY, Hou SJ, Wen R, Feng QF, et al
    Causal Association Between mTOR-Dependent Protein Levels and Alzheimer's Disease: A Mendelian Randomization Study.
    J Alzheimers Dis. 2023 Jun 30. doi: 10.3233/JAD-230128.
    PubMed     Abstract available


  1201. AKADA K, Koyama N, Miura Y, Takahashi K, et al
    Nationwide Database Analysis of Risk Factors Associated with Decreased Activities of Daily Living in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2023 Jun 30. doi: 10.3233/JAD-230106.
    PubMed     Abstract available


  1202. HANSEN SB
    Cholesterol's Function and Origin in the Alzheimer's Disease Brain.
    J Alzheimers Dis. 2023 Jun 29. doi: 10.3233/JAD-230538.
    PubMed     Abstract available


  1203. MOBASHERI K, Zaefizadeh M, Ghobeh M, Eidi A, et al
    Synthesis of Novel Magnetic Quercetin-Neuropeptide Nanocomposite as a Smart Nano-Drug Shuttle System: Investigation of Its Effect on Behavior, Histopathological Characteristics, and Expression of MAPT and APP Genes in Alzheimer's Disease Rats.
    J Alzheimers Dis. 2023 Jun 29. doi: 10.3233/JAD-221095.
    PubMed     Abstract available


  1204. MERTEN N, Pinto AA, Paulsen AJ, Chen Y, et al
    Associations of Midlife Lifestyle and Health Factors with Long-Term Changes in Blood-Based Biomarkers of Alzheimer's Disease and Neurodegeneration.
    J Alzheimers Dis. 2023 Jun 28. doi: 10.3233/JAD-221287.
    PubMed     Abstract available


  1205. SCHAFER HACKENHAAR F, Josefsson M, Nordin Adolfsson A, Landfors M, et al
    Sixteen-Year Longitudinal Evaluation of Blood-Based DNA Methylation Biomarkers for Early Prediction of Alzheimer's Disease.
    J Alzheimers Dis. 2023 Jun 27. doi: 10.3233/JAD-230039.
    PubMed     Abstract available


  1206. CHHIMPA N, Singh N, Puri N, Kayath HP, et al
    The Novel Role of Mitochondrial Citrate Synthase and Citrate in the Pathophysiology of Alzheimer's Disease.
    J Alzheimers Dis. 2023 Jun 27. doi: 10.3233/JAD-220514.
    PubMed     Abstract available


  1207. KANG JM, Shin JH, Kim WR, Seo S, et al
    Effects of the APOEvarepsilon4 Allele on the Relationship Between Tau and Amyloid-beta in Early- and Late-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2023 Jun 24. doi: 10.3233/JAD-230339.
    PubMed     Abstract available


  1208. SORRENTINO F, Fenoglio C, Sacchi L, Serpente M, et al
    Klotho Gene Expression Is Decreased in Peripheral Blood Mononuclear Cells in Patients with Alzheimer's Disease and Frontotemporal Dementia.
    J Alzheimers Dis. 2023 Jun 24. doi: 10.3233/JAD-230322.
    PubMed     Abstract available


  1209. ALVES SS, de Oliveira JAC, Lazarini-Lopes W, Servilha-Menezes G, et al
    Audiogenic Seizures in the Streptozotocin-Induced Rat Alzheimer's Disease Model.
    J Alzheimers Dis. 2023 Jun 24. doi: 10.3233/JAD-230153.
    PubMed     Abstract available


  1210. ZHANG J, Gao S, Liu W
    Bioinformatics-Based Analysis of Circadian Rhythm Regulation Mechanisms in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Jun 23. doi: 10.3233/JAD-230177.
    PubMed     Abstract available


  1211. AUDRONYTE E, Pakulaite-Kazliene G, Sutnikiene V, Kaubrys G, et al
    Odor Discrimination as a Marker of Early Alzheimer's Disease.
    J Alzheimers Dis. 2023 Jun 23. doi: 10.3233/JAD-230077.
    PubMed     Abstract available


  1212. KULMINSKI AM, Feng F, Loiko E, Nazarian A, et al
    Prevailing Antagonistic Risks in Pleiotropic Associations with Alzheimer's Disease and Diabetes.
    J Alzheimers Dis. 2023 Jun 22. doi: 10.3233/JAD-230397.
    PubMed     Abstract available


  1213. JEONG SH, Cha J, Jung JH, Yun M, et al
    Occipital Amyloid Deposition Is Associated with Rapid Cognitive Decline in the Alzheimer's Disease Continuum.
    J Alzheimers Dis. 2023 Jun 22. doi: 10.3233/JAD-230187.
    PubMed     Abstract available


  1214. HAUTECLOQUE-RAYSZ G, Sellal F, Bousiges O, Phillipi N, et al
    Epileptic Prodromal Alzheimer's Disease Treated with Antiseizure Medications: Medium-Term Outcome of Seizures and Cognition.
    J Alzheimers Dis. 2023 Jun 22. doi: 10.3233/JAD-221197.
    PubMed     Abstract available


  1215. BELAN AFR, Pais MV, Camargo MVZA, Sant'Ana LCFG, et al
    Diagnostic Performance of an Eye-Tracking Assisted Visual Inference Language Test in the Assessment of Cognitive Decline due to Alzheimer's Disease.
    J Alzheimers Dis. 2023 Jun 21. doi: 10.3233/JAD-230250.
    PubMed     Abstract available


  1216. CHEN W, Lin C, Su F, Fang Y, et al
    Early Diagnosis of Mild Cognitive Impairment due to Alzheimer's Disease Using a Composite of MemTrax and Blood Biomarkers.
    J Alzheimers Dis. 2023 Jun 21. doi: 10.3233/JAD-230182.
    PubMed     Abstract available


  1217. FU XX, Wei B, Cao HM, Duan R, et al
    Telmisartan Alleviates Alzheimer's Disease-Related Neuropathologies and Cognitive Impairments.
    J Alzheimers Dis. 2023 Jun 19. doi: 10.3233/JAD-230133.
    PubMed     Abstract available


  1218. ORTI-CASAN N, Wajant H, Kuiperij HB, Hooijsma A, et al
    Activation of TNF Receptor 2 Improves Synaptic Plasticity and Enhances Amyloid-beta Clearance in an Alzheimer's Disease Mouse Model with Humanized TNF Receptor 2.
    J Alzheimers Dis. 2023 Jun 19. doi: 10.3233/JAD-221230.
    PubMed     Abstract available


  1219. BOLLINGER RM, Gabel M, Coble DW, Chen SW, et al
    Retention of Study Partners in Longitudinal Studies of Alzheimer Disease.
    J Alzheimers Dis. 2023 Jun 18. doi: 10.3233/JAD-230079.
    PubMed     Abstract available


  1220. NAKAMURA Y, Omori T, Kim R, Nishiyama K, et al
    Efficacy and Safety of a Transdermal Donepezil Patch in Patients with Mild to Moderate Alzheimer's Disease: Open-Label, Extension Study.
    J Alzheimers Dis. 2023 Jun 14. doi: 10.3233/JAD-230387.
    PubMed     Abstract available


  1221. YAN R, Wang W, Yang W, Huang M, et al
    Mitochondria-Related Candidate Genes and Diagnostic Model to Predict Late-Onset Alzheimer's Disease and Mild Cognitive Impairment.
    J Alzheimers Dis. 2023 Jun 13. doi: 10.3233/JAD-230314.
    PubMed     Abstract available


  1222. JIANG WR, Wu W, Yang LJ, Yang W, et al
    Alteration of Cognitive Function in Aging and Alzheimer's Disease Mice Is Related to Dysfunction of the Neuroimmune System.
    J Alzheimers Dis. 2023 Jun 13. doi: 10.3233/JAD-230292.
    PubMed     Abstract available


  1223. MANSOR NI, Ling KH, Rosli R, Hassan Z, et al
    Centella asiatica (L.) Urban. Attenuates Cell Damage in Hydrogen Peroxide-Induced Oxidative Stress in Transgenic Murine Embryonic Stem Cell Line-Derived Neural-Like Cells: A Preliminary Study for Potential Treatment of Alzheimer's Disease.
    J Alzheimers Dis. 2023 Jun 13. doi: 10.3233/JAD-221233.
    PubMed     Abstract available


  1224. XU GY, Liu YH, Zeng XQ, Chen DW, et al
    The Diagnostic Potential of Circulating Autoantibodies to Amyloid-beta in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Jun 12. doi: 10.3233/JAD-230252.
    PubMed     Abstract available


  1225. QAISAR R, Karim A, Iqbal MS, Alkahtani SA, et al
    ACE Inhibitors Improve Skeletal Muscle by Preserving Neuromuscular Junctions in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2023 Jun 12. doi: 10.3233/JAD-230201.
    PubMed     Abstract available


  1226. PATEL S, Wei J, Shi Z, Rifkin AS, et al
    Refining Risk for Alzheimer's Disease Among Heterozygous APOEvarepsilon4 Carriers.
    J Alzheimers Dis. 2023 Jun 12. doi: 10.3233/JAD-230156.
    PubMed     Abstract available


  1227. PEAVY GM
    Can't Have One Without the Other: Study Partner Retention in Alzheimer's Disease Research.
    J Alzheimers Dis. 2023 Jun 10. doi: 10.3233/JAD-230455.
    PubMed     Abstract available


  1228. VANNINEN A, Lukkarinen H, Kokkola T, Koivisto AM, et al
    Cerebrospinal Fluid Diagnostics of Alzheimer's Disease in Patients with Idiopathic Normal Pressure Hydrocephalus.
    J Alzheimers Dis. 2023 Jun 10. doi: 10.3233/JAD-230144.
    PubMed     Abstract available


  1229. MILANO C, Hoxhaj D, Del Chicca M, Pascazio A, et al
    Alzheimer's Disease and Neurosyphilis: Meaningful Commonalities and Differences of Clinical Phenotype and Pathophysiological Biomarkers.
    J Alzheimers Dis. 2023 Jun 9. doi: 10.3233/JAD-230170.
    PubMed     Abstract available


  1230. HU D, Dong X, Wang Q, Liu M, et al
    PCP4 Promotes Alzheimer's Disease Pathogenesis by Affecting Amyloid-beta Protein Precursor Processing.
    J Alzheimers Dis. 2023 Jun 8. doi: 10.3233/JAD-230192.
    PubMed     Abstract available


  1231. ZHANG X, Liu Y, Huang M, Gunewardena S, et al
    Landscape of Double-Stranded DNA Breaks in Postmortem Brains from Alzheimer's Disease and Non-Demented Individuals.
    J Alzheimers Dis. 2023 Jun 8. doi: 10.3233/JAD-230316.
    PubMed     Abstract available


  1232. RUDGE JD
    The Lipid Invasion Model: Growing Evidence for This New Explanation of Alzheimer's Disease.
    J Alzheimers Dis. 2023 Jun 3. doi: 10.3233/JAD-221175.
    PubMed     Abstract available


    May 2023
  1233. SUN L, Ye KX, Wong HLK, Wang L, et al
    The Effects of Medium Chain Triglyceride for Alzheimer's Disease Related Cognitive Impairment: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2023 May 23. doi: 10.3233/JAD-230406.
    PubMed     Abstract available


  1234. HAZAN J, Liu K, Fox N, Howard R, et al
    Advancing Diagnostic Certainty in Alzheimer's Disease: A Synthesis of the Diagnostic Process.
    J Alzheimers Dis. 2023 May 23. doi: 10.3233/JAD-230186.
    PubMed     Abstract available


  1235. FINDLEY CA, McFadden SA, Cox MF, Sime LN, et al
    Prodromal Glutamatergic Modulation with Riluzole Impacts Glucose Homeostasis and Spatial Cognition in Alzheimer's Disease Mice.
    J Alzheimers Dis. 2023 May 23. doi: 10.3233/JAD-221245.
    PubMed     Abstract available


  1236. LI D, Yu YY, Hu N, Zhang M, et al
    Composite Indices of the Color-Picture Version of Boston Naming Test Have Better Discriminatory Power: Reliability and Validity in a Chinese Sample with Diverse Neurodegenerative Diseases.
    J Alzheimers Dis. 2023 May 23. doi: 10.3233/JAD-221227.
    PubMed     Abstract available


  1237. GONZALEZ A, Calfio C, Luttges V, Gonzalez-Madrid A, et al
    The Multifactorial Etiopathogenesis of Alzheimer's Disease: Neuroinflammation as the Major Contributor.
    J Alzheimers Dis. 2023 May 20. doi: 10.3233/JAD-230150.
    PubMed     Abstract available


  1238. LIU M, Li M, He J, He Y, et al
    Chiral Amino Acid Profiling in Serum Reveals Potential Biomarkers for Alzheimer's Disease.
    J Alzheimers Dis. 2023 May 20. doi: 10.3233/JAD-230142.
    PubMed     Abstract available


  1239. JARHOLM JA, Bjornerud A, Dalaker TO, Akhavi MS, et al
    Medial Temporal Lobe Atrophy in Predementia Alzheimer's Disease: A Longitudinal Multi-Site Study Comparing Staging and A/T/N in a Clinical Research Cohort.
    J Alzheimers Dis. 2023 May 20. doi: 10.3233/JAD-221274.
    PubMed     Abstract available


  1240. LIU J, Xie Y, Lu Y, Zhao Z, et al
    APP/PS1 Gene-Environmental Cadmium Interaction Aggravates the Progression of Alzheimer's Disease in Mice via the Blood-Brain Barrier, Amyloid-beta, and Inflammation.
    J Alzheimers Dis. 2023 May 20. doi: 10.3233/JAD-221205.
    PubMed     Abstract available


  1241. KARIMA S, Aghamollaii V, Mahmoodi Baram S, Balenci L, et al
    Boswellic Acids Improve Clinical Cognitive Scores and Reduce Systemic Inflammation in Patients with Mild to Moderate Alzheimer's Disease.
    J Alzheimers Dis. 2023 May 20. doi: 10.3233/JAD-221026.
    PubMed     Abstract available


  1242. MI Z, Abrahamson EE, Ryu AY, Malek-Ahmadi M, et al
    Vesicular Glutamate Transporter Changes in the Cortical Default Mode Network During the Clinical and Pathological Progression of Alzheimer's Disease.
    J Alzheimers Dis. 2023 May 19. doi: 10.3233/JAD-221063.
    PubMed     Abstract available


  1243. PUOYAN-MAJD S, Parnow A, Rashno M, Heidarimoghadam R, et al
    The Protective Effects of High-Intensity Interval Training Combined with Q10 Supplementation on Learning and Memory Impairments in Male Rats with Amyloid-beta-Induced Alzheimer's Disease.
    J Alzheimers Dis. 2023 May 18. doi: 10.3233/JAD-230096.
    PubMed     Abstract available


  1244. MORI H, Yoshino Y, Iga JI, Ochi S, et al
    Aberrant Expression of GABA-Related Genes in the Hippocampus of 3xTg-AD Model Mice from the Early to End Stages of Alzheimer's Disease.
    J Alzheimers Dis. 2023 May 18. doi: 10.3233/JAD-230078.
    PubMed     Abstract available


  1245. HUI HYH, Ran AR, Dai JJ, Cheung CY, et al
    Deep Reinforcement Learning-Based Retinal Imaging in Alzheimer's Disease: Potential and Perspectives.
    J Alzheimers Dis. 2023 May 18. doi: 10.3233/JAD-230055.
    PubMed     Abstract available


  1246. ELZAYAT EM, Shahien SA, El-Sherif AA, Hosney M, et al
    miRNAs and Stem Cells as Promising Diagnostic and Therapeutic Targets for Alzheimer's Disease.
    J Alzheimers Dis. 2023 May 18. doi: 10.3233/JAD-221298.
    PubMed     Abstract available


  1247. QUERRY M, Blanc F, Bousiges O, Philippi N, et al
    Memory Outcome in Prodromal and Mild Dementia with Lewy Bodies and Alzheimer's Disease: A Longitudinal Study.
    J Alzheimers Dis. 2023 May 18. doi: 10.3233/JAD-221243.
    PubMed     Abstract available


  1248. GONZALEZ C, Mimmack KJ, Amariglio RE, Becker JA, et al
    Associations of the Harvard Automated Phone Task and Alzheimer's Disease Pathology in Cognitively Normal Older Adults: Preliminary Findings.
    J Alzheimers Dis. 2023 May 18. doi: 10.3233/JAD-220885.
    PubMed     Abstract available


  1249. VOLLOCH V, Rits-Volloch S
    Effect of Lecanemab in Early Alzheimer's Disease: Mechanistic Interpretation in the Amyloid Cascade Hypothesis 2.0 Perspective.
    J Alzheimers Dis. 2023 May 16. doi: 10.3233/JAD-230164.
    PubMed     Abstract available


  1250. ORTNER M, Lanz K, Goldhardt O, Muller-Sarnowski F, et al
    Elecsys Cerebrospinal Fluid Immunoassays Accurately Detect Alzheimer's Disease Regardless of Concomitant Small Vessel Disease.
    J Alzheimers Dis. 2023 May 16. doi: 10.3233/JAD-221187.
    PubMed     Abstract available


  1251. WHEELERA CJ
    Evolutionary Selection of APOEvarepsilon4 Encourages Increased Focus on Immunity in Alzheimer's Disease.
    J Alzheimers Dis. 2023 May 13. doi: 10.3233/JAD-230390.
    PubMed     Abstract available


  1252. DINNERSETIN E
    The Time for Combination Therapy Research in Alzheimer's Disease is Now.
    J Alzheimers Dis. 2023 May 13. doi: 10.3233/JAD-230254.
    PubMed    


  1253. HIROTA Y, Sakakibara Y, Takei K, Nishijima R, et al
    Alzheimer's Disease-Related Phospho-Tau181 Signals Are Localized to Demyelinated Axons of Parvalbumin-Positive GABAergic Interneurons in an App Knock-In Mouse Model of Amyloid-beta Pathology.
    J Alzheimers Dis. 2023 May 13. doi: 10.3233/JAD-230121.
    PubMed     Abstract available


  1254. WHITE LR
    If Midlife Brain Injury Is a Risk Factor for Alzheimer's Disease and Related Dementias, What Is the Neuropathologic Mechanism?
    J Alzheimers Dis. 2023 May 12. doi: 10.3233/JAD-230332.
    PubMed     Abstract available


  1255. TOPPING M, Kim J, Fletcher J
    Area-Level Infant Mortality Exposure in Early Life and Alzheimer's Disease Mortality: Examining Variation Based on Age, Sex, and Place of Birth.
    J Alzheimers Dis. 2023 May 12. doi: 10.3233/JAD-230086.
    PubMed     Abstract available


  1256. BALIETTI M, Casoli T, Giorgetti B, Colangeli R, et al
    Generation and Characterization of the First Murine Model of Alzheimer's Disease with Mutated AbetaPP Inserted in a BALB/c Background (C.B6/J-APPswe).
    J Alzheimers Dis. 2023 May 11. doi: 10.3233/JAD-230195.
    PubMed     Abstract available


  1257. CARLOS AF, Machulda MM, Rutledge MH, Nguyen AT, et al
    Comparison of Clinical, Genetic, and Pathologic Features of Limbic and Diffuse Transactive Response DNA-Binding Protein 43 Pathology in Alzheimer's Disease Neuropathologic Spectrum.
    J Alzheimers Dis. 2023 May 11. doi: 10.3233/JAD-221094.
    PubMed     Abstract available


  1258. EIKELBOOM WS, van den Berg E, Coesmans M, Goudzwaard JA, et al
    Effects of the DICE Method to Improve Timely Recognition and Treatment of Neuropsychiatric Symptoms in Early Alzheimer's Disease at the Memory Clinic: The BEAT-IT Study.
    J Alzheimers Dis. 2023 May 10. doi: 10.3233/JAD-230116.
    PubMed     Abstract available


  1259. LIN H, Pan T, Wang M, Ge J, et al
    Metabolic Asymmetry Relates to Clinical Characteristics and Brain Network Abnormalities in Alzheimer's Disease.
    J Alzheimers Dis. 2023 May 10. doi: 10.3233/JAD-221258.
    PubMed     Abstract available


  1260. YAN Y, Wu Y, Xiao G, Wang L, et al
    White Matter Changes as an Independent Predictor of Alzheimer's Disease.
    J Alzheimers Dis. 2023 May 9. doi: 10.3233/JAD-221037.
    PubMed     Abstract available


  1261. CHENG J, Zheng H, Liu C, Jin J, et al
    Age-Associated UBE2O Reduction Promotes Neuronal Death in Alzheimer's Disease.
    J Alzheimers Dis. 2023 May 6. doi: 10.3233/JAD-221143.
    PubMed     Abstract available


  1262. LI Y, Chang J, Chen X, Liu J, et al
    Advances in the Study of APOE and Innate Immunity in Alzheimer's Disease.
    J Alzheimers Dis. 2023 May 5. doi: 10.3233/JAD-230179.
    PubMed     Abstract available


  1263. VIG V, Garg I, Tuz-Zahra F, Xu J, et al
    Vitreous Humor Biomarkers Reflect Pathological Changes in the Brain for Alzheimer's Disease and Chronic Traumatic Encephalopathy.
    J Alzheimers Dis. 2023 May 5. doi: 10.3233/JAD-230167.
    PubMed     Abstract available


  1264. SACCHI L, Contarino VE, Siggillino S, Carandini T, et al
    Banks of the Superior Temporal Sulcus in Alzheimer's Disease: A Pilot Quantitative Susceptibility Mapping Study.
    J Alzheimers Dis. 2023 May 5. doi: 10.3233/JAD-230095.
    PubMed     Abstract available


  1265. BLUSZTAJN JK, Slack BE
    Accelerated Breakdown of Phosphatidylcholine and Phosphatidylethanolamine Is a Predominant Brain Metabolic Defect in Alzheimer's Disease.
    J Alzheimers Dis. 2023 May 5. doi: 10.3233/JAD-230061.
    PubMed     Abstract available


  1266. ABBATE C
    The Adult Neurogenesis Theory of Alzheimer's Disease.
    J Alzheimers Dis. 2023 May 5. doi: 10.3233/JAD-221279.
    PubMed     Abstract available


  1267. HUGGINS LKL, Min SH, Kaplan S, Wei J, et al
    Meta-Analysis of Variations in Association between APOE varepsilon4 and Alzheimer's Disease and Related Dementias Across Hispanic Regions of Origin.
    J Alzheimers Dis. 2023 May 5. doi: 10.3233/JAD-221167.
    PubMed     Abstract available


  1268. MOYAERT P, Beun S, Achten E, Clement P, et al
    Effect of Acetylcholinesterase Inhibitors on Cerebral Perfusion and Cognition: A Systematic Review.
    J Alzheimers Dis. 2023 May 5. doi: 10.3233/JAD-221125.
    PubMed     Abstract available


  1269. BEADELL AV, Zhang Z, Capuano AW, Bennett DA, et al
    Genome-Wide Mapping Implicates 5-Hydroxymethylcytosines in Diabetes Mellitus and Alzheimer's Disease.
    J Alzheimers Dis. 2023 May 5. doi: 10.3233/JAD-221113.
    PubMed     Abstract available


    April 2023
  1270. HSIAO WW, Angela S, Le TN, Ku CC, et al
    Evolution of Detecting Early Onset of Alzheimer's Disease: From Neuroimaging to Optical Immunoassays.
    J Alzheimers Dis. 2023 Apr 28. doi: 10.3233/JAD-221202.
    PubMed     Abstract available


  1271. PRESS DZ, Musaeus CS, Zhao L, Breton J, et al
    Levetiracetam Increases Hippocampal Blood Flow in Alzheimer's Disease as Measured by Arterial Spin Labelling MRI.
    J Alzheimers Dis. 2023 Apr 26. doi: 10.3233/JAD-220614.
    PubMed     Abstract available


  1272. ZHANG K, Du X, Gao Y, Liu S, et al
    Mesenchymal Stem Cells for Treating Alzheimer's Disease: Cell Therapy and Chemical Reagent Pretreatment.
    J Alzheimers Dis. 2023 Apr 21. doi: 10.3233/JAD-221253.
    PubMed     Abstract available


  1273. LIU R, Zhang L, You H
    Insulin Resistance and Impaired Branched-Chain Amino Acid Metabolism in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Apr 21. doi: 10.3233/JAD-221147.
    PubMed     Abstract available


  1274. LIEW Y, Retinasamy T, Arulsamy A, Ali I, et al
    Neuroinflammation: A Common Pathway in Alzheimer's Disease and Epilepsy.
    J Alzheimers Dis. 2023 Apr 17. doi: 10.3233/JAD-230059.
    PubMed     Abstract available


  1275. LIANG J, LeFleur B, Hussainy S, Perry G, et al
    Gene Co-Expression Analysis of Multiple Brain Tissues Reveals Correlation of FAM222A Expression with Multiple Alzheimer's Disease-Related Genes.
    J Alzheimers Dis. 2023 Apr 17. doi: 10.3233/JAD-221241.
    PubMed     Abstract available


  1276. OTOKI Y, Yu D, Shen Q, Sahlas DJ, et al
    Quantitative Lipidomic Analysis of Serum Phospholipids Reveals Dissociable Markers of Alzheimer's Disease and Subcortical Cerebrovascular Disease.
    J Alzheimers Dis. 2023 Apr 17. doi: 10.3233/JAD-220795.
    PubMed     Abstract available


  1277. SINGH M, Jindal D, Kumar R, Pancham P, et al
    Molecular Docking and Network Pharmacology Interaction Analysis of Gingko Biloba (EGB761) Extract with Dual Target Inhibitory Mechanism in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Apr 12. doi: 10.3233/JAD-221222.
    PubMed     Abstract available


  1278. WILLIAMS E, Mutlu-Smith M, Alex A, Chin XW, et al
    Mid-Adulthood Cognitive Training Improves Performance in a Spatial Task but Does Not Ameliorate Hippocampal Pathology in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2023 Apr 12. doi: 10.3233/JAD-221185.
    PubMed     Abstract available


  1279. STARK J, Hiersche KJ, Yu JC, Hasselbach AN, et al
    Partial Least Squares Regression Analysis of Alzheimer's Disease Biomarkers, Modifiable Health Variables, and Cognitive Change in Older Adults with Mild Cognitive Impairment.
    J Alzheimers Dis. 2023 Apr 12. doi: 10.3233/JAD-221084.
    PubMed     Abstract available


  1280. HENDRIE HC
    Screening and Assessment for Alzheimer's Disease in the Days of Biological Biomarkers.
    J Alzheimers Dis. 2023 Apr 10. doi: 10.3233/JAD-230215.
    PubMed     Abstract available


  1281. TIAN J, Stucky C, Wang T, Muma NA, et al
    Mitochondrial Dysfunction Links to Impaired Hippocampal Serotonin Release in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2023 Apr 10. doi: 10.3233/JAD-230072.
    PubMed     Abstract available


  1282. ZHAO Z, Wang J, Wang Y, Liu X, et al
    18F-AV45 PET and MRI Reveal the Influencing Factors of Alzheimer's Disease Biomarkers in Subjective Cognitive Decline Population.
    J Alzheimers Dis. 2023 Apr 10. doi: 10.3233/JAD-221251.
    PubMed     Abstract available


  1283. EITHZ N, Sorensen J, Sopina L
    Healthcare Costs in the Year Before and After Alzheimer's Disease Diagnosis: A Danish Register-Based Matched Cohort Study.
    J Alzheimers Dis. 2023 Apr 10. doi: 10.3233/JAD-220821.
    PubMed     Abstract available


  1284. JIA J, Zhang Y, Shi Y, Yina X, et al
    Erratum to: A 19-Year-Old Adolescent with Probable Alzheimer's Disease.
    J Alzheimers Dis. 2023 Apr 5. doi: 10.3233/JAD-239001.
    PubMed    


  1285. MAO C, You H, Hou B, Chu S, et al
    Differentiation of Alzheimer's Disease from Frontotemporal Dementia and Mild Cognitive Impairment Based on Arterial Spin Labeling Magnetic Resonance Imaging: A Pilot Cross-Sectional Study from PUMCH Dementia Cohort.
    J Alzheimers Dis. 2023 Apr 4. doi: 10.3233/JAD-221023.
    PubMed     Abstract available


  1286. SULHEIM E, WiderOe M, Back M, Nilsson KPR, et al
    Contrast Enhanced Magnetic Resonance Imaging of Amyloid-beta Plaques in a Murine Alzheimer's Disease Model.
    J Alzheimers Dis. 2023 Apr 3. doi: 10.3233/JAD-220198.
    PubMed     Abstract available


  1287. QIAN L, Bian W, Wang D, Ming Z, et al
    Adeno-Associated Virus-Mediated Immunotherapy Based on Bispecific Tandem scFv for Alzheimer's Disease.
    J Alzheimers Dis. 2023 Apr 1. doi: 10.3233/JAD-221088.
    PubMed     Abstract available


  1288. NAGARAJA N, Wang WE, Duara R, DeKosky ST, et al
    Mediation of Reduced Hippocampal Volume by Cerebral Amyloid Angiopathy in Pathologically Confirmed Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2023 Apr 1. doi: 10.3233/JAD-220624.
    PubMed     Abstract available


    March 2023
  1289. SAKURAI K, Kaneda D, Morimoto S, Uchida Y, et al
    Voxel-Based and Surface-Based Morphometry Analysis in Patients with Pathologically Confirmed Argyrophilic Grain Disease and Alzheimer's Disease.
    J Alzheimers Dis. 2023 Mar 25. doi: 10.3233/JAD-230068.
    PubMed     Abstract available


  1290. RAHMANI F, Ghezzi L, Tosti V, Liu J, et al
    Twelve Weeks of Intermittent Caloric Restriction Diet Mitigates Neuroinflammation in Midlife Individuals with Multiple Sclerosis: A Pilot Study with Implications for Prevention of Alzheimer's Disease.
    J Alzheimers Dis. 2023 Mar 25. doi: 10.3233/JAD-221007.
    PubMed     Abstract available


  1291. ZIYAD SR, Alharbi M, Altulyan M
    Artificial Intelligence Model for Alzheimer's Disease Detection with Convolution Neural Network for Magnetic Resonance Images.
    J Alzheimers Dis. 2023 Mar 23. doi: 10.3233/JAD-221250.
    PubMed     Abstract available


  1292. SUN Y, Hu HY, Hu H, Huang LY, et al
    Cerebral Small Vessel Disease Burden Predicts Neurodegeneration and Clinical Progression in Prodromal Alzheimer's Disease.
    J Alzheimers Dis. 2023 Mar 23. doi: 10.3233/JAD-221207.
    PubMed     Abstract available


  1293. FORTEA J, Garcia-Arcelay E, Terrancle A, Galvez B, et al
    Attitudes of Neurologists Toward the Use of Biomarkers in the Diagnosis of Early Alzheimer's Disease.
    J Alzheimers Dis. 2023 Mar 23. doi: 10.3233/JAD-221160.
    PubMed     Abstract available


  1294. WIDJAYA MA, Cheng YJ, Kuo YM, Liu CH, et al
    Transcriptomic Analyses of Exercise Training in Alzheimer's Disease Cerebral Cortex.
    J Alzheimers Dis. 2023 Mar 23. doi: 10.3233/JAD-221139.
    PubMed     Abstract available


  1295. NAKAMURA T, Kawarabayashi T, Ueda T, Shimomura S, et al
    Plasma ApoE4 Levels Are Lower than ApoE2 and ApoE3 Levels, and Not Associated with Plasma Abeta 40/42 Ratio as a Biomarker of Amyloid-beta Amyloidosis in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Mar 23. doi: 10.3233/JAD-220996.
    PubMed     Abstract available


  1296. HOOK G, Kindy M, Hook V
    Cathepsin B Deficiency Improves Memory Deficits and Reduces Amyloid-beta in hAbetaPP Mouse Models Representing the Major Sporadic Alzheimer's Disease Condition.
    J Alzheimers Dis. 2023 Mar 21. doi: 10.3233/JAD-221005.
    PubMed     Abstract available


  1297. FILLENBAUM GG, Mohs R
    CERAD (Consortium to Establish a Registry for Alzheimer's Disease) Neuropsychology Assessment Battery: 35 Years and Counting.
    J Alzheimers Dis. 2023 Mar 13. doi: 10.3233/JAD-230026.
    PubMed     Abstract available


  1298. BAYAT S, Roe CM, Schindler S, Murphy SA, et al
    Everyday Driving and Plasma Biomarkers in Alzheimer's Disease: Leveraging Artificial Intelligence to Expand Our Diagnostic Toolkit.
    J Alzheimers Dis. 2023 Mar 13. doi: 10.3233/JAD-221268.
    PubMed     Abstract available


  1299. DOLCET-NEGRE MM, Imaz Aguayo L, de Eulate RG, Marti-Andres G, et al
    Predicting Conversion from Subjective Cognitive Decline to Mild Cognitive Impairment and Alzheimer's Disease Dementia Using Ensemble Machine Learning.
    J Alzheimers Dis. 2023 Mar 13. doi: 10.3233/JAD-221002.
    PubMed     Abstract available


  1300. MOON SW, Byun MS, Yi D, Kim MJ, et al
    Low Ankle-Brachial Index Relates to Alzheimer-Signature Cerebral Glucose Metabolism in Cognitively Impaired Older Adults.
    J Alzheimers Dis. 2023 Mar 13. doi: 10.3233/JAD-220911.
    PubMed     Abstract available


  1301. MAN S, Chen B, Zhang Y, Xu H, et al
    The Associations Between Cataracts and Alzheimer's Disease: A Bidirectional Two-Sample Mendelian Randomization Study.
    J Alzheimers Dis. 2023 Mar 10. doi: 10.3233/JAD-221137.
    PubMed     Abstract available


  1302. GOLAS AC, Salwierz P, Rajji TK, Bowie CR, et al
    Assessing the Role of Past Depression in Patients with Mild Cognitive Impairment, with and without Biomarkers for Alzheimer's Disease.
    J Alzheimers Dis. 2023 Mar 10. doi: 10.3233/JAD-221097.
    PubMed     Abstract available


  1303. HE Y, Li J, Yi L, Li X, et al
    Octadecaneuropeptide Ameliorates Cognitive Impairments Through Inhibiting Oxidative Stress in Alzheimer's Disease Models.
    J Alzheimers Dis. 2023 Mar 6. doi: 10.3233/JAD-221115.
    PubMed     Abstract available


  1304. HOLLENBENDERS Y, Pobiruchin M, Reichenbach A
    Two Routes to Alzheimer's Disease Based on Differential Structural Changes in Key Brain Regions.
    J Alzheimers Dis. 2023 Mar 6. doi: 10.3233/JAD-221061.
    PubMed     Abstract available


  1305. BONOMI CG, Assogna M, Di Donna MG, Bernocchi F, et al
    Cerebrospinal Fluid sTREM-2, GFAP, and beta-S100 in Symptomatic Sporadic Alzheimer's Disease: Microglial, Astrocytic, and APOE Contributions Along the Alzheimer's Disease Continuum.
    J Alzheimers Dis. 2023 Mar 6. doi: 10.3233/JAD-221010.
    PubMed     Abstract available


  1306. XU S, Xie L, Zhang Y, Wu X, et al
    Inferior Frontal Sulcal Hyperintensity on FLAIR Is Associated with Small Vessel Disease but not Alzheimer's Disease Pathology.
    J Alzheimers Dis. 2023 Mar 6. doi: 10.3233/JAD-220843.
    PubMed     Abstract available


  1307. XU Y, Zheng F, Zhong Q, Zhu Y, et al
    Ketogenic Diet as a Promising Non-Drug Intervention for Alzheimer's Disease: Mechanisms and Clinical Implications.
    J Alzheimers Dis. 2023 Mar 4. doi: 10.3233/JAD-230002.
    PubMed     Abstract available


  1308. GARCIA-ESCOBAR G, Puig-Pijoan A, Puente-Periz V, Fernandez-Lebrero A, et al
    NEURONORMA Cognitive Battery Associations with Cerebrospinal Fluid Amyloid-beta and Tau Levels in the Continuum of Alzheimer's Disease.
    J Alzheimers Dis. 2023 Mar 4. doi: 10.3233/JAD-220930.
    PubMed     Abstract available


  1309. SHAH J, Rahman Siddiquee MM, Krell-Roesch J, Syrjanen JA, et al
    Neuropsychiatric Symptoms and Commonly Used Biomarkers of Alzheimer's Disease: A Literature Review from a Machine Learning Perspective.
    J Alzheimers Dis. 2023 Mar 3. doi: 10.3233/JAD-221261.
    PubMed     Abstract available


  1310. LIU H, Reynolds GP, Wei X
    The Influence of Agricultural Work and Plasma Uric Acid on Hospital Admission for Alzheimer's Disease.
    J Alzheimers Dis. 2023 Mar 2. doi: 10.3233/JAD-221226.
    PubMed     Abstract available


    February 2023
  1311. LOUGHMAN A, Adler C, Macpherson H
    Unlocking Modifiable Risk Factors for Alzheimer's Disease: Does the Oral Microbiome Hold Some of the Keys?
    J Alzheimers Dis. 2023 Feb 27. doi: 10.3233/JAD-220760.
    PubMed     Abstract available


  1312. SOTO-MERCADO V, Mendivil-Perez M, Velez-Pardo C, Jimenez-Del-Rio M, et al
    Neuroprotective Effect of Combined Treatment with Epigallocatechin 3-Gallate and Melatonin on Familial Alzheimer's Disease PSEN1 E280A Cerebral Spheroids Derived from Menstrual Mesenchymal Stromal Cells.
    J Alzheimers Dis. 2023 Feb 24. doi: 10.3233/JAD-220903.
    PubMed     Abstract available


  1313. ATWOOD CS, Perry G
    Russian Roulette with Alzheimer's Disease Patients: Do the Cognitive Benefits of Lecanemab Outweigh the Risk of Edema and Stroke?
    J Alzheimers Dis. 2023 Feb 22. doi: 10.3233/JAD-230040.
    PubMed     Abstract available


  1314. WALKER JM, Gonzales MM, Goette W, Farrell K, et al
    Cognitive and Neuropsychological Profiles in Alzheimer's Disease and Primary Age-Related Tauopathy and the Influence of Comorbid Neuropathologies.
    J Alzheimers Dis. 2023 Feb 21. doi: 10.3233/JAD-230022.
    PubMed     Abstract available


  1315. DEMARSHALL CA, Viviano J, Emrani S, Thayasivam U, et al
    Early Detection of Alzheimer's Disease-Related Pathology Using a Multi-Disease Diagnostic Platform Employing Autoantibodies as Blood-Based Biomarkers.
    J Alzheimers Dis. 2023 Feb 21. doi: 10.3233/JAD-221091.
    PubMed     Abstract available


  1316. ACOSTA-BAENA N, Lopera-Gomez CM, Jaramillo-Elorza MC, Velilla-Jimenez L, et al
    Early Depressive Symptoms Predict Faster Dementia Progression in Autosomal-Dominant Alzheimer's Disease.
    J Alzheimers Dis. 2023 Feb 18. doi: 10.3233/JAD-221294.
    PubMed     Abstract available


  1317. YIN W, Wan K, Zhu W, Zhou X, et al
    Bilateral Hippocampal Volume Mediated the Relationship Between Plasma BACE1 Concentration and Memory Function in the Early Stage of Alzheimer's Disease: A Cross-Sectional Study.
    J Alzheimers Dis. 2023 Feb 18. doi: 10.3233/JAD-221174.
    PubMed     Abstract available


  1318. DING P, Gorenflo MP, Zhu X, Xu R, et al
    Aspirin Use and Risk of Alzheimer's Disease: A 2-Sample Mendelian Randomization Study.
    J Alzheimers Dis. 2023 Feb 18. doi: 10.3233/JAD-220787.
    PubMed     Abstract available


    January 2023
  1319. MASCARENHAS FONSECA L, Sage Chaytor N, Olufadi Y, Buchwald D, et al
    Intraindividual Cognitive Variability and Magnetic Resonance Imaging in Aging American Indians: Data from the Strong Heart Study.
    J Alzheimers Dis. 2023;91:1395-1407.
    PubMed     Abstract available


  1320. SACRIPANTE R, Girtler N, Doglione E, Nobili F, et al
    Forgetting Rates of Prose Memory in Mild Cognitive Impairment.
    J Alzheimers Dis. 2023;91:1385-1394.
    PubMed     Abstract available


  1321. HAYS WEEKS CC, Zlatar ZZ, Meloy MJ, Shin DD, et al
    APOE Genotype Modifies the Association of Fusiform Gyrus Cerebral Metabolic Rate of Oxygen Consumption and Object Naming Performance.
    J Alzheimers Dis. 2023;91:1371-1383.
    PubMed     Abstract available


  1322. JANSE A, van de Rest O, de Groot LCPGM, Witkamp RF, et al
    The Association of Vitamin D Status with Mild Cognitive Impairment and Dementia Subtypes: A Cross-Sectional Analysis in Dutch Geriatric Outpatients.
    J Alzheimers Dis. 2023;91:1359-1369.
    PubMed     Abstract available


  1323. MARIN-MARIN L, Miro-Padilla A, Costumero V
    Structural But Not Functional Connectivity Differences within Default Mode Network Indicate Conversion to Dementia.
    J Alzheimers Dis. 2023;91:1483-1494.
    PubMed     Abstract available


  1324. LIU C, Lee SH, Loewenstein DA, Galvin JE, et al
    Early Amnestic Mild Cognitive Impairment Is Associated with Reduced Total Cerebral Blood Flow with no Brain Tissue Loss.
    J Alzheimers Dis. 2023;91:1313-1322.
    PubMed     Abstract available


  1325. HUQUE H, Eramudugolla R, Chidiac B, Ee N, et al
    Could Country-Level Factors Explain Sex Differences in Dementia Incidence and Prevalence? A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2023;91:1231-1241.
    PubMed     Abstract available


  1326. BOUGES S, Fischer BL, Norton DL, Wyman MF, et al
    Effect of Metabolic Syndrome Risk Factors on Processing Speed and Executive Function in Three Racialized Groups.
    J Alzheimers Dis. 2023;92:285-294.
    PubMed     Abstract available


  1327. YOSHIDA M, Uemura T, Mizoi M, Waragai M, et al
    Urinary Amino Acid-Conjugated Acrolein and Taurine as New Biomarkers for Detection of Dementia.
    J Alzheimers Dis. 2023;92:361-369.
    PubMed     Abstract available


  1328. BAEZ S, Trujillo-Llano C, de Souza LC, Lillo P, et al
    Moral Emotions and Their Brain Structural Correlates Across Neurodegenerative Disorders.
    J Alzheimers Dis. 2023;92:153-169.
    PubMed     Abstract available


  1329. HUANG Z
    A Function of Amyloid-beta in Mediating Activity-Dependent Axon/Synapse Competition May Unify Its Roles in Brain Physiology and Pathology.
    J Alzheimers Dis. 2023;92:29-57.
    PubMed     Abstract available


  1330. GRASSET L, Power MC, Crivello F, Tzourio C, et al
    How Traumatic Brain Injury History Relates to Brain Health MRI Markers and Dementia Risk: Findings from the 3C Dijon Cohort.
    J Alzheimers Dis. 2023;92:183-193.
    PubMed     Abstract available


  1331. CORRERO II AN, Gauthreaux K, Perales-Puchalt J, Chen YC, et al
    Cognitive Aging with Dementia, Mild Cognitive Impairment, or No Impairment: A Comparison of Same- and Mixed-Sex Couples.
    J Alzheimers Dis. 2023;92:109-128.
    PubMed     Abstract available


  1332. MOEBIUS HJ, Church KJ
    The Case for a Novel Therapeutic Approach to Dementia: Small Molecule Hepatocyte Growth Factor (HGF/MET) Positive Modulators.
    J Alzheimers Dis. 2023;92:1-12.
    PubMed     Abstract available


  1333. YANG M, Qi R, Liu Y, Shen X, et al
    Casein Kinase 1delta Phosphorylates TDP-43 and Suppresses Its Function in Tau mRNA Processing.
    J Alzheimers Dis. 2023;91:1527-1539.
    PubMed     Abstract available


  1334. ONO R, Sakurai T, Sugimoto T, Uchida K, et al
    Mortality Risks and Causes of Death by Dementia Types in a Japanese Cohort with Dementia: NCGG-STORIES.
    J Alzheimers Dis. 2023;92:487-498.
    PubMed     Abstract available


  1335. GABRIELLI AP, Weidling I, Ranjan A, Wang X, et al
    Mitochondria Profoundly Influence Apolipoprotein E Biology.
    J Alzheimers Dis. 2023;92:591-604.
    PubMed     Abstract available


  1336. TAN YJ, Siow I, Saffari SE, Ting SKS, et al
    Plasma Soluble ST2 Levels Are Higher in Neurodegenerative Disorders and Associated with Poorer Cognition.
    J Alzheimers Dis. 2023;92:573-580.
    PubMed     Abstract available


  1337. ROYALL DR, Palmer RF
    Multiple Adipokines Predict Dementia Severity as Measured by delta: Replication Across Biofluids and Cohorts.
    J Alzheimers Dis. 2023;92:639-652.
    PubMed     Abstract available


  1338. MANN FD, Clouston SAP, Cuevas A, Waszczuk MA, et al
    Genetic Liability, Exposure Severity, and Post-Traumatic Stress Disorder Predict Cognitive Impairment in World Trade Center Responders.
    J Alzheimers Dis. 2023;92:701-712.
    PubMed     Abstract available


  1339. TANG M, Su N, Zhang D, Dai Y, et al
    The Differential Effects of APOEvarepsilon4 on Cerebral Volumetric Structures in Different Lifespan in Community-Dwelling Populations.
    J Alzheimers Dis. 2023;92:691-700.
    PubMed     Abstract available


  1340. GYLLENHAMMAR M, Rennie A, Padilla DF, Wallert J, et al
    The Association Between Temporal Atrophy and Episodic Memory Is Moderated by Education in a Multi-Center Memory Clinic Sample.
    J Alzheimers Dis. 2023;92:605-614.
    PubMed     Abstract available


  1341. JOHNSON CN, McCoin CS, Kueck PJ, Hawley AG, et al
    Relationship of Muscle Apolipoprotein E Expression with Markers of Cellular Stress, Metabolism, and Blood Biomarkers in Cognitively Healthy and Impaired Older Adults.
    J Alzheimers Dis. 2023;92:1027-1035.
    PubMed     Abstract available


  1342. TARAWNEH HY, Jayakody DMP, Verma S, Dore V, et al
    Auditory Event-Related Potentials in Older Adults with Subjective Memory Complaints.
    J Alzheimers Dis. 2023;92:1093-1109.
    PubMed     Abstract available


  1343. KANIA B, Sotelo A, Ty D, Wisco JJ, et al
    The Prevention of Inflammation and the Maintenance of Iron and Hepcidin Homeostasis in the Gut, Liver, and Brain Pathologies.
    J Alzheimers Dis. 2023;92:769-789.
    PubMed     Abstract available


  1344. LI QY, Li XM, Hu HY, Ma YH, et al
    Associations of Lung Function Decline with Risks of Cognitive Impairment and Dementia: A Meta-Analysis and Systematic Review.
    J Alzheimers Dis. 2023;92:853-873.
    PubMed     Abstract available


  1345. WELBERRY HJ, Chau T, Heffernan M, San Jose JC, et al
    Factors Associated with Participation in a Multidomain Web-Based Dementia Prevention Trial: Evidence from Maintain Your Brain (MYB).
    J Alzheimers Dis. 2023;92:959-974.
    PubMed     Abstract available


  1346. KIM BS, Jun S, Kim H
    Cognitive Trajectories and Associated Biomarkers in Patients with Mild Cognitive Impairment.
    J Alzheimers Dis. 2023;92:803-814.
    PubMed     Abstract available


  1347. ZHANG F, Niu L, Zhong R, Li S, et al
    Chronic Sleep Disturbances Alters Sleep Structure and Tau Phosphorylation in AbetaPP/PS1 AD Mice and Their Wild-Type Littermates.
    J Alzheimers Dis. 2023;92:1341-1355.
    PubMed     Abstract available


  1348. BUKHBINDER AS, Hinojosa M, Harris K, Li X, et al
    Population-Based Mini-Mental State Examination Norms in Adults of Mexican Heritage in the Cameron County Hispanic Cohort.
    J Alzheimers Dis. 2023;92:1323-1339.
    PubMed     Abstract available


  1349. KAWAKATSU S, Kobayashi R
    Towards Improved Clinical Diagnosis of Argyrophilic Grain Disease Using Brain Imaging.
    J Alzheimers Dis. 2023;93:389-392.
    PubMed     Abstract available


  1350. PARKA A, Volbracht C, Hall B, Bastlund JF, et al
    Visual Evoked Potentials as an Early-Stage Biomarker in the rTg4510 Tauopathy Mouse Model.
    J Alzheimers Dis. 2023;93:247-262.
    PubMed     Abstract available


  1351. GAO Y, Liu Y, Zhang Y, Wang Y, et al
    Olfactory Threshold Test as a Quick Screening Tool for Cognitive Impairment: Analysis of Two Independent Cohorts.
    J Alzheimers Dis. 2023;93:169-178.
    PubMed     Abstract available


  1352. TETLOW AM, Jackman BM, Alhadidy MM, Perumal V, et al
    Influence of Host Age on Intracranial AAV9 TauP301L Induced Tauopathy.
    J Alzheimers Dis. 2023;93:365-378.
    PubMed     Abstract available


  1353. RODRIGUES MARTINS D, Vandermeeren M, Van Kolen K, Brepoels E, et al
    Development and Characterization of Mouse-Specific Anti-Tau Monoclonal Antibodies: Relevance for Analysis of Murine Tau in Cerebrospinal Fluid.
    J Alzheimers Dis. 2023;93:151-167.
    PubMed     Abstract available


  1354. LV X, Chu M, Liu Y, Jing D, et al
    Neurofunctional Correlates of Activities of Daily Living in Patients with Posterior Cortical Atrophy.
    J Alzheimers Dis. 2023;93:295-305.
    PubMed     Abstract available


  1355. JANG S, Chorna N, Rodriguez-Graciani KM, Inyushin M, et al
    The Effects of Amyloid-beta on Metabolomic Profiles of Cardiomyocytes and Coronary Endothelial Cells.
    J Alzheimers Dis. 2023;93:307-319.
    PubMed     Abstract available


  1356. LANOOIJ SD, Eisel ULM, van der Zee EA, Kas MJH, et al
    Variation in Group Composition Alters an Early-Stage Social Phenotype in hAPP-Transgenic J20 Mice.
    J Alzheimers Dis. 2023;93:211-224.
    PubMed     Abstract available


  1357. UMFLEET LG, Bilder RM, Loring DW, Thames A, et al
    The Future of Cognitive Screening in Neurodegenerative Diseases.
    J Alzheimers Dis. 2023;93:47-59.
    PubMed     Abstract available


  1358. KREBS C, Brill E, Minkova L, Federspiel A, et al
    Investigating Compensatory Brain Activity in Older Adults with Subjective Cognitive Decline.
    J Alzheimers Dis. 2023;93:107-124.
    PubMed     Abstract available


  1359. WEIDUNG B, Lovheim H, Littbrand H, Wahlin J, et al
    Temporal Dementia and Cognitive Impairment Trends in the Very Old in the 21st Century.
    J Alzheimers Dis. 2023;93:61-74.
    PubMed     Abstract available


  1360. GRISANTI SG, Massa F, Chincarini A, Pretta S, et al
    Discrepancy Between Patient and Caregiver Estimate of Apathy Predicts Dementia in Patients with Amnestic Mild Cognitive Impairment.
    J Alzheimers Dis. 2023;93:75-86.
    PubMed     Abstract available


  1361. FLETCHER E
    Multifactorial Modeling of Cognitive Trajectories Using an Advanced Regression Technique: Improving Our Understanding of Biomarkers and Modifiable Variables that Support Cognition.
    J Alzheimers Dis. 2023;93:815-819.
    PubMed     Abstract available


  1362. CASTELLANI RJ, Shanes ED, McCord M, Reish NJ, et al
    Neuropathology of Anti-Amyloid-beta Immunotherapy: A Case Report.
    J Alzheimers Dis. 2023;93:803-813.
    PubMed     Abstract available


  1363. XIAO Y, Liao L, Huang K, Yao S, et al
    Coupling Between Hippocampal Parenchymal Fraction and Cortical Grey Matter Atrophy at Different Stages of Cognitive Decline.
    J Alzheimers Dis. 2023;93:791-801.
    PubMed     Abstract available


  1364. HICKEY M, Hueg TK, Priskorn L, Uldbjerg CS, et al
    Depression in Mid- and Later-Life and Risk of Dementia in Women: A Prospective Study within the Danish Nurses Cohort.
    J Alzheimers Dis. 2023;93:779-789.
    PubMed     Abstract available


  1365. CHEN CD, Ponisio MR, Lang JA, Flores S, et al
    Comparing Tau PET Visual Interpretation with Tau PET Quantification, Cerebrospinal Fluid Biomarkers, and Longitudinal Clinical Assessment.
    J Alzheimers Dis. 2023;93:765-777.
    PubMed     Abstract available


  1366. HATTORI Y, Saito S, Nakaoku Y, Ogata S, et al
    Taxifolin for Cognitive Preservation in Patients with Mild Cognitive Impairment or Mild Dementia.
    J Alzheimers Dis. 2023;93:743-754.
    PubMed     Abstract available


  1367. ZHANG LY, Wang DZ, Wang J, Guo L, et al
    Associations of Serum Antimicrobial Peptide LL-37 with Longitudinal Cognitive Decline and Neurodegeneration Among Older Adults with Memory Complaints.
    J Alzheimers Dis. 2023;93:595-603.
    PubMed     Abstract available


  1368. AGUILAR-BARBERA M, Soler-Girabau P, Tabuenca-Martin AI, Prieto-Del Val L, et al
    Fortasyn Connect Improves Neuropsychiatric Symptoms in Patients with Mild Cognitive Impairment and Dementia: Results from a Retrospective Real-World Study.
    J Alzheimers Dis. 2023;93:621-631.
    PubMed     Abstract available


  1369. SIBLE IJ, Nation DA
    Visit-to-Visit Blood Pressure Variability and Cognitive Decline in Apolipoprotein varepsilon4 Carriers versus Apolipoprotein varepsilon3 Homozygotes.
    J Alzheimers Dis. 2023;93:533-543.
    PubMed     Abstract available


  1370. BISWAS R, Kawas C, Montine TJ, Bukhari SA, et al
    Superior Global Cognition in Oldest-Old Is Associated with Resistance to Neurodegenerative Pathologies: Results from The 90+ Study.
    J Alzheimers Dis. 2023;93:561-575.
    PubMed     Abstract available


  1371. BROOK ES, D'Alonzo ZJ, Lam V, Chan DC, et al
    Plasma Amyloid-beta Homeostasis Is Associated with Body Mass Index and Weight Loss in People with Overweight and Obesity.
    J Alzheimers Dis. 2023;93:653-664.
    PubMed     Abstract available


  1372. RHYU JM, Park J, Shin BS, Kim YE, et al
    A Novel c.800G>C Variant of the ITM2B Gene in Familial Korean Dementia.
    J Alzheimers Dis. 2023;93:403-409.
    PubMed     Abstract available


  1373. DUFF K, Wan L, Embree L, Hoffman JM, et al
    Change in the Quick Dementia Rating System Across Time in Older Adults with and without Cognitive Impairment.
    J Alzheimers Dis. 2023;93:449-457.
    PubMed     Abstract available


  1374. ZHANG J, Zhang T, Wang Y, Yao L, et al
    Galpha13-Mediated Signaling Cascade Is Related to the Tau Pathology Caused by Anesthesia and Surgery in 5XFAD Transgenic Mice.
    J Alzheimers Dis. 2023;93:545-560.
    PubMed     Abstract available


  1375. IMAI A, Matsuoka T, Narumoto J
    Emotional Dysregulation in Mild Behavioral Impairment Is Associated with Reduced Cortical Thickness in the Right Supramarginal Gyrus.
    J Alzheimers Dis. 2023;93:521-532.
    PubMed     Abstract available


  1376. ZHENG YB, Sun J, Shi L, Su SZ, et al
    Association of Caffeine Consumption and Brain Amyloid Positivity in Cognitively Normal Older Adults.
    J Alzheimers Dis. 2023;93:483-493.
    PubMed     Abstract available


  1377. NOBLE JM, Papapanou PN
    With Teeth, Broken, or Fixed: The Challenges of Linking Periodontitis, Neuroepidemiology, and Biomarkers of Disease.
    J Alzheimers Dis. 2023;93:991-994.
    PubMed     Abstract available


  1378. GOLLOP C, Zingel R, Jacob L, Smith L, et al
    Incidence of Newly-Diagnosed Dementia After COVID-19 Infection versus Acute Upper Respiratory Infection: A Retrospective Cohort Study.
    J Alzheimers Dis. 2023;93:1033-1040.
    PubMed     Abstract available


  1379. FAN J, Zhu Z, Chen Y, Yang C, et al
    SORL1 rs1699102 Moderates the Effect of Sex on Language Network.
    J Alzheimers Dis. 2023;93:1051-1063.
    PubMed     Abstract available


  1380. WU J, Su Y, Chen Y, Zhu W, et al
    A Surface-Based Federated Chow Test Model for Integrating APOE Status, Tau Deposition Measure, and Hippocampal Surface Morphometry.
    J Alzheimers Dis. 2023;93:1153-1168.
    PubMed     Abstract available


  1381. JIANG C, Wang Y, Dong Y, Liu R, et al
    Associations of Microvascular Dysfunction with Mild Cognitive Impairment and Cognitive Function Among Rural-Dwelling Older Adults in China.
    J Alzheimers Dis. 2023;93:1111-1124.
    PubMed     Abstract available


  1382. MARSHALL AJ, Gaubert A, Kapoor A, Tan A, et al
    Blood-Derived Progenitor Cells Are Depleted in Older Adults with Cognitive Impairment: A Role for Vascular Resilience?
    J Alzheimers Dis. 2023;93:1041-1050.
    PubMed     Abstract available


  1383. NIJSKENS C, Henstra M, Rhodius-Meester H, Yasar S, et al
    Cardiovascular Risk Management in Persons with Dementia.
    J Alzheimers Dis. 2023;93:879-889.
    PubMed     Abstract available


  1384. GIBBONS LE, Power MC, Walker RL, Kumar RG, et al
    Association of Traumatic Brain Injury with Late Life Neuropathological Outcomes in a Community-Based Cohort.
    J Alzheimers Dis. 2023;93:949-961.
    PubMed     Abstract available


  1385. SMITH CJ, Ashford JW
    Apolipoprotein varepsilon4-Associated Protection Against Pediatric Enteric Infections Is a Survival Advantage in Pre-Industrial Populations.
    J Alzheimers Dis. 2023;93:907-918.
    PubMed     Abstract available


  1386. BAUERNSCHMIDT D, Hirt J, Langer G, Meyer G, et al
    Technology-Based Counselling for People with Dementia and Their Informal Carers: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2023;93:891-906.
    PubMed     Abstract available


  1387. PILONIETA G, Pisu M, Martin RC, Shan L, et al
    Specialist Availability and Drug Adherence in Older Adults with Dementia Across Regions of the United States.
    J Alzheimers Dis. 2023;93:927-937.
    PubMed     Abstract available


  1388. XIANG Q, Andersen SL, Sweigart B, Gunn S, et al
    Signatures of Neuropsychological Test Results in the Long Life Family Study: A Cluster Analysis.
    J Alzheimers Dis. 2023;93:1457-1469.
    PubMed     Abstract available


  1389. BEST MN, Lim Y, Ferenc NN, Kim N, et al
    Extracellular Tau Oligomers Damage the Axon Initial Segment.
    J Alzheimers Dis. 2023;93:1425-1441.
    PubMed     Abstract available


  1390. XU S, Ren Y, Liu R, Li Y, et al
    Prevalence and Progression of Subjective Cognitive Decline Among Rural Chinese Older Adults: A Population-Based Study.
    J Alzheimers Dis. 2023;93:1355-1368.
    PubMed     Abstract available


  1391. YANG F, Yang L, Fang X, Deng Y, et al
    Increased Cerebrospinal Fluid Levels of Soluble Triggering Receptor Expressed on Myeloid Cells 2 and Chitinase-3-Like Protein 1 in Idiopathic Normal-Pressure Hydrocephalus.
    J Alzheimers Dis. 2023;93:1341-1354.
    PubMed     Abstract available


  1392. NALLAPU BT, Petersen KK, Lipton RB, Grober E, et al
    Association of Alcohol Consumption with Cognition in Older Population: The A4 Study.
    J Alzheimers Dis. 2023;93:1381-1393.
    PubMed     Abstract available


  1393. ANDERSSON MJ, Stone J
    Best Medicine for Dementia: The Life-Long Defense of the Brain.
    J Alzheimers Dis. 2023;94:51-66.
    PubMed     Abstract available


  1394. DI J, Nelson RS, Jicha GA, Moga DC, et al
    Urinary Incontinence in a Community-Based Autopsy Cohort Is Associated with Limbic Predominant Age-Related TDP-43 Encephalopathy Neuropathologic Changes.
    J Alzheimers Dis. 2023;94:333-346.
    PubMed     Abstract available


  1395. MEDURI G, Guillemeau K, Daguinot C, Dounane O, et al
    Concomitant Neuronal Tau Deposition and FKBP52 Decrease Is an Early Feature of Different Human and Experimental Tauopathies.
    J Alzheimers Dis. 2023;94:313-331.
    PubMed     Abstract available


  1396. SINHA N, Fausto BA, Mander B, Gluck MA, et al
    High-Quality Sleep Mitigates ABCA7-Related Generalization Deficits in Healthy Older African Americans.
    J Alzheimers Dis. 2023;94:281-290.
    PubMed     Abstract available


  1397. BUAWANGPONG N, Pinyopornpanish K, Phinyo P, Jiraporncharoen W, et al
    Effect of Comorbidities on Ten-Year Survival in Patients with Dementia.
    J Alzheimers Dis. 2023;94:163-175.
    PubMed     Abstract available


  1398. DE ANDA-DURAN I, Kolachalama VB, Carmichael OT, Hwang PH, et al
    Midlife Neuropsychological Profiles and Associated Vascular Risk: The Bogalusa Heart Study.
    J Alzheimers Dis. 2023;94:101-113.
    PubMed     Abstract available


  1399. LOUGHREY DG, Leroi I
    Understanding the Association Between Sensory Impairment and Dementia: Toward Informing Future Research and Health Policy.
    J Alzheimers Dis. 2023;94:597-599.
    PubMed     Abstract available


  1400. OLIVEIRA FF
    Looking Behind the Curtain: Patient Stratification According to Genetic or Demographic Factors May Yield Unexpected Results in Studies of Neurodegenerative Diseases.
    J Alzheimers Dis. 2023;94:777-780.
    PubMed     Abstract available


  1401. CURTIS ME, Smith T, Nenov M, Blass BE, et al
    Retromer Stabilization Improves Cognitive Function and Synaptic Plasticity in a Mouse Model of Down Syndrome.
    J Alzheimers Dis. 2023;94:513-518.
    PubMed     Abstract available


  1402. LI B, Shi K, Ren C, Kong M, et al
    Detection of Tau-PET Positivity in Clinically Diagnosed Mild Cognitive Impairment with Multidimensional Features.
    J Alzheimers Dis. 2023;94:627-640.
    PubMed     Abstract available


  1403. TOCCACELI BLASI M, Valletta M, Trebbastoni A, D'Antonio F, et al
    Sundowning in Patients with Dementia: Identification, Prevalence, and Clinical Correlates.
    J Alzheimers Dis. 2023;94:601-610.
    PubMed     Abstract available


  1404. WANG J, Wang M, Ren S, Huang L, et al
    The Effect of Gender and APOE varepsilon4 Status on Brain Amyloid-beta Deposition in Different Age Groups of Mild Cognitively Impaired Individuals: A PET-CT Study.
    J Alzheimers Dis. 2023;94:763-775.
    PubMed     Abstract available


  1405. FARINA FR, Booi L, Occhipinti JA, Quoidbach V, et al
    Young Adult Brain Capital: A New Opportunity for Dementia Prevention.
    J Alzheimers Dis. 2023;94:415-423.
    PubMed     Abstract available


  1406. MAURER A, Himmel G, Lange C, Mathies F, et al
    Individualized Summary Assessment of Detailed Neuropsychological Testing for the Etiological Diagnosis of Newly Detected Cognitive Impairment in Hospitalized Geriatric Patients.
    J Alzheimers Dis. 2023;94:559-584.
    PubMed     Abstract available


  1407. EDWARDS L, Thomas KR, Weigand AJ, Edmonds EC, et al
    White Matter Hyperintensity Volume and Amyloid-PET Synergistically Impact Memory Independent of Tau-PET in Older Adults Without Dementia.
    J Alzheimers Dis. 2023;94:695-707.
    PubMed     Abstract available


  1408. CHOU OHI, Zhou J, Li L, Chan JSK, et al
    The Association Between Neutrophil-Lymphocyte Ratio and Variability with New-Onset Dementia: A Population-Based Cohort Study.
    J Alzheimers Dis. 2023;94:547-557.
    PubMed     Abstract available


  1409. LI T, Pappas C, Klinedinst B, Pollpeter A, et al
    Associations Between Insulin-Like Growth Factor-1 and Resting-State Functional Connectivity in Cognitively Unimpaired Midlife Adults.
    J Alzheimers Dis. 2023;94.
    PubMed     Abstract available


  1410. KOSTEV K
    Sex-Related Differences in the Association Between Body Mass Index and Dementia Risk.
    J Alzheimers Dis. 2023;94:961-962.
    PubMed     Abstract available


  1411. CASTELBLANCO-TORO SM, Jurado-Delgado J, Meneses-Bernal JF, Santacruz-Escudero JM, et al
    Fear of Falling as a Behavioral Symptom in Neurocognitive Impaired Patients: Evidence from an Underrepresented Population.
    J Alzheimers Dis. 2023;94:1197-1207.
    PubMed     Abstract available


  1412. CUBERO-PLAZAS L, Sancho-Cantus D, de la Rubia Orti JE, Prieto-Contreras L, et al
    Impact of Family Function on the Quality of Life and Health Perception of Non-Institutionalized Dementia Patients.
    J Alzheimers Dis. 2023;94:963-975.
    PubMed     Abstract available


  1413. PANZA F, Solfrizzi V, Sardone R, Dibello V, et al
    Depressive and Biopsychosocial Frailty Phenotypes: Impact on Late-life Cognitive Disorders.
    J Alzheimers Dis. 2023;94:879-898.
    PubMed     Abstract available


  1414. BAYRAM E, Holden SK, Fullard M, Armstrong MJ, et al
    Race and Ethnicity in Lewy Body Dementia: A Narrative Review.
    J Alzheimers Dis. 2023;94:861-878.
    PubMed     Abstract available


  1415. WANG G, Li DY, Vance DE, Li W, et al
    Alcohol Use Disorder as a Risk Factor for Cognitive Impairment.
    J Alzheimers Dis. 2023;94:899-907.
    PubMed     Abstract available


  1416. CAILLAUD M, Maltezos S, Hudon C, Mellah S, et al
    Hippocampal Volume and Episodic Associative Memory Identify Memory Risk in Subjective Cognitive Decline Individuals in the CIMA-Q Cohort, Regardless of Cognitive Reserve Level and APOE4 Status.
    J Alzheimers Dis. 2023;94:1047-1056.
    PubMed     Abstract available


  1417. CHWA WJ, Lopez OL, Longstreth WT, Dai W, et al
    Longitudinal Patterns of Brain Changes in a Community Sample in Relation to Aging and Cognitive Status.
    J Alzheimers Dis. 2023;94:1035-1045.
    PubMed     Abstract available


  1418. SANDISON H, Callan NGL, Rao RV, Phipps J, et al
    Observed Improvement in Cognition During a Personalized Lifestyle Intervention in People with Cognitive Decline.
    J Alzheimers Dis. 2023;94:993-1004.
    PubMed     Abstract available


  1419. LI D, Yang H, Lyu M, Wang J, et al
    Acupuncture Therapy on Dementia: Explained with an Integrated Analysis on Therapeutic Targets and Associated Mechanisms.
    J Alzheimers Dis. 2023;94.
    PubMed     Abstract available


  1420. GOTTSCHALK WK, Mahon S, Hodgson D, Barrera J, et al
    The APOE-TOMM40 Humanized Mouse Model: Characterization of Age, Sex, and PolyT Variant Effects on Gene Expression.
    J Alzheimers Dis. 2023;94:1563-1576.
    PubMed     Abstract available


  1421. SUSAC J, Vukojevic J, Debogovic S, Bajic Z, et al
    Share of and Absolute Costs of Informal Care in Five Subpopulations of Outpatients with Dementia in Croatia: A Latent Profile Analysis.
    J Alzheimers Dis. 2023;94:1417-1430.
    PubMed     Abstract available


  1422. BAYER TA, Jiang L, Erqou S, Kunicki ZJ, et al
    Incidence of New Dementia Diagnosis in Veterans Admitted to Nursing Homes After Heart Failure Hospitalization.
    J Alzheimers Dis. 2023;94:1397-1404.
    PubMed     Abstract available


  1423. LANSDELL TA, Xu H, Galligan JJ, Dorrance AM, et al
    Effects of Striatal Amyloidosis on the Dopaminergic System and Behavior: A Comparative Study in Male and Female 5XFAD Mice.
    J Alzheimers Dis. 2023;94:1361-1375.
    PubMed     Abstract available


  1424. YABUUCHI K, Kimura N, Masuda T, Matsubara E, et al
    Comparison of Brain Amyloid Deposition and Cortical Glucose Metabolism Between Clinic- and Community-Based Cohort.
    J Alzheimers Dis. 2023;95:299-306.
    PubMed     Abstract available


  1425. HUANG L, Li Y, Wu J, Chen N, et al
    Shanghai Cognitive Screening: A Mobile Cognitive Assessment Tool Using Voice Recognition to Detect Mild Cognitive Impairment and Dementia in the Community.
    J Alzheimers Dis. 2023;95:227-236.
    PubMed     Abstract available


  1426. CASTILLO C, Bravo-Arrepol G, Wendt A, Saez-Orellana F, et al
    Neuroprotective Properties of Eudesmin on a Cellular Model of Amyloid-beta Peptide Toxicity.
    J Alzheimers Dis. 2023;94.
    PubMed     Abstract available


  1427. NORRIS CM
    Is It Time to Repurpose Calcineurin Inhibitors for the Treatment of Cognitive Impairment and Dementia?
    J Alzheimers Dis. 2023;95:599-602.
    PubMed     Abstract available


  1428. PANIKKAR D, Vivek S, Crimmins E, Faul J, et al
    Pre-Analytical Variables Influencing Stability of Blood-Based Biomarkers of Neuropathology.
    J Alzheimers Dis. 2023;95:735-748.
    PubMed     Abstract available


  1429. PASSMORE SR, Longhurst C, Gerbitz A, Green-Harris G, et al
    "I Want to Know Everything ... ": The Return of Research Results and the Importance of Transparency in the Acceptability of Lumbar Punctures for African American Older Adults.
    J Alzheimers Dis. 2023;95:663-675.
    PubMed     Abstract available


  1430. ROSALES-LAGARDE A, Cubero-Rego L, Menendez-Conde F, Rodriguez-Torres EE, et al
    Dissociation of Arousal Index Between REM and NREM Sleep in Elderly Adults with Cognitive Impairment, No Dementia: A Pilot Study.
    J Alzheimers Dis. 2023;95:477-491.
    PubMed     Abstract available


  1431. VOLGMAN AS, Engelstein E, Aggarwal NT
    Vascular Cognitive Impairment: A Little Bit of Good News for Women or Bad News for Men?
    J Alzheimers Dis. 2023;95:407-409.
    PubMed     Abstract available


  1432. MIYAWAKI CE, McClellan A, Bouldin ED, Brohard C, et al
    Feasibility and Efficacy of Life Review Delivered by Virtually-Trained Family Caregivers.
    J Alzheimers Dis. 2023;95:573-583.
    PubMed     Abstract available


  1433. MACYCZKO JR, Wang N, Lu W, Jeevaratnam S, et al
    Upregulation of sFRP1 Is More Profound in Female than Male 5xFAD Mice and Positively Associated with Amyloid Pathology.
    J Alzheimers Dis. 2023;95:399-405.
    PubMed     Abstract available


  1434. BOGDAN A, Fabre R, Desmidt T, Golebiowski J, et al
    Different Trajectories of Apathy and Depression Among Subjective Cognitive Impairment Individuals with or without Conversion to Dementia: Results from the Memento Cohort in France.
    J Alzheimers Dis. 2023;95:415-426.
    PubMed     Abstract available


  1435. GUEVARA JE, Kurniadi NE, Duff K
    Assessing Longitudinal Cognitive Change in Mild Cognitive Impairment Using Estimated Standardized Regression-Based Formulas.
    J Alzheimers Dis. 2023;95:509-521.
    PubMed     Abstract available


  1436. NG PY, Zhang C, Li H, Baker DJ, et al
    Senescent Microglia Represent a Subset of Disease-Associated Microglia in P301S Mice.
    J Alzheimers Dis. 2023;95:493-507.
    PubMed     Abstract available


  1437. LOPES DAS NEVES P, Duraes J, Silva-Spinola A, Lima M, et al
    Serum Neurofilament Light Chain in the Diagnostic Evaluation of Patients with Cognitive Symptoms in the Neurological Consultation of a Tertiary Center.
    J Alzheimers Dis. 2023;95:391-397.
    PubMed     Abstract available


  1438. DALY T
    JAD: A Forum for Philosophy in Science.
    J Alzheimers Dis. 2023;95:411-413.
    PubMed     Abstract available


  1439. HUA S, Peters BA, Lee S, Fitzgerald K, et al
    Gut Microbiota and Cognitive Function Among Women Living with HIV.
    J Alzheimers Dis. 2023;95:1147-1161.
    PubMed     Abstract available


  1440. COSTA T, Premi E, Liloia D, Cauda F, et al
    Unleashing the Power of Bayesian Re-Analysis: Enhancing Insights into Lecanemab (Clarity AD) Phase III Trial Through Informed t-Test.
    J Alzheimers Dis. 2023;95:1059-1065.
    PubMed     Abstract available


  1441. POZZI FE, Appollonio I, Ferrarese C, Tremolizzo L, et al
    Can Traditional Board Games Prevent or Slow Down Cognitive Impairment? A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2023;95:829-845.
    PubMed     Abstract available


  1442. AL-LAHHAM R, Mendez N
    Tau Loss of Function, by Deletion or Aggregation, Contributes to Peripheral Insulin Resistance.
    J Alzheimers Dis. 2023;95:1041-1058.
    PubMed     Abstract available


  1443. VASSILAKI M, Fu S, Christenson LR, Garg M, et al
    Characterizing Performance Gaps of a Code-Based Dementia Algorithm in a Population-Based Cohort of Cognitive Aging.
    J Alzheimers Dis. 2023;95:931-940.
    PubMed     Abstract available


  1444. DI GIOIA C, Santonico M, Zompanti A, Sabatini A, et al
    Detecting Dementia by Saliva Analysis: A Fingerprinting Unobtrusive Method Based on a Fast and Cheap Sensor System.
    J Alzheimers Dis. 2023;95:1067-1075.
    PubMed     Abstract available


  1445. FLEISCHMAN DA, Arfanakis K, Zhang S, Leurgans SE, et al
    Acculturation in Context and Brain Health in Older Latino Adults: A Diffusion Tensor Imaging Study.
    J Alzheimers Dis. 2023;95:1585-1595.
    PubMed     Abstract available


  1446. WANG S, Liu S, Ke S, Zhou W, et al
    APOEvarepsilon4 Status and Plasma p-tau181 Levels May Influence Memory and Executive Function Decline in Older Adults Without Dementia.
    J Alzheimers Dis. 2023;95:1509-1518.
    PubMed     Abstract available


  1447. WATTS A, Haneline S, Welsh-Bohmer KA, Wu J, et al
    TOMM40 '523 Genotype Distinguishes Patterns of Cognitive Improvement for Executive Function in APOEvarepsilon3 Homozygotes.
    J Alzheimers Dis. 2023;95:1697-1707.
    PubMed     Abstract available


  1448. AMOFA-HO PA, Stickel AM, Chen R, Kobayashi LC, et al
    The Mediating Roles of Neurobiomarkers in the Relationship Between Education and Late-Life Cognition.
    J Alzheimers Dis. 2023;95:1405-1416.
    PubMed     Abstract available


  1449. MARCOLINI S, Rojczyk P, Seitz-Holland J, Koerte IK, et al
    Posttraumatic Stress and Traumatic Brain Injury: Cognition, Behavior, and Neuroimaging Markers in Vietnam Veterans.
    J Alzheimers Dis. 2023;95:1427-1448.
    PubMed     Abstract available


  1450. WANG R, Kuang C, Guo C, Chen Y, et al
    Automatic Detection of Putative Mild Cognitive Impairment from Speech Acoustic Features in Mandarin-Speaking Elders.
    J Alzheimers Dis. 2023;95:901-914.
    PubMed     Abstract available


  1451. DAAMEN M, Scheef L, Li S, Grothe MJ, et al
    Cortical Amyloid Burden Relates to Basal Forebrain Volume in Subjective Cognitive Decline.
    J Alzheimers Dis. 2023;95:1013-1028.
    PubMed     Abstract available


  1452. CODY SL, Miller GH, Fazeli PL, Wang G, et al
    Preventing Neurocognitive Decline in Adults Aging with HIV: Implications for Practice and Research.
    J Alzheimers Dis. 2023;95:753-768.
    PubMed     Abstract available


  1453. KEPP KP, Sensi SL, Johnsen KB, Barrio JR, et al
    The Anti-Amyloid Monoclonal Antibody Lecanemab: 16 Cautionary Notes.
    J Alzheimers Dis. 2023;94:497-507.
    PubMed     Abstract available


  1454. SAJI N, Ishihara Y, Murotani K, Uchiyama A, et al
    Cross-Sectional Analysis of Periodontal Disease and Cognitive Impairment Conducted in a Memory Clinic: The Pearl Study.
    J Alzheimers Dis. 2023;96:369-380.
    PubMed     Abstract available


  1455. DATLOW LY, King J, Leventhal M, Wallace TC, et al
    Association of Pork Intake with Cognitive Performance in Older Adults Enrolled in the National Health and Nutrition Examination Survey (NHANES), 2011-2014 Data Cycles.
    J Alzheimers Dis. 2023;96:351-358.
    PubMed     Abstract available


  1456. PACHECO PACHADO M, Casas AI, Elbatreek MH, Nogales C, et al
    Re-Addressing Dementia by Network Medicine and Mechanism-Based Molecular Endotypes.
    J Alzheimers Dis. 2023;96:47-56.
    PubMed     Abstract available


  1457. CHEN S, Huang W, He T, Zhang M, et al
    Exploring the Causality Between Plasma Brain-Derived Neurotrophic Factor and Neurological Diseases: A Mendelian Randomization Study.
    J Alzheimers Dis. 2023;96:135-148.
    PubMed     Abstract available


  1458. UTZ J, Olm P, Jablonowski J, Siegmann EM, et al
    Reconceptualization of the Erlangen Score for the Assessment of Dementia Risk: The ERlangen Score.
    J Alzheimers Dis. 2023;96:265-275.
    PubMed     Abstract available


  1459. HAMMERS DB, Lin JH, Polsinelli AJ, Logan PE, et al
    Criterion Validation of Tau PET Staging Schemes in Relation to Cognitive Outcomes.
    J Alzheimers Dis. 2023;96:197-214.
    PubMed     Abstract available


  1460. DING H, Mandapati A, Hamel AP, Karjadi C, et al
    Multimodal Machine Learning for 10-Year Dementia Risk Prediction: The Framingham Heart Study.
    J Alzheimers Dis. 2023;96:277-286.
    PubMed     Abstract available


  1461. LINDH-RENGIFO M, Jonasson SB, Ullen S, Palmqvist S, et al
    Effects of Brain Pathologies on Spatiotemporal Gait Parameters in Patients with Mild Cognitive Impairment.
    J Alzheimers Dis. 2023;96:161-171.
    PubMed     Abstract available


  1462. CAVUOTO MG, Robinson SR, O'Donoghue FJ, Barnes M, et al
    Associations Between Amyloid Burden, Hypoxemia, Sleep Architecture, and Cognition in Obstructive Sleep Apnea.
    J Alzheimers Dis. 2023;96:149-159.
    PubMed     Abstract available


  1463. SMITH GS, Kuwabara H, Yan H, Nassery N, et al
    Serotonin Degeneration and Amyloid-beta Deposition in Mild Cognitive Impairment: Relationship to Cognitive Deficits.
    J Alzheimers Dis. 2023;96:215-227.
    PubMed     Abstract available



  1464. Erratum to: Medial Temporal Lobe Atrophy in Predementia Alzheimer's Disease: A Longitudinal Multi-Site Study Comparing Staging and A/T/N in a Clinical Research Cohort.
    J Alzheimers Dis. 2023;96:859-860.
    PubMed    


  1465. BAHRANI AA, Abner EL, DeCarli CS, Barber JM, et al
    Multi-Site Cross-Site Inter-Rater and Test-Retest Reliability and Construct Validity of the MarkVCID White Matter Hyperintensity Growth and Regression Protocol.
    J Alzheimers Dis. 2023;96:683-693.
    PubMed     Abstract available


  1466. KARJADI C, Xue C, Cordella C, Kiran S, et al
    Fusion of Low-Level Descriptors of Digital Voice Recordings for Dementia Assessment.
    J Alzheimers Dis. 2023;96:507-514.
    PubMed     Abstract available


  1467. LI J, Weiss J, Rajadhyaksha A, Acosta D, et al
    Dementia Attributable Healthcare Utilizations in the Caribbean versus United States.
    J Alzheimers Dis. 2023;96:801-811.
    PubMed     Abstract available


  1468. MICHOPOULOU S, Prosser A, Dickson J, Guy M, et al
    Perfusion Imaging and Inflammation Biomarkers Provide Complementary Information in Alzheimer's Disease.
    J Alzheimers Dis. 2023;96:1317-1327.
    PubMed     Abstract available


  1469. ZHOU J, Wang ZB, Sun Y, Fu Y, et al
    Cerebrospinal Fluid Complement 4 Levels Were Associated with Alzheimer's Disease Pathology and Cognition in Non-Demented Elderly.
    J Alzheimers Dis. 2023;96:1071-1081.
    PubMed     Abstract available


  1470. CHWA WJ, Raji CA, Toups K, Hathaway A, et al
    Longitudinal White and Gray Matter Response to Precision Medicine-Guided Intervention for Alzheimer's Disease.
    J Alzheimers Dis. 2023;96:1051-1058.
    PubMed     Abstract available


  1471. TU MC, Chung HW, Hsu YH, Yang JJ, et al
    Neurovascular Correlates of Cobalamin, Folate, and Homocysteine in Dementia.
    J Alzheimers Dis. 2023;96:1329-1338.
    PubMed     Abstract available


  1472. BROSENS N, Samouil D, Stolker S, Katsika EV, et al
    Early Life Stress Enhances Cognitive Decline and Alters Synapse Function and Interneuron Numbers in Young Male APP/PS1 Mice.
    J Alzheimers Dis. 2023;96:1097-1113.
    PubMed     Abstract available


  1473. ZHU Y, Olchanski N, Cohen JT, Freund KM, et al
    Life-Sustaining Treatments Among Medicare Beneficiaries with and without Dementia at the End of Life.
    J Alzheimers Dis. 2023;96:1183-1193.
    PubMed     Abstract available


  1474. BERNARDES C, Lima M, Duro D, Silva-Spinola A, et al
    Montreal Cognitive Assessment in Mild Cognitive Impairment: Relationship with Cerebrospinal Fluid Biomarkers and Conversion to Dementia.
    J Alzheimers Dis. 2023;96:1173-1182.
    PubMed     Abstract available


  1475. NAISMITH SL, Michaelian JC, Santos C, Mehrani I, et al
    Tackling Dementia Together via The Australian Dementia Network (ADNeT): A Summary of Initiatives, Progress and Plans.
    J Alzheimers Dis. 2023;96:913-925.
    PubMed     Abstract available


  1476. KOULOUSAKIS P, Willems E, Schepers M, Rombaut B, et al
    Exogenous Oxytocin Administration Restores Memory in Female APP/PS1 Mice.
    J Alzheimers Dis. 2023;96:1207-1219.
    PubMed     Abstract available


  1477. HEALY E
    Impact of the MIND Diet on Cognition in Individuals with Dementia.
    J Alzheimers Dis. 2023;96:967-977.
    PubMed     Abstract available


  1478. ZHAO B, Ou YN, Zhang XY, Fu Y, et al
    Differential Associations of APOEvarepsilon2 and APOEvarepsilon4 Genotypes with Cerebrospinal Fluid Biomarkers of Alzheimer's Disease in Individuals Without Dementia.
    J Alzheimers Dis. 2023;96:1813-1825.
    PubMed     Abstract available


  1479. ROBINSON MJ, Newbury S, Singh K, Leonenko Z, et al
    The Interplay Between Cholesterol and Amyloid-beta on HT22 Cell Viability, Morphology, and Receptor Tyrosine Kinase Signaling.
    J Alzheimers Dis. 2023;96:1663-1683.
    PubMed     Abstract available


  1480. TIAN J, Du E, Jia K, Wang T, et al
    Elevated Ghrelin Promotes Hippocampal Ghrelin Receptor Defects in Humanized Amyloid-beta Knockin Mice During Aging.
    J Alzheimers Dis. 2023;96:1579-1592.
    PubMed     Abstract available


  1481. SLUGGETT JK, Air T, Cations M, Caughey GE, et al
    Clinical Quality Indicators for Monitoring Hospitalizations Among Older People with Dementia Accessing Aged Care Services.
    J Alzheimers Dis. 2023;96:1747-1758.
    PubMed     Abstract available


  1482. GAO Y, Duan X, Li W, Zhang X, et al
    Elevated Homocysteine Levels and Hypertension Relate to Cognitive Impairment via Increased White Matter Hyperintensity Volume.
    J Alzheimers Dis. 2023;96:1739-1746.
    PubMed     Abstract available


  1483. YOON J, Sasaki K, Tateoka K, Arai T, et al
    Evaluation of Cognitive and Physical Function Among Older Adults by Their Physical Activity: A Cross-Sectional Kasama Study, Japan.
    J Alzheimers Dis. 2023;96:1801-1812.
    PubMed     Abstract available


  1484. SOLIS-URRA P, Rodriguez-Ayllon M, Alvarez-Ortega M, Molina-Hidalgo C, et al
    Physical Performance and Amyloid-beta in Humans: A Systematic Review and Meta-Analysis of Observational Studies.
    J Alzheimers Dis. 2023;96:1427-1439.
    PubMed     Abstract available


  1485. GARCIA-ALBERCA JM, de la Rosa MD, Solo de Zaldivar P, Ledesma M, et al
    Effect of Nordic Sensi(R) Chair on Behavioral and Psychological Symptoms of Dementia in Nursing Homes Residents: A Randomized Controlled Trial.
    J Alzheimers Dis. 2023;96:1609-1622.
    PubMed     Abstract available


  1486. SHORT MI, Fohner AE, Skjellegrind HK, Beiser A, et al
    Proteome Network Analysis Identifies Potential Biomarkers for Brain Aging.
    J Alzheimers Dis. 2023;96:1767-1780.
    PubMed     Abstract available


  1487. BRICENO EM, Dhakal U, Sharma U, Adhikari N, et al
    Neuropsychological Assessment of Older Adults in Nepal for Population-Based Dementia Ascertainment: Needs, Challenges, and Opportunities.
    J Alzheimers Dis. 2023;96:1339-1352.
    PubMed     Abstract available


  1488. AXELSSON ANDREN E, Kettunen P, Bjerke M, Rolstad S, et al
    Diagnostic Performance of Cerebrospinal Fluid Neurofilament Light Chain and Soluble Amyloid-beta Protein Precursor beta in the Subcortical Small Vessel Type of Dementia.
    J Alzheimers Dis. 2023;96:1515-1528.
    PubMed     Abstract available


  1489. AGARWAL P, Ford CN, Leurgans SE, Beck T, et al
    Dietary Sugar Intake Associated with a Higher Risk of Dementia in Community-Dwelling Older Adults.
    J Alzheimers Dis. 2023;95:1417-1425.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.